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Abstract
The European Commission asked EFSA for a scientiﬁc opinion on the risks for animal and human
health related to the presence of chlorinated parafﬁns in feed and food. The data for experimental
animals were reviewed and the CONTAM Panel identiﬁed the liver, kidney and thyroid as the target
organs for the SCCP and MCCP mixtures tested in repeated dose toxicity studies. Decreased pup
survival and subcutaneous haematoma/haemorrhage were also identiﬁed as critical effects for an
MCCP mixture. For the LCCP mixtures tested, the liver was identiﬁed as the target organ. The
Panel selected as reference points a BMDL10 of 2.3 mg/kg bw per day for increased incidence of
nephritis in male rats, and of 36 mg/kg bw per day for increased relative kidney weights in male and
female rats for SCCPs and MCCPs, respectively. For LCCPs, a reference point relevant for humans could
not be identiﬁed. Due to the limitations in the toxicokinetic and toxicological database, the
Panel concluded that derivation of a health-based guidance value was not appropriate. Only limited
data on the occurrence of SCCPs and MCCPs in some ﬁsh species were submitted to EFSA. No data
were submitted for LCCPs. Thus, a robust exposure assessment and consequently a complete risk
characterisation could not be performed. A preliminary risk characterisation based only on the
consumption of ﬁsh was performed, and the calculated margins of exposure suggested no health
concern for this limited scenario. The Panel noted that dietary exposure will be higher due to the
contribution of CPs from other foods. The Panel was not able to identify reference points for farm
animals, horses and companion animals. No occurrence data for feed were submitted to EFSA.
Therefore, no risk characterisation could be performed for any of these animal species.
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Summary
The European Commission asked the European Food Safety Authority (EFSA) for a scientiﬁc opinion
on the risks for animal and human health related to the presence of chlorinated parafﬁns (CPs) in feed
and food. The Panel developed the draft scientiﬁc opinion which underwent a public consultation from
6 August 2019 to 17 September 2019. The comments received and how they were taken into account
when ﬁnalising the scientiﬁc opinion were published in an EFSA Technical Report (EFSA, 2020).
CPs are complex technical mixtures of polychlorinated alkanes, with varying chain length and
degree of chlorination. The commercially available CPs are generally divided into three groups: short-
chain CPs (SCCPs) comprising 10 to 13 carbon atoms, medium-chain CPs (MCCPs) comprising 14 to 17
carbon atoms and long-chain CPs (LCCPs) with 18 or more carbon atoms. Some technical mixtures
may contain CPs from more than one of these three groups, and some newer CPs do not conﬁne
themselves to these groups. Technically, the terms ‘SCCP’, ‘MCCP’ and ‘LCCP’ refer to the commercial
mixtures of CPs. In this opinion, the nomenclature of SCCP(s), MCCP(s) and LCCP(s) will be used to
refer to any CP mixture(s) that falls within the range of carbon chain lengths indicated above.
There is a vast number of possible combinations of chain length, position and degree of
chlorination, and the exact composition of technical mixtures can vary in terms of the amounts of
different congeners present. This means that the potential array of compounds that are of relevance is
of many thousands and that the analytical challenge for measuring these compounds is considerable.
Analysis of CPs is highly demanding and current methods have been shown to lack precision and
accuracy. Congener speciﬁc analysis is not currently possible. Several different approaches to analysis
exist, and lead to differences in results obtained. Only a limited number of analytical standards are
available, and these represent only a tiny fraction of the total number of individual CP congeners that
may be found. Care is therefore needed when using occurrence data to perform exposure estimates.
Human risk assessment
Information on the toxicokinetics and toxicity of CPs was identiﬁed for a limited number of
mixtures.
No studies on the toxicokinetics in humans of relevance for the risk assessment of CPs within the
scope of this opinion were identiﬁed. However, detection of CPs in human blood and milk samples
indicates that CPs are absorbed to some extent in humans and detection of CPs in umbilical cord blood
indicates that CPs can be transferred to the fetus.
Data on toxicokinetics for rats and mice were identiﬁed, although in several cases from studies not
designed as dedicated ADME studies.
Absorption to some extent is indicated in various animal species by excretion of a small amount of
radiolabelled CPs and or metabolites in the urine, distribution of radiolabelled CPs and or metabolites
to different organs and tissues, and systemic effects observed in toxicity studies. Accumulation in
adipose tissue and fat rich organs and tissues is reported and elimination from these tissues appeared
to be slower than from other organs and tissues. The available information is insufﬁcient to derive
elimination half-lives. Studies in mice suggested that highly chlorinated SCCPs and MCCPs are
metabolised and excreted via faeces whereas lower chlorinated SCCPs and MCCPs can be partly
metabolised and exhaled as carbon dioxide. Following oral administration of CPs to rats and mice, the
major route of excretion was the faeces with only a small proportion excreted in urine and expired air.
No studies on observations in humans of relevance for the risk assessment of CPs within the scope
of this opinion were identiﬁed.
In experimental animals, CPs are of low acute toxicity with oral LD50 values all exceeding 4 g/kg
body weight (bw).
In repeated dose toxicity studies in rats, mice and dogs, the liver, kidney and thyroid were identiﬁed
as the target organs for the two SCCPs (C10–12, 58% chlorination; C12, 60% chlorination) and the single
MCCP (C14–17, 52% chlorination) tested in the subchronic and chronic toxicity studies. For the LCCPs
tested in the subchronic and chronic toxicity studies, only the liver was identiﬁed as a target organ. Liver
toxicity observed consistently in rats and mice is considered secondary to an adaptive response and the
associated energy costs, but could be relevant to humans at high-dose levels. For an SCCP and an MCCP,
changes in thyroid hormone levels in rats were observed at a lower dose level than histopathological
effects in the thyroid.
For the SCCPs tested, a no-observed adverse effect level (NOAEL) of 10 mg/kg bw per day was
identiﬁed, based on increased kidney weights and histopathological changes in the kidney and thyroid.
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For the MCCP tested, a NOAEL of 10 mg/kg bw per day was identiﬁed, based on increased kidney
weights.
For the LCCPs, a lowest-observed adverse effect level (LOAEL) of 100 mg/kg bw per day was
considered for the two low chlorinated LCCPs (43%) tested and a NOAEL of 900 mg/kg bw per day for
the high chlorinated LCCP (70%) tested, based on liver effects, including increased weight and
histopathological changes.
An SCCP (carbon chain length not speciﬁed, 58% chlorination) caused teratogenic effects such as
absence of digits or shortened digits in rats at a high-dose level (2,000 mg/kg bw per day) in the
presence of maternal toxicity (high mortality and decreased body weight gain; the NOAEL for
developmental toxicity was 500 mg/kg bw per day, and for maternal toxicity 100 mg/kg bw per day. In
the developmental toxicity study in rabbits with the same SCCP, the NOAEL for developmental toxicity
was 10 mg/kg bw per day, based on increased number of resorptions, in the absence of maternal toxicity.
For the only MCCP tested (C14–17, 52% chlorination), no developmental toxicity was observed in
rats and rabbits at the highest dose levels tested, 5,000 mg/kg bw per day for rats and 100 mg/kg bw
per day for rabbits. No parental toxicity or effects on fertility were observed for the same MCCP in a
dose-range ﬁnding study for a two-generation dietary rat study. In this study, postnatal effects in the
form of decreased pup survival and subcutaneous haematoma/haemorrhage were observed; a NOAEL
of 9 mg/kg bw per day was identiﬁed for these effects.
For the two LCCPs tested (C22–26, 43% chlorination; C22–26, 70% chlorination), no developmental
toxicity was observed in rats and rabbits at the highest dose levels tested (1,000 mg/kg bw per day
for rabbits with the 70% chlorinated LCCP and 5,000 mg/kg bw per day in the three other studies with
the 43% or the 70% chlorinated LCCP).
The overall weight of evidence indicates that CPs are not genotoxic.
The SCCP tested (C12, 60% chlorination) caused increased incidences of tumours in rats and mice,
i.e. in the liver (rats, mice), kidneys (male rats only) and thyroid (female rats and mice). The LCCP
tested (C23, 43% chlorination) also caused increased incidences of tumours in mice, i.e. malignant
lymphomas (male mice), and to a marginal extent of hepatocellular neoplasms (female mice). No
carcinogenicity study on MCCPs was identiﬁed.
Regarding the mode of action, rodent hepatic enzyme induction and proliferation of the smooth
endoplasmic reticulum leading to hypertrophy (and associated increases in liver size) is considered as
an adaptive physiological response to CPs. In addition, proliferation of rodent peroxisomes occurs,
mediated by peroxisome proliferator activated receptor a (PPARa). These responses are considered
important for rodent liver carcinogenesis. However, based on the available information, the rodent liver
tumours induced by an SCCP, and associated with constitutive androstane receptor (CAR) or PPARa
transactivation, appear not to be relevant to humans provided cytotoxicity does not occur. These
responses could lead to toxicity if the energy balance to support this compensatory response becomes
sufﬁciently perturbed so as to compromise the cell viability.
SCCP-induced kidney tumours in male rats appear to relate to sustained nephropathy (induced
partly, but not necessarily entirely, by a2u-microglobulin accumulation), compensatory regenerative
hyperplasia and increased S-phase.
Thyroid effects caused by CPs in rodents can arise due to stimulation of the thyroid via a negative
feedback mechanism. This includes a potential increase in hepatic uptake of thyroid hormones,
increased hepatic uridine 5’-diphospho-glucuronosyltransferase (UDPGT) levels and conjugation of T4,
consequent decrease in plasma T4/T3, compensatory release of pituitary thyroid-stimulating hormone
(TSH) and a compensatory increase in T4 production in the thyroid. This eventually leads to
hypertrophy, hyperplasia and thyroid tumours. Additional mechanisms that may contribute to
carcinogenesis by CPs include oxidative stress and inhibition of intercellular communication.
The CONTAM Panel decided not to use changes in thyroid hormone levels as a basis for a reference
point since there were inconsistencies in the hormonal changes between the two available studies on
SCCPs, as well as gender differences in the available study with the MCCP. Overall, there is uncertainty
about the validity of extrapolating changes related to the thyroid from rats to humans when these
changes are mediated by induction of hepatic transporters and hepatic metabolism. However, despite
these uncertainties, the thyroid histopathology is used as a basis for the reference point. Potential
neurodevelopmental effects from thyroid hormone changes could not be assessed because of a lack of
developmental neurotoxicity studies.
In rats, an MCCP perturbed the clotting system in lactating neonates of treated mothers. The
haemorrhaging effects in the lactating neonates appear to result as a consequence of vitamin K
deﬁciency.
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The CONTAM Panel performed benchmark dose (BMD) modelling on data from different rodent
studies. For one tested SCCP (C10–12, 58% chlorination), a BMDL10 of 2.3 mg/kg bw per day for increased
incidence of nephritis in male rats was selected as the reference point for the risk characterisation. For the
tested MCCP (C14–17, 52% chlorination), a BMDL10 of 36 mg/kg bw per day for increased relative kidney
weights in male and female rats was selected as the reference point.
For the tested LCCPs, only liver effects were observed in the available studies. As the effects in the
liver are considered secondary to an adaptive response and the associated energy costs, and only
relevant to humans at high-dose levels, a reference point was not identiﬁed.
Due to the limitations and uncertainties in the current database on SCCPs, MCCPs and LCCPs the
CONTAM Panel did not consider it appropriate to derive health-based guidance values (HBGVs).
Instead, a margin of exposure (MOE) approach was applied to assess a possible health concern. The
Panel concluded that an MOE higher than 1,000 might indicate that there is no health concern, taking
into account the variability between species (a factor of 10), the variability within human individuals (a
factor of 10) and extrapolation from subchronic studies to chronic exposure duration (a factor of 2).
The CONTAM Panel considered an additional factor of 5 to take into account the limitations in the
database, i.e. toxicity data are only available for a few CPs whereas the risk assessment is covering a
large number of CPs, the impact of the degree of chlorination, chlorine position and carbon chain
length on toxicokinetics and toxicity cannot be evaluated, and no two-generation reproductive toxicity
study is available for any CP.
Only limited data on the occurrence of SCCPs and MCCPs, and only for some ﬁsh species, were
submitted to EFSA, while no data were submitted on the occurrence of LCCPs. Due to the
unavailability of sufﬁcient occurrence data on foodstuffs other than ﬁsh, a robust exposure assessment
and consequently a complete risk characterisation could not be performed.
A preliminary exposure assessment of the chronic exposure to SCCPs and MCCPs was made based
only on consumption of ‘Fish meat’ and for ﬁsh consumers only. A data set consisting of 422 analytical
results from 184 samples of ‘Fish meat’ collected in Germany between 2014 and 2017 was used for
this purpose. CPs were quantiﬁed in most of the samples, with 15% and 14% of left-censored data for
SCCPs and MCCPs, respectively. The mean and P95 occurrence levels were 7.5 and 18 lg/kg wet
weight (ww) (lower bound (LB) = upper bound (UB)) for SCCPs, respectively, and 13 and 44 lg/kg ww
(LB=UB) for MCCPs, respectively.
For SCCPs, the mean LB and UB exposure estimates across surveys and age groups ranged from
1.9 to 35 ng/kg bw per day. At the 95th percentile exposure, the LB and UB estimates ranged from
4.9 to 87 ng/kg bw per day. For MCCPs, the mean LB and UB exposure estimates ranged from 3.2 to
59 ng/kg bw per day. At the 95th percentile exposure, the LB and UB estimates ranged from 8.5 to
148 ng/kg bw per day. The lowest exposures were found in the Adult groups whilst the highest were
for Toddlers.
Comparison of the SCCP dietary exposures from ﬁsh consumption only with the BMDL10 of 2.3 mg/
kg bw per day resulted in MOEs of about 7 9 104 and 3 9 104 or higher for the mean and 95th
percentile exposure, respectively.
Comparison of the MCCP dietary exposures from ﬁsh consumption only with the BMDL10 of 36 mg/
kg bw per day resulted in MOEs of about 6 9 105 and 3 9 105 or higher for the mean and 95th
percentile exposure, respectively.
The CONTAM Panel concluded that these MOEs for this limited scenario do not suggest a health
concern, while noting uncertainties because the dietary exposure will be higher due to the contribution
of CPs from other foods, the lack of toxicokinetic data for humans and that only a few CPs have been
tested in the available toxicity studies.
For breastfed infants, an exposure estimate was made based on data from pooled human milk
samples from 11 European countries between 2014 and 2016 and analysed within the WHO/UNEP
Coordinated Survey of Human Milk for POPs. For SCCPs, the exposure ranged from 60 to 445 ng/kg
bw per day for average consumption of human milk, and from 90 to 668 ng/kg bw per day for high
consumption of human milk, respectively. For MCCPs, the exposure ranged from < 25 to 514 ng/kg bw
per day, and from < 38 to 771 ng/kg bw per day, respectively, for average and high consumption of
human milk. The Panel noted that since these were pooled samples, it was not possible to estimate
speciﬁc values for highly exposed individuals.
Comparison of the exposure estimates for SCCPs with the BMDL10 of 2.3 mg/kg bw per day, resulted
in MOEs of about 5 9 103 and 3 9 103 or higher for average and high human milk consumption,
respectively. For MCCPs, comparison of the exposure estimates with the BMDL10 of 36 mg/kg bw per day
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resulted in MOEs of about 7 9 104 and 5 9 104 or higher for average and high human milk consumption,
respectively. The CONTAM Panel concluded that these MOEs do not suggest a health concern.
In addition to dietary exposure, CPs in house dust can be an important additional source of
exposure. For children, crawling and hand-to-mouth habits should be considered as habits possibly
increasing the ingestion of dust. The CONTAM Panel made a scenario to estimate the ingestion from
dust in adults and toddlers considering an average dust ingestion of 20 and 50 mg/day, respectively.
Using the highest median values found in dust from four European countries, the resulting daily
exposures via dust ingestion would be 26, 150 and 11 ng/kg bw per day for toddlers and 1.8, 10 and
0.77 ng/kg bw per day for adults, for SCCPs, MCCPs and LCCPs, respectively. The CONTAM
Panel noted that this is only a very crude estimate of the exposure via dust and has a large associated
uncertainty, but it shows that for toddlers exposure from dust could be in the same order of
magnitude as the dietary exposure estimated from ﬁsh. For adults, the exposure from dust was lower
than for toddlers both in absolute terms and when compared with the exposure estimated from ﬁsh
consumption, but could nevertheless still be an important source of exposure to CPs.
The CONTAM Panel considered that the impact of the uncertainties on the risk assessment of
exposure to CPs in food is substantial, and due to the limited data on occurrence of CPs in food the
dietary exposure is considered to be underestimated.
Farm animals, horses and companion animals risk assessment
Only limited toxicokinetic data were available and only for some farm animal species. In broiler
chickens and laying hens given diets supplemented with an SCCP, the highest concentration was
recovered in abdominal fat. In the laying hens, a high concentration was also found in egg yolk and
liver. A similar distribution pattern was seen in laying Japanese quail given an SCCP or an MCCP orally.
The ﬁsh studies with rainbow trout indicated that CPs were rapidly accumulated and had high
assimilation efﬁciencies from food and that the half-lives increased with increasing carbon chain length
and chlorination degree. The studies also indicated that the CPs have the potential to biomagnify from
food to ﬁsh in aquatic food chains with increasing trends with increasing carbon chain length and
greater biotransformation of the short-chain CPs compared to the longer chain CPs. Studies with other
ﬁsh species support the potential of CPs to accumulate in ﬁsh tissues.
For ruminants, pigs, horses, cats or fur animals, no studies on the adverse effects of CPs were
identiﬁed.
For poultry, a limited number of studies have been conducted and some of these were designed to
assess the performance and capacity for food production. The CONTAM Panel concluded that none of
them was robust enough for the identiﬁcation of a NOAEL or a LOAEL as a reference point.
For rabbits, no studies have been located other than the developmental toxicity studies in
experimental animals. For an SCCP (carbon chain length not speciﬁed, 58% chlorination), the NOAEL
for developmental toxicity was 10 mg/kg bw per day, based on increased number of resorptions; the
no-observed effect level (NOEL) for maternal toxicity was 100 mg/kg bw per day (the highest dose
tested). For an MCCP (C14–17, 52% chlorination), the NOEL for developmental and maternal toxicity
was 100 mg/kg bw per day (the highest dose tested). For a low chlorinated LCCP (C22–26, 43%
chlorination; C22–26), the NOEL for developmental and maternal toxicity was 5,000 mg/kg bw per day
(the highest dose tested). For a high chlorinated LCCP (C22–26, 70% chlorination), the NOEL for
developmental and maternal toxicity was 1,000 mg/kg bw per day (the highest dose tested).
For ﬁsh, most studies showed no or minor effects. Based on the available information, the CONTAM
Panel could not identify a NOAEL or a LOAEL as reference point.
For dogs, a NOEL of 10 mg/kg bw per day was identiﬁed for an MCCP (C14–17, 52% chlorination)
from a dietary study in Beagle dogs, based on an increase of hepatic smooth endoplasmic reticulum.
No exposure assessment was possible for any of the farm animal species as no occurrence data for
feed were submitted to EFSA. The data for feed reported in the literature were too limited to attempt
an exposure scenario.
Due to the lack of occurrence data for feed and the lack of, or limited, data on adverse effects of
CPs in farm animals, horses and companion animals, a risk characterisation could not be performed.
Recommendations
In order to improve the risk assessment for both humans and animals, and reduce the
uncertainties, the CONTAM Panel recommends the following:
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• There is a need for validated analytical methods for the determination of CPs, as well as
suitable standards and reference materials.
• Research is needed to identify which speciﬁc CP congeners are more relevant in terms of
occurrence in food and of relevance for human health.
• There is a need for occurrence data in food for SCCPs, MCCPs and LCCPs to enable a robust
human exposure assessment as well as data on the possible transfer of CPs from, e.g. kitchen
equipment, during food preparation.
• More data on variation of occurrence of CPs in human milk are needed to enable a more
robust exposure assessment for breastfed infants.
• More information is needed on the toxicokinetics in humans and experimental animals, with
respect to the impact of the degree of chlorination, chlorine position and carbon chain length.
The development of TK models would facilitate a body burden approach.
• There is a need for chronic toxicity studies for relevant CP mixtures.
• A better understanding of the relevance of SCCP and MCCP thyroid hormone changes in
rodents and of SCCP-induced rodent thyroid tumours to humans is needed.
• There is a need for developmental neurotoxicity studies with SCCP and MCCP because of the
reported changes in rodent thyroid hormone levels.
• There is a need for occurrence data in feed.
• Data on the transfer of CPs from feed to the food of animal origin are needed.
• There is a need for data on adverse effects of CPs in ruminants, pigs, poultry and ﬁsh. Data in
horses, companion animals and fur animals would also be needed to perform a risk
assessment on these species.
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1. Introduction
1.1. Background and Terms of Reference as provided by the European
Commission
Background
Chlorinated parafﬁns (CPs) are complex mixtures of polychlorinated n-alkanes. The chlorination
degree of CPs can vary between 30 and 70 weight percent (wt%). CPs are typically subdivided
according to their carbon chain length into short chain CPs (SCCPs, C10-13), medium chain CPs (MCCPs,
C14-17) and long chain CPs (LCCPs, C>17).
CPs may be released into the environment during product use and though improper disposal. There
is also potential for contamination of the feed and food chain. CPs, in particular SCCPs and to a lesser
extent MCCPs, bioconcentrate in ﬁsh and molluscs. Food is considered the main source of human
exposure to CPs.
SCCPs are considered to be persistent toxic substances. CPs with an average carbon-chain length
C12 and an average degree of chlorination of approximately 60% are classiﬁed by the International
Agency for Research on Cancer (IARC) as possibly carcinogenic to humans (Group 2B).
Terms of reference
In accordance with Art. 29 (1) of Regulation (EC) No 178/2002, the European Commission asks the
European Food Safety Authority for a scientiﬁc opinion on the risks for animal and human health
related to the presence of chlorinated parafﬁns in feed and food.
1.2. Interpretation of the Terms of Reference
Technically, the terms ‘SCCP’, ‘MCCP’, and ‘LCCP’ refer to the commercial mixtures of CPs. However,
most literature uses this terminology for CPs within one of these speciﬁc groups, even when the CP
patterns deviate from the commercial mixtures due to for instance weathering or biotransformation.
In this opinion the nomenclature of SCCP(s), MCCP(s), and LCCP(s) will be used to refer to any CP
mixture(s) that falls within the range of carbon chain lengths indicated above.
This opinion focuses on chlorinated CPs only and not on brominated CPs, chloro/bromo CPs, or
sulpho-chlorinated CPs. Also chlorinated oleﬁns (i.e. chlorinated parafﬁns with some degree of
unsaturation) are not assessed, but it should be mentioned that they can interfere with the analysis of
CPs using certain analytical techniques.
1.3. Supporting information for the assessment
1.3.1. Physicochemical properties
Chlorinated parafﬁns (CPs) are complex technical mixtures of polychlorinated alkanes (PCAs), with
varying chain length and degree of chlorination with the general formula CxH(2x + 2)  yCly. The
commercially available CPs are generally divided into three groups: short-chain CPs (SCCPs) comprising
10–13 carbon atoms, medium-chain CPs (MCCPs) comprising 14–17 carbon atoms and long-chain CPs
(LCCPs) with 18 or more carbon atoms. Some technical mixtures may contain CPs from more than one
of these three groups, and some newer CPs do not conﬁne themselves to these classes (see
Section 1.3.2). CPs with 9 carbon atoms are becoming more widely used and are known as very
short-chain CPs or vSCCPs (Xia et al., 2019; Zhou et al., 2019a). There are a vast number of possible
combinations of chain length, position and degree of chlorination, and the exact composition of
technical mixtures can vary in terms of the amounts of different congeners present. This means that
the potential array of compounds that are of relevance is many thousands and that the analytical
challenge for measuring these compounds is considerable.
Other terms commonly used to refer to CPs include: chlorinated alkanes, chlorinated hydrocarbon
waxes, chlorinated parafﬁn waxes, chlorinated waxes, chloroalkanes, chlorocarbons, chloroparafﬁn
waxes, ‘parafﬁn, chlorinated’, ‘parafﬁns, chloro’, parafﬁn waxes, ‘chlorinated; paroils, chlorinated’;
polychlorinated alkanes and polychloro alkanes. Figure 1 shows the general structure of CPs and the
CAS numbers for some CPs are shown in Table 1.
Most CPs are viscous colourless or yellowish dense oils, but some LCCPs (C20- to C30- with a
chlorine content > 70%) are solid (Van Mourik et al., 2015). The physicochemical properties vary with
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the carbon chain length and chlorine content. An extensive review and discussion of the
physicochemical properties of CPs is given in previous assessments (WHO/IPCS, 1996; EU-RAR, 2000,
2005, 2011; Health Canada, 2008) and some of these CPs are shown in Table 2. More details for the
log Kow of 40 synthesised CPs along with a discussion of the inﬂuence of chain length and degree of
chlorination have been reported (Hilger et al., 2011).
(A)
(B) 
LCCPs
CxH(2x-y+2) Cly, where 
x ≥18 and y=1–30
MCCPs
CxH(2x-y+2) Cly, where 
x=14–17 and y=1–17
Cly Cly Cly
SCCPs 
CxH(2x-y+2) Cly, where 
x=10–13 and y=1–13
SCCP (C10H17Cl5)
MCCP (C17H31Cl5)
LCCP (C20H34Cl8)
Figure 1: (A) General structure of chlorinated parafﬁns (CPs) and (B) example of a short-chain
chlorinated parafﬁn, SCCP (C10H17Cl5), a medium-chain chlorinated parafﬁn, MCCP
(C17H31Cl5) and a long-chain chlorinated parafﬁn, LCCP (C20H34Cl8) of the many possible CP
structures
Table 1: CAS numbers for some chlorinated parafﬁns
Chemical name CAS number
Alkanes, C6–18, chloro 68920-70-7
Alkanes, C10–13, chloro 85535-84-8
Alkanes, C12–13, chloro 71011-12-6
Alkanes, C14–17, chloro 85535-85-9
Alkanes, C10–21, chloro 84082-38-2
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1.3.2. Production and industrial use
The many theoretical combinations for the position of chlorine atoms combined with the presence
of chiral centres leads to a large number of potential positional isomers, enantiomers and
diastereoisomers. For example, there are 122,161 positional isomers for MCCPs, based on the
assumption that no more than one chlorine atom binds to any carbon atom. In practice, there are
fewer because it is mainly the linear n-alkanes that are used to produce CPs. The degree of
chlorination typically varies between 30% and 72% by weight (Van Mourik et al., 2015). A similar
complex situation exists for SCCPs and LCCPs, and results in difﬁculties in terms of analysis of these
compounds, especially in environmental and food matrices.
There have been at least 200 CP formulations commercially available on the market (Alcock et al.,
1999). In recent years, production has decreased in Europe and North America, but it has increased
signiﬁcantly in Asia (e.g. India, China, Taiwan and Japan). Current production in Asia has not been
conﬁned to the traditional classiﬁcation of short-, medium- and long-chained mixtures, but also
includes more diverse products containing congeners from the short- to the long-chained CPs (Shen
Chemical name CAS number
Alkanes, C18–20, chloro 106232-85-3
Alkanes, C18–28, chloro 85535-86-0
Alkanes, C10–14, chloro 85681-73-8
Parafﬁns (petroleum), normal C > 10, chloro 97553-43-0
Alkanes, C10–26, chloro 97659-46-6
Alkanes, C10–22, chloro 104948-36-9
Alkanes, C10–12, chloro 108171-26-2
Alkanes, chloro 61788-76-9
Parafﬁn waxes and hydrocarbon waxes, chloro 51990-12-6
Parafﬁn waxes and hydrocarbon waxes, chloro 63449-39-8
Alkanes, C21–34-branched and linear, chloro 1417900-96-9
Alkanes, C22–30-branched and linear, chloro 1401974-24-0
CAS: Chemical Abstracts Service.
Table 2: Some physicochemical properties of chlorinated parafﬁns (from Nielsen and Ladefoged,
2013; EU-RAR, 2000, 2005, 2011)
SCCPs MCCPs LCCPs
Description Clear to yellowish mobile
to highly viscous oily
liquid
Liquid Liquid or solid(a)
Additives(b) Epoxidised vegetable oil, glycidyl ether, organophosphorous compounds
Boiling point > 200°C(c)
Solubility Practically insoluble in: Water (< 0.5 mg/L at 20°C), lower alcohols, glycerol and glycols
Soluble in: chlorinated solvents, aromatic hydrocarbons, ketones, esters, ethers, mineral oil
Vapour pressure Chlorine content 50%:
1.6 9 104 mmHg
(0.0213 Pa) (at 40°C)
Chlorine content 45%:
1.7 9 105 mmHg
(0.0023 Pa) (at 40°C)
Chlorine content 52%:
1.0 9 106–2.0 9 106 mmHg
(0.00013–0.00027 Pa) (at 20°C)
–
Log Po/w Chlorine content 49%:
4.39–6.93
Chlorine content 71%:
5.68–8.69
Chlorine content 45%:
5.52–8.21
Chlorine content 52%:
5.47–8.01
Chlorine content 42%:
9.29–> 12.83
Chlorine content 48%:
8.69–12.83
SCCPs: short-chain chlorinated parafﬁns; MCCPs: medium-chain chlorinated parafﬁns; LCCPs: long-chain chlorinated parafﬁns.
(a): Depending on the carbon chain length and chlorine content.
(b): As stabilisers, to improve thermal and photo stability.
(c): Around 200°C decomposition with release of hydrogen chloride occurs.
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et al., 2016; Glϋge et al., 2018), with greater attention being paid to chlorine content of the products
and less attention being given to carbon chain length. This is because the chlorine content is the most
important factor to consider for the intended use of the CPs. A list of some of the manufacturers is
available from http://www.eurochlor.org. There can be a wide variation in distribution of carbon chain
lengths and chlorine content between different CPs. Commercial names for CPs including historic
production, are for example: Arubren CP®, Cereclor®, Cloparin®, Chlorowax®, Essechlor®, FLX-0012®,
Hordaﬂex®, Paroil®, Ribeclor®, Uniclor® and Witaclor®. The letters and ﬁgures used in the commercial
names differ from country to country and describe both the average chain length and the chlorine
content.
Total world production of all CPs was estimated at 300,000 tonnes in 1985 (WHO/IPCS, 1996) and
production has increased considerably since then (Bayen et al., 2006). In the late 1990s, world annual
production of SCCPs was about 50,000 tonnes (Marvin et al., 2003). Production of all types of CPs in
the European Union (EU) had reached between 1,500 and 2,500 tonnes in 2006 and between 7,500
and 11,300 tonnes per year in the USA. Production of all types of CPs in China was around 100,000
tonnes per year before 2005 but had reached over 600,000 tonnes by 2007 (Fiedler, 2010). Figure 2
shows total estimated production of CPs between 1935 and 2012 (Glϋge et al., 2016).
More recent accurate data is not readily available. Because of this, Glϋge et al. (2016) evaluated an
extensive amount of data and reported emission factors, and performed some extrapolations in order
to provide estimates. At that time, they concluded that globally, SCCP production and use was
increasing. At the same time, worldwide production was estimated as at least 165,000 tonnes per year
with global production of total CPs exceeding 1 million tonnes per year. Emissions due to the disposal
of waste SCCPs could not be estimated accurately due to lack of essential information.
Glϋge et al. (2018) reported an annual production of 17,800 tonnes of MCCPs in North America
(year 1998), 40,000 tonnes in the UK (year 1991) and 27,000 tonnes in Russia (year 2011). No
production amounts were reported for Asia since manufacturers do not differentiate between chain
lengths, but the authors estimated that the production of MCCPs might have been around 600,000
tonnes in China for the year 2013 (Glϋge et al., 2018).
An estimate derived from the addition of each individual registrant volumes from the European
Chemicals Agency (ECHA) shows that the amount of CPs manufactured and/or imported in the
European Economic Area is around 10,000–100,000 tonnes per year, but it is difﬁcult to give more
precise estimates (C Howick, 2019, Personal Communication).
CPs have been produced since the 1930s for a variety of purposes (Fiedler, 2010; Van Mourik et al.,
2015). They are still used as additives in lubricants and cutting ﬂuids in the metal industry and are also
used as ﬂame retardants in the rubber industry and in PVC plastics and in sealants (e.g. polysulﬁde,
polyurethane, acrylic and other polymer sealants/adhesives) for use in building, automotive and
Figure 2: Production of chlorinated parafﬁns between 1935 and 2012 (from Glϋge et al., 20161)
1 Reprinted from Science of the Total Environment, 573, Gl€uge J, Wang Z, Bogdal C, Scheringer M and Hungerb€uhler K, Global
production, use, and emission volumes of short-chain chlorinated parafﬁns – A minimum scenario, 1132-1146, © Elsevier B.V.
(2016), with permission from Elsevier.
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industrial applications, and the longer chain mixtures are also used as plasticisers in paints and other
materials. CPs occupy free volume in the polymer, and screen polar sites on the polymer chains rather
than acting as a conventional plasticiser (C Howick, 2019, Personal Communication). They are used in
the leather industry as fat liquoring agents, due to the fact that they show better adhesion to the
animal skin than natural oils, and yet have similar fattening and softening properties. In the textile
industry, highly chlorinated SCCPs can be used in the production of ﬂame-resistant, water repellent
and rot-preventing textile ﬁnishes. These are used for applications such as the production of sail
cloths, industrial protective clothing and lorry tarpaulins. CPs with higher chlorine content are more
effective as ﬂame retardants as they start to decompose at temperatures above 300°C.
As a result of regulations and concerns about SCCPs, the use of MCCPs has increased and has
represented the majority of production over the last decades (Stern and Tomy, 2000; Glϋge et al.,
2016, 2018). MCCPs are now being found to dominate some environmental compartments, e.g. in
Australian sewage sludge (Brandsma et al., 2017). Glϋge et al. (2018) reported that congeners with a
chain length of C14 with medium degree of chlorination (Cl78) are the most prevalent MCCPs in the
environment followed by MCCPs with C16–17 which can make up to 30% of the total concentrations in
the environmental samples in which they could be measured.
1.3.3. Environmental fate and levels
CPs can enter the environment either as a result of production and usage by industry or
consumers, or at end of life of products that contain CPs. Largely due to the analytical complexity of
measuring these compounds, there is little knowledge about the environmental fate and transport of
CPs, in spite of the fact they have been in production and use for so long. The paragraphs below,
which do not claim to be complete, give an overview of some aspects related to the environmental
fate and levels of CPs.
1.3.3.1. Biodegradation
Biodegradation of SCCPs by soil organisms has been shown for various strains of microorganisms
(e.g. Rhodococcus, Pseudomonas) (Wischnak et al., 1998; Allpress and Gowland, 1999; Heath et al.,
2006). In general, the biodegradation decreases with increasing chlorine content and is dependent on
the carbon chain length (Madeley and Birtley, 1980; Omori and Alexander, 1987; Heath et al., 2006).
Madeley and Birtley (1980) used activated sludge to study the biodegradation of SCCPs (49–70%
chlorination), MCCPs (40–58% chlorination) and LCCPs (C20–30, 42% chlorination) using an extended
biochemical oxygen demand test. SCCPs were shown to be the most biodegradable. Anaerobic
microorganisms are less able to perform the biodegradation (Madeley and Birtley, 1980).
Heath et al. (2006) studied the aerobic biodegradation of single mono- to hexachlorinated compounds
((1-chlorodecane, 1,6-dichlorohexane, 1,10-dichlorodecane, 1-chlorohexadecane, 1,2,5,6,9,10-
hexachlorodecane, 1,2,9,10-tetrachlorodecane) and a MCCP mixture with 52% chlorine (Cereclor S52,
C14–17) using a Pseudomonas sp. strain 273. In addition, the authors studied the biodegradation in
relationship to the chlorine position, chlorination degree and carbon chain length. The main biodegradation
process was dechlorination. The position of the chlorines was of great inﬂuence on the biodegradation,
being more favourable for CPs that were chlorinated at one of the terminal positions. Substitution with
chlorine atoms away from the ends of the molecule reduced the biodegradability, and when chlorine atoms
were present at both ends of the molecule, no dechlorination occurred (Heath et al., 2006).
In the study by Omori and Alexander (1987), the biodegradation of SCCP (Toyoparax CP-265, 63%
chlorination), MCCP (Toyoparax C-145, 43.5% chlorination, Toyoparax CP-150, 50% chlorination) and
LCCP (Toyoparax A-400, 40.5% chlorination, Toyoparax A-50, 50% chlorination and Toyoparax A-70,
70% chlorination) was investigated using different bacterial strains (HK-3, HK-6, HK-8 and HK-10). The
HK-3 strain showed dechlorination of SCCP (CP-150), MCCP (CP-265) and LCCP (A-400), and the HK-8
strain only biotransformed SCCP (CP-150). Mixed strain cultures showed dechlorination of SCCP, MCCP
and LCCP (CP-145, CP-150, CP-265 and A-400). Activated sludge acclimatised to CPs showed little
biodegradation.
In the study of Wischnak et al. (1998), the biodegradation of a CP congener (1,10-dichlorodecane)
was studied using the Pseudomonas sp. strain 273. Dechlorination did not occur under anaerobic
conditions. The Pseudomonas sp. strain 273 showed biodegradation of 1,10-dichlorodecane as well as
for C9 to C12 chloroalkanes under aerobic conditions.
Li et al. (2019a) studied the uptake, translocation and transformation of four SCCP isomers using
whole pumpkin and soybean seedlings via hydroponic exposure. All tested isomers underwent
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dechlorination and chlorine rearrangement, and carbon chain decomposition products were found for
isomers with trichlorinated carbon atoms (CCl3 groups) in both pumpkin and soybean seedlings.
1.3.3.2. Bioaccumulation
An overview of the bioconcentration factors (BCFs) in ﬁsh for SCCP and MCCP made by Glϋge et al.
(2018) showed no trend between the CP carbon chain length or chlorination degree and BCF. The BCF
values for SCCPs in rainbow trout were reported to range from 574 to 7,273 based on parent
compound analysis (Madeley et al., 1983a), and in another study with rainbow trout and SCCPs (14C-
labelled study) the BCF was reported to range from 3,600 to 5,300 (Madeley et al., 1983b). A
Japanese study reported lipid normalised BCFs values for SCCPs (C13 48.7% chlorination) in common
carp. Three main components were determined: C13H23Cl5 (49.8% chlorination), C13H22Cl6 (54.5%
chlorination) and C13H21Cl7 (58.4% chlorination) and the BCF values were 1,962 to 2,150, 2,100 to
2,530 and 3,000 and 3,630, respectively (POPRC, 2009).
Fisk et al. (1996, 1998, 2000) performed a number of biomagniﬁcation studies in rainbow trout
with CPs based on 14C-radiolabelled compounds (C12H20Cl6, C12H16Cl10, C16H31Cl3, C16H21Cl13). The
biomagniﬁcation calculations were based on the 14C activity of the whole ﬁsh, which therefore include
the metabolites and provide maximum biomagniﬁcation factors (BMFs). BMFs were corrected for
growth dilution and lipid normalisation. The BMFs in the Fisk et al. (1996) study ranged from 0.6 to
0.93 for C12H20Cl6, from 1.76 to 2.15 for C12H16Cl10, from 0.9 to 1.07 for C16H31Cl3 and from 0.44 to
0.72 for C16H21Cl13. No clear trends between the carbon chain length and BMFs were found due to a
combination of metabolism and efﬁciency of uptake. The BMFs for MCCPs ranged from 0.3 to 5
(median 0.99), without a clear trend. The BMFs of LCCPs (C18H31Cl7) was studied by Fisk et al. (2000)
using rainbow trout and showed a lipid normalised BMF from 2.1 to 2.8.
Bioaccumulation factors (BAF) from a ﬁsh food-web study in the Great Lakes (US) showed lipid
corrected logBAF values for SCCPs from 4.1 to 7.0 for SCCPs, and for MCCPs from 6.3 to 6.8 (Houde
et al., 2008). In this study also, the trophic magniﬁcation of CPs was studied and showed trophic
magniﬁcation factors (TMF) for the food webs for SCCP from 0.41 to 2.4, and for MCCP between 0.06
and 0.36. Other TMF studies showed also that the TMF for MCCP is below 1 (NIVA, 2015a,b, 2017;
Huang et al., 2017).
In ﬁeld studies, SCCPs and MCCPs have been found in various organisms ranging from low to
higher trophic levels. Limited information is available on the occurrence of LCCPs in food webs. Recent
information on the occurrence of CPs in terrestrial birds and mammals in Sweden showed that LCCPs
can be found in speciﬁc predatory birds, especially peregrine falcons, and CPs up to C30 can be found
in the terrestrial environment (Yuan and de Wit, 2018).
A study by Cui et al. (2019) investigated the bioaccessibility of SCCPs in meat and seafood. The
bioaccessibility percentages ranged from 33% to 84%, and the authors suggested that factors such as
protein and lipid content had an inﬂuence on the observed values.
1.3.3.3. Occurrence in the outdoor environment and wildlife
Only few data exist and it is difﬁcult to draw trends and/or conclusions for differences at a
congener level. Most data exist for SCCPs, with few data for MCCPs and very little if any data at all in
some matrices for LCCPs.
Chen et al. (2019) studied the global environmental fate of SCCPs. The environmental
concentrations and compartmental distribution of SCCPs were simulated using a mechanistic fugacity-
based multimedia model. A discrepancy between modelled concentrations based on a single and
multiple sets of properties was observed, and was more evident in regions with colder climate and
lower pollution levels, such as the Arctic. The model tended to underestimate the environmental
occurrence and environmental risk in remote and cold regions, and did not allow conclusions on which
SCCP component is of greatest concern. The authors found that treating tens of SCCP homologues as
a whole and representing them using a single set of properties minimised the information required for
modelling, but resulted in a bias when estimating the environmental occurrence of SCCPs in remote
background areas. It was therefore not possible to determine which SCCP homologue poses the
greatest concern.
Outdoor air
SCCPs and MCCPs have been measured in air, and levels have been found to be highest in Asia,
with peak concentrations of MCCPs measured in China with up to 360,000 pg/m3 (Wang et al., 2013).
Lowest concentrations have been found in polar regions with levels in Europe somewhere between the
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two. However, data is scarce and not available at all for some global regions and therefore, care needs
to be taken with this conclusion (Glϋge et al., 2018).
Zhou et al. (2019b) analysed 66 outdoor air samples with particulate matters (PMs) of 100, 10 and
2.5 lm. The samples were taken from 24 homes located near the Pearl River Delta, China. The
smallest particles were found to be dominant (93.0%) and CPs were mainly present in that fraction.
The mean concentrations of MCCPs exceeded the SCCPs (22.0 vs. 9.2 ng/m3) in all particle samples.
Li et al. (2019b) investigated seasonal variations and inhalation of SCCPs in PM2.5 in Jinan, China.
Concentrations of SCCPs ranged from 9.80 to 105 ng/m3, with a mean value of 38.7 ng/m3. The
highest concentrations of SCCPs were found in winter months, and the lowest values were found in
summer.
Surface water, efﬂuents and sludge of municipal waste water treatment plants (WWTPs)
For surface water, there are a few data from Norway and Canada (Lake Ontario and the Arctic)
with levels of both SCCPs and MCCPs typically from around 10 to over 100 ng/L (Glϋge et al., 2018).
Efﬂuents and sludge of municipal WWTPs can contain CPs. In general, the concentrations of MCCPs
are dominant in sludge from WWTPs. Sewage sludge from Swedish WWTPs collected between 2004
and 2010 showed a median concentration for SCCPs of 1,100 ng/g dry weight (dw) and for MCCPs a
median concentration of 3,800 ng/g dw (Olofsson et al., 2012). Also in sludge from WWTPs in the
Czech Republic, collected near a chemical company (Pribylova et al., 2006), Switzerland (Z€urich)
(Bogdal et al., 2015) and Australia (Brandsma et al., 2017), the MCCP concentrations were higher than
SCCPs. Higher SCCP concentrations than MCCPs have been found in sludge from municipal and
industrial WWTPs in China (800–52,700 ng/g dw, Zeng et al., 2012) and the UK (SCCPs: 6,900–
200,000 ng/g dw, MCCPs: 30–9,700 ng/g dw, Stevens et al., 2003). Nicholls et al. (2001) reported for
several regions in the UK levels for the sum of SCCP and MCCPs ranging from 1,800 to 93,100 ng/g dw.
Two studies analysed LCCPs in sludge (Olofsson et al., 2012; Brandsma et al., 2017). Samples from
Swedish sewage sludge contained a median LCCP concentration of 31,000 ng/g dw, and in the
Australian study the median concentration of LCCPs was about 300 times lower.
Soil and sediments
For soil and sediment, levels of SCCPs and MCCPs are typically from around 10 to over 100 ng/g
dw, although higher levels tend to be present in sediment from Asia, and in samples taken from close
to known sources where concentrations up to around 10,000 ng/g dw have been found (Glϋge et al.,
2018).
Birds
Concentrations of SCCPs and MCCPs in bird eggs and bird tissue have been reported to be broadly
similar to those collected from the Arctic and Norway, and contained similar levels of SCCPs and
MCCPs, ranging from around 2 to 170 ng/g fat, but lower than concentrations in samples from China
(Glϋge et al., 2018). Levels in blood and muscle/liver were also similar for both SCCPs and MCCPs and
were around an order of magnitude higher (201,700 ng/g fat).
Mammals
A few studies exist on CPs in mammals, again showing similar concentrations for SCCPs and
MCCPs. Data is available for ringed seals and polar bears from the Arctic, and ﬁnless porpoise, Indo-
Paciﬁc humpback dolphins and yellow weasels from China. Levels are typically an order of magnitude
higher in samples from China when compared with the Arctic, and are higher for the yellow weasel
followed by dolphin species, porpoises, polar bear and lowest concentrations in the ringed seal (Glϋge
et al., 2018). Samples taken in 2014 were signiﬁcantly higher than those taken 10 years earlier, and
some samples exceeded 50,000 ng/g fat for SCCPs and MCCPs.
Fish
Concentrations of SCCPs and MCCPs in ﬁsh from the Arctic, Canada, Europe and north-eastern
China are all similar and range between around 10 and 700 ng/g fat. SCCP and MCCP levels are higher
in samples from the South China Sea and from paddy ﬁelds in the Yangtze River Delta in South East
Asia, where concentrations were up to around 2,600 ng/g fat. MCCP concentrations in Arctic ﬁsh from
a lake on Bear Island were in general higher than those found in ﬁsh elsewhere in Canada and in
Europe. Given the remote location of this island, the contamination was explained by two possible
reasons (Evenset et al., 2004). The lake is located in mountains and receives heavy rainfall, and large
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seabird colonies use the lake as resting area, resulting in large amounts of guano that can cause an
increase in concentrations of persistent organic pollutants (POPs) in general. The contamination of this
remote area supports the conclusions that MCCPs are able to undergo long-range atmospheric
transport (Glϋge et al., 2018).
The occurrence of CPs in ﬁsh samples from European markets is reported in Section 3.2.2.
Kr€atschmer et al. (2019) determined the levels of SCCPs and MCCPs in salmon samples from German
supermarkets and reported the SCCP and MCCPs homologue proﬁles of wild and farmed salmon
samples from different geographic origins (see Figure 3). The homologue proﬁles in samples from
Europe (Norway, Denmark and Scotland, n = 95) were similar and showed different CP proﬁles
compared to farmed salmon from Chile and wild catch salmon from the Paciﬁc. While European farmed
salmon was characterised mainly by high-chlorinated C11Cl9–11 (13% of the total SCCP and MCCP
content), Chilean farmed salmon showed higher levels of lower chlorinated C10Cl5–7 (27.6% of the total
SCCP and MCCP content). In Chilean salmon, the contribution of MCCPs to the total CP content was
lower than in the European samples. Wild salmon presented CP proﬁles similar to the Chilean farmed
salmon. Differences were also observed between the two types of wild salmon analysed: hump salmon
(higher contribution and Cl range of C11) and wild chum salmon (higher abundance of C10). The
authors reported that the CP proﬁles can be inﬂuenced by habitat and feed, and wild catch can be
subject to several more inﬂuences including age, season of catch or local contamination hotspots
(Kr€atschmer et al., 2019).
The data generated for the above studies were obtained in some cases with techniques using low-
resolution mass spectrometry (LRMS). Congener proﬁles are therefore considered as more qualitative
than quantitative, making congener proﬁles difﬁcult to assess.
Chlorinated parafﬁns in feed and food
www.efsa.europa.eu/efsajournal 18 EFSA Journal 2020;18(3):5991
1.3.3.4. Occurrence in the indoor environment
Indoor air
In a Swedish study, indoor air and house dust was sampled in apartments and SCCPs and MCCPs
were analysed (Friden et al., 2011). Concentrations of the sum of SCCPs and MCCPs ranged from < 5
to 210 ng/m3 (Friden et al., 2011).
Figure 3: Arithmetic means of the relative homologue group concentration for short-chain chlorinated
parafﬁns and medium-chain chlorinated parafﬁns in Norwegian, Danish, Scottish and
Chilean farmed salmon and in different Eastern Paciﬁc wild salmon (from Kr€atschmer et al.,
20192)
2 Reprinted from Chemosphere, 227, Kr€atschmer K, Sch€achtele A, Malisch R and Vetter W, Chlorinated parafﬁns (CPs) in salmon
sold in southern Germany: Concentrations, homologue patterns and relation to other persistent organic pollutants, 630-637, ©
Elsevier Ltd. (2019), with permission from Elsevier.
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Zhou et al. (2019b) analysed 72 indoor air samples with particulates classed as PM100, PM10 and
PM2.5. They were taken from 24 homes located near the Pearl River Delta, China. The smallest
particles were found to be dominant (89.1%), and CPs were mainly present in that fraction. The mean
concentrations of MCCPs exceeded the SCCPs (22.0 vs. 9.2 ng/m3) in all particle samples. Both SCCPs
and MCCPs in the indoor particles (mean 13.4 and 30.9 ng/m3) were approximately twice as high as in
the outdoor environment (mean 6.1 and 15.2 ng/m3). C11 and C14 chain lengths and six and seven
chlorine containing CPs were found to be predominant.
Dust
Levels of CPs in indoor dust were reviewed by Coelhan and Hilger (2014). Concentrations of SCCPs
were reported ranging from < 5 to > 2,000 lg/g from a number of different countries and
environments. Concentrations of MCCPs ranged from 36 to 892 lg/g but were only measured in a few
of the studies. Other reports of CPs in dust include one study where CPs were found in house dust
from Germany, Taiwan and Sweden. Concentrations ranged from 1,200 to 892,000 ng/g house dust
(Friden et al., 2011; Hilger et al., 2013; Chen et al., 2016). The German study showed that the
concentrations of SCCPs were lower (4,000–27,000 ng/g) than the concentrations of MCCPs (8,000–
892,000 ng/g). Wong et al. (2017) determined SCCPs, MCCP and also LCCPs in dust samples from
ofﬁces homes and non-residential buildings from Australia, UK, Canada, Sweden and China. The
highest CP levels were found in dust from China (mean of 3,044 lg/g). The levels in the other
countries ranged from 280 to 1,330 lg/g. MCCPs were the predominant in all samples (accounting
between 41% to 65% of the total CPs), except in the Swedish samples, in which LCCPs accounted for
84% of the total CP content. Compared to other ﬂame retardants analysed in the same samples, the
levels of CPs were signiﬁcantly higher. CPs were also detected in house dust sample from Canada with
median (range) concentrations of 6.2 (4.0–57) lg/g and 19 (5.9–901) lg/g for SCCPs and MCCPs,
respectively (Shang et al., 2019).
Within the SHINE project,3 SCCPs, MCCPs and LCCPs in ofﬁce and house dust collected between
2016 and 2017 from the Netherlands, Belgium, Sweden and Ireland were analysed by atmospheric
pressure chemical ionisation-mass spectrometry (APCI-MS) (P Leonards, Personal communication,
2019). Concentrations of SCCPs ranged from 27 to around 55,000 ng/g, with the highest levels found
in the Swedish house and kindergarten dust samples. The levels of MCCPs were higher in all dust
samples, and ranged from 190 to around 349,000 ng/g. LCCPs were reported at lower concentrations,
ranging from < 1 to around 9,000 ng/g. The highest median values found in dust from the four
European countries were around 6,300 ng/g SCCPs; 35,000 ng/g for MCCPs and 2,700 ng/g for LCCPs.
Kitchen equipment
A limited number of studies considered the occurrence of CPs in the kitchen (Bendig et al., 2013;
Gallistl et al., 2018). In fat of kitchen hoods, CPs have been found with a median concentration of
2,500 ng/g fat). SCCPs were found in all samples (n = 15), and MCCPs were found in 20% of the
samples. The sum of SCCP and MCCPs ranged from 140 to 15,000 ng/g fat. In a follow up study, fat
collected in the inner surface of 21 baking ovens from Germany showed that CPs in the mg/g fat
range were detected in about 50% of the ovens. MCCP concentrations exceeded those for SCCPs,
which were found in only three out of the 21 ovens contained SCCPs. The source of MCCP was found
to be the components of the inner site of the oven casing. The mean concentration of MCCP was
12.6 mg/g fat (expressed here as 12,600,000 ng/g fat in order to be consistent with units used for
occurrence data), with the highest concentration of 93,200,000 ng/g fat.
1.3.4. Sampling and methods of analysis
Sample preparation
The sample preparation of CPs consists of extraction, clean-up and fractionation steps before the
ﬁnal analysis. The extraction step should be able to extract the CPs which have a wide range of
physicochemical properties (e.g. log Kow 5–12). Extraction is often performed with a Soxhlet or
accelerated organic solvent extraction (ASE) for solid materials (e.g. tissues, sediment), and for dust
also ultrasonic extraction can be used (Van Mourik et al., 2015). Solid phase extraction (SPE) or liquid–
liquid (LLE) extraction is mainly used for water samples, and polyurethane foam in combination with a
3 SHINE Project: Target and non-target screening of chemicals in the indoor environment for human exposure assessment.
CEFIC-Long-range Research Activity B17.
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ﬁlter to extract CPs from air (Van Mourik et al., 2015). For the sediment, soil and biological samples, a
clean-up step is needed to remove extract matrix such as lipids, humic acid and sulfur-containing
compounds that interfere with the ﬁnal analysis. For lipid removal, various adsorbents can be used
such as sulfuric acid silica gel, sulfuric acid treatment, or aluminium oxide. For sediments and soil,
sulfur-containing compounds can be present in large amounts and should be removed using, for
instance, activated copper or gel permeation chromatography. Some studies use a multi-layer column
consisting of activated silica gel and/or ﬂorisil and silica gel with sulfuric acid, and/or silica gel with
sodium hydroxide. A highly important step in the sample treatment is the fractionation step to remove
interfering compounds such as polychlorinated biphenyls (PCBs) and some pesticides (e.g. toxaphene)
that can have similar retention times or mass-to-charge (m/z) ratios as the CPs if for instance electron
capture detection (ECD) or LRMS are used for the detection of CPs. For the fractionation, mainly
adsorption chromatography is used such as silica gel and/or alumina. For high-resolution MS (HRMS),
the fractionation step is not necessary as the high-resolution power of the MS is able to separate the
interfering compounds from the CPs.
A lack of analytical standards is a key factor in hindering the development of improved methods
(Schinkel et al., 2018).
Analytical techniques
Due to the complexity of the mixtures, there are a number of challenges in the analysis of CPs,
especially their characterisation and determination. An overview of different techniques used for
the analysis of CPs is given in Table 3. An example of a chromatogram illustrating the complexity
of the separation and measurement of SCCPs and MCCPs is shown in Figure 4 (Kr€atschmer,
2019).
Table 3: Different separation and detection techniques for chlorinated parafﬁns. Information on the
sensitivity, selectivity, detection of isomers and calibration are provided
Technique Sensitivity Selectivity
Detection of
SCCP, MCCP,
LCCP
Chlorine
content of
isomers
Carbon length
chlorine
distribution
Calibration
(response
factors)
GC-ECNI-
LRMS
High Moderate SCCP, MCCP ≥ Cl5 Yes Depending on
chlorination degree
GC-ECNI-
HRMS
High High SCCP, MCCP ≥ Cl5 Yes Depending on
chlorination degree
GC-MS/MS
(EI mode)
High Low, much
fragmentation
SCCP, MCCP No congener-
and
homologue-
speciﬁc
information
Not possible Less critical for
differences in
chlorine content
and carbon chain
length
LC-APCI-
qTOF-MS
(HRMS)
High High SCCP, especially
sensitive for
MCCP and LCCP
Cl2–Clx Yes Less critical for
differences in
chlorine content
GCxGC-
TOF-MS
(ECNI)
High High SCCP, MCCP ≥ Cl5 Yes Depending on
chlorination degree
GCxGC-ECD High High SCCP, MCCP,
(LCCP)
Cl2–Clx Yes Depending on
chlorination degree
GC-FID and
GC-MS
(carbon
skeleton
method)
Moderate High –
assuming
alkanes are
removed
during sample
clean-up
SCCP, MCCP,
LCCP
No congener-
and
homologue-
speciﬁc
information
No, only carbon
length
Good calibration
based on
hydrocarbon
number only
SCCPs: short-chain chlorinated parafﬁns; MCCPs: medium-chain chlorinated parafﬁns; LCCPs: long-chain chlorinated parafﬁns;
APCI: atmospheric pressure chemical ionisation; ECD: electron capture detector; ECNI: electron capture negative ionisation; FID:
ﬂame ionisation detector; GC: gas chromatography; LRMS: low-resolution MS; GC9GC: comprehensive two-dimensional gas
chromatography; HRMS: high-resolution MS; MS: mass spectrometry; TOF-MS: time-of-ﬂight MS.
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In general, the techniques are not able to completely separate and detect isomeric groups, and
individual congeners cannot be reported. There is no ideal technique that can be used for analysis of
CPs; all available methods have limitations and are a compromise in some aspect, and thus can
generate different results.
The most commonly used technique is gas chromatography (GC) combined with LRMS in the
electron capture negative ionisation (ECNI) mode (e.g. Reth et al., 2005) or high-resolution MS
(HRMS) (e.g. Tomy et al., 1997). The ECNI technique is a sensitive technique for the detection of CP
congeners with ≥ Cl5; however lower chlorinated congeners are hardly detected (Zencak et al., 2005).
In practice, only congeners with ≥ Cl5 are reported with this technique. It should be noted that some
CP products can have a relatively large number of congeners with < Cl5, which shows the importance
of other detection techniques to provide information on the chlorine distribution. Another drawback of
ECNI is the decrease in sensitivity from SCCPs, to MCCPs to LCCPs, where LCCPs are almost
undetectable. If LRMS is used, interfering compounds such as PCBs with the same nominal mass,
should be separated from the CPs using fractionation before the ﬁnal analysis.
Other less frequently used techniques such as ECD especially in combination with comprehensive
two-dimensional gas chromatography (GC9GC) (Korytar et al., 2005; Xia et al., 2014) are able to
detect the lower chlorinated congeners. The advantage of GC9GC-ECD is the high separation power of
CP isomers and the detection of lower chlorinated CPs (Cl2–Cl4). Another advantage is the group
separation of CP isomeric, and the analysis of SCCPs, MCCPs and LCCPs simultaneously in one run.
This technique is not used by many laboratories because of the relative complicated optimisation and
time-consuming quantiﬁcation (Van Mourik et al., 2015). The disadvantage of the ECD is that SCCP,
MCCP and LCCP groups can overlap if single GC is used, or other halogenated compounds can
interfere with the analysis. GC9GC also has been combined successfully with low to moderate
resolution time of ﬂight (TOF)-MS for the analysis of CPs in the ECNI mode (Korytar et al., 2005; Xia
et al., 2016). However, GC9GC-ECNI-TOF-MS has insufﬁcient sensitivity to measure the lower
chlorinated CPs (< Cl5). An alternative method is the carbon skeleton method coupled with GC-ﬂame
ionisation detector (FID) (Cooke et al., 1980) and MS detector (Pellizzato et al., 2009a). This method
dechlorinates the CPs to alkanes and quantiﬁcation is performed with n-alkanes. This reduces the
calibration problems found with ECNI as the FID detector response is independent of the chlorine
content (see below). The disadvantage is that no information on the chlorine content can be provided,
and this is important for the hazard and risk assessment.
Other methods have been developed including GC combined with triple quadrupole MS (GC-MS/MS),
novel APCI-TOF-MS using CP pattern matching and deconvolution algorithms, and GC-Orbitrap. A
Figure 4: Example of a GC-ECNI-Orbitrap-HRMS chromatogram illustrating the total ion count (TIC,
black line) and mass-to-charge ratios (m/z, coloured lines) for a few selected short-chain
chlorinated parafﬁns (SCCPs) and medium-chain chlorinated parafﬁns (MCCPs) homologues
(Kr€atschmer, 2019)
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promising analytical method using liquid chromatography (LC) coupled to APCI–TOF-HRMS was
developed (Bogdal et al., 2015). This enables the use of an analytical column to be avoided, since the
extract is directly injected into a qTOF-MS system followed by quantiﬁcation of CPs by mathematical
deconvolution using technical CPs. This technique can also detect the lower chlorinated congers (Cl2–Cl4),
and SCCPs, MCCPs and LCCPs can simultaneously be analysed in one single run. In recent interlaboratory
studies, the APCI-TOF method showed good results (see below).
Another challenge in CP analysis is the reliable determination of CPs, which is important for
assessing the persistence, bioaccumulation and hazard assessment of these compounds. Currently,
only semi-quantitative analysis is possible due to a lack of proper analytical standards and the
complexity of data analysis and processing. Using the novel techniques described above and using
pattern matching and deconvolution, accuracy and precision are improving. One signiﬁcant problem
with the determination of CPs is that the only available analytical standards do not match the chlorine
conﬁguration of the congeners present in the technical CPs mixtures. Commercial standards contain
chlorine atoms at the end positions of the carbon chain while the CPs present in the technical mixtures
mainly have chlorines in the middle of the chain. For many years, commercial companies have tried to
synthesise individual CPs with chlorine atoms in the mid position and some of them have been made
available. No information was available concerning the response factors of these congeners.
In contrast to the low number of analytical standards, over the last 10 years globally more than
200 CP formulations have been used in various applications globally (Zeng et al., 2015). Each of these
formulations contain CPs with different carbon length and chlorination degree.
Also because of the fact that during weathering, biotransformation, metabolism and uptake, the
carbon length and chlorination degree of the technical CP mixtures that are present may change as
degradation occurs (see Section 1.3.3). There are no suitable analytical standards available and it is
challenging even to ﬁnd commercial technical CPs that may be suitable as an inferior method for the
quantiﬁcation of CPs in environmental and food samples.
Analytical quality assurance
Several interlaboratory studies have been carried out using samples of different complexity
(analytical standards, sample extracts and real samples) (Tomy et al., 1999; Pellizzato et al., 2009b;
Van Mourik et al., 2015). These studies show that the accuracy and precision is improving. The
variation between laboratories can be more than 100% when the most commonly used technique, GC-
ECNI-MS, is used (Van Mourik et al., 2015). The results of a ﬁrst interlaboratory study showed that the
variation in the analysis of a standard solution was between 22 and 56%. If real life samples (unspiked
ﬁsh extract) were analysed the variation increased to 137%, and the results fell in two groups which
had a difference of about 10-fold in concentration. This variation is probably due to the different types
of analytical techniques used to quantify CPs (Van Mourik et al., 2015).
An overview of the SCCP 2011–2017 Quasimeme worldwide interlaboratory studies is given in
Table 4. In the last round, ﬁve different analytical techniques were used (Van Mourik et al., 2018).
The participants (overall 33 laboratories from 14 countries) analysed test solutions to various matrices
and the relative standard deviations (RSDs) varied between 23 and 137% of these materials. The RSD
of the test solution in the last round (25%) was acceptable. Interestingly, the results with GC-ECNI-MS
varied the most, and those obtained with newer techniques (APCI-qTOF-MS) showed good agreement
between the consensus values and the true value.
Table 4: Overview of Quasimeme interlaboratory studies (from Van Mourik et al., 2018)
Round (year) Provided sample (extract) Provided sample preparation Exercise
1 (2012) Test solution SCCPs in isooctane Quantify
2 (2014) Fish PLE + Al2O3 + silica Quantify
3 (2015) a. Sediment
b. Sediment
a. PLE + acid silica + SILICA
b. PLE only
a. Quantify
b. Clean-up and Quantify
4 (2017) a. Test solution
b. House dust
c. Soil
d. Fish
a. SCCPs in isooctane
b. PLE + acid silica + silica 2x
c. PLE + acid silica + silica 2x
d. PLE + acid silica + silica 2x
a. Quantify
b. Quantify
c. Quantify
d. Quantify
PLE: pressurised liquid extraction; SCCPs: short-chain chlorinated parafﬁns.
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Between 2017 and 2019, the two ﬁrst rounds of an interlaboratory study on the determination of
CPs in food samples was organised by the EU Reference Laboratory (EU-RL) for Halogenated POPs in
Feed and Food (Kr€atschmer and Sch€achtele, 2019). The ﬁrst round consisted of samples of coconut fat
spiked with SCCP and MCCP standards, and the second round consisted of lard samples spiked with
SCCPs and MCCPs mimicking homologue proﬁles commonly found in ﬁsh, and to which PCBs and
PBDEs were added to some of the test samples to reﬂect the content of real food samples. More than
55% of the participating laboratories (18 and 9 participants in the ﬁrst and second round, respectively)
had a satisfactory overall performance. The authors reported that the assigned z-scores for the
different samples suggest difﬁculties in the correct quantiﬁcation of SCCPs in the presence of MCCPs, a
situation likely to reﬂect real food samples. HRMS and LRMS were both reported to perform
satisfactorily. The authors identiﬁed as the main factors inﬂuencing the quality of the results, the
choice of calibration standards, the instrument and type of quantiﬁcation/data processing method.
Further rounds of this interlaboratory study are planned for 2019–2020.
1.3.5. Previous assessments
Several international bodies have carried out hazard or risk assessments related to CPs. These
assessments evaluated in a number of cases the environmental risks as well as the risk for human
health. The latter are summarised below and in Tables 5 (for SCCPs), 6 (for MCCPs), 7 (for LCCPs)
and 8 (all three groups combined). Existing classiﬁcations for SCCPs, MCCPs and LCCPs are
summarised in Table 9.
No assessments related to the risk for farm animals, horses and companion animals have been
identiﬁed.
1.3.5.1. SCCPs
The National Toxicology Program (NTP) has conducted toxicology and carcinogenesis studies of
SCCPs (C12, 60% chlorination) in rats and mice (NTP, 1986a). NTP concluded that there was clear
evidence of carcinogenicity for F344/N rats. This was based on increased incidences of hepatocellular
neoplasms (primarily neoplastic nodules) in male and female rats, of adenomas or adenocarcinomas
(combined) of the kidney tubular cells in male rats, and of follicular cell adenomas or carcinomas
(combined) of the thyroid gland in female rats; and for B6C3F1 mice as shown by increased incidences
of hepatocellular adenomas and of adenomas or carcinomas (combined) in male and female mice and
increased incidences of adenomas and of adenomas or carcinomas (combined) of thyroid gland
follicular cells in female mice. NTP concluded that ‘SCCPs (C12, 60% chlorination) are reasonably
anticipated to be human carcinogens based on sufﬁcient evidence of carcinogenicity from studies in
experimental animals’ (NTP, 2016).
The International Agency for Research on Cancer (IARC) concluded that there was sufﬁcient
evidence for the carcinogenicity of SCCPs (C12, 60% chlorination) in experimental animals and
classiﬁed it as Group 2B ‘possibly carcinogenic to humans’ (IARC, 1990). IARC also noted that no data
were available from studies in humans on the carcinogenicity of CPs.
In 1993, Health Canada assessed the CPs in terms of ‘Toxic’ under the Canadian Environmental
Protection Act (CEPA) for Environment (CEPA Paragraph 11a), for Environment on which human life
depends (CEPA Paragraph 11b) and for human Life or health (CEPA Paragraph 11c) (Health Canada,
1993). SCCPs were considered to be ‘toxic’ as deﬁned under Paragraph 11(c) of the CEPA due to their
carcinogenicity.
The WHO/IPCS reviewed the information available in relation to effects of CPs on human health
and the environment (WHO/IPCS, 1996). For SCCPs, a tolerable daily intake (TDI) of 100 lg/kg body
weight (bw) per day was derived for non-neoplastic effects based on the lowest reported no-observed
effect level (NOEL) of 10 mg/kg bw per day and applying an uncertainty factor of 100 to account for
inter- and intraspecies variations (10 9 10). Increases in liver and kidney weights and hypertrophy of
the liver and thyroid were observed at the next highest dose level in a 13-week study on rats (IRDC,
1984, as cited in WHO/IPCS, 19964) For neoplastic effects, it was recommended that daily doses of
SCCPs for the general population should not exceed 11 lg/kg bw per day. This recommendation was
4 IRDC, 1984. 13-week oral (gavage) toxicity study in rats with combined excretion, tissue level and elimination studies:
determination of excretion, tissue level and elimination after single oral (gavage) administration to rats. Chlorinated parafﬁn:
58% chlorination of short-chain length n-parafﬁns; 14C-labelled CP. Mattawan, Michigan, International Research and
Development Corporation, 350 pp (Report No. 438-029/022). As cited in WHO/IPCS (1996). Note: Study report also provided
to EFSA (IRDC, 1984b, see Documentation provided to EFSA).
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based on the estimated dose associated with a 5% increase in tumour incidence (hepatocellular
adenomas or carcinomas (combined) in male mice) of 11 mg/kg bw per day and an uncertainty factor
of 1,000 for a non-genotoxic carcinogen (not further detailed in the WHO/IPCS document). Compared
to the estimated worst case, daily intake of dairy products and mussels of 4.3 and 25 lg/kg bw per
day, respectively (see Section 3.3.1.2 for further details on the exposure assessment), the
Committee concluded that, in general, the calculated daily intakes are below the TDIs estimated for
non-neoplastic effects of the SCCPs, as well as the recommended value for neoplastic effects for
SCCPs.
In the context of the programme on high production volume (HPV) chemicals, the Organisation for
Economic Co-operation and Development (OECD) has reviewed the toxicological data on SCCPs (C10–
13, chloro) and published the results in a Screening Information Dataset (SIDS) Initial Assessment
Proﬁle (OECD, 2000). It was concluded that SCCPs are of low toxicity with no-observed adverse effect
levels (NOAELs) for general toxicity (decreased body weight gain and increased kidney weight) of 100
and 1,000 mg/kg bw per day for rats and mice, respectively, following repeated exposure.
A risk assessment report (RAR) for SCCPs (C10–13, chloro) performed under the remit of the
European Chemicals Bureau was ﬁnalised in 1999 and published in 2000 (EU-RAR, 2000). The
assessment concluded on the risk for worker’s exposure, consumer’s exposure from products
containing SCCPs (e.g. from their use in textiles or leather treatment), and also the general population
from indirect exposure via the environment, including food. A NOAEL of 100 mg/kg bw per day was
identiﬁed based on general non-speciﬁc toxicity from repeated dose toxicity studies in rats and mice,
and of 500 mg/kg bw per day for developmental effects. Based on the NTP studies in rodents (NTP,
1986a) it was noted that the SCCPs tested produced toxicologically signiﬁcant, dose-related increases
in the incidence of several tumour types. For the liver, the chronic tissue damage was considered to be
caused by peroxisome proliferation and for the thyroid by long-term hormonal stimulation, and not
relevant to human health. For the kidney, the benign tumours observed in male rats were not
considered likely to be relevant for human health. An estimated human intake of 20 lg/kg bw per day
from indirect exposure via the environment (including food) was considered to be a reasonable worst-
case prediction based on real data (see Section 3.3.1.2 for further details on the exposure
assessment). A ‘margin of safety’ of 5,000 between the NOAEL for repeated dose toxicity of 100 mg/
kg bw per day and the estimated human intake of 20 lg/kg bw per day indicates that there is no
signiﬁcant risk to man exposed via the environment’, including food. In an updated version of the RAR
(EU-RAR, 2008), risk characterisation for exposure of infants exposed via milk was included, based on
the information from the MCCP EU-RAR (see below) that internal haemorrhaging leading to deaths has
been observed in suckling rat pups from dams treated with MCCPs. Exposure of infants via human milk
and cow’s milk was estimated based on available published data. Large margins between the
estimated infant intake (of both human milk and cow’s milk) and the levels at which adverse effects
mediated via lactation have been seen in animals exposed to MCCPs indicate there is no signiﬁcant risk
to infants from intake of human milk and cow’s milk.
The Commonwealth of Australia has published an assessment of SCCPs in 2001, which was carried
out under the ‘National Industrial Chemicals Notiﬁcation and Assessment Scheme (NICNAS)’ (NICNAS,
2001). The assessment was based on information from a number of sources. The purpose of the
assessment was to: (1) determine manufacture/importation volumes; (2) identify likely or potential
uses of SCCPs in Australia; (3) review the properties of SCCPs; (4) determine the potential for public
and occupational exposure and exposure to the environment resulting from use; (5) review and
summarise the health and environmental effects; and (6) determine whether or not the signiﬁcance for
risk is such that a full (risk) assessment should be undertaken. NICNAS recommended that a full risk
assessment of the use of SCCPs in metal work was needed for the environment, if new data indicating
acceptable releases to sewer was not identiﬁed. Whereas, further assessment work for workers and
the public was not recommended.
Upon request from the Danish Environmental Protection Agency, Nielsen and Ladefoged (2013)
evaluated the health hazards from exposure to CPs to propose a health-based quality criterion for CPs
in ambient air. The assessment was ﬁnalised in 2006 and published in 2013. The assessment of SCCPs
was based on the EU-RARs for SCCPs (EU-RAR, 2000), as well as on the WHO/IPCS (1996) and IARC
(1990) evaluations. The authors identiﬁed an overall NOAEL for CPs of 10 mg/kg bw per day for
effects in the liver, kidney and thyroid as well as for the effects observed in developing offspring. A TDI
of 100 lg/kg bw per day was calculated by applying an uncertainty factor of 100 to account for inter-
and intraspecies variations (10 9 10).
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In 2008, Health Canada published an assessment of SCCPs (C10–13) (Health Canada, 2008). An
exposure assessment of the Canadian population was done considering uptake via ambient air, indoor
air, drinking water, food and soil based on measured concentrations from published studies, although a
high degree of uncertainty was acknowledged in the food estimates. Health Canada considered that
the lowest-observed adverse effect level (LOAEL) of 100 mg/kg bw per day for increases in liver and
kidney weights and hypertrophy of the liver and thyroid, identiﬁed from a 90-day gavage study in rats
(IRDC, 1984, as cited by Health Canada, 20085) was the most sensitive LOAEL for mammals.
Regarding carcinogenic effects, Health Canada referred to the WHO/IPCS (1996) estimated dose
associated with a 5% increase in tumour incidence (tumourigenic dose05 [TD05]) of 11 mg/kg bw per
day. The adult (20–59 years old) upper bound (UB) exposure was estimated at 7.18 lg/kg bw per day
(see Section 3.3.1.2 for further details on the exposure assessment). The highest exposure
estimates were for younger age groups, with infants not formula fed showing the highest estimate
(25.97 lg/kg bw per day), while breastfed infants and formula fed infants were estimated to have an
intake of 1.7 and 0.01 lg/kg bw per day, respectively (Health Canada, 2008). The committee did not
establish a TDI, but based on the TDI for non-neoplastic effects of 100 lg/bw per day established by
WHO/IPCS (1996), Health Canada concluded that the highest exposure estimate of 25.97 lg/kg bw
per day was within the range of the TDI. For the carcinogenic effects, Health Canada concluded that
the margin (440) between the WHO/IPCS TD05 of 11 mg/kg bw per day and the highest estimate of
exposure was inadequate, considering the uncertainty in the mode of induction of tumours.
The UK Committee on Toxicity (UK-COT) published in 2009 a statement on SCCPs (C10–13) (UK-COT,
2009). The Committee established a TDI of 30 lg/kg bw per day, based on a NOAEL of 10 mg/kg bw
per day for increased kidney weight, mild nephritis in males and brown pigmentation in renal tubules
in females from a 90 day gavage and dietary study described in the EU-RAR (1999, as cited by UK-
COT, 20096). An uncertainty factor of 3 was applied to take into account that the NOAEL was not from
a long-term study, as well as uncertainty factors of 10 for interspecies variation and 10 for intraspecies
variation. For the exposure assessment, and due to the scare data available, the Committee made the
conservative assumption that all solid food consumed contained SCCPs at the level of 6.0 lg/kg (as
the highest value reported in freshwater eel) (see Section 3.3.1.2 for further details on the exposure
assessment). The exposure of a 97.5th percentile adult consumer would be 0.12 lg/kg bw per day
while for children 4–6 years old it would be 0.29 lg/kg bw per day. The Committee concluded that the
large margin between the TDI and the exposure estimates indicated no cause for concern regarding
dietary exposure to SCCPs.
5 IRDC, 1984. 13-week dietary toxicity study in rats with combined excretion, tissue level and elimination studies/determination
of excretion, tissue level and elimination after single oral (gavage) administration to rats. Chlorinated parafﬁn: 70% chlorination
of long-chain length n-parafﬁns; 14C-labelled CP. Mattawan, Michigan, International Research and Development Corporation,
316 pp (Report No. 438-027/024). As cited in Health Canada (2008). Note: Study report also provided to EFSA (IRDC, 1984e,
see Documentation provided to EFSA).
6 ECB (European Chemicals Bureau), 1999. Alkanes, C10-13, chloro. European Union Risk Assessment Report. As cited in UK-COT
(2009). Note: report cited in this opinion as EU-RAR (2000).
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Table 5: Previous assessments on short-chain chlorinated parafﬁns (C10–13)
Organisation
TDI
(lg/kg bw
per day)
NOAEL
(mg/kg bw per day)
Critical endpoint (s)
Relevant
Study
Study
reference
Uncertainty
factor
Remarks
WHO/IPCS
(1996)
100
(for non-neoplastic
effects)
10 ↑ liver and kidney weights
and hypertrophy of the liver
and thyroid
90-day rat study IRDC (1984)(a) 100 Uncertainty factor for intra-
and interspecies variation
(10 9 10)
WHO/IPCS
(1996)
11
(for neoplastic
effects)
11 (the estimated dose
associated with a 5%
increase in tumour
incidence)
hepatocellular adenomas or
carcinomas (combined)
2-year mouse
study
NTP (1986a),
Bucher et al.
(1987)
1,000 Uncertainty factor for non-
genotoxic carcinogen
OECD (2000) Not derived 100 ↓ body weight gain and
increased kidney weight
Rat studies n.a. n.a. –
EU-RAR
(2000)
Not derived 100
500
General non-speciﬁc toxicity
Developmental effects
Rat and mouse
studies
n.a.
n.a.
n.a. –
Health Canada
(2008)
Not derived 100 (LOAEL) ↑ liver and kidney
weights and hypertrophy of
the liver and thyroid
90-day rat study IRDC (1984)(b) n.a. –
UK-COT
(2009)
30 10 ↑ kidney weight, mild
nephritis in males and brown
pigmentation in renal tubules
in females
90-day rat
studies
As cited in EU-
RAR (1999)(c)
300 Uncertainty factor for intra-
(10) and interspecies (10)
variations, and an additional
uncertainty factor of 3 for a
non-chronic study
NOAEL: no-observed adverse effect level; LOAEL: lowest-observed adverse effect level; TDI: tolerable daily intake; bw: body weight.
(a): IRDC, 1984. 13-week oral (gavage) toxicity study in rats with combined excretion, tissue level and elimination studies: determination of excretion, tissue level and elimination after single oral
(gavage) administration to rats. Chlorinated parafﬁn: 58% chlorination of short-chain length n-parafﬁns; 14C-labelled CP. Mattawan, Michigan, International Research and Development
Corporation, 350 pp (Report No. 438-029/022). As cited in WHO-IPCS (1996). Note: Study report also provided to EFSA (IRDC, 1984b, see Documentation provided to EFSA).
(b): IRDC, 1984. 13-week dietary toxicity study in rats with combined excretion, tissue level and elimination studies/determination of excretion, tissue level and elimination after single oral
(gavage) administration to rats. Chlorinated parafﬁn: 70% chlorination of long-chain length n-parafﬁns; 14C-labelled CP. Mattawan, Michigan, International Research and Development
Corporation, 316 pp (Report No. 438-027/024). As cited in Health Canada (2008). Note: Study report also provided to EFSA (IRDC, 1984e, see Documentation provided to EFSA).
(c): ECB (European Chemicals Bureau), 1999. Alkanes, C10–13, chloro. European Union Risk Assessment Report. As cited in COPT (2009). Note: report cited in this opinion as EU-RAR (2000).
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1.3.5.2. MCCPs
In 1993, Health Canada assessed the CPs in terms of ‘Toxic’ under the CEPA for Environment (CEPA
Paragraph 11a), for Environment on which human life depends (CEPA Paragraph 11b) and for human
Life or health (CEPA Paragraph 11c) (Health Canada, 1993). It could not be assessed whether MCCPs
were ‘toxic’ as deﬁned under Paragraph 11(c) of the CEPA. This was due to that the available data
were considered inadequate for an assessment of whether current concentrations of MCCPs present in
the environment could constitute a danger in Canada to human life or health.
The WHO/IPCS reviewed the information available in relation to effects of MCCPs on human health
and the environment (WHO/IPCS, 1996). A TDI of 100 lg/kg bw per day was derived for non-
neoplastic effects based on a NOAEL of 10 mg/kg bw per day and applying an uncertainty factor of
100 to account for inter- and intraspecies variations (10 9 10). Increases in liver and kidney weight
were observed at the next highest dose level in a 13-week study on rats (IRDC, 1984, as cited in
WHO/IPCS, 19967) Compared to the estimated worst-case daily intake of dairy products and mussels
of 4.3 and 25 lg/kg bw per day, respectively (see Section 3.3.1.2 for further details on the exposure
assessment), the Committee concluded that in general, the calculated daily intakes are below the TDI
estimated for MCCPs.
A RAR on human health by the European Chemicals Bureau for MCCPs (C14–17, chloro) was ﬁnalised
in 2008 and published in 2011 (EU-RAR, 2011). The assessment concluded on the risk for worker’s
exposure, consumer’s exposure from products containing MCCPs (e.g. from their use in textiles or
leather treatment), and also the general population from indirect exposure via the environment,
including food. A NOAEL of 23 mg/kg bw per day was identiﬁed for increased kidney weight from
repeated dose toxicity studies in rats. In the absence of carcinogenicity studies, it could not be ruled
out that the observed kidney toxicity might lead to kidney tumours through a non-genotoxic mode of
action; therefore, it was decided to apply the same NOAEL of 23 mg/kg bw per day for neoplastic
effects for the risk characterisation. From studies on effects in lactating rat pups (internal
haemorrhaging and deaths) of dams treated with MCCPs, a maternal NOAEL of 100 mg/kg bw per day
was selected for the risk characterisation of haemorrhaging effects potentially occurring in pregnant
women at the time of parturition. A maternal NOAEL of 47 mg/kg bw per day was selected for the risk
characterisation of an adult population of breastfeeding mothers that might be exposed to MCCPs via
the environment, including food. Overall, 50% absorption by the oral route was used for risk
characterisation purposes. The total daily human exposure from regional sources has been estimated
to 1.3 9 104 mg/kg bw per day and the highest continuous local exposure was estimated to be
0.016 mg/kg bw per day. The margins between the NOAELs and the estimated human exposures from
regional and local sources indicated that there was no signiﬁcant risk to man exposed via the
environment, including food. Exposure of infants via human milk and cow’s milk was estimated based
on available published data. Very large margins between the estimated infant intake (of both human
milk and cow’s milk) and the levels at which adverse effects mediated via lactation have been seen in
animals indicated that there was no signiﬁcant risk to infants from intake of human milk and cow’s
milk.
Upon request from the Danish Environmental Protection Agency, Nielsen and Ladefoged (2013)
evaluated the health hazards from exposure to CPs to propose a health-based quality criterion for CPs
in ambient air. The assessment was ﬁnalised in 2006 and published in 2013. The assessment of MCCPs
was based on the EU-RAR for MCCPs (unpublished at the time of the Nielsen and Ladefoged
assessment, later published as EU-RAR, 2011), as well as on the WHO/IPCS (1996) and IARC (1990)
evaluations. The authors identiﬁed an overall NOAEL for CPs of 10 mg/kg bw per day for effects in the
liver, kidney and thyroid as well as for the effects observed in developing offspring. A TDI of 100 lg/kg
bw per day was calculated by applying an uncertainty factor of 100 to account for inter- and
intraspecies variations (10 9 10).
In 2008, Health Canada published an assessment of MCCPs (C14–17) (Health Canada, 2008). An
exposure assessment of the Canadian population was done considering uptake via ambient air, indoor
air, drinking water, food and soil based on measured concentrations from published studies, although a
high degree of uncertainty was acknowledged in the food estimates. Health Canada noted that the
7 IRDC, 1984. 13-week oral (dietary) toxicity study in rats with combined excretion, tissue level and elimination studies:
determination of excretion, tissue level and elimination after single oral (gavage) administration to rats. Chlorinated parafﬁn:
52% chlorination of intermediate-chain length n-parafﬁns, 14C-labelled CP. Mattawan, Michigan, International Research and
Development Corporation, 328 pp (Report No. 438-023/026). As cited in WHO/IPCS (1996). Note: Study report also provided
to EFSA (IRDC, 1984c, see Documentation provided to EFSA).
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lowest effect level observed for mammals is the LOAEL of 4.2 mg/kg bw per day (NOAEL = 0.4 mg/kg
bw per day) for mild effects on the kidney and thyroid of female rats from a 13-week feeding study
(Poon et al., 1995). Health Canada indicated that a TDI based on the NOAEL from the Poon et al.
(1995) study would be similar to the TDI of 6 lg/kg bw per day as previously established. Regarding
the exposure estimates, the adult (20–59 years old) UB exposure was 4.69 lg/kg bw per day (see
Section 3.3.1.2 for further details on the exposure assessment). The largest total exposure was
found for infants not formula fed (25.51 lg/kg bw per day). No exposure estimate was reported for
breastfed infants, while for formula fed infants it was 0.05 lg/kg bw per day (Health Canada, 2008).
The Committee concluded that these estimates exceed the TDI (6 lg/kg bw per day), for infants not
formula fed up to fourfold.
The UK-COT published in 2009 a statement on MCCPs (C14–17) (UK-COT, 2009). The Committee
established a TDI of 4 lg/kg bw based on a NOAEL of 4 mg/kg bw per day identiﬁed for changes in
relative liver weight and minimal changes in the inner cortex of the kidney in female rats from a
90-day dietary study described in the EU-RAR (2004, as cited by UK-COT, 20098). Besides the
uncertainty factors of 10 for interspecies and 10 for intraspecies variation, an additional uncertainty
factor of 10 was applied to account for the absence of longer term studies and the lack of a NOAEL for
reproductive and developmental effects. For the exposure assessment, and due to the scarce data
available, the Committee made the conservative assumption that all solid food consumed contained
MCCPs at the level of 31.9 lg/kg (as the highest value reported in freshwater eel). The exposure of a
97.5th percentile adult consumer would be 0.63 lg/kg bw per day while for children 4–6 years old it
would be 1.6 lg/kg bw per day. The Committee concluded that the margin between the TDI and the
exposure estimates indicated no cause for concern regarding dietary exposure to MCCPs.
In 2011, the German Federal Institute for Occupational Safety and Health (BauA) summarised the
information on MCCPs (BauA, 2011). An occupational exposure limit of 6 mg/m3 (8-hour time-
weighted average) was proposed based on the NOAEL of 23 mg/kg bw per day for increased kidney
weight identiﬁed from a 90-day rat study (CXR, 2005, as cited in BauA, 20119).
In 2015, US-Environmental Protection Agency (US-EPA) reviewed the toxicity of MCCPs in the frame
of a pre-manufacture notice submission to assess the occupational and non-occupational risks (US-
EPA, 2015). The lowest NOAEL of 23 mg/kg bw per day for increased kidney weight identiﬁed from a
90-day rat study (CXR, 2005, as cited in US-EPA, 201510) was used to assess the risk. This oral NOAEL
was converted to a human equivalent dose (HED). The margin between the HED and the exposure
estimates were considered by US-EPA to indicate a low risk to the general population from
environmental releases of MCCPs via exposure to drinking water or ﬁsh ingestion.
8 ECB (European Chemicals Bureau), 2004. Alkanes, C14–17, chloro. Draft European Union Risk Assessment Report. Note:
report cited in this opinion as EU-RAR (European Union-Risk Assessment Report) (2011).
9 CXR, 2005. A dietary study to determine the 90-day NOAEL of medium chain chlorinated parafﬁns (Cereclor S52) in male and
female Fisher 344 rats. CXR0273. CXR Bioscience Ltd, Dundee, UK. Unpublished report. As cited by BauA (2011). Note: Study
report also provided to EFSA (CXR, 2005b, see Documentation provided to EFSA).
10 CXR, 2005. Study to Investigate the Elimination of Medium Chain Chlorinated Parafﬁns in Male F344 Rats. CXR0204. Elcombe,
B.M., Dundee, UK. As cited by US-EPA (2015).
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Table 6: Previous assessments on medium-chain chlorinated parafﬁns (C14–17)
Organisation
TDI(lg/kg bw
per day)
NOAEL(mg/kg
bw per day)
Critical endpoint(s) Relevant study
Study
reference
Uncertainty
factor
Remarks
WHO/IPCS
(1996)
100 10 ↑ liver and kidney weight 90-day rat study IRDC
(1984)(a)
100 Uncertainty factor for intra- and
interspecies variations (10 9 10)
EU-RAR
(2011)
Not derived 23
100
47
↑ kidney weight,neoplastic
effects
Maternal effects – for risk
characterisation of
haemorrhaging effects
Maternal effects – for risk
characterisation of
breastfeeding mothers
Rat studies n.a.
Health Canada
(2008)
Not derived 4.2 (LOAEL) Mild effects on the kidney
and thyroid of female rats
90-day rat study Poon et al.
(1995)
n.a.
UK-COT
(2009)
4 4 Changes in relative liver
weight and minimal changes
in the inner cortex of the
kidney in female rats
90-day rat study As cited in
EU-RAR
(2004)(b)
1,000 Uncertainty factor for intra- and
interspecies variations (10 9 10), and an
additional uncertainty factor of 10 to
allow for the absence of longer term
studies and the lack of a NOAEL for
reproductive and developmental effects
BauA (2011) Not derived 23 ↑ kidney weight 90-day rat study CXR (2005)(c) n.a. For derivation of the NOAEL: Uncertainty
factor for intra- and interspecies
variations (5 9 1), and an additional
uncertainty factor of 2 for subchronic to
chronic duration. Allometric scaling
applied for conversion of dose in the rat
study to the human situation
US-EPA (2015) not derived 23 ↑ kidney weight 90-day rat study CXR (2005)(d) n.a.
NOAEL: no-observed adverse effect level; LOAEL: lowest-observed adverse effect level; TDI: tolerable daily intake; bw: body weight.
(a): IRDC, 1984. 13-week oral (dietary) toxicity study in rats with combined excretion, tissue level and elimination studies: determination of excretion, tissue level and elimination after single oral
(gavage) administration to rats. Chlorinated parafﬁn: 52% chlorination of intermediate-chain length n-parafﬁns, 14C-labelled CP. Mattawan, Michigan, International Research and Development
Corporation, 328 pp (Report No. 438-023/026). As cited in WHO/IPCS (1996). Note: Study report also provided to EFSA (IRDC, 1984c, see Documentation provided to EFSA).
(b): ECB (European Chemicals Bureau), 2004. Alkanes, C14–17, chloro. Draft European Union Risk Assessment Report. Note: report cited in this opinion as EU-RAR (2011).
(c): CXR, 2005. A dietary study to determine the 90 day NOAEL of medium-chain chlorinated parafﬁns *Cereclor S52(in male and female Fisher 344 rats. CXR0273. CXR Bioscience Ltd, Dundee,
UK. Unpublished report. As cited by BauA (2011). Note: Study report also provided to EFSA (CXR, 2005b, see Documentation provided to EFSA).
(d): CXR, 2005. Study to Investigate the Elimination of Medium Chain Chlorinated Parafﬁns in Male F344 Rats. CXR0204. Elcombe, B.M., Dundee, UK. As cited by US-EPA (2015).
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1.3.5.3. LCCPs
The NTP has conducted toxicology and carcinogenesis studies of LCCPs (C23, 43% chlorination)
(NTP, 1986b). NTP concluded that there was no evidence of carcinogenicity for male F344/N rats,
equivocal evidence of carcinogenicity for female F344/N rats as shown by an increased incidence of
adrenal gland medullary pheochromocytomas, clear evidence of carcinogenicity for male B6C3F1 mice
as shown by an increase in the incidence of malignant lymphomas, and equivocal evidence of
carcinogenicity for female B6C3F1 mice as shown by a marginal increase in the incidence of
hepatocellular neoplasms.
IARC (1990) concluded that there is limited evidence for the carcinogenicity of LCCPs (C23, 43%
chlorination) in experimental animals.
In 1993, Health Canada assessed the CPs in terms of ‘Toxic’ under the CEPA for Environment (CEPA
Paragraph 11a), for Environment on which human life depends (CEPA Paragraph 11b) and for human
Life or health (CEPA Paragraph 11c) (Health Canada, 1993). It could not be assessed whether LCCPs
were ‘toxic’ as deﬁned under Paragraph 11(c) of the CEPA. This was due to that the available data
were considered inadequate for an assessment of whether current concentrations of LCCPs present in
the environment could constitute a danger in Canada to human life or health.
The WHO/IPCS reviewed the information available in relation to effects of LCCPs on human health
and the environment (WHO/IPCS, 1996). A TDI of 100 lg/kg bw per day was derived for non-
neoplastic effects based on a LOAEL of 100 mg/kg bw per day for multifocal granulomatous hepatitis
and increased liver weight in female rats (NTP, 1986b; Bucher et al., 1987; Serrone et al., 1987). An
uncertainty factor of 1,000 was applied to account for inter- and intraspecies variations (10 9 10) and
because the TDI was derived based on a LOAEL instead of a NOAEL (a factor of 10). Compared to the
estimated worst-case daily intake of dairy products and mussels of 4.3 and 25 lg/kg bw per day,
respectively (see Section 3.3.1.2 for further details on the exposure assessment), the Committee
concluded that in general, the calculated daily intakes are below the TDI estimated for LCCPs.
The National Research Council (NRC, 2000) reviewed the toxicological risks of selected ﬂame
retardants, including LCCPs (C20–30, with high chlorine content, i.e. 70% chlorination) used in
residential furniture. A NOAEL of 900 mg/kg bw per day was identiﬁed for an LCCP (C22–26, 70%
chlorination) from a 13-week study in rats (Serrone et al., 1987). This was based on liver toxicity
(increased relative liver weight, hepatocellular hypertrophy, cytoplasmic fat vacuolation, increases in
serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities) and kidney
toxicity (a slight increase in the incidence of nephritis in males). Based on this NOAEL, a reference
dose (RfD) of 300 lg/kg bw per day was derived for LCCPs (C20–30, 70% chlorination). Uncertainty
factors were applied to account for interspecies variation (a factor of 3 instead of 10 was used because
the toxicokinetics and toxicodynamics of LCCPs were anticipated to be similar in rodents and humans)
and intraspecies variation (factor of 10), as well as two additional factors (10 to account for less-than-
lifetime toxicity data and 10 because the toxicity database for LCCPs (C22–26, 70% chlorination) was
incomplete).
Upon request from the Danish Environmental Protection Agency, Nielsen and Ladefoged (2013)
evaluated the health hazards from exposure to CPs to propose a health-based quality criterion for CPs
in ambient air. The assessment was ﬁnalised in 2006 and published in 2013. The assessment of LCCPs
was based on the WHO/IPCS (1996) and IARC (1990) evaluations. The authors identiﬁed an overall
NOAEL for CPs of 10 mg/kg bw per day for effects in the liver, kidney and thyroid as well as for the
effects observed in developing offspring. A TDI of 100 lg/kg bw per day was calculated by applying an
uncertainty factor of 100 to account for inter- and intraspecies variations (10 9 10).
In 2008, Health Canada published an assessment of LCCPs (C≥18), with an update in 2012 (Health
Canada, 2008, 2012). An exposure assessment of the Canadian population was done considering
uptake via ambient air, indoor air, drinking water, food and soil based on measured concentrations
from published studies, although a high degree of uncertainty was acknowledged in the food
estimates. Health Canada considered that the lowest effect level was 100 mg/kg bw per day (NTP,
1986b; Bucher et al., 1987; Serrone et al., 1987); the main effects were seen on the liver. A TDI of
71 lg/kg bw per day is mentioned for non-neoplastic effects; however, there is no information on how
this TDI has been established (Health Canada, 2008). According to the updated assessment on LCCPs
(Health Canada, 2012), the TDI of 71 lg/kg bw per day was based on the LOAEL of 100 mg/kg bw
per day for adverse effects (diffuse lymphohistiocytic inﬂammation in the liver and in the pancreatic
and mesenteric lymph nodes in female rats) from a carcinogenicity study (NTP, 1986b; Bucher et al.,
1987). An uncertainty factor of 1,000 (10 for intraspecies variation, 10 for interspecies variation, 10 for
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use of a LOAEL rather than a NOAEL) was applied and multiplied by a factor of 5/7 (for conversion of
5 days per week administration to daily exposure). Regarding the exposure estimates, the adult
(20–59 years old) UB exposure was 2.12 lg/kg bw per day. The largest total exposure was found for
infants not formula fed (16.83 lg/kg bw per day). No exposure estimate was reported for breastfed
infants, while for formula fed infants it was 0.07 lg/kg bw per day (Health Canada, 2008). The
Committee concluded that none of the highly uncertain exposure estimates for the general population
exceeds the TDI (71 lg/kg bw per day), whereas for infants not formula fed, it is noted that the
exposure is within the same order of magnitude as the TDI. In the updated assessment on LCCPs
(Health Canada, 2012), the adult (20–59 years old) UB exposure was 0.009 lg/kg bw per day. The
largest total exposure was found for the 0.5- to 4-year age group (0.024 lg/kg bw per day). The total
exposure for infants not formula fed was 0.018 lg/kg bw per day and for formula fed infants it was
below 0.01 lg/kg bw per day; no estimate was reported for breastfed infants. The Committee
concluded that the exposure estimates are well below the established TDI.
In 2009, the UK Environment Agency issued a science report on the environmental risks of LCCPs
(UK-Environment Agency, 2009). A LOAEL of 100 mg/kg bw per day was identiﬁed for one LCCP (C22–26,
43% chlorination) based on the presence of liver changes in female rats at all treatment levels (IRDC,
1984, as cited in UK-Environment Agency, 200911). A LOAEL of 100 mg/kg bw per day was identiﬁed for
another LCCP (C23, 43% chlorination) for non-neoplastic changes, based on the presence of microscopic
changes in the liver and lymph nodes at the lowest dose level (NTP, 1986b). And a NOAEL 900 mg/kg bw
per day for a third LCCP (C20–26, 70% chlorination) based on the observation of effects on body weight
gain, food consumption and the liver (IUCLID, 2003). The LOAEL of 100 mg/kg bw per day was taken
forward to the risk assessment for the C20–30 LCCPs, regardless of the chlorination degree, owing to the
uncertainties regarding the inﬂuence of the chlorination state on the toxicity of LCCPs. It was suggested
to divide the LOAEL of 100 mg/kg bw per day by three to provide an estimate of the NOAEL (i.e. assumed
NOAEL = 33.3 mg/kg bw per day). For the C18–20 LCCPs, a NOAEL of 23 mg/kg bw per day was assigned,
based on the repeated dose toxicity data for MCCPs.
In 2015, US-EPA reviewed the toxicity of LCCPs in the frame of a pre-manufacture notice
submission to assess the occupational and non-occupational risks (US-EPA, 2015). A LOAEL of
100 mg/kg bw per day identiﬁed for granulomatous inﬂammation of the liver in female rats from a
2-year rat study (NTP, 1986b) for one LCCP (C23, 43% chlorination) was used to assess the risk. This
oral LOAEL was converted to a HED. The margin between the HED and the exposure estimates were
considered by US-EPA to indicate a low risk to the general population from environmental releases of
LCCPs via exposure to drinking water or ﬁsh ingestion.
1.3.5.4. CPs
In 1990, the German MAK Commission summarised the information on CPs (German MAK
Commission, 1990). The Commission concluded that a MAK value could not be established for the CPs
and therefore, the CPs could not be classiﬁed in one of their pregnancy groups. Regarding
carcinogenicity, the CPs were placed in Section III B12 of the ‘List of MAK Values’.
11 IRCD, 1984. Chlorinated parafﬁn: 43 per cent chlorination of long chain length parafﬁns. 13-week day oral toxicity study in
rats, with combined excretion, tissue level and elimination study. IRDC report 438-028/438-021. As cited in UK-Environment
Agency (2009). Note: Study report also provided to EFSA (IRDC, 1984d, see Documentation provided to EFSA).
12 The section of the List of MAK and BAT Values previously called ‘III B’ was renamed as Category 3B of Section III, which
includes substances that cause concern that they could be carcinogenic for man but cannot be assessed conclusively because
of lack of data. The classiﬁcation in Category 3 is provisional. Classiﬁcation in Category 3B is for substances for which in vitro
or animal studies have yielded evidence of carcinogenic effects that is not sufﬁcient for classiﬁcation of the substance in one
of the other categories. Further studies are required before a ﬁnal decision can be made. A MAK or BAT value can be
established provided no genotoxic effects have been detected (from https://onlinelibrary.wiley.com/doi/pdf/10.1002/
9783527812127.oth).
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Table 7: Previous assessments on long-chain chlorinated parafﬁns (C18–26)
Organisation
TDI
(lg/kg bw
per day)
NOAEL
(mg/kg bw per
day)
Critical endpoint(s)
Relevant
study
Study
reference
Uncertainty
factor
Remarks
WHO/IPCS
(1996)
100 100 (LOAEL) Multifocal granulomatous
hepatitis and increased liver
weight in female rats
2-year rat
study
NTP (1986b);
Serrone et al.
(1987); Bucher
et al. (1987)
1,000 Uncertainty factor for intra- and
interspecies variations (10 9 10), and an
additional factor of 10 for LOAEL instead of
NOAEL
NRC (2000) 300 (RfD) 900 C22–26, 70% chlorination:
liver toxicity (↑ relative liver
weight, hepatocellular
hypertrophy, cytoplasmic fat
vacuolation, ↑ in serum ALT
and AST activities) and
kidney toxicity (a slight ↑ in
the incidence of nephritis in
males)
90-day rat
study
Serrone et al.
(1987)
3,000 A factor of 3 (instead of 10) for
interspecies variation because
toxicokinetics and dynamics of LCCPs were
anticipated to be similar in rodents and
humans, a factor of 10 for intraspecies
variation, a factor of 10 to account for
less-than-lifetime toxicity data, a factor of
10 because the toxicity database for the
LCCPs (C22–26, 70% chlorination) was
incomplete
Health Canada
(2008, 2012)
71 100 (LOAEL) Diffuse lymphohistiocytic
inﬂammation in the liver and
in the pancreatic and
mesenteric lymph nodes in
female rats
2-year rat
study
NTP (1986b) 1,000 Uncertainty factor for intra- and
interspecies variations (10 9 10), an
additional factor of 10 for LOAEL instead of
NOAEL and a factor 5/7 for conversion of
5 days/week administration to daily
exposure
UK-Environment
Agency (2009)
Not derived C22–26, 43%
chlorination:
100 (LOAEL)
C23, 43% chlorination:
100 (LOAEL)
C20–26, 70%
chlorination:
900 (NOAEL)
C18–20:
23 (NOAEL), based on
read-across from
MCCP
Liver changes in females at
all treatment levels
Microscopic changes in the
liver and lymph nodes
Effects on body weight gain,
food consumption and the
liver
90-day rat
study
2-year rat
study
90-day rat
study
IRDC (1984)(a)
NTP (2016)
IUCLID (2003)
n.a. For the risk characterisation, it was
suggested to divide the LOAEL by 3 to
provide an estimate of the NOAEL
www.efsa.europa.eu/efsajournal 33 EFSA Journal 2020;18(3):5991
Chlorinated parafﬁns in feed and food
Organisation
TDI
(lg/kg bw
per day)
NOAEL
(mg/kg bw per
day)
Critical endpoint(s)
Relevant
study
Study
reference
Uncertainty
factor
Remarks
US-EPA (2015) Not derived 100 (LOAEL) Granulomatous inﬂammation
of the liver in female rats
2-year rat
study
NTP (1986b) n.a.
ALT: alanine aminotransferase; AST: aspartate aminotransferase; NOAEL: no-observed adverse effect level; LOAEL: lowest-observed adverse effect level; TDI: tolerable daily intake; bw: body weight.
(a): IRDC, 1984. Chlorinated parafﬁn: 43 per cent chlorination of long-chain length n-parafﬁns. 13-week day oral toxicity study in rats, with combined excretion, tissue level and elimination study.
IRDC report 438-028/438-021. As cited in UK-Environment Agency (2009). Note: Study report also provided to EFSA (IRDC, 1984d, see Documentation provided to EFSA).
Table 8: Group assessment of short-chain chlorinated parafﬁns, medium-chain chlorinated parafﬁns and long-chain chlorinated parafﬁns
Organisation
TDI
(lg/kg bw
per day)
NOAEL
(mg/kg
bw per day)
Critical endpoint
Relevant
study
Study
reference
Uncertainty
factor
Nielsen and
Ladefoged (2013)(a)
100
(group TDI)
10 Effects in the liver, kidney and thyroid as
well as in developing offspring
– several studies 100 For intra- and
interspecies variations
NOAEL: no-observed adverse effect level; TDI: tolerable daily intake; bw: body weight.
(a): The assessment was ﬁnalised in 2006 and was published in 2013.
Table 9: Existing carcinogenicity evaluations for short-chain chlorinated parafﬁns (SCCPs) and long-chain chlorinated parafﬁns (LCCPs)
Organisation Outcome Remarks
SCCPs
NTP
(1986a, 2016)
C12, 60% chlorination:
Clear evidence of carcinogenicity for F344/N rats and for B6C3F1 mice (NTP, 1986a)
Reasonably anticipated to be human carcinogens based on sufﬁcient evidence of
carcinogenicity from studies in experimental animals (NTP, 2016)
IARC
(1990)
C12, 60% chlorination:
Group 2B (possibly carcinogenic to humans)
There is sufﬁcient evidence for the carcinogenicity in experimental
animals. No data were available from studies in humans
LCCPs
Organisation Outcome Remarks
NTP
(1986b)
C23, 43% chlorination:
No evidence of carcinogenicity for male F344/N rats, equivocal evidence of
carcinogenicity for female F344/N rats, clear evidence of carcinogenicity for male
B6C3F1 mice, equivocal evidence of carcinogenicity for female B6C3F1 mice
IARC
(1990)
C23, 43% chlorination:
No IARC Group assigned
There is limited evidence for the carcinogenicity in experimental
animals. No data were available from studies in humans
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1.3.6. Legislation
In order to protect public health, Article 2 of Council Regulation (EEC) No 315/9313 of 8 February
1993 laying down Community procedures for contaminants in food stipulates that, where necessary,
maximum tolerances for speciﬁc contaminants shall be established. Thus, maximum levels for certain
contaminants, e.g. polychlorinated dibenzo-p-dioxins and furans, dioxin-like and non-dioxin-like PCBs
and several polycyclic aromatic hydrocarbons in foodstuffs are currently laid down in Commission
Regulation (EC) No. 1881/200614 of 19 December 2006 (and further amendments). However, none of
the CPs considered in this opinion are regulated under this Regulation or under any other speciﬁc EU
regulation for food.
Council Directive 2002/32/EC15 regulates undesirable substances in animal feed. While maximum
levels are set for a number of inorganic and organic contaminants in various feed materials, none of
the CPs considered in this opinion are regulated under this Directive or any other speciﬁc EU regulation
for feed.
Regulation (EC) No 850/200416 on POPs implements the commitments of the EU under the Stockholm
Convention on POPs. In 2012, it was amended by Commission Regulation (EU) No 519/201217 to include
SCCPs to its Annex I, which lists substances subject to prohibitions. SCCPs (Alkanes C10–13, chloro, CAS
No 85535-84-8, EC no 287-476-5) were listed with speciﬁc exemptions on intermediate use or other
speciﬁcations. The exemptions allowed (i) the production, placing on the market and use of substances
or mixtures containing SCCPs in concentrations < 1% by weight, and (ii) the production, placing on the
market and use of certain applications provided the MS reported on the progress made to eliminate
SCCPs. These derogations were to be reviewed with a view to phasing out the remaining uses of SCCPs
as soon as new information on details of uses and safer alternatives or technologies became available.
In 2015, Commission Regulation (EU) 2015/203018 clariﬁed that articles that contain SCCP in
concentrations lower than 0.15% by weight were allowed to be placed on the market and used
(considering this as the amount of SCCP that may be present as an impurity in an article produced with
MCCP).
According to ANNEX VI of Regulation (EC) No 1272/2008 (Classiﬁcation, Labelling and Packaging
(CLP) Regulation), SCCPs are classiﬁed Carc. 2 H 351 (Suspected of causing cancer), Aquatic Acute
1 H 400 (Very toxic to aquatic life) and Aquatic Chronic 1 H 410 (Very toxic to aquatic life with long
lasting effects). MCCPs are classiﬁed Lact. H 362 (May cause harm to breastfed children), Aquatic
Acute 1 H 400 (Very toxic to aquatic life) and Aquatic Chronic 1 H 410 (Very toxic to aquatic life with
long lasting effects). For LCCPs there is no harmonised classiﬁcation in the EU.
The placing on the market and use of SCCPs is restricted in the EU by Regulation (EC) No 1907/2006
of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and
Restriction of Chemicals (REACH). ‘Alkanes C10–13, chloro’ (CAS No 85535-84-8, SCCPs) are included in
the 2008 candidate list of substances of very high concern for Authorisation on the basis of PBT
(persistent, bioaccumulative and toxic) and vPvB (very persistent and very bioaccumulative) properties,
for eventual inclusion in Annex XIV. The substance was registered but the registration is no longer
active.19 ‘Alkanes C10–12, chloro’ (CAS No 108171-26-2, SCCPs) was in the pre-registration process with
an envisaged registration deadline 31 May 2018. The ﬁnal registration deadline passed, and no
registration dossier was received. ‘Alkanes C14–17, chloro’ (CAS No 85535-85-9, MCCPs) appear as
manufactured and/or imported in the European Economic Area in 10,000–100,000 tonnes per year. This
substance is under the substance evaluation process, as additional data were requested in order to
clarify, among others, whether the substance is a PBT substance.20 ‘Parafﬁn waxes and Hydrocarbon
waxes, chloro’ (CAS No 63449-39-8, LCCPs) appears as manufactured and/or imported in the European
13 Council Regulation (EEC) No 315/93 of 8 February 1993 laying down Community procedures for contaminants in food. OJ L
37, 13.2.1993, p. 1.
14 Commission Regulation (EC) No 1881/2006 of 19 December 2006 setting maximum levels for certain contaminants in
foodstuffs, OJ L 364, 20.12.2006, p. 5-24.
15 Directive 2002/32/EC of the European Parliament and of the Council of 7 May 2002 on undesirable substances in food. OJ L
140, 30.2.2002, p. 10.
16 Regulation (EC) No 850/2004 of the European Parliament and of the Council of 29 April 2004 on persistent organic pollutants
and amending Directive 79/117/EEC. OJ L 158, 29.04.2004. p.7.
17 Commission Regulation (EU) No 519/2012 of 19 June 2012 amending Regulation (EC) No 850/2004 of the European
Parliament and of the Council on persistent organic pollutants as regards Annex I. OJ L 159, 19.06.2012. p.1.
18 Commission Regulation (EU) 2015/2030 of 13 November 2015 amending Regulation (EC) No 850/2004 of the European
Parliament and of the Council on persistent organic pollutants as regards Annex I. OJ L 298, 13.11.2015. p. 1.
19 https://echa.europa.eu/information-on-chemicals/dossier-evaluation-status/-/dislist/substance/100.079.496
20 https://echa.europa.eu/registration-dossier/-/registered-dossier/15252
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Economic Area in 10,000–100,000 tonnes per year.21 There has not been any formal authority
assessment of the PBT/vPvB status under REACH, but there was an assessment under the Existing
Substances Regulation.22
CPs have been listed in other international conventions as described by Fiedler (2010), which is
giving increased global concern on CPs. SCCPs are regulated in the global Stockholm Convention and
in the United Nations Economic Commission for Europe (UNECE) Protocol to the 1979 Convention on
Long-Range Transboundary Air Pollution on POPs (LRTAP POPs). Under the Stockholm Convention,
SCCPs are listed in Annex A for chemicals where measures must be taken to eliminate their production
and use.23 SCCPs (alkanes C10–13 chloro, chlorine content > 48%) were listed with speciﬁc exemptions
in production and use. Due to their inclusion in Annex A of the Stockholm Convention, it is anticipated
that the production and use of SCCPs will decrease in future years, and SCCPs will be replaced in most
applications.
Regarding MCCPs, the Swedish Chemicals Agency is proposing that the use of MCCPs in electrical
and electronic equipment is restricted,24 and the Norwegian authorities are proposing to prohibit the
production, import, export and selling of consumer products containing more than 0.1% MCCPs (CAS
No 85535-85-9) by weight. This will not apply to products with special ﬂame-retardant (ﬁre-safety)
requirements and where no satisfactory alternatives exist.25
Some regulatory agencies including the US-EPA26 and Environment and Health Canada27 have
undertaken risk assessments for MCCPs, but to date no production or restrictions in terms of use have
been formally established. Canada set Federal Environmental Quality Guidelines (FEQGs) for water,
sediments and mammalian wildlife under the Canadian Environmental Protection Act, 1999. These
guidelines are not efﬂuent limits or never-to-be-exceeded values, but provide benchmarks for the
quality of the ambient environment to protect aquatic life and mammalian (non-human) consumers of
aquatic life from adverse effects of CPs (Environment and Climate Change Canada, 2016). In water, the
FEQG is 2.4 lg/L for SCCPs, MCCPs and LCCPs. For ﬁsh tissues,28 the FEQGs are 1.8 and 0.76 lg/g fat
for SCCPs and MCCPs, respectively. No value is reported for LCCPs. For sediments, the FEQGs are 1.8,
5.4 and 100 mg/kg dw for SCCPs, MCCPs and LCCPs (C18–20 liquid), respectively. For mammalian
wildlife diet,29 the FEQGs are 18, 0.54 and 18 or 770 mg/kg food wet weight (ww), for SCCPs, MCCPs
and LCCPs (C>20 liquid or C>20 solid).
2. Data and methodologies
The CONTAM Panel applied the general principles for the assessment of chemicals in food as
described by WHO/IPCS (2009). In addition, EFSA guidances pertaining to risk assessment were
followed for the development of the risk assessment when necessary (EFSA, 2009, 2010a,b, 2011a;
EFSA Scientiﬁc Committee, 2011, 2012a,b, 2017a,b,c).
21 https://echa.europa.eu/registration-dossier/-/registered-dossier/14895/2/1
22 https://echa.europa.eu/documents/10162/53d22bf8-517b-41fb-9808-84a9535b4574
23 www.pops.int
24 https://www.kemi.se/en/news-from-the-swedish-chemicals-agency/2017/the-swedish-chemicals-agency-is-considering-a-proposal-
to-restrict-medium-chained-chlorinated-paraffins/
25 http://ec.europa.eu/growth/tools-databases/tris/de/index.cfm/search/?trisaction=search.detail&year=2010&num=9018
26 US-EPA, TSCA New chemicals review program standard review risk assessment on medium-chain chlorinated parafﬁns and
long-chain chlorinated parafﬁns; EPA: Washington, DC, 2015. And CPIA. MCCP and LCCP US Regulatory Status Update –
March 2017; CPIA: Washington, DC, 2017.
27 Environment and Climate Change Canada. Proposed Risk Management Approach for Chlorinated Parafﬁns. http://ec.gc.ca/lc
pecepa/default.asp?lang=En&n=D048964A-1. And Environment and Climate Change Canada. Follow-up Report on a PSL1
Assessment for Which Data Were Insufﬁcient to Conclude Whether the Substances Were ‘Toxic’ to the Environment and to the
Human Health: Chlorinated Parafﬁns; 2008 https://www.ec.gc.ca/lcpe-cepa/09F567A7-B1EE-1FEE-73DB-8AE6C1EB7658/cps_f
ollowup-eng.pdf
28 According to Environment and Climate Change Canada (2016), the ﬁsh tissue guidelines are benchmarks for aquatic
ecosystems that are intended to protect ﬁsh themselves from direct adverse effects.
29 According to Environmental and Climate Change Canada (2016), the wildlife dietary guidelines are intended to protect non-
human mammalian consumers of aquatic biota. These are benchmark concentrations of substances in aquatic biota (whole
body, wet-weight) that are consumed by terrestrial and semi-aquatic wildlife.
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2.1. Supporting information for the assessment and hazard
identiﬁcation and characterisation
2.1.1. Identiﬁcation, collection and selection of evidence
The identiﬁcation of the evidence used to inform the sections on supporting information and hazard
identiﬁcation and characterisation was done through a literature search that interrogated two
bibliographic databases or scientiﬁc citation research platforms: Web of ScienceTM 30 and PubMed.31
Details about the search strings are shown in Table 10.
The outcomes of the searches in the two databases were saved in EndNote,32 and duplicates
automatically detected. The resulting references were transferred to the web-based systematic review
software DistillerSR® (Evidence Partners, Ottawa, Canada), where an additional automatic duplicate
detection was made. The selection for relevance was performed in DistillerSR®. Each reference underwent
a series of questions to identify studies relevant to the risk assessment of CPs in food and feed.
The ﬁrst literature search was done in September 2017 and updates of the search were done on 21
September 2018 and on 11 March 2019 in Web of Science and PubMed, respectively, using the same
search string. Since that date, the literature was monitored to identify studies relevant for the risk
assessment until the time of endorsement.
Additionally, relevant scientiﬁc evaluations by national or international bodies were considered for the
current risk assessment, e.g. EU-RAR, ECHA, IARC and NTP. A dedicated search in the Organohalogen
Compounds database (extended abstracts from DIOXIN conferences) was also performed.
When relevant papers were identiﬁed during the risk assessment process (e.g. from other studies
or reviews), they were also considered.
In addition, the draft scientiﬁc opinion underwent a public consultation from 6 August 2019 to 17
September 2019. The comments received and how they were taken into account when ﬁnalising the
scientiﬁc opinion were published in an EFSA Technical Report (EFSA, 2020).
2.1.2. Appraisal of evidence
The information retrieved was screened and evaluated by relevant domain experts from the
CONTAM Working Group on CPs in food and was used for the present assessment. Selection of the
scientiﬁc papers for inclusion or exclusion was based on consideration of the extent to which the study
was relevant to the assessment or on general study quality considerations (e.g. sufﬁcient details on
the methodology, performance and outcome of the study, on dosing, substance studied and route of
administration and on statistical description of the results), irrespective of the results. Major limitations
in the information used are documented in this scientiﬁc opinion.
Table 10: Search strings and other relevant data for the identiﬁcation of evidence to inform the
sections on supporting information and hazard identiﬁcation and characterisation
Search strings (chlorinated parafﬁn*) OR (short-chain chlorinated parafﬁn*) OR (medium-chain chlorinated
parafﬁn*) OR (long-chain chlorinated parafﬁn*) OR (short-chained chlorinated parafﬁn*) OR
(medium-chained chlorinated parafﬁn*) OR (long-chained chlorinated parafﬁn*) OR
(polychlorinated n-alkane*) OR (polychlorinated alkane*) OR (SCCP*) OR (MCCP*) OR
(LCCP*) OR (chlorinated alkane*) OR (chlorinated parafﬁn waxes) OR (chlorinated
hydrocarbon waxes) OR (chlorinated waxes) OR (chlorocarbons) OR (chloroparafﬁn waxes)
OR (parafﬁn, chlorinated) OR (parafﬁns, chloro) OR (parafﬁn waxes, chlorinated) OR
(paroils, chlorinated) OR (poly-chlorinated alkanes) OR (polychloro alkanes)
Publication year 1950–September 2017
Language All
Type of documents All (peer reviewed articles, reviews, books, reports, patents, editorials, thesis, letters, abstracts)
30 Web of Science (WoS), formerly ISI Web of Knowledge, Thomson Reuters. Available online: http://thomsonreuters.com/
thomson-reuters-web-of-science/. It encompasses the following databases: Web of ScienceTM Core Collection, BIOSIS Citation
IndexSM, CABI: CAB Abstracts®, Current Contents Connect®, Data Citation IndexSM, FSTA® – the food science resource,
MEDLINE®, SciELO Citation Index, Zoological Record®.
31 PubMed, Entrez Global Query Cross-Database Search System, National Center for Biotechnology Information (NCBI), National
Library of Medicine (NLM), Department of the National Institutes of Health (NIH), United States Department of Health and
Human Services. Available online: http://www.ncbi.nlm.nih.gov/pubmed/
32 EndNote X8, Thomson Reuters. Available online: http://endnote.com/
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2.2. Occurrence data submitted to EFSA
Data collection and validation
Following a European Commission mandate to EFSA, a call for annual collection of chemical
contaminant occurrence data in food and feed, including CPs, was issued by the former EFSA Dietary
and Chemical Monitoring Unit (now DATA Unit) in December 2010 with a closing date of 1 October of
each year. European national authorities and similar bodies, research institutions, academia, food
business operators and other stakeholders were invited to submit analytical data on CPs in food and
feed.
The data submission to EFSA followed the requirements of the EFSA Guidance on Standard Sample
Description (SSD) for Food and Feed (EFSA, 2010a); occurrence data were managed following the
EFSA standard operational procedures (SOPs) on ‘Data collection and validation’ and on ‘Data analysis
of food consumption and occurrence data’.
Two data sets were submitted to EFSA containing data on SCCPs and MCCPs in food. The data sets
were the following.
– Data set A: 88 analytical results of 44 samples from the year 2007.
– Data set B: 422 analytical results of 184 ﬁsh samples from 2014 onwards to 2017, which were
used for the present assessment.
The CONTAM Panel noted that Data set A corresponded to the same occurrence data reported in
UK-COT (2009), and that Data set B was partly reported in the study by Kr€atschmer et al. (2019).
In addition, data on the occurrence of CPs in oil-based dietary supplements was submitted to EFSA.
These data could not be included on time in the EFSA Data warehouse for the current risk assessment,
but the data were published by Sprengel et al. (2019) and the outcome is described in Sections 3.2.2
and 3.3.2.
No data were submitted on LCCPs for food, and there were not data submitted on any CPs for feed
materials.
Data analysis
The data received were carefully evaluated by EFSA in view of cleaning and validating. Special
attention was paid to the identiﬁcation of duplicates and to the accuracy of different parameters, such
as ‘Analytical methods’, ‘Reporting unit’ and the coding of the different samples under FoodEx
classiﬁcation. Upon identiﬁcation of potential inconsistencies, data providers were contacted to provide
further clariﬁcation.
The left-censored data (analytical data below the limit of detection (LOD) or limit of quantiﬁcation
(LOQ)) were treated by the substitution method as recommended in the ‘Principles and Methods for
the Risk Assessment of Chemicals in Food’ (WHO/IPCS, 2009). The same method is described in the
EFSA scientiﬁc report ‘Management of left-censored data in dietary exposure assessment of chemical
substances’ (EFSA, 2010b) as an option for the treatment of left-censored data. The guidance
suggests that the lower bound (LB) and upper bound (UB) approach should be used for chemicals
likely to be present in the food. At the LB, results below the LOQ or LOD were replaced by zero; at
the UB, the results below the LOD were replaced by the numerical values of the LOD and those below
the LOQ were replaced by the value reported as LOQ. The use of different cut-off values on the
reported LOQs was also evaluated in order to reduce the uncertainty associated to the exposure
estimations.
2.3. Food consumption data
The EFSA Comprehensive European Food Consumption Database (Comprehensive Database)
provides a compilation of existing national information on food consumption at individual level. It was
ﬁrst built in 2010 (EFSA, 2011a; Huybrechts et al., 2011; Merten et al., 2011). Details on how the
Comprehensive Database is used are published in the Guidance of EFSA (EFSA, 2011a). The latest
version of the Comprehensive Database updated in 2018 contains results from a total of 60 different
dietary surveys carried out in 25 different Member States covering 119,458 individuals.
Within the dietary studies, subjects are classiﬁed in different age classes as follows:
Infants: < 12 months old
Toddlers: ≥ 12 months to < 36 months old
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Other children: ≥ 36 months to < 10 years old
Adolescents: ≥ 10 years to < 18 years old
Adults: ≥ 18 years to < 65 years old
Elderly: ≥ 65 years to < 75 years old
Very elderly: ≥ 75 years old
Four additional surveys provided information on speciﬁc population groups: ‘Pregnant women’
(≥ 15 years to ≤ 45 years old, Latvia; 17 years old to 46 years old, Portugal) and ‘Lactating
women’ (≥ 28 years to ≤ 39 years old, Greece; 18 years old to 45 years old, Estonia).
For chronic exposure assessment, food consumption data were available from 53 different dietary
surveys carried out in 22 different European countries. When for one particular country and age class
two different dietary surveys were available, only the most recent one was used. This resulted in a
total of 38 dietary surveys selected to estimate chronic dietary exposure.
In a separate Excel document (Annex A, Table 1), these dietary surveys and the number of
subjects available for the acute and chronic exposure assessment are described.
The food consumption data gathered by EFSA in the Comprehensive Database are the most
complete and detailed data currently available in the EU. Consumption data were collected using single
or repeated 24- or 48-hour dietary recalls or dietary records covering from three to seven days per
subject. Because of the differences in the methods used for data collection, direct country-to-country
comparisons can be misleading.
2.4. Food classiﬁcation
Consumption data were classiﬁed according to the FoodEx classiﬁcation system (EFSA, 2011b).
FoodEx is a food classiﬁcation system developed by EFSA in 2009 with the objective of simplifying the
linkage between occurrence and food consumption data when assessing the exposure to hazardous
substances. The system consists of a large number of individual food items aggregated into food
groups and broader food categories in a hierarchical parent-child relationship. It contains 20 main food
categories (ﬁrst level), which are further divided into subgroups having 140 items at the second level,
1,261 items at the third level and reaching about 1,800 end-points (food names or generic food
names) at the fourth level.
2.5. Exposure assessment
The CONTAM Panel considered that only chronic dietary exposure had to be assessed.
Due to the unavailability of up-to-date data on foodstuff other than ﬁsh, the Panel decided to only
estimate the exposure using the newer data on the 211 analytical results of 184 ﬁsh samples for the
consumer only population. The Panel noted that dietary exposure will be higher due to the
contribution of CPs from other foods.
As suggested by the EFSA Working Group on Food Consumption and Exposure (EFSA, 2011a),
dietary surveys with only 1 day per subject were not considered for chronic exposure as they are not
adequate to assess repeated exposure. Similarly, subjects who participated only 1 day in the dietary
studies, when the protocol prescribed more reporting days per individual, were also excluded for the
chronic exposure assessment. Not all countries provided consumption information for all age groups,
and in some cases the same country provided more than one consumption survey.
For calculating chronic dietary exposure to SCCPs and MCCPs, food consumption and body weight
data at the individual level were accessed in the Comprehensive Database. Occurrence data and
consumption data were linked at the relevant FoodEx level. In this case, as only data on ﬁsh were
available, the data were linked on FoodEx level2 of the generic ‘Fish meat’.
The mean and the high (95th percentile) chronic dietary exposures were calculated by combining
mean occurrence values for the ﬁsh samples collected in different countries (pooled European
occurrence data) with the average daily consumption of ‘Fish meat’ at individual level in each dietary
survey and age class. Consequently, individual average exposures per day and body weight were
obtained for all individuals. On the basis of distributions of individual exposures, the mean and 95th
percentile exposure were calculated per survey and per age class. Dietary exposure was assessed
using overall European LB and UB mean occurrence of CPs.
All analyses were run using the SAS Statistical Software (SAS enterprise guide 7.15).
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2.6. Risk characterisation
The general principles of the risk characterisation for chemicals in food as described by WHO/IPCS
(2009) will be applied as well as the different EFSA guidance documents relevant to this step of the
risk assessment (see above). For the farm animal, horses and companion animals risk characterisation,
the same principles were applied.
3. Assessment
3.1. Hazard identiﬁcation and characterisation
Some of the original study reports (unpublished) cited in this section were not available to the
CONTAM Panel and thus the information could not be veriﬁed. In such cases, the second source from
where the information was retrieved from is indicated.
3.1.1. Toxicokinetics
3.1.1.1. Laboratory animals
A number of studies on the toxicokinetics of CPs in rodents (rats and mice) have been retrieved in
the literature search. The main outcomes of these studies are described below while a more detailed
description of each individual study can be found in Appendix A.
3.1.1.1.1. Studies in rats
Twelve studies on toxicokinetics in rats are available, three studies on SCCPs, six on MCCPs and
three on LCCPs. Administration of CPs was both via diet (repeated exposure) and gavage (repeated
exposure and single dose).
Following administration of a single oral dose of a 14C-labelled SCCP (C10–12, 58% chlorination, 10
or 625 mg/kg bw) to rats, either after 13 weeks of dietary administration of the SCCP or control diet,
radioactivity was predominantly detected in the faeces with 54–66% recovered in 7 days;
approximately 14% was recovered in the urine and less than 1% in exhaled air as carbon dioxide
(IRDC, 1984a, unpublished study, see Documentation provided to EFSA). Blood and tissue levels were
generally proportional to the dose level. The highest initial concentrations of radioactivity were found
in the liver, adipose tissue, kidneys and ovaries. In general, the elimination of radioactivity from the
adipose tissue was slower than for the other three tissues. Only small differences were observed
between sexes, dose levels or dosing regimen. Similar results were reported in an identical gavage
study (IRDC, 1984b, unpublished study, see Documentation provided to EFSA), except for a slight
difference in the percentage of the administered radioactivity recovered in faeces (approximately
48–65%) and urine (approximately 13%). A recent study (Geng et al., 2016) in male rats showed that
SCCPs (mixture of C10-, C11-, C12- and C13-CPs, 56.5% chlorination) was rapidly absorbed following a
single oral administration (1,000 mg/kg bw). Also in this study, the main route of excretion was via
faeces (about 28%) with urine as a minor route (about 3.5%). Congener group abundance proﬁles
indicated a relative increase of Cl5-SCCPs in blood and urine in the elimination phase and a higher
accumulation of Cl8–10-SCCPs in faeces indicating that the distribution discrepancies of SCCPs congener
groups in blood and excreta were more dependent on chlorination degree than on carbon chain
lengths.
In a dietary study with an MCCP (Cereclor S52, C14–17, 52% chlorination, 10 or 625 mg/kg bw)
(IRDC, 1984c, unpublished study, see Documentation provided to EFSA) performed as for the dietary
and gavage studies with SCCP described above, faecal excretion was also the main route of elimination
(40–48% and 53–61% in low- and high-dose males, respectively; 28–31% and 62–74% in low- and
high-dose females) with only a small proportion excreted in urine (0.8–3%) and expired air
(0.1–0.3%). As for the SCCPs, there was an indication that blood and tissue levels were proportional
to the administered dose although not as clear as for the SCCP. As for the SCCPs, the highest initial
concentrations of radioactivity were found in the liver, ovaries and kidneys, whereas for adipose tissue,
the concentration of radioactivity was highest at 7 days after the last dose and then declined more
slowly than for the other tissues. Distribution of the same MCCP (C14–17, 52% chlorination) to the liver
and adipose tissue was also reported in two other dietary studies (Birtley et al., 1980; Poon et al.,
1995). One study (doses from 0.4 to 400 mg/kg bw per day) reported a dose-dependent increase in
the concentration of the MCCP in both liver and abdominal fat (Poon et al., 1995) and the other study
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(doses of 0.4 and 40 mg/kg diet) reported a rapid elimination from the liver (within one week) and
slow elimination from the abdominal fat (half-life of approximately 8 weeks) (Birtley et al., 1980). In
addition, a dietary study (CXR, 2005a, unpublished study, see Documentation provided to EFSA) with
the same MCCP (C14–17, 52% chlorination, approximately 200 mg/kg bw per day) reported that the
content in the white adipose tissue increased with time until the steady-state concentration was
achieved at week 13; then there was an initial rapid elimination where after the elimination rate
decreased markedly. Also following a single oral dose of an MCCP (C15, 52% chlorination, 525 mg/kg
bw) by gavage (CXR, 2005, as cited in EU-RAR, 2011) faecal excretion was the main route of
elimination (approximately 50% excreted within the ﬁrst 24 h after dosing and approximately 70%
after 5 days) and only a minor proportion in the urine (approximately 5% of the administered
radioactivity was eliminated in the urine by after 5 days). Similarly, the initial highest concentrations of
radioactivity were detected in the liver, kidney and fat and elimination half-life was rapid for most
tissues (approximately 2–5 days) and slower for white adipose tissue (about 2 weeks).
Only one study (Ahlman et al., 1986) has examined metabolism, i.e. formation of sulfur-containing
metabolites in female bile duct-cannulated rats given an MCCP (1-chloro-polychloro[U-14C]hexadecane,
65% chlorination, 5–6 mg/kg) by injection into the portal vein. The MCCP was conjugated to
mercapturic acid and glutathione and less than 3% of the total radioactivity excreted in the bile was
due to the parent compound.
In two studies with LCCPs (both C22–26, either 43% or 70% chlorination, 100 or 3,750 mg/kg bw)
(IRDC, 1984d,e, unpublished studies, see Documentation provided to EFSA), performed as for the
dietary and gavage studies with SCCPs described above, faecal excretion was also the main route of
elimination with only insigniﬁcant amounts of radioactivity detected in urine and expired air. For the
lower chlorinated LCCP, the concentrations in blood were similar between the two dose levels
regardless of sex and dosing regimen, whereas for the higher chlorinated LCCP, the concentrations of
radioactivity in blood were greater in relatively high-dose animals. As for the SCCP and MCCP, the
highest initial concentration of radioactivity was found in the liver for both LCCPs. In adipose tissue,
the concentration increased between 7 and 28 days and then declined only slightly by 90 days for the
lower chlorinated LCCP, whereas for the higher chlorinated LCCP, the concentration increased slowly
after dosing with only a small decline by 90 days. For the lower chlorinated LCCP, the concentration in
ovaries was higher than in the adipose tissue after 12 h and 7 days, but was comparable with the that
in the adipose tissue at 28 days, whereas for the higher chlorinated LCCP, the concentration in ovaries
were generally similar or lower than in other tissues. Similarly, following a single oral radiolabelled dose
of a shorter chain LCCP (C18, 50–53% chlorination) by gavage (Yang et al., 1987), the highest
proportion of radioactivity was excreted in the faeces (76%), and approximately 20% of which was
identiﬁed as the parent LCCP.
3.1.1.1.2. Studies in mice
Five studies on toxicokinetics in mice are available, two studies on three SCCPs with the same
carbon chain length (C11) but different degrees of chlorination (17.4%, 55.9% and 68.5%), and three
studies on MCCPs with the same carbon chain length (C16) but different degrees of chlorination (34%
and 69%). These studies were all performed by the same Swedish group and applied the same
methodology, i.e. single oral dose by gavage or by i.v. injection of radiolabelled test compounds
predominantly to female mice followed by visual determination of tissue distribution by whole body
autoradiography (WBA), and evaluation of tissue retention and elimination in excreta by measuring
radioactivity levels of test compounds and metabolites. The CONTAM Panel noted that the WBA is a
semiquantitative measure.
The WBA part of the study with three different C11 SCCPs (SCCP-I: (C11H18.1Cl4.9)-
14CH2Cl, 55.9%
chlorination; SCCP-II (C11H14.2Cl8.8)-
14CH2Cl, 68.5% chlorination; SCCP-III: H
3C-(CH2)10-
14CH2Cl,
17.4% chlorination, chlorinated only at the 14C-atom) (Darnerud et al., 1982), showed highest initial
radioactivities in tissues with high cell turnover/high metabolic activity (e.g. intestinal mucosa, bone
marrow, salivary glands and thymus), which was more pronounced for SCCP-III, less for SCCP-I and
weak for SCCP-II, as well as in the liver and white fat (oral administration). Radioactivity was also
observed in the central nervous system for SCCP-III and SCCP-I, but not for SCCP-II (30–60 days after
i.v. injection). Distribution of radioactivity in fetuses was similar to the distribution in adult females
(late gestation) and was most pronounced for SCCP-III and only weak for SCCP-II. A similar picture
was seen following administration of a low chlorinated MCCP (1-14C-C16H30.7Cl3.3, 34.1% chlorination)
(Darnerud and Brandt, 1982), i.e. initial distribution to tissues with high cell turnover/high metabolic
activity (intestinal mucosa, bone marrow, exocrine glands and brown fat), but only a low distribution to
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the white fat depots (oral administration); radioactivity in the brain (30 days after i.v. injection); and
distribution of radioactivity in fetuses partly similar to that observed in adult females (late gestation).
However, following oral administration of a higher chlorinated radiolabelled MCCP (14C-labelled
C16H20.6Cl13.4, 69% chlorination) (Biessmann et al., 1983), the WBA showed initial high levels of
radioactivities in bile, liver, kidney and intestinal contents, as well as in corpora lutea up to 30 days
after dosing. A long retention in fat was seen. High levels of radioactivity in adipose tissue, adrenals
and in myelinated areas of the brain were seen in autoradiograms from pre-weaning (10-day-old) mice
orally dosed with a highly chlorinated MCCP (C16, 69% chlorination) (Eriksson and Darnerud, 1985).
The tissue retention part of the SCCPs study (Darnerud et al., 1982) showed a marked labelling in
the liver and fat at 24 h after oral administration of SCCP-I and SCCP-II; at 30 days, the radioactivity
was minimal in the liver but still high in the fat. For the low chlorinated MCCP (Darnerud and Brandt,
1982), measurable radioactivity was present in all tissues examined (i.e. blood, liver, kidney, white and
brown fat and brain). In pre-weaning mice given the highly chlorinated MCCP (Eriksson and Darnerud,
1985), the level of radioactivity in the brain was approximately 3% of the dose administered in 3-day-
old mice, and approximately 0.5% in 20-day-old mice (24 h after administration). At seven days the
level of radioactivity was lower in both brain and liver samples.
The elimination part of the SCCPs study (Darnerud et al., 1982) showed that 67% of the
administered radioactivity was recovered 12 h after oral administration of SCCP-I with 33% as 14CO2 in
exhaled air, 29% in the urine and 5% in the faeces, whereas for SCCP-II, only 33% was recovered
12 h after oral administration with 8% as 14CO2 in exhaled air, 4% in the urine and 21% in the faeces.
For the low chlorinated MCCP (Darnerud and Brandt, 1982), about 33% of the administered
radioactivity was exhaled as 14CO2 within 12 h after oral administration with 6.5% of the radioactivity
in the urine and 14% in the faeces. For the higher chlorinated MCCP (Biessmann et al., 1983), the
elimination of radioactivity in urine was about 3% and about 66% in the faeces during 96 h; the
elimination in exhaled air was about 1%.
A study in female mice given the two different SCCPs above mentioned (SCCP-I and SCCP-II) by i.v.
injection (Darnerud, 1984) after pretreatment with cytochrome P450 (CYP450) inducers or inhibitors
showed that pretreatment with inducers (phenobarbital, 3-methylcholanthrene, Aroclor 1254) had
limited effects on the degree of 14CO2-exhalation, whereas pretreatment with inhibitors (piperonyl
butoxide, metyrapone) decreased the exhalation of 14CO2 considerably. The inhibitor effects increased
with increasing degree of chlorination of the CPs. The results suggest a CYP450-dependent
degradation of SCCPs to 14CO2 in vivo and that the degradation seems to be more important for the
higher chlorinated SCCP. For the low chlorinated MCCP (Darnerud and Brandt, 1982), TLC of samples
taken from the liver, kidney and brown fat revealed a radiolabelled substance with the same retention
value as the reference parent compound suggesting that this MCCP was distributed to these tissues
without further metabolism.
According to the authors of the article on the three different SCCPs in mice (Darnerud et al., 1982),
the uptake of radioactivity in metabolically active tissues and the formation of 14CO2 were inversely
related to the degree of chlorination of the SCCPs and the retention of radioactivity in liver and fat was
most marked for the highest chlorinated SCCP (i.e. SCCP-II). This means, according to the authors,
that the metabolic fate of CPs depends on the chlorine contents (and probably also chain length) and
that results from one CP preparation cannot be considered valid for CPs in general. Similarly, it was
stated by the authors of the article on the low chlorinated MCCP in mice (Darnerud and Brandt, 1982),
that the results in this speciﬁc study are valid only for the MCCP studied and should not be taken as
general for all CP preparations.
3.1.1.2. Humans
No studies on the toxicokinetics in humans of relevance for the risk assessment of CPs within the
scope of this opinion were retrieved from the literature search.
One study was identiﬁed reporting levels of SCCPs and MCCPs in paired samples of maternal and
umbilical cord blood serum collected in China (Beijing) in 2013 (Qiao et al., 2018) and several studies
have reported levels in human milk (see Section 3.2.4). Detection of CPs in human blood and milk
samples indicates that CPs are absorbed to some extent in humans and detection of CPs in umbilical
cord blood indicates that CPs can be transferred to the fetus.
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3.1.1.3. Farm animals, horses and companion animals
A number of studies on the toxicokinetics of CPs in farm animals (poultry and ﬁsh) have been
retrieved from the literature search. The main outcomes of these studies are described below while a
more detailed description of each individual study can be found in Appendix B.
3.1.1.3.1. Studies in poultry
In broiler chickens (Uebersch€ar and Matthes, 2004) and laying hens (Uebersch€ar et al., 2007) given
diets supplemented with an SCCP (C10–13, 60% chlorination) at different dietary concentrations, the
SCCP concentrations in tissues were related linearly to the SCCP concentration of the feed with the
highest concentration recovered in abdominal fat. In the laying hens, a high concentration was also
found in abdominal fat, egg yolk and liver, whereas levels in breast muscle were low. In the laying
hens, the elimination was biphasic with a rapid phase (4–40 minutes) followed by a slower phase.
In female laying Japanese quail orally given an SCCP (14C-labelled C12H20.1Cl5.9, 55.9% chlorination)
or an MCCP (14C-labelled C16H30.7Cl3.3, 34.1% chlorination) (Biessmann et al., 1982), the
autoradiography distributions showed initial high radioactivities in tissues with high metabolic activity
and/or high cell turnover rate, e.g. liver, intestinal mucosa, spleen, bone marrow and oviduct. High
levels were also seen in the gall bladder and the kidney, as well as in lipid-rich tissues such as the
outer layers of the yolk of the growing follicles, in the uropygial gland epithelium and fat. There was
also a high uptake of radioactivity in the eggshells and, to a lesser extent, in the albumen. After
exposure times of 4 and 8 days, the highest radioactivity was observed in fat, the yolk of the follicles
and in the uropygial gland. The distribution patterns of the SCCPs and the MCCPs were almost
identical after all exposure times: in the egg yolk and albumen the concentration of the SCCP was
about half of the MCCP. However, the distribution was somewhat different following administration of a
higher chlorinated MCCP (14C-labelled C16H20.6Cl13.4, 69% chlorination) (Biessmann et al., 1983) with
initial high radioactivities in bile, liver, kidney and intestinal contents; high radioactivity was also seen in
the hypophysis, retina, blood and egg yolk. After 12 days, radioactivity was only observed in the lipid-
rich tissues (fat, uropygial gland, egg yolk) as for the SCCP and the lower chlorinated MCCP; and in
the liver. In the elimination part of the study with the SCCP and the lower chlorinated MCCP
(Biessmann et al., 1982), the exhalation of 14CO2 during 8 hours following dosing with the MCCP was
about twice (38.8%) that of the SCCP (21.6%); the excretion of radioactivity in urine and faeces
(combined, during 8 hours) was also higher following dosing with the MCCP (13.5%) compared with
SCCP (9.8%). For the higher chlorinated MCCP (Biessmann et al., 1983), the elimination of
radioactivity in urine and faeces (combined) was about 58% during 96 hours after administration; the
elimination in exhaled air was about 1%.
3.1.1.3.2. Studies in ﬁsh
Several studies were performed in bleak (Alburnus alburnus L.). Although it is not usually farmed,
the CONTAM Panel noted it belongs to the carp family (Cyprinidae) and studies might be relevant to
farmed species. Studies in which the ﬁsh were exposed via the tank water were also included,
although this exposure route is not entirely relevant to dietary exposure.
Two different LCCPs (Cereclor 42, C22–30, 42% chlorination; Chlorez 700, C20–28, 70% chlorination)
given to juvenile Atlantic salmon (Salmo salar) with dry ﬁsh food for up to 181 days followed by a
control diet for 74 days were not reported to accumulate in the ﬁsh (Zitko, 1974).
An SCCP (Chlorowax 500C, C10–12, 50% chlorination) was found in ﬁngerling rainbow trout (Salmo
gairdneri Richardson) following administration in the feed for up to 82 days (Lombardo et al., 1975).
In juvenile rainbow trout (Oncorhynchus mykiss) (Fisk et al., 1996) fed diets with two different
SCCPs (C12H20Cl6, 56% chlorination; C12H16Cl10, 69% chlorination) and two different MCCPs
(C16H31Cl3, 35% chlorination; C16H21Cl13, 69% chlorination) for 40 days and followed by 160 days
(C12H20Cl6, C12H16Cl10, C16H31Cl3) or 173 days (C16H21Cl13) of depuration, all four CPs accumulated in
the ﬁsh by day 5 of the uptake phase without reaching steady state; the depuration rate in ﬁsh
exposed to C16H31Cl3 was signiﬁcantly more rapid than the depuration rates in ﬁsh exposed to the
other three CPs. The highest percentages of radioactivity were found in the carcass for all four CPs
(ranging from 50% to higher than 70%). Relative amounts in the liver were low (about 1.5% of the
total ﬁsh weight). The metabolism of the CPs was most pronounced for the lower chlorinated SCCP.
According to the authors, the highly chlorinated SCCP and the lower chlorinated MCCP appear to have
the greatest potential for biomagniﬁcation among CP components. The authors also stated that
reduced accumulation of the lower chlorinated SCCP should be attributed to metabolism, while uptake
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from the GI of the highly chlorinated MCCP may have been hindered because of its large molecular
size.
In another study (Fisk et al., 1998) with juvenile rainbow trout (Oncorhynchus mykiss) fed diets
containing 19 different CPs with varying carbon chain length (C10, C11 and C14) and chlorine content
(4–8 chlorine atoms) for 40 days followed by 80 days of depuration, all of the CPs were detected in
the ﬁsh after 5 days of exposure. With the exception of the C14–CPs, most compounds reached steady
state between food and ﬁsh within 30 or 40 days. Differences in bioaccumulation parameters between
CPs with the same molecular formula, but different chlorine positions were observed for some of the
CPs. The half-lives of the CPs ranged from 7 to 53 days. There was a large range in the assimilation
efﬁciencies (from 13–130%). These results showed that all of the CPs were rapidly accumulated and
had high assimilation efﬁciencies from food, that the half-lives increased with increasing carbon chain
length and chlorine content, indirectly, that the CPs were metabolised in the rainbow trout with the
susceptibility to metabolism decreasing with greater carbon chain length and chlorine content, and
that higher chlorinated C10- and C11-CPs, and all C14-CPs, would biomagnify from food to ﬁsh in
aquatic food chains.
In a third study (Fisk et al., 2000) with juvenile rainbow trout (Oncorhynchus mykiss) fed diets with
three different 14C-CPs (C10H15.3Cl6.7, C14H23.3Cl6.7 and C18H31.4Cl6.6) at two different concentrations for
40 days followed by 160 days of depuration, all three CPs accumulated readily from the food, but
without reaching steady state; the uptake curves were similar for all three CPs, and for the two
concentrations. The assimilation efﬁciencies varied from 10 to 22%, except for the high-concentration
SCCP group (approximately 72%). The half-lives of the LCCP (79 and 91 days) were signiﬁcantly
greater than those of the two shorter chain CPs (26–58 days). The BMFs calculated assuming
assimilation efﬁciencies of 50 and 90% exhibited increasing trends with increasing carbon chain length
and indicate that the CPs have the potential to biomagnify in aquatic food chains. These results
showed that all three CPs have the potential to biomagnify in aquatic food chains with increasing
trends with increasing carbon chain length and greater biotransformation of the short-chain compared
to the longer chain CPs.
A high uptake was initially observed (WBA) in the liver, olfactory organs, gills, skin and kidneys in
rainbow trout (Salmo gairdneri) exposed during 7 days to a highly chlorinated SCCP (1-chloro-
polychloro-[1-14C]dodecane (PCDD-H), 68.5% chlorination) added to tank water (Darnerud et al.,
1989). Then the radioactivity decreased in the olfactory organs, gills and skin, while the radioactivity in
fat steadily increased and at the end of the experiment radioactivity was mainly present in fat,
intestinal contents, liver and bile. Following exposure to a low chlorinated MCCP (1-chloro-polychloro-
[U-14C]hexadecane (PCHD-L), 23.1% chlorination), the initial highest radioactivities were seen in the
contents of the gall bladder, pyloric caeca and intestines; a pronounced uptake was also seen in the
olfactory organs and gills. After 7 days in contaminated water, the uptake in the olfactory organs and
gills was less marked whereas the concentration of radioactivity in fat tissue had increased. After 7 and
21 days in clean water, the distribution pattern were similar to that found after seven days in
contaminated water; the olfactory organs and the gills still retained radioactivity. Following exposure to
a higher chlorinated MCCP (1-chloro-polychloro-[U-14C]hexadecane (PCHD-M), 51.4% chlorination), the
initial distribution pattern was almost similar to that observed for PCHD-L; however, the liver was
comparably more labelled after PCHD-M exposure. After seven days in contaminated water, the uptake
was also generally the same as for PCHD-L; however, the uptake in fat seemed more accentuated for
PCHD-M and the accumulation of radioactivity in fatty tissues was even more prominent at later time
points.
In carp (Cyprinus carpio) given an MCCP (polychloro-1-14C-hexadecane (PCHD), 34% chlorination)
by injection, the cumulated excretion of 14CO2 during 96 h amounted to 6.4% of the injected
radioactivity (Darnerud et al., 1983). WBA showed initial highest radioactivity in bile, intestinal
contents, kidney, liver, nasal mucosa and fat; a marked uptake was also observed in gills, testis and
brain. Tissue levels were generally lower 13 days after dosing. In bleak (Alburnus alburnus) exposed
for 14 days to this MCCP added to the tank water, a marked initial uptake of radioactivity was noted in
gills, nasal cavity, skin, liver and fat; a high level was also present in the brain, bile and intestinal
contents. A similar distribution pattern was seen after 14 days of exposure, as well as in ﬁsh allowed
to recover for 1, 7 and 35 days.
A direct correlation was observed between the amount of an SCCP in contaminated feed (Witaclor
149, C10–13, 49% chlorination, three different concentrations: 590, 2,500 and 5,800 lg/g feed) and the
level of organic chlorine found in bleak (Alburnus alburnus) tissues during the ﬁrst 56 days of
exposure; the increase continued in the low- and mid-dose groups, while levels in the high-dose group
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were unchanged in the remaining part of the exposure duration (91 days) (Bengtsson and Ofstad,
1982). The uptake was about 45% in the low-dose group, about 10% in the mid-dose group and
about 5% in the high-dose group at the end of the exposure period. The levels of Witaclor 149
decreased rapidly during the elimination period (316 days). For a higher chlorinated SCCP (Witaclor
171P, C10–13, 71% chlorination, 3,180 lg/g feed), the bioaccumulation pattern was similar to the mid-
dose Witaclor 149 group with a fairly constant uptake during the exposure period; the uptake was
around 6% at the end of the exposure period. This SCCP remained in the ﬁsh tissues on a steady level
until the end of the elimination period. The uptake was inefﬁcient for an LCCP (Witaclor 549, C18–26,
49% chlorination, 3,400 lg/g feed) with only about 2% by the end of the exposure period. About
50% was excreted within 4–5 weeks, whereas the remaining 50% did not seem to be excreted during
the subsequent 40 weeks.
A clear relationship between the structure of CPs and their uptake was seen in bleak (Alburnus
alburnus L.) when added to tank water (Bengtsson et al., 1979). A short-chain length, i.e. SCCPs and a
low level of chlorination showed the most effective form for uptake among the ﬁve tested CPs. The CP
test solutions included Witaclor 149 (C10–13, 49% chlorination), Witaclor 159 (C10–13, 9% chlorination),
Witaclor 171P (C10–13, 71% chlorination), Witaclor 350 (C14–17, 50% chlorination) and Witaclor 549
(C18–26, 49% chlorination).
Madeley and Birtley (1980) reported that an LCCP (C20–30, 42% chlorination) was found in the
tissues of rainbow trout (Salmo gairdneri) and mussels (Mytilus edulis) when mixed with the feed.
Comparison of the LCCP concentration in tissues suggested that mussels eliminated the LCCP as the
parent compound whereas the ﬁsh appeared to metabolise the test compound.
3.1.1.4. Summary on toxicokinetics
No studies on the toxicokinetics in humans of relevance for the risk assessment of CPs within the
scope of this opinion were identiﬁed from the literature search.
Data on toxicokinetics for various animal species were identiﬁed, although in several cases from
studies not designed as dedicated absorption, distribution, metabolism and elimination (ADME) studies.
Following oral administration (diet, gavage) of CPs (single 14C-labelled dose) to rats the major route
of excretion was the faeces with only a small proportion excreted in urine and expired air. The highest
initial concentrations of radioactivity were found in the liver (SCCPs, MCCPs, LCCPs), kidneys (SCCPs,
MCCPs) and ovaries (SCCPs, MCCPs, LCCPs). Initial high concentrations of radioactivity were also seen
in the adipose tissue following administration of SCCPs whereas for MCCPs the concentration of
radioactivity was highest at 7 days and for LCCPs the concentration of radioactivity increased up to
28 days. In general, the elimination of radioactivity from the adipose tissue was slower than for the
other three tissues for all three CP groups; the elimination rate from the adipose tissue decreased with
increasing carbon chain length and chlorination degree. One study in rats demonstrated that
differences between the distribution of SCCP congeners in blood, urine and faeces were more
dependent on chlorination degree than on carbon chain lengths.
A similar picture regarding distribution and elimination was seen in mice administered radiolabelled
SCCPs or MCCPs orally (gavage) and/or by i.v. injection followed by visual determination of tissue
distribution by WBA and evaluation of tissue retention and elimination in excreta by measuring
radioactivity levels. One study with two relatively highly chlorinated SCCPs suggested that CYP450-
dependent degradation seems to be more important for the higher chlorinated SCCPs. The studies in
mice suggested that highly chlorinated SCCPs and MCCPs are metabolised and excreted via faeces
whereas lower chlorinated SCCPs and MCCPs can be partly metabolised and exhaled as carbon dioxide.
The studies in mice also suggested that results from one CP are valid only for the CP studied and
should not be taken as general for all CPs.
In broiler chickens and laying hens given diets supplemented with an SCCP the highest
concentration was recovered in abdominal fat. In the laying hens, a high concentration was also found
in egg yolk and liver. A similar distribution pattern was seen in laying Japanese quail given an SCCP or
an MCCP orally.
The ﬁsh studies with rainbow trout indicated that CPs were rapidly accumulated and had high
assimilation efﬁciencies from food and that the half-lives increased with increasing carbon chain length
and chlorination degree. The studies also indicated that the CPs have the potential to biomagnify from
food to ﬁsh in aquatic food chains with increasing trends with increasing carbon chain length and
greater biotransformation of the short-chain CPs compared to the longer chain CPs. Studies with other
ﬁsh species support the potential of CPs to accumulate in ﬁsh tissues.
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3.1.1.5. Physiologically based kinetic (PBK) modelling
No PBK model publications for the risk assessment of CPs within the scope of this opinion were
identiﬁed from the literature search.
3.1.2. Toxicity in experimental animals
3.1.2.1. Acute toxicity studies
In studies with rats and mice, the oral LD50 values for CPs were always greater than the highest
administered dose, indicating that CPs are of low acute oral toxicity. The LD50 values all exceeded 4 g/
kg bw (Table 11).
Single oral doses of SCCP (C12, 60% chlorination) or LCCP (C23, 43% chlorination) up to 13.6 g/kg
bw in rats and 27.2 g/kg bw in mice by gavage caused no mortality. The animals were inactive and
ataxic. Rats manifested diarrhoea, while mice had rufﬂed fur 2–6 days after dosing (NTP, 1986a,b,
Bucher et al., 1987).
In a single-administration study, rats were given three different chlorinated SCCPs (C10–13; 41–50%
chlorination, 51–60% chlorination or 61–70% chlorination) by gavage, with a range of maximum doses
of 4–13 g/kg bw. Piloerection, muscular incoordination, faecal and urinary incontinence were observed
in rats that received doses of 2 g/kg bw or more, generally independent of the chlorine content. No
deaths were noted except for one rat treated with 13 g/kg bw of SCCP (C10–13, 63% chlorination)
(Birtley et al., 1980; WHO/IPCS, 1996). MCCP (C14–17, 51–60% chlorination) and LCCPs (C20–30; 41–
51% chlorination, 51–61% chlorination or 61–70% chlorination) caused similar clinical symptoms to
those reported for SCCPs (Birtley et al., 1980).
3.1.2.2. Repeated dose toxicity studies
3.1.2.2.1. SCCPs
Ten repeated dose toxicity studies on SCCPs in rats and ﬁve in mice were identiﬁed. They are
summarised in Table 12 and discussed below.
Studies in rats
In a 14-day rat study, SCCP (C10–12, 58% chlorination) was administered in the diet at dose levels
of 0, 100, 300, 1,000 or 3,000 mg/kg bw per day (IRDC, 1983a, unpublished study, see
Documentation provided to EFSA). No animals died and no clinical signs of toxicity could be observed.
Body weight and food consumption was decreased by approximately 50% at the highest dose after
2 weeks. The absolute and relative liver weights were increased in all treatment groups; the relative
liver weights in females by 20% (lowest dose) up to 240% (highest dose) compared to controls. The
Table 11: Oral acute toxicity studies of chlorinated parafﬁns (CPs)
CP
category
CP speciﬁcation
Species/
strain
LD50
(g/kg bw)
Reference
SCCPs C12, 60% chlorination F344/N rat > 13.6 NTP (1986a); Bucher et al. (1987)
C12, 59% chlorination Rat > 21.5 Diamond Shamrock Chem. Co (1975,
unpublished study, as cited by Howard et al.
(1975) and WHO/IPCS (1996)
C12, 60% chlorination B6C3F1 mouse > 27.2 NTP (1986a), Bucher et al. (1987)
Cereclor 50LV, C10–13,
50% chlorination
Wistar rat > 4 Birtley et al. (1980)
MCCPs C14–17, 40–52%
chlorination
Rat > 15 Kuhnert (1986a,b), Chater (1978), as cited by
EU-RAR (2011)
Cereclor S52, C14–17,
52% chlorination
Wistar rat > 4 Birtley et al. (1980)
LCCPs C23, 43% chlorination F344/N rat > 11.7 NTP (1986b); Bucher et al. (1987)
C23, 43% chlorination B6C3F1 mouse > 23.4 NTP (1986b); Bucher et al. (1987)
Cereclor 42, C20–30,
42% chlorination
Wistar rat > 4 Birtley et al. (1980)
LCCPs: long-chain chlorinated parafﬁns; MCCPs: medium-chain chlorinated parafﬁns; SCCPs: short-chain chlorinated parafﬁns;
LD50: lethal dose, median.
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incidence of hepatocellular hypertrophy increased in all treatment groups in a dose-dependent manner.
Liver microsomal aminopyrine N-demethylase (APND) activity and total CYP450 content was increased
in all dose groups. These effects were signiﬁcant in females from 300 mg/kg bw per day and in males
from 1,000 mg/kg bw per day. The LOAEL of this study was 100 mg/kg bw per day, based on
increased relative liver weight and increased incidence of hepatocellular hypertrophy in all treated
groups.
SCCP (C10–12, 58% chlorination) was given to rats in doses of 0, 30, 100, 300, 1,000 or 3,000 mg/kg
bw per day in corn oil by gavage for 14 days (IRDC, 1981a, unpublished study, see Documentation
provided to EFSA). No deaths occurred that were related to the treatment with the test substance.
Several clinical signs of toxicity were reported including staining around mouth, nose and anogenital
region, decreased motor activity, laboured breathing and excessive lachrymation. Twenty per cent
reduction of body weight could be observed at top-dose females at day 14 compared to the control
group. Average food consumption was reduced in top-dose males and females. A signiﬁcant increase
(> 10%) in average water consumption was noted for the males at doses of 1,000 mg/kg bw per day
or more. The absolute and relative liver weight was increased at doses of 300 mg/kg bw per day or
more in both sexes. At 100 mg/kg bw per day, there was already a 18% increase of relative liver weight
in males compared to controls. Diffuse mild hepatocellular hypertrophy was observed at the two highest
dose levels in all animals. The authors also reported ‘trace’ (not further speciﬁed) centrilobular
hypertrophy in 2 out of 5 animals of each sex at 300 mg/kg bw per day. Dose-related increase in hepatic
microsomal enzyme activity (APND) was noted in females treated with 300 mg/kg bw per day and
above. At 3,000 mg/kg bw per day, relative and absolute ovary weights were decreased. Absolute ovary
weights were decreased to 42% of the control value. At the same dose level, a signiﬁcant reduction in
absolute and relative thymus weights of both sexes was noted. Absolute thymus weights of males
were decreased to 19% of the control value at 3,000 mg/kg bw per day. The NOAEL of this study was
30 mg/kg bw per day, based on relative liver weight increase (18%) in males at 100 mg/kg bw per day.
Male rats (5 per group) were administered two different SCCPs (Cereclor 56L, C10–13, 56%
chlorination, or Chlorowax 500C, C10–13, 58% chlorination) in corn oil in doses of 0, 10, 50, 100, 250,
500 or 1,000 mg/kg bw per day per gavage for 14 days (Wyatt et al., 1993). For Cereclor 56L,
absolute liver weights were signiﬁcantly increased at 10 mg/kg bw per day and from 100 mg/kg bw per
day or greater (irregular dose response). Relative liver weights were signiﬁcantly increased at 50 mg/kg
bw per day (approximately 17%) or greater in a dose-related manner. For Chlorowax 500C, both
absolute and relative liver weights were signiﬁcantly and dose-relatedly increased from 100 mg/kg bw
per day (approximately 15%). Palmitoyl coenzyme A (CoA) oxidation, an indicator for peroxisome
proliferation, was signiﬁcantly increased by Cereclor 56L at 1,000 mg/kg bw per day and by Chlorowax
500C from 250 mg/kg bw per day. For Cereclor 56L and Chlorowax 500C, palmitoyl CoA oxidation was
2.5-fold and 3-fold higher than the control values at the top dose. Free thyroxine (FT4) and total
thyroxine (TT4) levels in plasma were signiﬁcantly decreased and thyroid-stimulating hormone (TSH)
levels in plasma were signiﬁcantly increased by both SCCPs at 1,000 mg/kg bw per day, the only dose
at which these parameters had been determined. No differences in free triiodothyronine (FT3) or total
triiodothyronine (TT3) levels in plasma could be observed for either SCCPs at 1,000 mg/kg bw per day.
The capacity of liver microsomes to glucuronidate T4 was markedly increased (approximately 2-fold) by
Cereclor 56L and Chlorowax 500C (1,000 mg/kg bw per day). Glucuronidation of p-nitrophenol was only
signiﬁcantly increased by Chlorowax 500C but not by Cereclor 56L. The NOAEL for Cereclor 56L was
10 mg/kg bw per day based on the increase of relative liver weights (> 17% at 50 mg/kg bw per day)
in a dose-related manner. The NOAEL for Chlorowax 500C was 50 mg/kg bw per day based on
increased absolute and relative liver weights (> 15% increase in relative liver weight at 100 mg/kg bw
per day). For more information on the mode of action from this study see also in Section 3.1.5.1 and
3.1.5.3.
Rats were treated with SCCP (C12, 60% chlorination) in doses of 0, 469, 938, 1,875, 3,750 or
7,500 mg/kg bw per day in corn oil by gavage for 16 days 5 days per week (NTP, 1986a; Bucher
et al., 1987). Three deaths occurred in top-dose animals (1 male, 2 females). Livers were enlarged in
all dose groups except the 469 mg/kg bw per day group of females. Histological examinations were
not performed. The LOAEL was 469 mg/kg bw per day based on enlarged livers observed at all dose
levels in males.
To investigate the effects on thyroid hormones and mode of actions, male rats (9 per group) were
administered SCCP (C10–13, 56.5% chlorination; mass ratio of C10:C11:C12:C13 = 1:1:1:1) at doses of 0,
1, 10 or 100 mg/kg bw per day in corn oil by gavage for consecutive 28 days (Gong et al., 2018).
Relative thyroid weights were not affected at any dose level. No effects could be observed on thyroid
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histology at 100 mg/kg bw per day, the only dose examined. At 10 and 100 mg/kg per day, plasma
FT3 levels were signiﬁcantly and dose-relatedly decreased (20% at 10 mg/kg bw per day), while
plasma TSH levels were signiﬁcantly and dose-relatedly increased (15% at 10 mg/kg bw per day). At
100 mg/kg bw per day, plasma levels of FT4 and hepatic T4 were signiﬁcantly decreased, while
hepatic T3 levels were signiﬁcantly increased. Various changes in gene expression were observed, and
those relevant to the mode of action are described in Sections 3.1.5.1 and 3.1.5.3. The NOEL was
1 mg/kg bw per day, based on effects on thyroid hormones (decrease of plasma FT3 and increase of
plasma TSH).
In a 90-day dietary study, SCCP (C10–12, 58% chlorination) was administered to rats in doses of 0,
10, 100 or 625 mg/kg bw per day (Serrone et al., 1987; IRDC, 1984a, unpublished study, see
Documentation provided to EFSA). No mortality and no clinical signs of toxicity were observed. There
was a slight reduction in body weight gain (high-dose males). In the blood biochemistry analyses,
signiﬁcant increases in total protein and serum cholesterol in the highest dose, and glucose levels in
mid- and high-dose animals were also observed. Slight dose-related increases in liver protein content
were noted in the treated males with corresponding increases in total CYP450 content and APND
activity, particularly in top-dose males. Absolute and relative weights of liver and kidney were
signiﬁcantly increased in the mid- and high-dose group (both sexes). Histopathological ﬁndings
included increased incidences of hepatocellular hypertrophy in the mid- and high-dose group (both
sexes). An increased incidence and severity of trace-to-mild thyroid hypertrophy and hyperplasia was
observed in mid- and high-dose males. An increased incidence of thyroid hypertrophy was also
observed in high-dose females. An increased incidence and severity of trace-to-mild chronic nephritis33
was also observed in kidney at the mid-dose and high-dose males. Increased pigmentation of the renal
tubules occurred in the high-dose females. The NOAEL was 10 mg/kg bw per day, based on increased
liver and kidney weights and histopathological changes in liver, kidney and thyroid at 100 mg/kg bw
per day.
In an accompanying gavage study, SCCP (C10–12, 58% chlorination) was administered to rats for
90 days at doses of 0, 10, 100 or 625 mg/kg bw per day in corn oil (Serrone et al., 1987; IRDC,
1984b, unpublished study, see Documentation provided to EFSA). Similar ﬁndings were observed as in
the dietary study. No mortality occurred and no clinical signs of toxicity were observed. There was a
slight increase in body weight gain in high-dose females. There was an increase in food consumption
in the high-dose groups of both sexes. Absolute and relative liver and kidney weights were increased
in the mid- and high-dose groups of both sexes. Absolute and relative thyroid weights were increased
in the high-dose males. In the males of the mid- and high-dose groups, increased incidences of
hepatocellular hypertrophy were observed. The degree of severity in the mid-dose group was trace
and in the high-dose group it was mild-to-moderate. An increased incidence and severity of thyroid
hypertrophy and hyperplasia was observed in high-dose males. Trace and trace-to-mild nephropathy
occurred in males of the mid- and high-dose groups, respectively. In the kidneys of high-dose females,
a greater degree than normal of brown pigments in the cytoplasm of cortical tubular epithelial cells
was noted. The NOAEL was 10 mg/kg bw per day, based on the increase in liver and kidney weights,
as well as histopathological changes in liver (hepatocellular hypertrophy, males) and kidney
(nephropathy, males) at 100 mg/kg bw per day.
In a 90-day rat study, SCCP (C12, 60% chlorination) was given in doses of 0, 313, 625, 1,250,
2,500 or 5,000 mg/kg bw per day in corn oil by gavage 5 days per week (NTP, 1986a; Bucher et al.,
1987). No mortality was observed. The ﬁnal body weights of the males that received 2,500 and
5,000 mg/kg bw per day were 11 and 12% lower than the control group. Relative liver weight was
signiﬁcantly increased at all dose levels, the increase ranging from 25% (lowest dose) to 100%
(highest dose). Hepatocellular hypertrophy was observed in all top-dose animals, and nephropathy in
all top-dose males, in 3/10 top-dose females and in 8/10 male controls. Histopathological examination
was performed in high-dose and control animals only. No histopathological ﬁndings were reported in
the heart, thymus, thyroid or spleen. The LOAEL of this study was 313 mg/kg bw per day, based on
increased relative liver weights observed at all dose levels.
Groups of 50 male and 50 female F344/N rats were given SCCP (C12, 60% chlorination) in doses of
0, 312 or 625 mg/kg bw per day in corn oil by gavage 5 days per week for 2 years (NTP, 1986a;
Bucher et al., 1987). Additional groups (20/sex per group) were included in the 6- and 12-month
33 Described in the study report as ‘Characterised by the inﬁltration of mixed inﬂammatory cells into the interstitium and tubular
regeneration with minimal tubular degeneration. The regenerated tubules contained prominent brown granular pigment’. IRDC
(1984a, unpublished study, see Documentation provided to EFSA).
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studies. In the main study, survival of the low- and high-dose males and low-dose females was lower
than that of the control (control: 27/34; low-dose: 6/23; high-dose: 3/29 for males/females,
respectively). Body weight gain was reduced by 12% at 6 and 12 months, and by 23% in the main
study. Liver and kidney weights (absolute and relative) were increased in a dose-related manner; the
increase was signiﬁcant at both 6 and 12 months (up to 124% for liver and up to 46% for kidney), but
there was no difference in weight at the two time points. In the main study, the organ weights were
not reported. Several non-neoplastic histopathological changes were found. These included effects in
the liver (hepatocellular hypertrophy, necrosis, focal cellular changes and gross dilation of the blood
vessels), kidney (cysts; in the cortex of males), tubular cell hyperplasia (in males), nephropathy
(incidence and severity in females, severity in males), parathyroid (ﬁbrous osteodystrophy in males),
forestomach (ulcers, inﬂammation, epithelial hyperplasia and hyperkeratosis in males) and glandular
stomach (oedema and erosion in males). The LOAEL was 312 mg/kg bw per day, based on the
increase in liver and kidney weight and non-neoplastic lesions observed at both doses. The neoplastic
lesions observed in this study are addressed in the carcinogenicity subsection (see Section 3.1.2.7).
Studies in mice
Two different SCCPs (Cereclor 56L, C10–13, 56% chlorination or Chlorowax 500C, C10–13, 58%
chlorination) in corn oil were administered to male mice (5 per group) in doses of 0, 10, 50, 100, 250,
500 or 1,000 mg/kg bw per day per gavage for 14 days (Wyatt et al., 1993). For Cereclor 56L,
absolute and relative liver weights were signiﬁcantly increased from 100 mg/kg bw per day
(approximately 26 and 28%, respectively). For Chlorowax 500C, relative liver weight was increased
from 250 mg/kg bw per day (approximately 23%), while absolute liver weight from 500 mg/kg bw per
day (approximately 73%). Palmitoyl CoA oxidation as an indicator for peroxisome proliferation was
signiﬁcantly increased from 250 mg/kg bw per day for both Cereclor 56L and Chlorowax 500C. The
NOAEL was 50 mg/kg bw per day for Cereclor 56L based on increased relative and absolute liver
weights, while it was 100 mg/kg bw per day for Chlorowax 500C based on increased relative liver
weights.
In a 16-day study in mice, SCCP (C12, 60% chlorination) was administered in doses of 0, 938,
1,875, 3,750, 7,500 or 15,000 mg/kg bw per day in corn oil by gavage 5 days per week (NTP, 1986a;
Bucher et al., 1987). All animals died that received doses from 3,750 mg/kg bw per day or more. At
1,875 mg/kg bw per day, 4/5 males and 2/5 females died. Diarrhoea occurred in all dose groups
except in low-dose females. Enlargement of the livers were reported in all treated mice that survived.
No histopathological examination was performed in this study. The LOAEL was 938 mg/kg bw per day
based on liver enlargement.
SCCP (C12, 60% chlorination) was administered to mice in doses of 0, 125, 250, 500, 1,000 or
2,000 mg/kg bw per day in corn oil by gavage 5 days per week for 90 days (NTP, 1986a; Bucher
et al., 1987). No substance-related deaths occurred. Body weight gain was reduced by 13% in high-
dose males. Relative liver weights were increased in a dose-related manner in both sexes. This effect
was signiﬁcant in females from 250 mg/kg bw per day (21%) and in males from 500 mg/kg bw per
day (38%). Hepatocellular hypertrophy was reported from 250 mg/kg bw per day in both sexes, and
focal hepatic necrosis from 500 mg/kg bw per day in males and at 2,000 mg/kg bw per day in
females. No changes were observed in the thyroid. The NOAEL was 125 mg/kg bw per day, based on
hepatocellular hypertrophy (both sexes) and increase in relative liver weight (21%) (females only) at
250 mg/kg bw per day.
In a 2-year study with B6F3C1 mice, SCCP (C12, 60% chlorination) was administered in doses of 0,
125 or 250 mg/kg bw per day in corn oil by gavage 5 days per week (NTP, 1986a; Bucher et al.,
1987). Reduced survival of high-dose females occurred after week 100 (surviving from original 50
animals, control: 34/35; low-dose: 30/31; high-dose: 30/25 for males/females, respectively). Body
weights were decreased by about 10% in treated females compared to the controls. Non-neoplastic
histopathological changes were found in the thyroid (follicular cell lesions in all groups ranging from
early hyperplasia to multi-layered projections that extended into the lumen, 10%/32%, 12%/55%,
24%/45% in control, mid- and high-dose males/females, respectively) and in the kidney (increased
incidence of nephropathy in females). No non-neoplastic lesions were reported in the liver. The LOAEL
for non-neoplastic lesions was 125 mg/kg bw per day based on the effects in the kidney (females) and
thyroid at both doses. The neoplastic lesions observed in this study are addressed in the
carcinogenicity subsection (see Section 3.1.2.7).
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Table 12: Repeated dose toxicity studies on SCCPs in rats and mice
Species/
strain
Number of
animals per
group
SCCP
speciﬁcation
Duration Administration
Dose levels
(mg/kg bw
per day)
Most sensitive endpoints
NOAEL
(mg/kg bw
per day)
LOAEL
(mg/kg bw
per day)
Reference
Studies in rats
F344 rat 5/sex per
group
C10–12,
58% chlorination
14 days Diet 0, 100, 300,
1,000, 3,000
↑ absolute and relative liver
weights, ↑ incidence of
hepatocellular hypertrophy
– 100 IRDC (1983a)(a)
F344 rat 5/sex per
group
C10–12,
58% chlorination
14 days Gavage (corn
oil)
0, 30, 100, 300,
1,000, 3,000
↑ relative liver weights in
males
30 100 IRDC (1981a)(a)
Alpk:APfSD
rat
5/males per
group
Cereclor 56L, C10–
13,
56% chlorination
14 days Gavage (corn
oil)
0, 10, 50, 100,
250, 500, 1,000
↑ relative liver weights(b) 10 50 Wyatt et al.
(1993)
Alpk:APfSD
rat
5/males per
group
Chlorowax 500C,
C10–13, 58%
chlorination
14 days Gavage (corn
oil)
0, 10, 50, 100,
250, 500, 1,000
↑ absolute and relative liver
weights
50 100 Wyatt et al.
(1993)
F344 rat 5/sex per
group
C12,
60% chlorination
16 days Gavage (corn
oil)
0, 469, 938,
1,875, 3,750,
7,500
Liver enlargement – 469 NTP (1986a),
Bucher et al.
(1987)
Sprague–
Dawley rat
9/males per
group
C10–13,
56.5% chlorination
28 days Gavage (corn
oil)
0, 1, 10, 100 ↓ plasma FT3, ↑ plasma TSH 1 (NOEL) 10 (LOEL) Gong et al.
(2018)
F344 rat 15/sex per
group
C10–12,
58% chlorination
90 days Diet 0, 10, 100, 625 ↑ absolute and relative liver
and kidney weights;
histopathological changes
such as hepatocellular
hypertrophy (both sexes),
mild nephritis (males only),
and thyroid hypertrophy and
hyperplasia (males only)
10 100 IRDC (1984a)(a),
Serrone et al.
(1987)
F344 rat 15/sex per
group
C10–12,
58% chlorination
90 days Gavage
(corn oil)
0, 10, 100, 625 ↑ absolute and relative liver
and kidney weights;
histopathological changes
such as hepatocellular
hypertrophy (males only),
mild nephropathy (males
only)
10 100 IRDC (1984b)(a),
Serrone et al.
(1987)
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Species/
strain
Number of
animals per
group
SCCP
speciﬁcation
Duration Administration
Dose levels
(mg/kg bw
per day)
Most sensitive endpoints
NOAEL
(mg/kg bw
per day)
LOAEL
(mg/kg bw
per day)
Reference
F344 rat 10/sex per
group
C12,
60% chlorination
90 days Gavage (corn
oil)
0, 313, 625,
1,250, 2,500,
5,000
↑ relative liver weights – 313 NTP (1986a),
Bucher et al.
(1987)
F344 rat 50/sex per
group
20/sex per
group
C12,
60% chlorination
2 years Gavage (corn
oil)
0, 312, 625 ↑ liver and kidney weights;
histopathological ﬁnding in
the liver, kidney, stomach,
forestomach and parathyroid
– 312 NTP (1986a),
Bucher et al.
(1987)
Studies in mice
Alpk:APfCD-
1 mouse
5/males per
group
Cereclor 56L, C10–
13, 56%
chlorination
14 days Gavage (corn
oil)
0, 10, 50, 100,
250, 500, 1,000
↑ absolute and relative liver
weights
50 100 Wyatt et al.
(1993)
Alpk:APfCD-
1 mouse
5/males per
group
Chlorowax 500C,
C10–13, 58%
chlorination
14 days Gavage (corn
oil)
0, 10, 50, 100,
250, 500, 1,000
↑ relative liver weights 100 250 Wyatt et al.
(1993)
B6F3C1
mouse
5/sex per
group
C12,
60% chlorination
16 days Gavage (corn
oil)
0, 938, 1,875,
3,750, 7,500,
15,000
liver enlargement – 938 NTP (1986a),
Bucher et al.
(1987)
B6F3C1
mouse
10/sex per
group
C12,
60% chlorination
90 days Gavage (corn
oil)
0, 125, 250,
500, 1,000,
2,000
↑ relative liver weights
(females), hepatocellular
hypertrophy (both sexes)
125 250 NTP (1986a),
Bucher et al.
(1987)
B6F3C1
mouse
50/sex per
group
C12,
60% chlorination
2 years Gavage (corn
oil)
0, 125, 250 Histopathological ﬁndings in
the kidney (females only)
and in the thyroid (both
sexes)
– 125 NTP (1986a),
Bucher et al.
(1987)
SCCPs: short-chain chlorinated parafﬁns; NOAEL: no-observed adverse effect level; LOAEL: lowest-observed adverse effect level; bw: body weight; T3: triiodothyronine; TSH: thyroid-stimulating
hormone; FT3: free T3.
(a): Unpublished study report, see Documentation provided to EFSA.
(b): For absolute liver weight increase, the lowest signiﬁcant effect was at 10 mg/kg bw per day but followed an irregular dose response. As consequence, it was not used for the determination of
NOAEL and LOAEL.
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3.1.2.2.2. MCCPs
Six repeated dose toxicity studies on MCCPs in rats, one study in mice and one study in dogs were
identiﬁed. They are summarised in Table 13 and discussed below.
Studies in rats
In a 14-day dietary study with rats, MCCP (Cereclor S52, C14–17, 52% chlorination) was
administered at doses of 0, 17.3, 57.5, 173, 547 or 1,537 mg/kg bw per day to males and 0, 18.1,
57.9, 180, 576 or 1,287 mg/kg bw per day to females (IRDC, 1981b, unpublished study, see
Documentation provided to EFSA). No mortality and no clinical signs were observed. Food
consumption was reduced by up to 31% (in top-dose females). Absolute and relative liver weights
were increased by up to 80% at the two highest dose levels in both sexes. Relative liver weights in
females were already signiﬁcantly increased by 19% at 180 mg/kg bw per day. Also, absolute and
relative ovary weights were decreased (by 38%) at the top dose in females. Diffuse mild
hepatocellular hypertrophy was noted at the two highest dose levels in males. No histopathological
ﬁndings were observed in the ovary. The NOAEL of this study was 58 mg/kg bw per day based on an
increased relative liver weight (19% at 180 mg/kg bw per day) in females.
MCCP (Chlorparafﬁn 40G, C14–17, 40% chlorination) in corn oil was administered to male rats (5 per
group) in doses of 0, 10, 50, 100, 250, 500 or 1,000 mg/kg bw per day per gavage for 14 days (Wyatt
et al., 1993). Signiﬁcant increase in relative liver weights was observed at 10 mg/kg bw per day, at
100 mg/kg bw per day and from 500 mg/kg bw per day (irregular dose response). Absolute liver
weight was signiﬁcantly increased at 100 mg/kg bw per day and from 500 mg/kg bw per day
(irregular dose response). Palmitoyl CoA oxidation was increased from 500 mg/kg bw per day. The
NOAEL was 50 mg/kg bw per day based on increased absolute and relative liver weights (18 and
19%, respectively) at 100 mg/kg bw per day.
In a 90-day dietary study, F344 rats received MCCP (Cereclor S52, C14–17, 52% chlorination) at
doses of 0, 2.4, 9.3, 23 or 222 mg/kg bw per day to males and 0, 2.5, 9.7, 24.6 or 242 mg/kg bw per
day to females (CXR, 2005b, unpublished draft study, see Documentation provided to EFSA). No
adverse effects on body weight, body weight gain or food consumption were measured. At the highest
dose level, absolute and relative liver and kidney weights were signiﬁcantly increased by 13–31% and
by 9–13%, respectively. A small but statistically signiﬁcant increase by 7% in relative kidney weight
was already observed at 24.6 mg/kg bw per day only in females. Such a small change was not
considered of toxicological relevance. Thyroid, liver and kidney histopathology was performed in all
samples of both sexes. Minimal centrilobular hepatocellular hypertrophy could be found in the top-dose
males. There was a slight increase of the incidence of ultimobranchial cysts in thyroids of males at
23 mg/kg bw per day (3 out of 10 vs. 1 out of 10 in the control group). Signiﬁcant decreases in
plasma triglycerides (by 28–39%) and cholesterol (by 14–23%) were observed in top-dose animals.
Hepatic microsomal T4-uridine 5’-diphospho-glucuronosyltransferase (UDPGT) activity was increased in
high-dose males (by 82%) and in females at the three highest dose levels (30, 30 and 252%). There
was no increase on palmitoyl CoA oxidation that would be indicative for peroxisome proliferation. A
signiﬁcant decrease of plasma FT3 levels was detected in males at 23 and 222 mg/kg bw per day by
26 and 22%, respectively. In contrast, TT3 levels, FT4 and TT4 levels were not changed. A signiﬁcant
decrease of plasma FT4 levels could be found in high-dose females (by 41%) while TT4 levels, or FT3
and TT3 levels were not affected. An increase in plasma TSH levels was reported in females at the two
highest dose levels (by 20 and 39%) and in high-dose males (by 17%). The NOEL was 9.3/9.7 mg/kg
bw per day, for males/females, respectively, based on effects on thyroid hormones (decrease of
plasma FT3 of males and increase of plasma TSH in females).
Sprague–Dawley rats were fed diets containing MCCP (C14–17, 52% chlorination) at doses of 0, 0.4,
3.6, 36.2 or 362.9 mg/kg bw per day in males and 0, 0.4, 4.2, 42.2 or 418.9 mg/kg bw per day in
females for a period of 90 days (Poon et al., 1995). No mortality and no clinical signs of toxicity were
reported. Body weight, body weight gain and food consumption were not affected by the treatment.
Relative liver weights were increased in females at the two highest dose levels (by 7 and 47%) and in
high-dose males (by 27%). Relative kidney weights were increased in high-dose animals (by 8–11%).
Serum cholesterol was increased in females by about 22, 20 and 28% at 4, 42 and 420 mg/kg bw per
day, respectively. However, standard deviations were large but not given in numbers so that no
statement on the statistical signiﬁcance of the cholesterol effect can be made. Such a trend was not
observable in males. In males at 360 mg/kg bw per day, AST activity was about 20% higher than
control, and inorganic phosphate about 13% higher than control. A signiﬁcant increase in hepatic
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UDPGT activity was detected in top-dose males and females (by 58 and 70%). In the liver, minimal to
mild anisokaryosis and vesiculation of the nuclei were observed at the two highest dose levels. There
was an increase in perivenous hepatocyte homogeneity in high-dose males and in females at the two
highest dose levels. The CONTAM Panel noted that it is not clear from the paper what ‘perivenous
hepatocyte homogeneity’ refers to as this was not further described. Single cell necrosis occurred in
high-dose animals. In the kidney of all treated males, hyaline-droplet like cytoplasmic inclusions were
observed, but these ﬁndings were only signiﬁcant in the high-dose group. Inner medullary tubular
dilation of minimal severity occurrence in a dose-related manner with incidences of 0/10, 0/10, 1/10,
4/10 and 8/10 in females at 0, 0.4, 4.2, 42 and 420 mg/kg bw per day, respectively. In the thyroid of
males from 36 mg/kg bw per day and of females from 4 mg/kg bw per day, reduced follicle sizes,
collapsed angularity, increased follicle height, cytoplasmic vacuolation and nuclear vesiculation were
observed. The changes were generally minimal to mild in nature. Mild cytoplasmic vacuolation of the
pituitary gland and sinus hyperplasia of the spleen were observed at the highest doses. It was noted
that the average scorings in females at 4.2 mg/kg bw per day were minimal to mild. It was not
possible for the CONTAM Panel to obtain the scorings for individual animals from the study authors.
Therefore, the Panel was not able to interpret the histopathological ﬁndings in the liver, kidney and
thyroid, and thus not able to identify a NOAEL from this study.
In a 90-day dietary study in F344 rats, MCCP (Cereclor S52, C14–17, 52% chlorination) was given at
dose levels of 0, 10, 100 or 625 mg/kg bw per day (IRDC, 1984c, unpublished study, see
Documentation provided to EFSA). Two female rats died during the conduct of this study. The deaths
were reported to be unrelated to the treatment. Body weight gain was slightly reduced (< 5%) and
could be observed in males and females. There was an increase (by 25%) in serum cholesterol in
high-dose females. Absolute and relative liver weights were increased in mid-dose (up to 28%) and
high-dose animals (up to 100%) of both sexes. Absolute and relative kidney weights were increased in
animals of both sexes up to 11% at 100 mg/kg bw per day and up to 25% at 625 mg/kg bw per day.
Increased absolute thyroid weights (50%) in males only, and increased adrenals weights in both sexes
(up to 39%) were observed at the top dose. Histopathological changes were noted in the liver
(hepatocellular hypertrophy of mild severity) in high-dose males and females (13/15 in both sexes),
with males (1/15) at 100 mg/kg bw per day also affected. In the thyroid of almost all control and
treated males, trace to moderate hypertrophy and hyperplasia were observed. There was a trend
towards increasing severity with increasing dose. At 625 mg/kg bw per day, thyroid hypertrophy was
observed in mild form (9/15) and in moderate form (3/15). At the same dose level, thyroid hyperplasia
occurred in mild form (9/15). Kidney effects were reported including chronic nephritis in males (1/15,
3/15, 4/15, 10/15) and as renal tubular pigmentation in high-dose females. The NOAEL was 10 mg/kg
bw per day, based on an increase in absolute and relative liver and kidney weights at higher dose
levels.
In a 90-day dietary study with Wistar rats, an MCCP (Cereclor S52, C14–17, 52% chlorination,
containing epoxidised vegetable oil stabiliser) was administered at dose levels of 0, 33, 167 or
333 mg/kg bw per day in males and of 0, 32, 160 or 320 mg/kg bw per day in females (Birtley et al.,
1980). No animals died and no clinical signs of toxicity were reported. Body weight gain was reduced
by 17 and 25%. Relative liver weight was increased in males from 167 mg/kg bw per day (by 15 and
22%) and in females from 32 mg/kg bw per day (by 11, 21 and 48%). Using electron microscopy,
histopathological changes in the liver included a dose-related proliferation of smooth endoplasmic
reticulum could be found, starting from the lowest dose. The LOAEL was 32 mg/kg bw per day, based
on increased relative liver weights (in females) and proliferation of smooth endoplasmic reticulum. In
the same dietary study performed with a time shift of several weeks, rats were administered dose
levels of 0, 16 and 16.5 mg/kg bw per day in males and females, respectively, for 13 weeks. No
changes could be observed in the relative liver weights between treated animals and the control group
and no histopathological abnormalities could be found. Combining these ﬁndings, it can be concluded
that the NOAEL for the endpoint of relative liver weight is 16 mg/kg bw per day.
Studies in mice
Male mice (5 per group) were administered MCCP (Chlorparafﬁn 40G, C14–17, 40% chlorination) in
corn oil in doses of 0, 10, 50, 100, 250, 500 or 1,000 mg/kg bw per day per gavage for 14 days
(Wyatt et al., 1993). Absolute and relative liver weights were signiﬁcantly increased at 1,000 mg/kg bw
per day. Palmitoyl CoA oxidation was signiﬁcantly increased from 500 mg/kg bw per day (270%). The
NOAEL was 250 mg/kg bw per day based on increased palmitoyl CoA oxidation.
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Studies in dogs
Beagle dogs were fed MCCP (Cereclor S52, C14–17, 52% chlorination, containing epoxidised
vegetable oil stabiliser) in the diet at dose levels of 0, 10, 30 or 100 mg/kg bw per day during a period
of 90 days (Birtley et al., 1980). Serum alkaline phosphatase activity and relative liver weight in males
were increased at 100 mg/kg bw per day. In addition, smooth endoplasmic reticulum of hepatocytes
as measured by electron microscopy, was increased in males at 30 and 100 mg/kg bw per day. The
NOEL was 10 mg/kg bw per day, based on an increase of hepatic smooth endoplasmic reticulum in
males at higher dose levels.
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Table 13: Repeated dose toxicity studies on MCCPs in rats, mice and dogs
Species/
strain
Number of
animals per
group
MCCP
speciﬁcation
Duration Administration
Dose levels
(mg/kg bw
per day)
Most sensitive
endpoints
NOAEL
(mg/kg bw
per day)
LOAEL
(mg/kg bw
per day)
Reference
Studies in rats
F344 rat 5/sex per
group
Cereclor S52, C14–17,
52% chlorination
14 days Diet 0, 17.3, 57.5,
173, 547, 1,537
(males);
0, 18.1, 57.9,
180, 576, 1,287
(females)
↑ relative liver weight
(females)
58 180 IRDC (1981b)(a)
Alpk:APfSD
rat
5/males per
group
Chlorparafﬁn 40G,
C14–17, 40%
chlorination
14 days Gavage (corn
oil)
0, 10, 50, 100,
250, 500, 1,000
↑ absolute and relative
liver weights(b)
50 100 Wyatt et al.
(1993)
F344 rat 10/sex per
treated
group;
20/sex per
control
Cereclor S52, C14–17,
52% chlorination
90 days Diet 0, 2.4, 9.3, 23,
222 (males);
0, 2.5, 9.7, 24.6,
242 (females)
↓ plasma FT3 in males
↑ plasma TSH in females
9.3/9.7
(NOEL)
23/24.6
(LOEL)
CXR (2005b, draft
study)(a)
Sprague–
Dawley rat
10/sex per
group
C14–17,
52% chlorination
90 days Diet 0, 0.4, 4, 36,
360 (males);
0, 0.4, 4, 42,
420 (females)
Histopathological changes
in liver, kidney and thyroid
– –(c) Poon et al.
(1995)
F344 rat 15/sex per
group
Cereclor S52, C14–17,
52% chlorination
90 days Diet 0, 10, 100, 625 ↑ absolute and relative
liver and kidney weights
10 100 IRDC (1984c)(a)
Wistar rat 24/sex per
group
Cereclor S52, C14–17,
52% chlorination;
containing 0.2%
(w/v) epoxidised
vegetable oil as
stabiliser
90 days Diet 0, 33, 167, 333
(males);
0, 32, 160, 320
(females)
0, 16.5 (males;
0, 16 (females)
↑ relative liver weights
(females), proliferation of
smooth endoplasmic
reticulum
No signiﬁcant changes in
relative liver weights
–
16
32
–
Birtley et al.
(1980)
Studies in mice
Alpk:APfCD-
1 mouse
5/males per
group
Chlorparafﬁn 40G,
C14–17, 40%
chlorination
14 days Gavage (corn
oil)
0, 10, 50, 100,
250, 500, 1,000
↑ palmitoyl CoA oxidation
(indicator for peroxisome
proliferation)
250 500 Wyatt et al.
(1993)
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Species/
strain
Number of
animals per
group
MCCP
speciﬁcation
Duration Administration
Dose levels
(mg/kg bw
per day)
Most sensitive
endpoints
NOAEL
(mg/kg bw
per day)
LOAEL
(mg/kg bw
per day)
Reference
Studies in dogs
Beagle dog 4/sex per
group
Cereclor S52, C14–
17, 52%
chlorination;
containing 0.2%
(w/v) epoxidised
vegetable oil as
stabiliser
90 days Diet 0, 10, 30, 100 ↑ hepatic smooth
endoplasmic reticulum
(males)
10 (NOEL) 30 (LOEL) Birtley et al.
(1980)
MCCPs: medium-chain chlorinated parafﬁns; NOAEL: no-observed adverse effect level; LOAEL: lowest-observed adverse effect level; bw: body weight; NOEL: no-observed effect level; LOEL:
lowest-observed effects level; T3: triiodothyronine; TSH: thyroid-stimulating hormone; FT3: free T3.
(a): Unpublished study report, see Documentation provided to EFSA.
(b): Relative liver weights were signiﬁcantly increased at 10 mg/kg bw per day but did not follow a regular dose response. LOAEL of 100 mg/kg bw per day was determined since both absolute
and relative livers weights were signiﬁcantly increased at this dose level.
(c): The CONTAM Panel was not able to interpret the histopathological ﬁndings in the liver, kidney and thyroid, and thus not able to identify a NOAEL from this study.
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3.1.2.2.3. LCCPs
Seven repeated dose toxicity studies on LCCPs in rats and three studies in mice were identiﬁed.
They are summarised in Table 14 and discussed below.
Studies in rats
LCCP (43% chlorination)
Rats were treated with LCCP (C22–26, 43% chlorination) at doses of 0, 30, 100, 300, 1,000 or
3,000 mg/kg bw per day in corn oil by gavage during 14 days (IRDC, 1981c, unpublished study, see
Documentation provided to EFSA). No compound-related effects were observed except the increase in
kidney nephrolithiasis at 3,000 mg/kg bw per day in females (3 out of 5 animals compared to 1 out of
5 animals in the control group). The NOAEL was 1,000 mg/kg bw per day, based on the kidney
nephrolithiasis at the highest dose.
F344/N rats were exposed to LCCP (C23, 43% chlorination) at doses of 0, 235, 469, 938, 1,875 or
3,750 mg/kg bw per day in corn oil by gavage 5 days per week over a 16-day period (NTP, 1986b;
Bucher et al., 1987). No compound-related clinical signs or gross pathologic effects were observed.
The NOAEL was 3,750 mg/kg bw per day (the highest dose in the study).
LCCP (C22–26, 43% chlorination) was administered in corn oil by gavage for 90 days to F344 rats at
doses of 0, 100, 900 or 3,750 mg/kg bw per day (IRDC, 1984d, unpublished study, see Documentation
provided to EFSA). There was an increase in absolute liver weights (13–15%) in all exposed females
and in relative liver weights in females at 900 and 3,750 mg/kg bw per day, but not in males.
Multifocal granulomatous hepatitis involving inﬂammatory changes and necrosis was observed in all
groups of treated females. Mineralisation in the kidneys was observed in high-dose female rats and
mild nephropathy was observed in high-dose male rats. The LOAEL was 100 mg/kg bw per day (the
lowest dose tested), based on liver effects in females.
F344/N rats were exposed to LCCP (C23, 43% chlorination) at doses of 0, 235, 469, 938, 1,875 or
3,750 mg/kg bw per day for 90 days (NTP, 1986b; Bucher et al., 1987). LCCP was administered in
corn oil by gavage 5 days per week. No clinical signs of toxicity were recorded and no changes in body
weight or in organ weights were observed when compared to the control group. A dose-related
increase in the incidence of granulomatous inﬂammation was reported in the liver in all groups of
treated females. Lesions were characterised by multiple, randomly distributed accumulations of
histiocytes within the liver sinusoids, which usually compressed the adjacent liver parenchyma. The
smaller lesions were usually nodular, whereas the larger, more extensive accumulations appeared to
result from the coalescence of adjacent smaller nodules. Lymphoid cells were present in the centre of
some histiocytic foci but were most commonly seen at the periphery of the histiocytic accumulations.
Large epithelioid cells were present near the centre of some nodules. Numerous lesions contained a
small number of hyaline acidophilic cells. The LOAEL was 235 mg/kg bw per day (the lowest dose
tested), based on increased incidence of granulomatous inﬂammation in the liver of females.
Groups of 50 male and 50 female F344/N rats were given LCCP (C23, 43% chlorination) at doses of
0, 1,875 or 3,750 mg/kg bw per day in males and 0, 100, 300 or 900 mg/kg bw per day in females for
2 years (NTP, 1986b; Bucher et al., 1987). LCCP was administered in corn oil by gavage 5 days per
week. Additional groups (20/sex per group) were included for concurrent 6- and 12-month studies.
Survival was not affected. Relative liver weights were signiﬁcantly increased in males at 3,750 mg/kg
bw per day after 12 months and in females at 900 mg/kg bw per day after 6 months and at 300 and
900 mg/kg bw per day after 12 months. Histopathological changes were found in form of diffuse
lymphohistiocytic inﬂammation in the liver and in the pancreatic and mesenteric lymph nodes in all
exposed groups of males and females. Congestion in the spleens that occurred in all dose groups was
reported to be a secondary effect of the granulomatous liver lesion, and was reported to impair the
hepatic blood ﬂow by obstruction of the sinusoids. In females, ALT was slightly elevated in serum at
the medium and high dose after six months, while AST and sorbitol dehydrogenase were slightly
elevated at the medium and high dose after 12 months. In males, all three serum enzyme levels were
increased at low and high dose after 6 and 12 months. Leukocyte and lymphocyte counts in high-dose
females after 6 months and mid-dose and high-dose females at 12 months, neutrophil counts in mid-
dose and high-dose females after 12 months, and lymphocyte counts in mid-dose males were
signiﬁcantly greater than those of the control groups. The LOAEL for non-neoplastic effects was
100 mg/kg bw per day, based on increased relative liver weight and histopathological changes
(lymphohistiocytic inﬂammation in the liver and in the pancreatic and mesenteric lymph nodes)
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observed at all dose levels in females. The neoplastic lesions observed in this study are addressed in
the carcinogenicity subsection (see Section 3.1.2.7).
LCCP (70% chlorination)
In a 14-day dietary study with rats, LCCP (Electroﬁne S70, C22–26, 70% chlorination) was
administered at doses of 0, 17.1, 55, 169, 565 or 1,715 mg/kg bw per day (IRDC, 1981d, unpublished
study, see Documentation provided to EFSA). No compound-related effects were noted. The NOAEL
was 1,715 mg/kg bw per day (the highest dose tested).
LCCP (Electroﬁne S70, C22–26, 70% chlorination) was administered to F344 rats in the diet for
90 days at doses of 0, 100, 900 and 3,750 mg/kg bw per day (IRDC, 1984e, unpublished study, see
Documentation provided to EFSA). A slight decrease in body weight gain was observed in males at
3,750 mg/kg bw per day compared to the control group. Increased relative liver weights were
observed in high-dose males (13%) and in high-dose females (23%). Hepatocellular hypertrophy,
cytoplasmic fat vacuolation and increased occurrence of fat droplets, revealed by Oil Red O staining,
were noted in the liver at the highest dose level of both sexes. In the blood chemistry analyses, ALT
activity was increased in both sexes at the highest dose level, and AST activity was also increased in
females of this group. Glucose levels were slightly decreased in the high-dose females at week 13.
There was a slight reduction in serum cholesterol at weeks 8 and 13 in males and at weeks 5 and 13
in females at the high-dose level. The NOAEL was 900 mg/kg bw per day, based on increased relative
liver weight and histopathological changes in the liver.
Studies in mice
Mice were exposed to LCCP (C23, 43% chlorination) at doses of 0, 469, 938, 1,875, 3,750 or
7,500 mg/kg bw per day during 16 days (NTP, 1986b; Bucher et al., 1987). LCCP was administered in
corn oil by gavage 5 days per week. No clinical signs or gross pathological effects were observed. The
NOAEL was 7,500 mg/kg bw per day (the highest dose tested in this study).
LCCP (C23, 43% chlorination) was administered to B6C3F1 mice by gavage for 90 days at doses of
0, 469, 938, 1,875, 3,750 or 7,500 mg/kg bw per day in corn oil (NTP, 1986b; Bucher et al., 1987). No
effects on body or organ weights, no clinical signs of toxicity and no histopathological effects were
noted. The NOAEL was 7,500 mg/kg bw per day (the highest dose tested in this study).
In a 2-year mice study, LCCP (C23, 43% chlorination) was administered at doses of 0, 2,500 or
5,000 mg/kg bw per day (NTP, 1986b; Bucher et al., 1987). LCCP was given in corn oil by gavage
5 days per week. Survival was impacted by the treatment until week 65. No clinical signs of toxicity
were reported. However, a Klebsiella oxytoca infection strongly affected the females after week 65:
60–70% of the early deaths in each treatment group of females were attributed to this infection. No
signiﬁcant non-neoplastic lesions occurred. The NOAEL for non-neoplastic effects was 5,000 mg/kg bw
per day (the highest dose tested in this study). The neoplastic lesions reported in this study are
addressed in the carcinogenicity subsection (see Section 3.1.2.7).
3.1.2.2.4. Summary on repeated dose toxicity (non-neoplastic effects)
A number of repeated dose toxicity studies has been performed using a few CPs of different carbon
chain length and different degrees of chlorination. These studies have shown that the liver, kidney and
thyroid are the target organs for SCCPs and MCCPs, and liver for LCCPs.
SCCPs
For the SCCP (C10–13, 56.5% chlorination; mass ratio of C10:C11:C12:C13 = 1:1:1:1) used in the
28-day male rat gavage study by Gong et al. (2018), changes in thyroid hormone plasma levels were
observed at 10 mg/kg bw per day. No histopathological changes were observed in the thyroid at
100 mg/kg bw per day, the only dose examined. The NOEL was 1 mg/kg bw per day, based on effects
on thyroid hormones (decrease of plasma FT3 and increase of plasma TSH).
In two 90-day rat studies with the same SCCP (C10–12, 58% chlorination), one with dietary
administration (IRDC, 1984a, unpublished study, see Documentation provided to EFSA) and the other
with gavage (IRDC, 1984b, unpublished study, see Documentation provided to EFSA) the NOAEL was
10 mg/kg bw per day. In the dietary study, increased liver and kidney weights and histopathological
changes in liver, kidney (males) and thyroid (males) were observed at 100 mg/kg bw per day. In the
gavage study, increased liver and kidney weights and histopathological changes in liver (males) and
kidneys (males) were observed at 100 mg/kg bw per day.
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In two chronic gavage studies in rats and mice with an SCCP (C12, 60% chlorination) (NTP, 1986a),
effects were observed at the lowest tested dose levels of 312 mg/kg bw per day for rats (liver and
kidney) and 125 mg/kg bw per day for mice (kidney and thyroid).
MCCPs
In a dietary 90-day rat study with an MCCP (C14–17, 52% chlorination), a NOEL of 9.3/9.7 mg/kg
bw per day for males/females, respectively, was observed, based on decreased plasma FT3 in males
and increased plasma TSH in females. A small increase in histopathological changes (ultimobranchial
cysts) was observed in the thyroid of male rats at 23 mg/kg per day; this was not seen at higher dose
levels and therefore, not considered of toxicological relevance (CXR, 2005b, unpublished study, see
Documentation provided to EFSA). In another dietary rat study with the same MCCP, a NOAEL of
10 mg/kg bw per day was observed, based on an increase in liver and kidney weights (IRDC, 1984c,
unpublished study, see Documentation provided to EFSA). A NOEL of 10 mg/kg bw per day was
observed in a 90-day dietary study in dogs with the same MCCP, based on an increase of hepatic
smooth endoplasmic reticulum in males (Birtley et al., 1980).
LCCPs
For an LCCP (C22–26, 43% chlorination), the LOAEL was 100 mg/kg bw per day (the lowest dose
level tested), based on increased liver weight and histopathological changes in the liver (inﬂammatory
changes and necrosis) of female rats in a 90-day gavage study (IRDC, 1984d, unpublished study, see
Documentation provided to EFSA). For another LCCP of a higher chlorination degree (C22–26, 70%
chlorination), the NOAEL was 900 mg/kg bw per day, based on liver effects in a 90-day rat dietary
study (IRDC, 1984e, unpublished study, see Documentation provided to EFSA). In a chronic gavage
study in rats with an LCCP (C23, 43% chlorination), effects (increased liver weight and histopathological
changes such as diffuse lymphohistiocytic inﬂammation in liver, pancreatic and mesenteric lymph nodes)
were observed at 100 mg/kg bw per day for female rats (the lowest dose level tested) (NTP, 1986b).
No effects were observed in a chronic gavage study in mice with the same LCCP at dose levels up to
5,000 mg/kg bw per day (the highest dose level tested) (NTP, 1986b).
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Table 14: Repeated dose toxicity studies on LCCPs in rats and mice
Species/
strain
N animals
per group
LCCP
speciﬁcation
Duration Administration
Dose levels
(mg/kg bw
per day)
Most sensitive endpoints
NOAEL
(mg/kg bw
per day)
LOAEL
(mg/kg bw
per day)
Reference
Studies in rats
F344 rat 5/sex per
group
C22–26, 43%
chlorination
14 days Gavage (corn
oil)
0, 30, 100, 300,
1,000, 3,000
Nephrolithiasis (females) 1,000 3,000 IRDC (1981c)(a)
F344 rat 5/sex per
group
C23, 43%
chlorination
16 days Gavage (corn
oil)
0, 235, 469, 938,
1,875, 3,750
No effects observed 3,750 – NTP (1986b), Bucher
et al. (1987)
F344 rat 15/sex per
group
C22–26, 43%
chlorination
90 days Gavage (corn
oil)
0, 100, 900,
3,750
↑ absolute liver weight
(females), liver
histopathology (females)
– 100 IRDC (1984d)(a)
F344 rat 10/sex per
group
C23, 43%
chlorination
90 days Gavage (corn
oil)
0, 235, 469, 938,
1,875, 3,750
Liver histopathology
(females)
– 235 NTP (1986b), Bucher
et al. (1987)
F344 rat 50/sex per
group;
20/sex per
group
C23, 43%
chlorination
2 years Gavage (corn
oil)
0, 1,875, 3,750
(males);
0, 100, 300, 900
(females)
↑relative liver weight
(females), histopathological
changes (lymphohistiocytic
inﬂammation in liver,
pancreatic and mesenteric
lymph nodes) (females)
– 100 NTP (1986b), Bucher
et al. (1987)
F344 rat 5/sex per
group
Electroﬁne S70,
C22–26, 70%
chlorination
14 days Diet 0, 17.1, 55, 169,
565, 1,715
No effects observed 1,715 – IRDC (1981d)(a)
F344 rat 15/sex per
group
Electroﬁne S70,
C22–26, 70%
chlorination
90 days Diet 0, 100, 900,
3,750
↑relative liver weight, liver
histopathology
900 3,750 IRDC (1984e)(a)
Studies in mice
B6C3F1
mouse
5/sex per
group
C23, 43%
chlorination
16 days Gavage (corn
oil)
0, 469, 938,
1,875, 3,750,
7,500
No effects observed 7,500 – NTP (1986b), Bucher
et al. (1987)
B6C3F1
mouse
10/sex per
group
C23, 43%
chlorination
90 days Gavage (corn
oil)
0, 469, 938,
1,875, 3,750,
7,500
No effects observed 7,500 – NTP (1986b), Bucher
et al. (1987)
B6C3F1
mouse
50/sex per
group
C23, 43%
chlorination
2 years Gavage (corn
oil)
0, 2,500, 5,000 No non-neoplastic effects
observed
5,000 – NTP (1986b), Bucher
et al. (1987)
LCCPs: long-chain chlorinated parafﬁns; NOAEL: no-observed adverse effect level; LOAEL: lowest-observed adverse effect level; bw: body weight.
(a): Unpublished study report, see Documentation provided to EFSA.
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3.1.2.3. Developmental and reproductive toxicity studies
The developmental and reproductive studies on CPs are summarised in Table 15.
3.1.2.3.1. SCCPs
No studies speciﬁcally investigating effects of SCCPs on fertility in mammals have been identiﬁed,
however, examination of reproductive organs was performed in two repeated dose toxicity studies.
Two developmental toxicity studies on SCCPs were identiﬁed (one in rats and one in rabbits).
In a 14-day gavage study in female rats with SCCP (C10–12, 58% chlorination) (see Section 3.1.2.2.1),
reduced absolute (48%) and relative (35%) ovary weight compared to controls at 3,000 mg/kg bw per day
were observed (IRDC, 1981a, unpublished study, see Documentation provided to EFSA).
No changes were seen in the seminal vesicles, prostate, testes, ovaries or uterus when rats and
mice were treated for 90 days with up to 5,000 and 2,000 mg SCCP (C12, 60% chlorination)/kg bw per
day, respectively (NTP, 1986a; Bucher et al., 1987) (see Section 3.1.2.2.1).
In a developmental toxicity study, pregnant Charles River COBS CD rats (25 per group) were
administered SCCP (carbon chain length not speciﬁed, 58% chlorination) at doses of 0, 100, 500 or
2,000 mg/kg bw per day of in corn oil by gavage from day 6 to 19 of gestation (IRDC, 1982a,
unpublished study, see Documentation provided to EFSA, also described in Serrone et al., 1987). The
mortality in pregnant rats of the high-dose group was 32%. Clinical signs of maternal toxicity, such as
decreased activity, matted, stained or oily fur, emaciated appearance, and excessive salivation,
occurred in the mid- and high-dose groups. A decrease in body weight gain by 35% was reported in
the high-dose group. Due to both early and later resorptions in the high-dose groups, the number of
post-implantation loss was signiﬁcantly increased. Signiﬁcant decreases in viable feti per dam were
observed in the high-dose group. Shortened digits and/or adactyly (absence of digits) were noted in
19 feti from 3/15 litters in the high-dose group. There were no changes in developmental parameters
in the mid-dose group. Dams and feti in the low-dose group were also not affected. The NOAEL for
maternal toxicity was 100 mg/kg bw per day, based on several clinical symptoms (matted, stained or
oily haircut, emaciated appearance, excessive salivation and decreased activity) at 500 mg/kg bw per
day. The NOAEL for developmental toxicity was 500 mg/kg bw per day, based on teratogenic effects,
post-implantation loss and decreased viable fetuses at 2,000 mg/kg bw per day. The role of maternal
toxicity, as manifested in high mortality and decreased body weight gain, for the induction of fetal
malformations remained unclear.
In another developmental toxicity study, pregnant Dutch Belted rabbits (16 per group) were given
doses of 0, 10, 30 or 100 mg/kg bw per day of SCCP (carbon chain length not speciﬁed, 58%
chlorination) in corn oil by gavage from day 6 to 27 of gestation (IRDC, 1983b, unpublished study, see
Documentation provided to EFSA, also described in Serrone et al., 1987). No mortality in pregnant
rabbits and no signs of maternal toxicity were observed. Early whole litter resorptions occurred in two
dams of the high-dose group and in one dam of the medium-dose group. This effect is seldom
observed in this species and therefore, these ﬁndings were considered to represent signiﬁcant
embryotoxicity. Because both females in the high-dose group had only two implantations, the net
effect on the group mean post-implantation loss was negligible. SCCP showed also some degree of
fetotoxicity at 30 mg/kg bw per day. In addition to the early whole litter loss in one dam mentioned
above, the number of early and late resorptions was slightly increased (8 and 5 at 30 mg/kg bw per
day compared to 3 and 1 at 0 mg/kg bw per day and at 10 mg/kg bw per day, while 5 and 0 at
100 mg/kg bw per day). No effect was observed in the occurrence of malformations at any dose
levels. The NOEL for maternal toxicity was 100 mg/kg bw per day (the highest dose tested in this
study). The NOAEL for developmental toxicity was 10 mg/kg bw per day based on increased number
of resorptions that are regarded as embryotoxic effects.
3.1.2.3.2. MCCPs
Two rat studies were identiﬁed that investigated reproductive and postnatal effects of MCCPs.
Three studies were found that dealt with developmental effects (two studies in rats and one study in
rabbits).
In a dose-range ﬁnding study for a two-generation study (that was never conducted or reported),
Wistar rats (5 males and 10 females per group) were administered MCCP (Cereclor S52, C14–17, 52%
chlorination) at concentrations of 0, 100, 1,000 or 6,250 mg/kg diet for 28 days prior to mating,
during mating and up to post-natal day 21 (females only) (IRDC, 1985, unpublished study, see
Documentation provided to EFSA; also described in Serrone et al., 1987). The average doses received
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were 0, 9, 90 or 560 mg/kg bw per day for males and females.34 From the F1 pups, ﬁve males and 10
females from each group were selected and retained on the same diet as their parents from weaning,
for up to 70 days after birth. No animals among the parental F0 generation died and no macroscopic
abnormalities were observed. A signiﬁcant decrease in food consumption was found in high-dose F0
females during lactation days 7–21. There were no treatment-related effects on fertility indices.
Survival of F1 treated groups on day 0 and on lactation day 4 was not affected. F1 pup survival was
signiﬁcantly decreased in the high-dose group on lactation day 10 (survival 40%) and no pups
survived until weaning. Decreased F1 pup survival was also noted in the mid-dose group on lactation
day 21 (survival 89%), although not signiﬁcantly different from the control group. Dose-related clinical
observations in mid- and high-dose F1 pups included bruised areas, decreased activity, laboured
breathing, pale discolouration and/or blood around the oriﬁces. At the external necropsy of pups that
died or were sacriﬁced during the lactation period, subcutaneous haematoma/haemorrhage were
observed in the mid-dose group (in 9 of 17 pups) and in the high-dose group (in all 64 pups
examined), but not in the control group or the low-dose group. Pale liver, kidney and lungs, and blood
in the cranial cavity, brain, stomach and intestines and/or the abdominal or thoracic cavities were also
observed in mid- and high-dose pups. There were no macroscopic lesions in the majority of mid-dose
F1 pups surviving until sacriﬁce on lactation day 21; blood in the brain or cranial cavity was only
observed in one mid-dose litter. Erythrocyte counts, haemoglobin concentration and haematocrit were
decreased in high-dose F1 pups on lactation day 6 compared to the control group (only one single
litter examined from each group); clinical pathology was not performed in low- and mid-dose F1 pups.
Decreased F1 pup weights were observed on lactation days 7 and 14 in all treated groups, and in the
low- and mid-dose groups on lactation day 21. The F1 pup weights in the treated groups were not
signiﬁcantly different from the pup weights in the control group at any time point. The decreases in F1
pup weights in the low- and mid-dose groups were almost similar at all time points (4/5% and 7/6%
in low-/mid-dose males and females, respectively, on lactation day 7; 12/9% and 15/14% in low-/mid-
dose males and females, respectively, on lactation day 14; 8/12% and 12/15% in low-/mid-dose males
and females, respectively, on lactation day 21). After weaning (day 21), the body weights in F1 males
were lower in low- and mid-dose groups compared to the control group, but almost similar at all time
points in the two dose groups (11/13% at postnatal day (PND) 28 to 4/7% at PND 70 in low-/mid-
dose, respectively. Slight decreases (4–7%) were observed in F1 female body weights after weaning in
low- and mid-dose groups compared to the control group and were almost similar at all time points in
the two dose groups. The NOEL for parental toxicity and fertility was 560 mg/kg bw per day (the
highest dose tested). The NOAEL for postnatal effects is considered to be 9 mg/kg bw per day, based
on decreased pup survival at the two higher dose levels although not being statistically signiﬁcant in
the mid-dose group, but survival of only 89% is considered as adverse because of the severity of the
effect, as well as subcutaneous haematoma/haemorrhage at the two higher dose levels.
In a reproduction/developmental screening toxicity test (OECD Test Guideline 421, but did not
comply with all the requirements of this Test Guideline), Sprague–Dawley rats were administered MCCP
(Cereclor S52, C14–17, 52% chlorination) at concentrations of 0 (17 animals/sex), 300 (12 animals/sex),
600 (12 animals/sex) or 1,200 (17 animals/sex) mg/kg diet for 28 day before mating, throughout
gestation and lactation (CXR, 2006, unpublished study, see Documentation provided to EFSA). The
mean dosages for males prior to mating were 0, 21, 44 and 84 mg/kg bw per day and for females 0,
23, 47 and 99 mg/kg bw per day. No clinical signs of toxicity were recorded and no changes in body
weight, body weight gain or food consumption were observed in treated groups of F0 males and
females prior to mating or for females during gestation or lactation when compared to the control
group. In addition, oestrus cycles, mating performance, precoital interval, fertility and gestation
lengths were similar in the treated groups and in the control group. In the F0 females at the highest
dose, increased absolute and relative liver weights (by 12% and 10%, respectively) were observed
when compared to controls. There were no treatment-related effects on the number of implantations,
litter size, sex ratio or pup survival. No clinical signs of toxicity could be observed in the treated male
and female offspring. Offspring body weights, body weight gains to weaning and macropathology35
ﬁndings were also unaffected by treatment. The absolute liver weights in female offspring were
34 Conversion of the concentration in feed into doses calculated using a conversion factor of 0.09 as recommended by the
Guidance on selected default values to be used by the EFSA Scientiﬁc Committee, Scientiﬁc Panels and Units in the absence of
actual measured data to be used for subchronic studies (EFSA Scientiﬁc Committee, 2012a).
35 It was noted that no histopathology but only a macroscopic examination was carried out in this study. However, haemorrhagic
effects in the pups should have been likely visible macroscopically as red or dark staining at the organ surface.
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increased by 21%, 18% and 11% at 23, 47 and 99 mg/kg bw per day as maternal dose, respectively.
In this study, the offspring was only observed until PND21 instead until PND70 in the dose-range
ﬁnding study for a two-generation study (IRDC, 1985, unpublished study, see Documentation provided
to EFSA). The NOAEL for parental toxicity was 47 mg/kg bw per day, based on the increased relative
liver weights (10%) in females. The NOELs for fertility were 84 and 99 mg/kg bw per day (the highest
dose tested), for males and females, respectively. The NOEL for developmental toxicity was 99 mg/kg
bw per day as maternal dose (the highest dose tested in this study).
Besides the study by CXR (2006), other follow-up studies were conducted to investigate the effect
on survival on offspring, the mode of action of haemorrhages (ICI, 1985; CXR, 2003, CXR, 2004,
unpublished studies, see Documentation provided to EFSA). For further details, see Section 3.1.5.5.
In a developmental toxicity study, doses of 0, 500, 2,000 or 5,000 mg/kg bw per day of MCCP
(Cereclor S52, C14–17, 52% chlorination) in corn oil were administered by gavage to pregnant Charles
River COBS CD rats (25 per group) from day 6 to 19 of gestation (IRDC, 1984f, unpublished study, see
Documentation provided to EFSA; also described in Serrone et al., 1987). One female from the mid-
dose group died. There were no effects on body weight gain or uterine weight. Clinical signs of toxicity
such as wet and/or matted fur in the anogenital region with red or yellow staining, increased incidence
of soft stool prior to sacriﬁce, occurred in mid- and high-dose animals. Developmental indices,
including malformations at dose levels up to 5,000 mg/kg bw per day, were not affected. The NOAEL
for maternal toxicity was 500 mg/kg bw per day based on several clinical signs. The NOEL for
developmental toxicity was 5,000 mg/kg bw per day (the highest dose tested in this study).
In another developmental toxicity study, doses of 0, 10, 30 or 100 mg/kg bw per day of MCCP
(Cereclor S52, C14–17, 52% chlorination) in corn oil were administered by gavage to pregnant Dutch
Belted rabbits (16 per group) from day 6 to 27 of gestation (IRDC, 1983c, unpublished study, see
Documentation provided to EFSA; also described in Serrone et al., 1987). Three dams died during the
study period: one in the control group, one in the 10 mg/kg bw per day group, and one in the 30 mg/
kg bw per day group. Congestion of the lobes of the lungs was observed with an increased frequency
when compared to the controls. However, this effect was not clearly dose-related and its toxicological
signiﬁcance remained unclear. Abortions occurred in the control group (1 dam), in the 30 mg/kg bw
per day group (2 dams), and in the 100 mg/kg bw per day group (2 dams). No changes in
developmental parameters, including malformations, could be observed. The NOEL for maternal and
developmental toxicity was 100 mg/kg bw per day (the highest dose tested in this study).
3.1.2.3.3. LCCPs
No studies could be identiﬁed that speciﬁcally investigated the effects of LCCPs on fertility. Four
studies could be identiﬁed that analysed the developmental effects of LCCPs (two studies in rats and
two studies in rabbits).
LCCP (43% chlorination)
In a developmental toxicity study, doses of 0, 500, 2,000 or 5,000 mg/kg bw per day of LCCP
(C22–26, 43% chlorination) in corn oil were administered by gavage to pregnant Charles River COBS
CD rats (25 per group) from day 6 to 19 of gestation (IRDC, 1983d, unpublished study, see
Documentation provided to EFSA; also described in Serrone et al., 1987). No maternal effects were
observed. One female in the high-dose group died late in gestation; the cause of death could not be
ascertained. There were no treatment-related effects on pre- and post-implantation loss, in fetal
weights, or in the incidences of external, visceral and skeletal variations, and malformations in the
treated groups when compared to the control group. The NOEL for maternal and developmental
toxicity was 5,000 mg/kg bw per day (the highest dose tested in this study).
In a developmental toxicity study, pregnant Dutch Belted rabbits (16 animals per group) were
administered by gavage doses of 0, 500, 2,000 or 5,000 mg/kg bw per day of LCCP (C22–26, 43%
chlorination) in corn oil from day 6 to 27 of gestation (IRDC, 1982b, unpublished study, see
Documentation provided to EFSA; also described in Serrone et al., 1987). One high-dose female died
due to a gavage error. One mid-dose dam and two high-dose dams aborted. The post-implantation
loss was slightly higher (not statistically signiﬁcant) in the high-dose group when compared to the
control group, and correspondingly, the mean number of viable fetuses was slightly lower (not
statistically signiﬁcant) in this dose group. No changes in fetal weights or in the incidences of external,
visceral and skeletal variations and malformations were observed in the treated groups when
compared to the control group. The NOEL for maternal and developmental toxicity was 5,000 mg/kg
bw per day (the highest dose tested in this study).
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LCCP (70% chlorination)
In a developmental toxicity study, LCCP (Electroﬁne S70, C22–26, 70% chlorination) was
administered to pregnant Charles River COBS CD rats (25 per group) at doses of 0, 500, 2,000 or
5,000 mg/kg bw per day in corn oil by gavage from day 6 to 19 of gestation (IRDC, 1984g,
unpublished study, see Documentation provided to EFSA; also described in Serrone et al., 1987). No
treatment-related maternal or developmental effects were observed. The NOEL for maternal and
developmental toxicity was 5,000 mg/kg bw per day (the highest dose tested in this study).
In a developmental toxicity study, LCCP (Electroﬁne S70, C22–26, 70% chlorination) was
administered by gavage to groups of pregnant Dutch Belted rabbits (16 per group) in the vehicle 1%
carboxymethyl cellulose in water at dose levels of 0, 100, 300 or 1,000 mg/kg bw per day from day 6
to 27 of gestation (IRDC, 1983e, unpublished study, see Documentation provided to EFSA; also
described in Serrone et al., 1987). Two high-dose dams died due to gavage errors and one mid-dose
dam died; the cause of death could not be ascertained. No treatment-related clinical signs of toxicity
were recorded in dams and no changes in bodyweight gain were observed when compared to the
control group. There were no treatment-related effects on pre- and post-implantation loss, in fetal
weights, or in the incidences of external, visceral and skeletal variations and malformations in the
treated groups when compared to the control group. The NOEL for maternal and developmental
toxicity was 1,000 mg/kg bw per day (the highest dose tested in this study).
3.1.2.3.4. Summary on developmental and reproductive toxicity
Fertility:
No speciﬁc studies on the reproductive effects of SCCPs and LCCPs were identiﬁed.
For an MCCP (C14–17, 52% chlorination), the NOEL for parental toxicity and fertility was 560 mg/kg
bw per day (the highest dose tested), in the dose-range ﬁnding study for a two-generation study in
rats; the two-generation study was never conducted or reported. In a reproduction/developmental
screening toxicity study in rats with the same MCCP, the NOEL for fertility was 84 and 99 mg/kg bw
per day (the highest dose tested), for males and females, respectively. The NOAEL for maternal
toxicity was 47 mg/kg bw per day, based on the increased relative liver weights. The NOEL for
paternal toxicity was 84 mg/kg bw per day (the highest dose tested).
Developmental toxicity:
An SCCP (carbon chain length not speciﬁed, 58% chlorination) caused teratogenic effects in the
form of absence of digits (adactyly) or shortened digits in rats at 2,000 mg/kg bw per day. Post-
implantation loss and decreased number of viable fetuses were also observed at this dose level. The
NOAEL for developmental toxicity was 500 mg/kg bw per day, and for maternal toxicity 100 mg/kg bw
per day, based on several clinical signs of toxicity. The NOAEL for developmental toxicity was 10 mg/kg
bw per day in the rabbit study, based on increased number of resorptions and the NOEL for maternal
toxicity was 100 mg/kg bw per day (the highest dose tested).
For an MCCP (C14–17, 52% chlorination), no malformations were observed in the developmental
toxicity studies in rats and rabbits. The NOELs for developmental toxicity were 5,000 and 100 mg/kg
bw per day (the highest doses tested) in rats and rabbits, respectively. The NOAELs for maternal
toxicity in rats was 500 mg/kg bw per day (based on several clinical signs). The NOEL for maternal
toxicity in rabbits was 100 mg/kg bw per day (the highest dose tested). In the dose-range ﬁnding
study for a two-generation study in rats, the NOEL for parental toxicity and fertility was 560 mg/kg bw
per day (the highest dose tested). F1 pup survival was signiﬁcantly decreased in the high-dose group
on lactation day 10 and no pups survived until weaning. Decreased F1 pup survival was also noted in
the mid-dose group on lactation day 21 (survival 89%), although not signiﬁcantly different from the
control group. Subcutaneous haematoma/haemorrhage were observed in the mid- and high-dose
groups, but not in the control group or the low-dose group. The NOAEL for postnatal effects is
considered to be 9 mg/kg bw per day, based on decreased pup survival and subcutaneous
haematoma/haemorrhage at the two higher dose levels.
In the developmental toxicity studies with an LCCP (C22–26, 43% chlorination) in rats and rabbits, the
NOEL was 5,000 mg/kg bw per day for developmental and maternal toxicity. For another LCCP (C22–26,
70% chlorination), the NOEL for maternal and developmental toxicity was 5,000 mg/kg bw per day in the
rat study, and 1,000 mg/kg bw per day in the rabbit study. These values were the highest doses tested.
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Table 15: Developmental and reproductive toxicity studies on chlorinated parafﬁns
Species/
strain
Number of
animals per
group
CP
speciﬁcation
Duration Administration
Dose levels
(mg/kg bw
per day)
Most sensitive endpoints
NOAEL
(mg/kg bw
per day)
LOAEL
(mg/kg bw
per day)
Reference
SCCPs
Charles River
COBS CD
rats
25/group Carbon chain
length not
speciﬁed, 58%
chlorination
GD6–19 Gavage (corn
oil)
0, 100, 500,
2,000
M: clinical signs (decreased
activity, matted, stained or
oily fur, emaciated
appearance, excessive
salivation);
D: shortened digits and/or
adactyly, post-implantation
losses, decreased number of
viable fetuses per dam
M: 100
D: 500
M: 500
D: 2,000
IRDC (1982a)(a),
Serrone et al.
(1987)
Dutch belted
rabbits
16/group Carbon chain
length not
speciﬁed, 58%
chlorination
GD6–27 Gavage (corn
oil)
0, 10, 30,
100
M: no adverse effects
D: increased number of
resorptions
M: 100 (NOEL)
D: 10
M: –
D: 30
IRDC (1983b)(a),
Serrone et al.
(1987)
MCCPs
Wistar rats 5 males per
group;
10 females
per group
Cereclor S52,
C14–17, 52%
chlorination
From
28 days
prior do
mating, to
PND 21(c)
Diet 0, 9, 90, 560 P: no adverse effects
F: no adverse effects
PN: decreased pup survival,
subcutaneous haematoma/
haemorrhage
P: 560 (NOEL)
F: 560 (NOEL)
PN: 9
P: –
F: –
PN: 90
IRDC (1985)(a),
Serrone et al.
(1987)
Sprague–
Dawley rats
12 or 17
animals/sex
per group
Cereclor S52,
C14–17, 52%
chlorination
From
28 days
prior to
mating to
PND 21(d)
Diet 0, 21, 44, 84
(males);
0, 23, 47, 99
(females)
P: ↑ relative liver weight
(females), no effects (males)
F: no adverse effects
D: no adverse effects
P: 47 (females),
84 (males)
F: 84 (males),
99 (females)
(NOEL)
D: 99(b) (NOEL)
P: 99
(females), –
(males)
F: –
D: –
CXR (2006)(a)
Charles River
COBS CD
rats
25/group Cereclor S52,
C14–17, 52%
chlorination
GD6–19 Gavage (corn
oil)
0, 500,
2,000, 5,000
M: clinical signs (wet and/or
matted fur anogenital region
with staining, increased
incidence of soft stool)
D: no adverse effects
M: 500
D: 5,000
M: 2,000
D: –
IRDC (1984f),
Serrone et al.
(1987)
Dutch Belted
rabbits
16/group Cereclor S52,
C14–17, 52%
chlorination
GD6–27 Gavage (corn
oil)
0, 10, 30,
100
M, D: no adverse effects M: 100 (NOEL)
D: 100 (NOEL)
M: –
D: –
IRDC (1983c),
Serrone et al.
(1987)
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Species/
strain
Number of
animals per
group
CP
speciﬁcation
Duration Administration
Dose levels
(mg/kg bw
per day)
Most sensitive endpoints
NOAEL
(mg/kg bw
per day)
LOAEL
(mg/kg bw
per day)
Reference
LCCPs
Charles River
COBS CD
rats
25/group C22–26, 43%
chlorination
GD6–19 Gavage (corn
oil)
0, 500,
2,000, 5,000
M, D: no adverse effects M: 5,000 (NOEL)
D: 5,000 (NOEL)
M: –
D: –
IRDC (1983d),
Serrone et al.
(1987)
Dutch belted
rabbits
16/group C22–26, 43%
chlorination
GD6–27 Gavage (corn
oil)
0, 500,
2,000, 5,000
M, D: no adverse effects M: 5,000 (NOEL)
D: 5,000 (NOEL)
M: –
D: –
IRDC (1982b),
Serrone et al.
(1987)
Charles River
COBS CD
rats
25/group Electroﬁne
S70, C22–26,
70%
chlorination
GD6–19 Gavage (corn
oil)
0, 500,
2,000, 5,000
M, D: no adverse effects M: 5,000 (NOEL)
D: 5,000 (NOEL)
M: –
D: –
IRDC (1984 g),
Serrone et al.
(1987)
Dutch belted
rabbits
16/group Electroﬁne
S70, C22–26,
70%
chlorination
GD6–27 Gavage (1%
carboxymethyl
cellulose in
water)
0, 100, 300,
1,000
M, D: no adverse effects M: 1,000 (NOEL)
D: 1,000 (NOEL)
M: –
D: –
IRDC (1983e),
Serrone et al.
(1987)
D: developmental toxicity; F: fertility effects; GD: gestational day; M: maternal toxicity; P: parental toxicity; PN: postnatal toxicity; PND: postnatal day; NOAEL: no-observed adverse effect level;
LOAEL: lowest-observed adverse effect level; LCCPs: long-chain chlorinated parafﬁns; MCCPs: medium-chain chlorinated parafﬁns; SCCPs: short-chain chlorinated parafﬁns.
(a): Unpublished study report, see Documentation provided to EFSA.
(b): As maternal dose.
(c): Observation until PND70.
(d): Observation until PND21.
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3.1.2.4. Neurotoxicity studies
3.1.2.4.1. SCCPs
No oral studies speciﬁcally investigating the neurotoxicity of SCCPs have been identiﬁed.
3.1.2.4.2. MCCPs
The effects of an MCCP (C16, unknown % chlorination) on muscarinic receptors and sodium-
dependent choline uptake were investigated in the central nervous system of immature mice (Eriksson
and Nordberg, 1986). Ten-day-old NMRI mice of both sexes were administered a single dose of 1 mg
MCCP/kg bw by gavage. The CONTAM Panel noted that the dose is not clear as 1) the dose of
1.4 lmol/kg bw corresponds to 1 mg according to the abstract and to 1 mg/kg bw according to
Methods, and 2) there is no information on the identity/structure/composition of the test compound
and thus, no information on the molecular weight to be applied for conversion of the dose in lmol/kg
bw. The mice were sacriﬁced at 24 hours and 7 days after treatment. Crude synaptosomal fractions
(pooled samples) were prepared from the cerebral cortex and the hippocampus and the density of the
muscarinic receptors was determined. No changes were observed between treated and control mice.
The presynaptically sodium-dependent choline uptake system was also examined. There was a
signiﬁcant decrease in Vmax (to 65% of the control value) in treated mice at 7 days after treatment,
but not at 24 hours after treatment; there were no differences in Km between the two groups at 24 h
of 7 days after treatment.
3.1.2.4.3. LCCPs
No studies on the neurotoxicity of LCCPs have been identiﬁed.
3.1.2.4.4. Neurobehavioural effects in zebraﬁsh larvae
Effects of CPs on locomotion, path angle and social interactions were studied in zebraﬁsh larvae
(Yang et al., 2019). Five days after fertilisation they were exposed to four different commercial CPs at
concentrations of 0, 10, 100 or 1,000 lg/L. CP-52b is a SCCP (C10–13, 52% chlorination) and CP-42 is
a LCCP (C21–24, 42% chlorination). CP-70 is dominated by LCCP (C21–24, 70% chlorination) with 20%
composition of SCCP (C11). CP-52a consists mainly of LCCP (C21–25, 52% chlorination) with < 10%
composition of SCCP (C10–11). In the locomotion test, the swimming distance is measured which is a
good indicator for the background activities of the larvae. As a general trend, the higher the chlorine
content the more signiﬁcant was larval locomotion inhibition, particularly at higher CP concentrations.
CP-42 (LCCP) had no effect on the larval locomotion. CP-52b (SCCP dominant) was more active
compared to CP-52a (LCCP dominant). In the path angle test, CP-70 signiﬁcantly inhibited the larval
turning activities at the two highest concentrations with the most impact at 100 lg/L. CP-52b caused
signiﬁcant turning inhibition, especially at 1,000 lg/L in the ranges between 90° to 10° and +10° to
+90°. In contrast to that, exposure to 10 and 100 lg/L CP-52a stimulated hyperactivity of the larvae in
the ranges between -90° to -10° and +10° to +90°. In the two-ﬁsh interaction activity test at the
highest concentration, CP-70 and CP-52b signiﬁcantly stimulated the social activity, while CP-52a
signiﬁcantly shortened the social duration per contact. CP-42 (LCCP) had no effect on social activity.
3.1.2.5. Immunotoxicity studies
3.1.2.5.1. SCCPs
To study immunomodulatory effects, an SCCP (C9:C10:C11:C12:C13 = 1:1:1:1:1, 52% chlorination)
was administered to adult male C57BL/6 mice at doses of 0, 1, 10 and 100 mg/kg bw per day in corn
oil via gavage for 28 days (Wang et al., 2019a). Absolute and relative spleen weights were signiﬁcantly
increased at 10 and 100 mg/kg bw per day. Massive delimited and atrophic germinal centres with
disperse cell distribution and disorganised boundaries were observed in the spleen at 100 mg/kg bw
per day. Treatment with 100 mg/kg bw per day caused signiﬁcant increases in white blood cell count,
neutrophil count, lymphocyte count, monocyte count and platelet count. At the same dose level,
signiﬁcant increases in the blood serum levels of interleukin 12 and tumour necrosis factor a were
measured compared to the control group. In the spleen, adenosine triphosphate (ATP) level and
phosphofructokinase activity were increased at 100 mg/kg bw per day and pyruvate kinase activity at
10 and 100 mg/kg bw per day, indicating disturbance of energy metabolism. Treatment with 100 mg/kg
bw per day caused 424 differentially expressed genes in the spleen. Many of these genes are
immune-related such as ly75, mcl1, runx1, ccr9, tcf4, nfatc2, nfat5, tnfaip3, stat1, ptk2b or involved in
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immune-related pathways such as the chemokine signalling pathway, NF-jB signalling pathway, Jak-
STAT signalling pathway or Th17 cell differentiation. In conclusion, these results suggest that SCCP
could cause immunomodulatory effects in mice.
3.1.2.5.2. MCCPs
No studies speciﬁcally investigating the immunotoxicity of MCCPs have been identiﬁed.
3.1.2.5.3. LCCPs
No studies speciﬁcally investigating the immunotoxicity of LCCPs have been identiﬁed.
3.1.2.6. Genotoxicity studies
3.1.2.6.1. SCCPs
SCCPs have been tested in six in vitro tests, four reverse mutation assays and two gene mutation
tests, as well as in four in vivo studies. These studies are described in Table 16 and a summary of
the results are presented below.
SCCPs are not mutagenic in bacterial test systems.
In mammalian cells in vitro, an SCCPs (C12, 60% chlorination) showed a mutagenic response in
mouse lymphoma cells in the absence of metabolic activation; no mutagenic response was observed
with another SCCP (C10–12, 56% chlorination) in Chinese hamster V79 cells with and without metabolic
activation.
Negative results were noted in three in vivo assays, i.e. in a rat bone marrow chromosomal
aberration test, in a mouse bone marrow micronucleus test, and in a dominant lethal test in rats, after
exposure by gavage. A negative result was also reported in an in vivo unscheduled DNA synthesis
(UDS) assay in rat hepatocytes; this is considered as a supplementary result because of the low
sensitivity of the UDS test in detecting in vivo genotoxicants, and therefore, the use of the UDS test is
no longer recommended (EFSA Scientiﬁc Committee, 2017c).
3.1.2.6.2. MCCPs
MCCPs have been tested in four in vitro tests, all reverse mutation assays, as well as in three
in vivo studies. These studies are described in Table 17 and a summary of the results are presented
below.
MCCPs are not mutagenic in bacterial test systems.
Negative results were also reported in three in vivo assays, i.e. in a rat bone marrow chromosomal
aberration test and in two mouse bone marrow micronucleus tests, after exposure by gavage.
3.1.2.6.3. LCCPs
LCCPs have been tested in four in vitro tests, two reverse mutation assays, a chromosomal
aberration test and an SCE test, as well as in two in vivo studies. These studies are described in
Table 18 and a summary of the results is presented below.
LCCPs are not mutagenic in bacterial test systems.
Sister chromatid exchanges (SCEs) were induced by an LCCP (C23, 43% chlorination) in Chinese
hamster ovary cells in vitro with and without metabolic activation.
Chromosomal aberrations were only observed in the absence of metabolic activation at a high
concentration.
In two in vivo rat bone marrow chromosomal aberration tests using oral administration of LCCPs
(gavage), no clastogenic effects were reported.
3.1.2.6.4. Summary on genotoxicity
CPs have been tested in vitro in bacterial and mammalian cells, as well as in in vivo studies. A
number of the original study reports were, however, not available to the CONTAM Panel and the
information could therefore, not be veriﬁed.
Negative results were reported in gene mutation assays in bacterial test systems (SCCPs, MCCPs,
LCCPs) and in Chinese hamster V79 cells (an SCCP).
A mutagenic response was reported in an in vitro mouse lymphoma test with an SCCP, and
chromosomal aberration and sister chromatid exchanges were induced by an LCCP.
In several in vivo studies using oral administration of CPs, including rat bone marrow cell
chromosomal aberration studies (SCCPs, MCCPs, LCCPs), micronucleus tests in mice (SCCPs and
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MCCPs), UDS in rat hepatocytes (SCCPs) and a germ cell mutagenicity study in rats (SCCPs), neither
mutagenic nor clastogenic effects have been reported.
The overall weight of evidence indicates that CPs are not genotoxic.
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Table 16: Genotoxicity studies on short-chain chlorinated parafﬁns
Compound Type of test
Experimental
system
Exposure conditions Result Comments Reference
C10–13, 50%
chlorination
(containing
1% epoxy
stabiliser)
Reverse
mutation assay
S. Typhimurium
TA 98, TA 100,
TA 1535, TA
1537, TA 1538
E. coli WP2uvrA
Up to 10,000 lg/plate
+/ S9 (rat liver)
Around a twofold
increase in revertants in
TA 98 ( S9) and in TA
100 (+/ S9) from
500 lg/plate and above
Negative
No toxicity observed
No further details: the original study
report was not available to the CONTAM
Panel and the information could therefore
not be veriﬁed
Hoechst (1986)
Unpublished study, as
cited by EU-RAR (2000)
and WHO/IPCS (1996)
C12, 57%
chlorination
Reverse
mutation assay
S. Typhimurium
TA 98, TA 100,
TA 1535, TA
1537, TA 1538
E. coli WP2uvrA
Up to 5,000 lg/plate
+/ S9 (rat liver)
Negative No further details: the original study
report was not available to the CONTAM
Panel and the information could therefore
not be veriﬁed
Hoechst (1988)
Unpublished study, as
cited by EU-RAR (2000)
and WHO/IPCS (1996)
C12, 60%
chlorination
Reverse
mutation assay
S. Typhimurium
TA 97, TA 98, TA
100, TA 1535
Up to 3,333 lg/plate
+/ S9 (rat and hamster
liver)
Negative – 20-minute pre-incubation period
– No cytotoxicity observed
– No precipitation reported
NTP (1986a)
Cereclor 50LV
(C10–13, 50%
chlorination)
Reverse
mutation assay
S. Typhimurium
TA 98, TA 100,
TA 1535, TA
1538
Up to 2,500 lg/plate
+/ S9 (rat liver)
Neg. control: DMSO
Pos. control: 1,3-
propanesultone and 2AA
Negative – No cytotoxicity observed
– No precipitation reported
Birtley et al. (1980)
C10–13, 56%
chlorination
In vitro
Gene mutation
assay (hprt
locus)
Chinese hamster
V79 cells
Up to cytotoxic
concentrations
+/ S9 (rat liver)
No signiﬁcant increased
numbers of mutant
colonies
Negative
– Well-conducted, performed to modern
protocols (EU-RAR, 2000)
No further details: the original study
report was not available to the CONTAM
Panel and the information could therefore,
not be veriﬁed
Hoechst (1987)
Unpublished study, as
cited by EU-RAR (2000)
and WHO/IPCS (1996)
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Compound Type of test
Experimental
system
Exposure conditions Result Comments Reference
C12, 60%
chlorination
In vitro
Gene mutation
assay (TK+/
locus)
Mouse
lymphoma
L5178Y
cells
0, 24, 36, 48, 60,
72 lg/mL
Without metabolic
activation
Neg. control: acetone
Pos. control: MMS
Experiment I: average
mutant frequency
statistically signiﬁcantly
higher at 48, 60 and
72 lg/mL, clear
concentration
relationship
Experiment II: average
mutant frequency
statistically signiﬁcantly
higher only at 60 lg/mL
Positive
Experiment I: decrease in cloning efﬁciency
in 1 of 2 replicates at ≥ 60 lg/mL
Precipitation at 60 lg/mL
Experiment II: decrease in cloning
efﬁciency at 60 lg/mL, toxic at 72 lg/mL
Size of colonies not reported
Myhr et al. (1990)
C12, 60%
chlorination
In vivo
UDS
Male rats
Hepatocytes
4 animals/group
Gavage, single dose
0, 500, 1,000, 2,000
mg/kg bw
Exposure: 2 h or 12 h
Neg. Control: corn oil
Pos. Control: NDMA, 4AB,
MMS, 2AAF, 6BT,
Benzidine
Negative Ashby et al. (1990)
C10–12, 58%
chlorination
In vivo
Chromosomal
aberration
Bone-marrow
cells
Male F344 rats 8 animals/group
Gavage, daily for 5 days
0, 250, 750, 2,500 mg/kg
bw per day
Neg. control: corn oil
Pos. control:
cyclophosphamide
7 high-dose animals
died
Decreased bw in mid-
dose animals
No increased frequency
of chromosomal
aberrations, excluding
gaps at 250 or 750
mg/kg bw per day, or in
the one surviving at
2,500 mg/kg bw per
day, detected in
samples taken at day 6
Negative
– Incidence of chromosomal gaps not
assessed
– No other sampling times
– Cytotoxicity not assessed and
therefore, no direct measure of
whether or not the test substance
reached the bone marrow.
IRDC (1983f)
Unpublished study, see
Documentation
provided to EFSA
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Compound Type of test
Experimental
system
Exposure conditions Result Comments Reference
C10–13, 58%
chlorination
In vivo
Mouse
micronucleus
assay
NMRI mice and
Hoe NMRKF SPF
71
bone-marrow
cells
5 animals/sex per group
Gavage, single dose
0, 50, 5,000 mg/kg bw
No differences in
polychromatic cells with
micronuclei or in the
ratio of polychromatic
erythrocytes to
normocytes detected at
24, 48 and 72 h after
administration (high-
dose), or at 24 h after
administration (low-
dose) compared to
control
Negative
No further details: the original study
report was not available to the CONTAM
Panel and the information could therefore,
not be veriﬁed
No indication if bone marrow was
exposed
Hoechst (1989)
Unpublished study, as
cited by WHO/IPCS
(1996)
C10–12, 58%
chlorination
In vivo
Germ cell
mutagenicity
Dominant lethal
assay
Male rats 15 animals/group
Gavage, daily for 5 days
0, 250, 750, 2,000 mg/kg
bw per day
Two days after the ﬁnal
treatment, M were paired
with two F for 5 days,
and after a 2-day break
with another two F, until
each M had been paired
with 20 F
Neg. control: corn oil
Pos. control:
cyclophosphamide
Uterine examinations
were conducted in F
15 days after the
introduction of the M
Slight decrease in bw in
high-dose animals
during treatment
Slight decrease in bw
gain in mid-dose
animals
Mean bw were then
comparable throughout
the remainder of the
study
No mutagenic effects
on the post-meiotic
stage of
spermatogenesis at any
dose level, as
demonstrated by the
absence of effect on the
mean number of viable
embryos during the ﬁrst
4 weeks of mating
Negative
IRDC (1983 g)
Unpublished study, see
Documentation
provided to EFSA
bw: body weight; F: female; M: male; UDS: unscheduled DNA synthesis.
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Table 17: Genotoxicity studies on MCCPs.
Compound Type of test
Experimental
system
Exposure conditions Result Comments Reference
C14–17, 40%
chlorination
Reverse
mutation assay
S. Typhimurium
TA 98, TA 100,
TA 1535, TA
1537, TA 1538
Up to 5,000 lg/plate
+/ S9
Negative No data presented relating to
positive controls
No further details: the original study
report was not available to the
CONTAM Panel and the information
could therefore not be veriﬁed
Wiegand (1989)
As cited by EU-RAR
(2005)
C14–17, 42%
chlorination
Reverse
mutation assay
S. Typhimurium
TA 98, TA 100,
TA 1535, TA
1537, TA 1538
Up to 5,000 lg/plate
+/ S9
Negative No further details: the original study
report was not available to the
CONTAM Panel and the information
could therefore not be veriﬁed
Conz and Fumero (1988a)
As cited by EU-RAR
(European Union-Risk
Assessment Report)
(2011) and WHO/IPCS
(1996)
C14–17, 45%
chlorination
Reverse
mutation assay
S. Typhimurium
TA 98, TA 100,
TA 1535, TA
1537, TA 1538
Up to 5,000 lg/plate
+/ S9
Negative No further details: the original study
report was not available to the
CONTAM Panel and the information
could therefore not be veriﬁed
Elliott (1989a)
As cited by EU-RAR
(European Union-Risk
Assessment Report)
(2011) and WHO/IPCS
(1996)
Cereclor S52
(C14–17, 52%
chlorination)
With or without
0.2% epoxidised
vegetable oil
stabiliser
Reverse
mutation assay
S. Typhimurium
TA 98, TA 100,
TA 1535, TA
1538
4, 20, 100, 500,
2500 lg/plate
+/ S9 (rat liver)
Neg. control: DMSO
Pos. control: 1,3-
propanesultone and
2AA
About a threefold increase in
the number of revertants in
TA 1538 (+ S9) only at the
two lowest concentrations
without stabiliser
No increases under any
other test conditions
Negative
No cytotoxicity observed Birtley et al. (1980)
Cereclor S52
(C14–17, 52%
chlorination)
In vivo
Chromosomal
aberration
Bone-marrow
cells
Male F344 rats 8 animals/group
Gavage, daily for 5 days
0, 500, 1,500 or
5,000 mg/kg bw per
day
No animals died and no
signs of toxicity
No increased frequency of
chromosomal aberrations,
including and excluding gaps
detected in samples taken at
day 6
Negative
– No other sampling times
– Cytotoxicity not assessed and
therefore no direct measure of
whether or not the test substance
reached the bone marrow
IRDC (1983 h)
Unpublished study, see
Documentation provided
to EFSA
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Compound Type of test
Experimental
system
Exposure conditions Result Comments Reference
C14–17, 42%
chlorination
In vivo
Mouse
micronucleus
assay
Mice (CD-1) 5 animals/sex
Gavage, single dose
5,000 mg/kg bw
Neg. control: corn oil
Frequency of micronuclei not
increased when examined at
18, 43 and 66 hours after
administration
Negative
No further details: the original study
report was not available to the
CONTAM Panel and the information
could therefore not be veriﬁed
Conz and Fumero (1988b)
As cited by EU-RAR
(European Union-Risk
Assessment Report)
(2011) and WHO/IPCS
(1996)
C14–17, 45%
chlorination
In vivo
Mouse
micronucleus
assay
Mice (C57B1/
6JFCD-1/Alpk)
5 animals/sex per group
Gavage, single dose
0, 3,125, 5,000 mg/kg
bw
Examination at 24, 48
and 72 h after
administration (high-
dose), or 24 h after
administration (low
dose)
No increases in micronucleus
formation
Negative
No further details: the original study
report was not available to the
CONTAM Panel and the information
could therefore not be veriﬁed
Elliott (1989b)
As cited by EU-RAR
(2011) and WHO/IPCS
(1996)
bw: body weight.
Table 18: Genotoxicity studies on long-chain chlorinated parafﬁns
Compound Type of test
Experimental
system
Exposure conditions Result Comments Reference
C23, 43%
chlorination
Reverse mutation
assay
S. Typhimurium
TA 97, TA 98, TA
100, TA 1535
Up to 10,000 lg/plate
+/ S9 (rat and hamster
liver)
Negative – 20-minute pre-incubation period
– No cytotoxicity observed
– Precipitation not reported
NTP (1986b)
Cereclor 42
(C20–30, 42%
chlorination)
Reverse mutation
assay
S. Typhimurium
TA 98, TA 100,
TA 1535, TA
1538
Up to 2,500 lg/plate
+/ S9 (rat liver)Neg.
control: DMSOPos. control:
1,3-propanesultone and 2AA
Negative – No cytotoxicity observed
– Precipitation not reported
Birtley et al.
(1980)
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Compound Type of test
Experimental
system
Exposure conditions Result Comments Reference
C23, 43%
chlorination
Chromosomal
aberration test
Chinese hamster
ovary cells
S9:
First experiment: 0, 1,250,
2,500, 5,000 lg/mL
Exposure: 8 h, harvesting:
2–2.5 h later
Second experiment: 0,
3,784, 4,400, 5,000 lg/mL
+S9 (rat liver):
0, 2.513, 3,750, 5,000 lg/mL
Exposure: 2 h, harvesting:
8–10 h later
Neg. control: acetone
Pos. control: S9: MMC,
+S9: cyclophosphamide
S9:
First experiment:
Signiﬁcant increase at 5,000 lg/mL,
no concentration response
relationship
Second experiment:Signiﬁcant
increase at 5,000 lg/mL, clear
concentration response relationship
+S9:
No increase CA
Positivewithoutmetabolic
activation
Cytotoxicity not reported,
Oily droplets formed at
doses > 157 lg/mL
Anderson et al.
(1990)
C23, 43%
chlorination
SCE Chinese hamster
ovary cells
S9:
First experiment: 0, 0.5, 5.0,
5,000 lg/mL,
Second experiment:
0, 5.0, 1,700 and
5,000 lg/mL
+S9 (rat liver):
0, 5.0, 500, 1,700 and
5,000 lg/mL
First experiment:
S9:
Signiﬁcant increase at 5,000 lg/
mL, concentration response
relationship
Second experiment:Signiﬁcant
increase at all three
concentrations, concentration
response relationship
+S9:
Signiﬁcant increase at all four
concentrations, concentration
response relationship up to
500 lg/mL, at the two highest
concentrations induction of SCE
was lower than at 500 lg/mL
Positive
Cytotoxicity not reported Anderson et al.
(1990)
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Compound Type of test
Experimental
system
Exposure conditions Result Comments Reference
C22–26, 43%
chlorination
In vivo
Chromosomal
aberration
Bone-marrow
cells
Male F344 rats 8 animals/group
Gavage, daily for 5 days
0, 500, 1,500 or 5,000 mg/kg
bw per day
Negative control: corn oil.
Positive control:
cyclophosphamide
No signs of toxicity
No increased frequency of
chromosomal aberrations,
excluding gaps detected in
samples taken at day 6
Negative
– Incidence of chromosomal gaps
not assessed
– No other sampling times
– Cytotoxicity not assessed and
therefore, no indication of
whether or not the test
substance reached the bone
marrow
IRDC (1983i)
Unpublished
study, see
Documentation
provided to
EFSA
C20–30, 70%
chlorination
In vivo
Chromosomal
aberration
Bone-marrow
cells
F344 rats 8 animals/group
Gavage, daily for 5 days
0, 500, 1,500 or 5,000 mg/kg
bw per day
bw gain decreased in high-dose
animals
No increased frequency of
chromosomal aberrations
Negative
Cytotoxicity not reported and
therefore, no indication of whether
or not the test substance reached
the bone marrow
IRDC (1983, as
cited by WHO/
IPCS, 1996)
bw: body weight; SCE: sister chromatid exchange.
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3.1.2.7. Carcinogenicity
3.1.2.7.1. SCCPs
In a 2-year study with F344 rats, SCCP (C12, 60% chlorination) was administered in doses of 0, 312
or 625 mg/kg bw per day (50/sex per group) in corn oil by gavage 5 days per week (NTP, 1986a;
Bucher et al., 1987). Survival in low- and high-dose males and in low-dose females was signiﬁcantly
lower than in controls (control: 27/34; low-dose: 6/23; high-dose: 3/29 for males/females,
respectively). Signiﬁcantly increased incidences were observed for tumours in the liver (both sexes),
kidney (only male) and thyroid (only females) (Table 19). In treated males, there was a slight
increase in the incidences of pancreatic acinar cell carcinomas (control: 0/50; low-dose: 0/50; high-
dose: 2/49), pancreatic acinar adenomas (control: 11/50; low-dose: 22/50; high-dose: 15/49) and
squamous cell papillomas in the forestomach (control: 0/50; low-dose: 0/50; high-dose: 3/49).
In a 2-year study with B6C3F1 mice, SCCP (C12, 60% chlorination) was given in doses of 0, 125 or
250 mg/kg bw per day in corn oil by gavage 5 days per week to 50 males and 50 females per dose
(NTP, 1986a; Bucher et al., 1987). Reduced survival of high-dose females was observed after week
100 (control: 34/35; low-dose: 30/31; high-dose: 30/25 for males/females, respectively). Incidences of
tumours in the liver (both sexes) and thyroid (only females) were signiﬁcantly increased (Table 20).
Incidence of Harderian gland adenomas in females was signiﬁcantly increased, but not dose-related.
No effects were seen in males. Signiﬁcantly increased incidences of alveolar/bronchiolar carcinomas
were observed in high-dose males; the trend with dose was also signiﬁcant. There was no increased
incidence of lung tumours in females.
Table 19: Incidence of tumours in rats administered short-chain chlorinated parafﬁns (C12, 60%
chlorination) (NTP, 1986a)
Males Females
Dose
(mg/kg bw per day)
Control 312 625 Control 312 625
Hepatocellular
neoplastic nodules
0/50 (0%) 10/50
(20%)(a),(b)
16/48
(33%)(a),(b)
0/50
(0%)
4/50
(8%)(a)
7/50
(14%)(a),(b)
Hepatocellular
carcinomas
0/50 (0%) 3/50
(6%)(a),(b)
2/48
(4%)
0/50
(0%)
1/50
(2%)
1/50
(2%)
Hepatocellular
neoplastic nodules or
carcinomas
0/50 (0%)(c) 13/50
(26%)(a),(b)
16/48
(33%)(a),(b)
0/50
(0%)(d)
5/50 (10%)(a) 7/50
(14%)(a),(b)
Renal tubular-cell
adenomas or
adenocarcinomas
0/50 (0%)(e) 9/50
(18%)(a),(b)
3/49
(6%)
0/50
(0%)
0/50
(0%)
0/50
(0%)
Mononuclear cell
leukaemia
7/50 (14%)(f) 12/50
(24%)(a)
14/50
(28%)(a)
11/50
(22%)(g)
22/50
(44%)(a)
16/50
(32%)
Thyroid follicular cell
adenomas or
carcinomas
3/50 (6%) 3/50
(6%)
3/50
(6%)
0/50
(0%)(h)
6/50
(12%)(a),(b)
6/50
(12%)(a),(b)
bw: body weight.
(a): Life table analysis, p < 0.05, increase relative to control.
(b): Incidental tumour test for trend, p < 0.05, increase relative to control.
(c): Historical incidence at the study laboratory (mean  SD): 8/299 (3%  3%); historical incidence in NTP studies: 43/1,098
(4%  4%).
(d): Historical incidence at the study laboratory (mean  SD): 2/300 (0.7%  1%); historical incidence in NTP studies: 21/1,098
(2%  3%).
(e): Historical incidence at the study laboratory (mean): 1/300 (0.3%); historical incidence in NTP studies: 5/1,098 (0.5%).
(f): Historical incidence at the study laboratory (mean  SD): 19/300 (6%  6%); historical incidence in NTP studies: 152/1,100
(14%  8%).
(g): Historical incidence at the study laboratory (mean  SD): 36/300 (12%  6%); historical incidence in NTP studies: 196/1,100
(18%  9%).
(h): Historical incidence at the study laboratory (mean  SD): 3/297 (1%  1%); historical incidence in NTP studies: 15/1,076
(1%  2%).
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3.1.2.7.2. MCCPs
No in vivo carcinogenicity studies on MCCPs have been identiﬁed.
3.1.2.7.3. LCCPs
In a 2-year study with F344 rats, LCCP (C23, 43% chlorination) was administered at doses of 0,
1,875 or 3,750 mg/kg bw per day in males and 0, 100, 300 or 900 mg/kg bw per day in females (NTP,
1986b; Bucher et al., 1987). Survival was not affected. In female rats, pheochromocytomas occurred
with a signiﬁcant positive trend, and the incidence in the high-dose group was signiﬁcantly greater
than in the control group and in the historical control (Table 21). The incidence of endometrial
stromal polyps in the uterus in the low-dose female rats was signiﬁcantly greater than in the controls
and in the mid- and high-dose group. Two endometrial stromal sarcomas were observed in the low-
dose group (one in an animal with a polyp), but none was noted in any other dose group or in the
control. The incidence of endometrial stromal polyps or sarcomas was signiﬁcantly increased in the
female low-dose group, but not in the mid- and high-dose groups.
In a 2-year study with B6C3F1 mice, LCCP (C23, 43% chlorination) was given in doses of 0, 2,500
or 5,000 mg/kg bw per day in corn oil by gavage 5 days per week to 50 males and 50 females per
dose (NTP, 1986b; Bucher et al., 1987). Survival in females was lower than in males (control: 29/21;
low-dose: 36/22; high-dose: 28/20 for males/females, respectively). Survival in females was strongly
inﬂuenced after week 65 by a Klebsiella oxytoca infection; 60–70% of the early deaths in each female
group were attributed to this utero-ovarian infection and the low survival may have decreased the
sensitivity to detect carcinogenic effects. In male mice, malignant lymphomas occurred with a dose-
related positive trend, the incidence in the high-dose group was signiﬁcantly greater than that in the
control group and in the historical control (Table 22). In female mice, hepatocellular carcinomas and
hepatocellular adenomas or carcinomas (combined) occurred with positive trends, but the incidences in
the dosed groups were, according to the authors, not signiﬁcantly greater than the controls. The
CONTAM Panel noted that the infection of the females might impact the reliability of the study.
Table 20: Incidence of tumours in mice administered short-chain chlorinated parafﬁn (C12, 60%
chlorination) (NTP, 1986a)
Males Females
Dose
(mg/kg bw per day)
Control 125 250 Control 125 250
Hepatocellular adenomas 11/50 (22%) 20/50
(40%)(a),(b)
29/50
(58%)(a),(b)
0/50
(0%)
18/50
(36%)(a),(b)
22/50
(44%)(a),(b)
Hepatocellular
carcinomas
11/50 (22%) 15/50 (30%) 17/50
(34%)
3/50
(6%)
4/50
(8%)
9/50
(18%)(a)
Hepatocellular adenomas
or carcinomas
20/50
(40%)(c)
34/50
(68%)(a),(b)
38/50
(76%)(a),(b)
3/50
(6%)(d)
22/50
(44%)(a),(b)
28/50
(56%)(a),(b)
Thyroid follicular cell
adenomas or carcinomas
3/49
(6%)
4/50
(8%)
3/49
(6%)
8/50
(16%)(e)
12/49
(24%)
15/49
(31%)(a),(b)
Harderian gland
adenomas
– – – 1/50
(2%)(f)
6/50
(12%)(a),(b)
2/50
(4%)
Alveolar/bronchiolar
carcinomas
0/50
(0%)(g)
3/50
(6%)
6/50
(12%)(a),(b)
– – –
bw: body weight.
(a): Life table analysis, p < 0.05, increase relative to control.
(b): Incidental tumour test for trend, p < 0.05, increase relative to control.
(c): Historical incidence at the study laboratory (mean  SD): 109/298 (37%  12%); historical incidence in NTP studies: 357/
1,091 (33%  10%).
(d): Historical incidence at the study laboratory (mean  SD): 18/300 (6%  3%); historical incidence in NTP studies: 74/1,092
(7%  4%).
(e): Historical incidence at the study laboratory (mean  SD): 19/291 (7%  3%); historical incidence in NTP studies: 40/1,009
(4%  3%).
(f): Historical incidence at the study laboratory (mean  SD): 5/300 (2%  2%); historical incidence in NTP studies: 21/1,096
(2%  3%).
(g): No speciﬁc historical incidence data reported for alveolar/bronchiolar carcinomas. Historical incidence of the alveolar/
bronchiolar tumours (adenomas and carcinomas) at the study laboratory (mean  SD): 54/298 (18%  7%); historical
incidence of the alveolar/bronchiolar tumours in NTP studies: 169/1,093 (15%  6%).
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3.1.2.7.4. Summary on carcinogenicity
Oral gavage dosing of an SCCP (C12, 60% chlorination) caused tumours at several different tissue
sites in rats and mice. Administration by gavage increased the incidence of benign and malignant liver
tumours (hepatocellular adenomas and carcinomas) in mice of both sexes, the thyroid gland (follicular-
cell adenoma and carcinoma) in female mice and rats, and the kidney (tubular-cell adenomas and
carcinomas) in male rats. It also caused benign liver tumours (hepatocellular neoplastic nodules) in
rats of both sexes and mononuclear-cell leukaemia in male rats. Therefore, this SCCP (C12, 60%
chlorination) is carcinogenic in rats and mice.
Oral dosing of an LCCP (C23, 43% chlorination) caused tumours in different tissues in rats and
mice. Administration by gavage increased the incidence of malignant lymphomas in male mice, of
adrenal gland medullary pheochromocytomas in female rats, and to a marginal extent of hepatocellular
neoplasms in female mice. Therefore, there is some evidence for this LCCP (C23, 43% chlorination) to
be carcinogenic in mice and rats at very high-dose levels (2,500 and 5,000 mg/kg bw per day).
The relevance of these tumours for humans is discussed in Section 3.1.5.
3.1.3. Observations in humans
Only very limited information on observations in humans have been retrieved from the literature
search.
Table 21: Incidence of tumours in female rats administered long-chain chlorinated parafﬁn (C23,
43% chlorination) (NTP, 1986b)
Dose
(mg/kg bw per day)
Control 100 300 900
Adrenal medulla,
pheochromocytomas (all types)
1/50
(2%)(d)
4/50
(8%)(a)
6/50
(12%)
7/50
(14%)(b),(c)
Uterus, endometrial stromal polyps 9/50
(18%)
17/50
(34%)(b),(c)
10/50
(20%)
10/50
(20%)
Uterus, endometrial stromal sarcomas 0/50
(0%)
2/50
(4%)
0/50
(0%)
0/50
(0%)
Uterus, endometrial stromal polyps and/or
sarcomas
9/50
(18%)(e)
18/50
(36%)(b),(c)
10/50
(20%)
10/50
(20%)
bw: body weight.
(a): One female rat had a malignant pheochromocytoma.
(b): Life table analysis, p < 0.05, increase relative to control.
(c): Incidental tumour test for trend, p < 0.05, increase relative to control.
(d): Historical incidence at the study laboratory (mean  SD): 16/300 (5%  3%); historical incidence in NTP studies: 65/1,093
(6%  3%).
(e): Historical incidence at the study laboratory (mean  SD): 76/300 (25%  6%); historical incidence in NTP studies: 252/
1,089 (23%  6%).
Table 22: Incidence of tumours in male mice administered long-chain chlorinated parafﬁn (C23,
43% chlorination) (NTP, 1986b)
Dose
(mg/kg bw per day)
Males Females
Control 2,500 5,000 Control 2,500 5,000
Malignant lymphomas 6/50
(12%)(c)
12/50 (24%) 16/50
(32%)(a),(b)
15/50
(30%)
12/49
(24%)
20/50
(40%)
Hepatocellular carcinomas 9/50
(18%)
12/50 (24%) 12/50 (24%) 1/50
(2%)
1/49
(2%)
6/50
(12%)
Hepatocellular adenomas
and/or carcinomas
18/50 (36%) 21/50 (42%) 23/50 (46%) 4/50
(8%)(d)
3/49
(6%)
10/50
(20%)
bw: body weight.
(a): Life table analysis, p < 0.05, increase relative to control.
(b): Incidental tumour test for trend, p < 0.05, increase relative to control.
(c): Historical incidence at the study laboratory (mean  SD): 35/299 (12%  5%); historical incidence in NTP studies: 132/1,097
(12%  4%).
(d): Historical incidence at the study laboratory (mean  SD): 18/300 (6%  3%); historical incidence in NTP studies: 74/1,092
(7%  4%).
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A case report of acute renal toxicity following ingestion of a CP containing lava light liquid has been
reported (Erickson et al., 1996). A 65-year-old man was hospitalised with acute kidney failure after
having ingested a red lava light liquid 12–24 h before admission to the hospital. The lava light liquid
contained water (38%), CP (36%; no information on the identity of the CP), polyethylene glycol
(molecular weight 200; 13%), kerosene (7%) and microcrystalline wax (6%). According to the
authors, the renal toxicity was most probably related to the polyethylene glycol in the lava light liquid.
This case story could not be used for this risk assessment because of the mixed exposure and because
the observed effects were most probably associated with polyethylene glycol, not CPs. In addition, no
information on the identity of the CP in the lava light liquid was provided.
A registry-based case control study nested in a cohort assessed the association between
hepatobiliary cancer (cancer in the liver and biliary tract) and occupational exposure to metalworking
ﬂuids (MWF) and additives thereof (Bardin et al., 2005). For an exposure window between 1920 and
1994 and in addition to different types of MWFs used at the three automobile manufacturing plants,
exposure to several MWF additives, including CPs used in extreme pressure operations with straight
oils, was evaluated. Exposures to CPs were reported to be limited; however, no information was
provided regarding the identity of the CPs. In total, 63 cases of hepatobiliary cancer (39 liver cancers
and 24 biliary tract cancers) were reported. Of these, one liver cancer patient and ﬁve biliary track
cancer patients were exposed to CPs. Exposure to CPs was associated with a non-statistically
signiﬁcant fourfold increased risk for biliary tract cancer. Due to the small number of exposed
individuals, the primary focus on MWFs and the lack of characterisation of individual CPs, this cohort
study could not be used for this risk assessment.
3.1.4. Adverse effects in farm animals, horses and companion animals
3.1.4.1. Ruminants
No studies investigating effects of CPs in ruminants have been identiﬁed.
3.1.4.2. Pigs
No studies investigating effects of CPs in pigs have been identiﬁed.
3.1.4.3. Poultry
A limited number of studies have been conducted in poultry, and some of these were designed to
assess the performance and capacity for food production. These studies are summarised below.
The acute oral LD50 values of MCCP (Cereclor S52, C14–17, 52% chlorination) were reported to be
> 24,606 mg/kg bw per day for ring-necked pheasants and > 10,280 mg/kg bw per day for mallard
ducks. After 5-day dietary treatment, the LC50 values of MCCP (C14–17, 52% chlorination) for ring-
necked pheasants and also for mallard ducks were reported to be > 24,063 mg/kg diet (Madeley and
Birtley, 1980).
SCCP (Cereclor 50LV, C10–13, 49% chlorination), SCCP (Cereclor 70L, C10–13, 70% chlorination) or
LCCP (Cereclor 42, C22–26, 42% chlorination) were injected into the yolks of hens’ eggs (White
Leghoorn) after 4 days of incubation at sublethal doses of 0 or 300 mg/kg egg, respectively,
(Brunstr€om, 1985). The liver weight, the CYP450 concentration in the liver and the liver microsomal
activity of APND, aryl hydrocarbon (benzo[a]pyrene) hydroxylase (AHH) and 7-ethoxycoumarin O-
deethylase (ECOD) were determined in the chick embryos after incubation for 20 days. SCCP (C10–13,
70% chlorination) was the most potent in causing signiﬁcant increases in liver weight, CYP450
concentration and APND activity. LCCP (C22–26, 42% chlorination) was the least potent in these
respects, even causing signiﬁcantly reduced APND activity. A signiﬁcant decrease in AHH activity
occurred in chick embryos treated with SCCP (C10–13, 49% chlorination), and a signiﬁcant reduction in
ECOD activity was observed as a result of treatment with LCCP (C22–26, 42% chlorination) and SCCP
(C10–13, 49% chlorination).
Effects of SCCPs on growth rate were investigated in broiler chickens (Uebersch€ar and Matthes,
2004). Male ‘Lohmann meat’ broiler chickens (1 day old) were given diets supplemented with SCCP
(C10–13, 60% chlorination) in concentrations of 0 (48 animals), 2 (eight animals), 20 (eight animals),
45 (eight animals), 70 (eight animals) and 100 mg/kg feed (48 animals) for 31 days (corresponding to
0, 0.095, 0.95, 2.1, 3.3 and 4.7 mg/kg bw per day36). Feed consumption and live weights were
determined weekly in groups of eight animals. At the end of the study, all animals were weighed
36 Considering a body weight of 1,490 g and a feed intake of 70.6 g per day (Uebersch€ar and Matthes, 2004).
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before slaughtering. The weights of inner organs (liver, kidneys, pancreas, thyroid, heart, gizzard,
spleen, bursa of Fabricius) were determined for the control group and the high-dose group, and the
weights were calculated as a percentage of live weights. The mean of six groups of eight animals each
were used for the statistical analysis of the performance data. Live weight gain was also based on
values for single animals obtained after 4 weeks or 31 days. Seven animals died during the study
period, three in the control group, one in the 20 mg/kg group and three in the 100 mg/kg group. No
treatment-related effects between the control group and the high-dose group were observed on
performance (feed intake, live weight gain, feed to gain ratio) for up to 31 days. No indications of
lesions, inﬂammation or other pathological anomalies were observed in the gross macroscopic
examination of inner organs and glands. Signiﬁcantly lower mean live weights and higher relative
spleen weights were observed in the high-dose group compared to the control group. The highest
concentration of 100 mg/kg feed (corresponding to 4.7 mg/kg bw per day) is considered as a LOAEL.
A NOAEL cannot be evaluated as results have only been presented for the control group and the high-
dose group in the article. The CONTAM Panel noted discrepancies between text in the abstract and in
the results section, as well as at other places in the article, which hamper the reliability of this study.
Effects of SCCPs on laying performance were investigated in laying hens (Uebersch€ar et al., 2007).
Laying hens of the ‘Lohmann selected Leghorn’ strain (24 weeks old) were given diets supplemented
with SCCP (C10–13, 60% chlorination) in concentrations of 0 (21 animals), 2 (nine animals), 20 (nine
animals), 45 (nine animals), 70 (nine animals) and 100 mg/kg feed (36 animals) for 8 weeks
(corresponding to 0, 0.2, 1.5, 3.4, 5.3 and 7.6 mg/kg bw per day37). Feed consumption of all animals
in the control group and the high-dose group was recorded weekly. Laying performance was calculated
over two periods of 28 days and the egg weights were calculated as the mean weights of eggs
collected for 4 days in the 4th or 8th week of experiment, for the control group and the high-dose
group. At the end of the study (32 weeks of age), all animals were weighed. Nine birds from each
group were sacriﬁced and the inner organs (liver, kidneys, pancreas, thyroid, heart, gizzard, spleen)
were weighed and the weights were calculated as a percentage to the live weights of the individual
birds. No mortality was observed in the study. No treatment-related effects between the control group
and the high-dose group were noted on the performance (feed intake, egg weight, laying intensity,
daily egg mass, feed conversion), live weight and relative organ weights during the 8-week study
period. The highest concentration of 100 mg/kg feed (corresponding to 7.6 mg/kg bw per day) is
considered as a NOAEL.
In a reproductive study in mallard ducks (Wildlife International Ltd, 1984, unpublished study, as
cited in Serrone et al., 1987), SCCP (C10–13, 58% chlorination) was fed at levels of 0, 28, 166 or
1,000 mg/kg diet (corresponding to 0, 1.4, 8.3 or 50 mg/kg bw per day38) for 22 weeks to young
adult mallard ducks approaching their ﬁrst breeding season. Each group consisted of 20 pens, each
containing one pair (a drake and a hen). Eggs were collected daily during the 10-week egg-laying
period, they were incubated and hatched, and the offspring were maintained on basal diet for
14 days. The authors reported no effects of the SCCP in adults or in hatchlings at any dose level. At
the highest dose a reduction in egg fertility was reported. This effect was not reported to be
statistically signiﬁcant when the number of viable embryos of eggs set was compared to controls over
the entire study. However, when weekly comparisons were made, a signiﬁcant difference was found
for two of the 10-week collection periods (week 3 and 6). Also at the highest dose, the authors
reported a slight decrease in eggshell thickness (control 0.375 mm v. high dose 0.355 mm). Although
the difference was statistically signiﬁcant, the authors considered the biological signiﬁcance was
questionable, as the mean was within the range of normal values and no increase in cracked shells
was observed in the study. No treatment-related differences in embryo viability or eggshell thickness
were noted at 1.4 or 8.3 mg/kg bw per day groups when compared with the control. No effects on
egg weight, eggshell cracks, eggs laid, 21-day embryos or hatchability were observed in any of the
treatment groups. Serrone et al. (1987) considered that the NOEL was 166 mg/kg feed, corresponding
to 8.3 mg/kg bw per day, for reduction in egg fertility. The CONTAM Panel could not identify a NOAEL
based on the summary of this study as reported by Serrone et al. (1987).
In conclusion, the CONTAM Panel did not consider any of the studies sufﬁciently robust for risk
assessment in poultry.
37 Considering a live weight of 1,521 g and a feed intake of 115 g/day (Uebersch€ar et al., 2007).
38 Assuming a body weight of 1,200 g and a feed intake of 60 g/day.
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3.1.4.4. Rabbits
No oral CP toxicity studies in rabbits have been identiﬁed other than the developmental toxicity
studies described already in Section 3.1.2.3.
For an SCCP (carbon chain length not speciﬁed, 58% chlorination), the NOAEL for developmental
toxicity was 10 mg/kg bw per day, based on increased number of resorptions. The NOEL for maternal
toxicity was 100 mg/kg bw per day (the highest dose tested).
For an MCCP (C14–17, 52% chlorination), the NOEL for developmental and maternal toxicity was
100 mg/kg bw per day (the highest dose tested).
For an LCCP (C22–26, 43% chlorination), the NOEL for developmental and maternal toxicity was
5,000 mg/kg bw per day (the highest dose tested). For another LCCP (C22–26, 70% chlorination), the
NOEL for developmental and maternal toxicity was 1,000 mg/kg bw per day (the highest dose tested).
3.1.4.5. Fish
Several studies were performed in bleak (Alburnus alburnus L.). Although it is not usually farmed,
the CONTAM Panel noted it belongs to the carp family (Cyprinidae) and studies might be relevant to
farmed species. Studies in which the ﬁsh were exposed via the tank water were also included,
although this exposure route is not entirely relevant to dietary exposure.
The acute toxicity of several CPs was examined in two different ﬁsh species. For SCCP (C10–12, 58%
chlorination), the 96-h LC50 in rainbow trout (Oncorhynchus mykiss) was reported to be > 300 mg/L
(Howard et al., 1975). In bleak (Alburnus alburnus), the 96-h LC50 values were either > 5,000 mg/L (C10–13,
49% chlorination; C10–13, 63% chlorination; C10–13, 71% chlorination) or > 10,000 mg/L (C10–13, 56%
chlorination; C11.5, 70% chlorination) (Linden et al., 1979). For MCCPs, the 96-h LC50 values in bleak
(Alburnus alburnus) were found to be > 5,000 mg/L (C15.5, 40% chlorination; C14–17, 50% chlorination) or
> 10,000 mg/L (C14–17, 52% chlorination) (Linden et al., 1979). For LCCPs, the 96-h LC50 values in rainbow
trout (Oncorhynchus mykiss) were either > 300 mg/L (C>20, 40–42% chlorination; C>20, 48–54%
chlorination; C>20, 70% chlorination) or > 700 mg/L (C20–30, 42% chlorination). In bleak (Alburnus
alburnus), the 96-h LC50 of LCCP (C22–26, 42% chlorination) was > 5,000 mg/L for (Linden et al., 1979). The
CONTAM Panel noted that effect concentrations were given as nominal concentrations without further
considering the water solubility of the CPs.
The toxicity following dietary administration for 40 days of two SCCPs (20 and 200 ng/g feed) and
two MCCPs (20 and 200 ng/g feed, one of the high chlorinated MCCPs at 2,000 ng/g) was evaluated
in rainbow trout (Oncorhynchus mykiss) (Fisk et al., 1996) (see Section 3.1.1.3.2 and Appendix B
for details). The doses of 20, 200 and 2,000 ng/g feed corresponded to 0.0003, 0.003 and 0.03 mg/kg
bw per day.39 No reduced growth rates or hepatic monooxygenase enzyme induction were seen in any
of the CP groups when compared with the control group indicating no toxicity in the juvenile rainbow
trout to the four CPs tested under the conditions of this study.
The toxicity following dietary administration of 19 different CPs with varying carbon chain length
(C10, C11 and C14) and chlorination pattern was studied in rainbow trout (Oncorhynchus mykiss) (Fisk
et al., 1998) (see Section 3.1.1.3.2 and Appendix B for details). Only a single dose level was used
for each CP precluding the identiﬁcation of NOELs. Exposure to the CPs did not appear to inﬂuence the
health of the rainbow trout as growth rates were not signiﬁcantly different between the CP exposed
and control populations. Lipid percentages and liver somatic indices were also similar between
treatments. No deaths occurred in any of the treatments.
The toxicity following dietary administration of three different CPs (C10H15.3Cl6.7, C14H23.3Cl6.7 and
C18H31.4Cl6.6) for 40 days followed by 160 day of clean food, was studied in the rainbow trout
(Oncorhynchus mykiss) (Fisk et al., 2000) (see Section 3.1.1.3.2 and Appendix B for details). The
ﬁsh were fed with feed spiked with C10H15.3Cl6.7 at 1.4 and 15 lg/g feed (corresponding to 0.02 and
0.23 mg/kg bw per day40), with C14H23.3Cl6.7 at 1.3 and 13 lg/g feed (corresponding to 0.02
and 0.20 mg/kg bw per day41) and with C18H31.4Cl6.6 at 1.6 and 15 lg/g feed (corresponding to 0.02
and 0.23 mg/kg bw per day41). No mortalities occurred in any treatment group. Body and liver growth
rates and liver somatic indices did not vary between CP-exposed and control rainbow trout showing that
exposure to CPs at the concentrations used in this study did not affect the health of the rainbow trout.
39 Considering a body weight of 69 g (from Fisk et al., 2000) and a feed intake of 1.5% of the body weight.
40 Considering a ﬁsh weight of 69 g and a feed intake of 1.5% of the body weight.
41 Considering 7 g as the body weight of the Juvenile Atlantic salmon at the start of the study, and a feed intake of 2.5% of the
body weight.
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Juvenile Atlantic salmon (Salmo salar) (20 ﬁsh per tank) were fed with dry ﬁsh feed containing two
different CPs (Cereclor 42, 42% chlorination; Chlorez 700, 70% chlorination) at concentrations of 10
and 100 mg/kg feed (corresponding to 0.25 and 2.5 mg/kg bw per day41) for up to 181 days followed
by a control diet for 74 days (Zitko, 1974). Mortalities occurred both among ﬁsh fed the CPs and
among ﬁsh on the control diet. The LT50
42 values of ﬁsh fed the CPs were lower (39–80 days)
compared to that of ﬁsh on the control diet (138 days). Cereclor 42 was more toxic at 10 than at
100 mg/kg feed (LT50 values of 47 and 80 days, respectively), whereas the opposite was seen for
Chlorez 700 (LT50 values of 71 and 39 days, respectively). The amount of feed ingested by the ﬁsh
was not determined in the study and, according to the authors, it is possible that ﬁsh could taste
Cereclor 42 and fed less on feed containing the higher concentration of this CP.
Bioaccumulation of a CP from feed was studied in rainbow trout (Lombardo et al., 1975). Fingerling
rainbow trout (Salmo gairdneri Richardson) were fed a diet containing Chlorowax 500C at 10 mg/kg
feed (corresponding to 0.15 mg/kg bw per day43) for up to 82 days. The treated ﬁsh gained
signiﬁcantly less weight than the controls. Adverse effects were also observed, but both the controls
and the experimental ﬁsh were similarly affected. No gross toxicological effects were noted in the
experimental ﬁsh.
Bleak (Alburnus alburnus L.) caught in the Baltic Sea and acclimated to laboratory conditions during
three to ﬁve months (15 ﬁsh per group) were exposed during 14 days to the CP test solutions
(125 lg/L) added to the tank water (natural Baltic Sea water) and renewed every second or third day
(Bengtsson et al., 1979) (see Section 3.1.1.3.2 and Appendix B for details). The CP test solutions
included Witaclor 149 (C10–13, 49% chlorination), Witaclor 159 (C10–13, 9% chlorination), Witaclor 171P
(C10–13, 71% chlorination), Witaclor 350 (C14–17, 50% chlorination) and Witaclor 549 (C18–26, 49%
chlorination). The ﬁsh were not fed during the experiments. No mortality occurred in any of the
groups. Changes in the behaviour (sluggish movements, absence of shoaling behaviour and abnormal
vertical postures) were observed after about seven days in ﬁsh exposed to Witaclor 149, 159 and
171P. The abnormalities were most pronounced in ﬁsh exposed to Witaclor 149, followed by Witaclor
159 and the by Witaclor 171P. The behaviour became normal again after the ﬁsh had been kept in
clean water for a couple of days. No effects on behaviour were observed for Witaclor 350 and Witaclor
549.
Uptake and elimination of CPs was studied in bleak (Alburnus alburnus, 30 ﬁsh/group) (Bengtsson
and Ofstad, 1982) (see Section 3.1.1.3.2 and Appendix B for details). The CPs included Witaclor
149 (C10–13, 49% chlorination, at 590, 2,500, 5,800 mg/kg feed, corresponding to 15, 63 and 145 mg/
kg bw per day44), Witaclor 171P (C10–13, 71% chlorination, 3,180 mg/kg feed, corresponding to
80 mg/kg bw per day44) and Witaclor 549 (C18–26, 49% chlorination, 3,400 mg/kg feed, corresponding
to 85 mg/kg bw per day44). No signiﬁcant increase in mortality was observed in the exposed groups.
Changes in the behaviour (sluggishly swimming and closer to the bottom than usual, generally
accompanied by folded dorsal ﬁns and minor balance problems) were observed in three of the
exposed groups and were ﬁrst noted in the high-dose Witaclor 149 group after 5 weeks of the
accumulation period. After 7 weeks of the accumulation period, the same changed behaviour was also
observed in the mid-dose Witaclor 149 group, and after 12 weeks also in the group exposed to
Witaclor 171. These effects gradually disappeared within a couple of weeks of the subsequent
elimination period.
SCCP (C12, 49% chlorination; Witaclor 149) or SCCP (C12, 70% chlorination, H€uls 70C) were
administered to ﬂounder (Platichthys ﬂesus L.) of both sexes orally in gelatine capsules via stomach
tube (Haux et al., 1982). The animals were dosed twice, at day 1 and 4, to obtain a total exposure of
1,000 mg/kg bw. Fish were caught in bays from the Swedish East and West coast. They were placed
in tanks of brackish water (7.4& salinity) and in marine water (25–30& salinity) in groups of 15–30
ﬁsh. With the exception of the dry ﬁsh food in capsules, the animals were starved throughout the
experiment. Sampling was performed 13 and 27 days after the ﬁrst SCCPs administration. SCCP (C12,
49% chlorination) caused a 21% reduction in haematocrit in the brackish water female ﬁsh after
13 days compared to the control group. In marine female ﬂounders, SCCP (C12, 49% chlorination)
caused a 13% increase in both haematocrit and number of red blood cells observed after 13 days,
while after 27 days no effects were seen. After 27 days, a hypoglycaemia was observed for marine
female ﬁsh exposed to SCCP (C12, 49% chlorination; Witaclor 149). The liver somatic index was
42 The LT50 is the time required for 50% of the animals to die following exposure to a known concentration of the test agent.
43 Considering 30.3 g as body weight and a feed intake of 1.5% of the body weight (Fisk et al., 2000).
44 Considering 4 g as body weight and a feed intake of 2.5% of the body weight.
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increased in the SCCP (C12, 70% chlorination, H€uls 70C)-treated brackish water male group after
13 days. SCCP (C12, 70% chlorination, H€uls 70C) changed activities of two steroid metabolising
enzymes. There was a decrease in the 6b-hydroxylase activity in marine female ﬁsh after 13 days as
well as an increase in the 5a,b-reductase activity in brackish water female ﬁsh after 13 days. Based on
the information in this study the CONTAM Panel could not identify a NOAEL.
Juvenile rainbow trout (Oncorhynchus mykiss) were exposed to CPs (C10-, C11-, C12- and C14) for
either 21 or 85 days (Cooley et al., 2001). Commercial ﬁsh feed was spiked with one of four SCCPs
(C10H15.5Cl6.5, 63% chlorination
45; 14C-C10H15.3Cl6.7, 63.7% chlorination; C11H18.4Cl5.6, 56.9%
chlorination; 14C-C12H19.5Cl6.5, 58.5% chlorination) or one of two MCCPs (C14H24.9Cl5.1, 48%
chlorination; 14C-C14H23.3Cl6.7, 55% chlorination) separately. The juvenile rainbow trout (10/group;
initial weights approx. 2 g) were exposed to each CP at three different CP concentrations, ranging
from 0.082 to 290 mg/kg feed. In many of the trouts, no or diminished startle response could be
observed. Failure to feed on certain days were also observed, and animals from the highest dose
groups in many cases stopped feeding. Many trouts showed loss of equilibrium and developed dark
coloration. In each exposure group, histopathological liver lesions were seen. Most severe lesions were
observed in livers of ﬁsh exposed to 14C-C10H15.3Cl6.7 (C10, 63.7% chlorination) and C11H18.4Cl5.6 (C11,
56.9% chlorination) (whole ﬁsh concentrations 0.92 and 5.5 mg/kg, respectively) in which extensive
ﬁbrous lesions were present that were not present in any other exposure group. Other effects in the
treatment groups included sites of inﬂammation, hepatocyte necrosis and depletion of glycogen/lipids.
The mean hepatocyte volume index of trout treated with C10H15.5Cl6.5 (C10, 63% chlorination),
C12H19.5Cl6.5 (C12, 58.5% chlorination) and C14H24.9Cl5.1 (C14, 48% chlorination) were smaller than the
controls. No lesions or abnormalities were seen in the thyroids of ﬁsh exposed to SCCPs or MCCPs. The
authors noted that the toxicity of terminal chlorinated CPs was not different than that of CPs which are
not chlorinated on the terminal carbons (Cooley et al., 2001). The CONTAM Panel concluded that the
study indicates adversity in the liver based largely on descriptive endpoints that could not be quantiﬁed
to demonstrate a dose response. It is uncertain if the effects in the liver are direct or secondary to
changes in food intake. Although effects were reported in all treatment groups, a LOAEL could not be
identiﬁed because of inconsistencies in the reporting of the feed concentrations.
In conclusion, most studies showed no or minor effects. Based on the available information, the
CONTAM Panel could not identify a NOAEL or a LOAEL for ﬁsh.
3.1.4.6. Horses
No studies investigating effects of CPs in horses have been identiﬁed.
3.1.4.7. Companion animals (cats and dogs)
No studies investigating effects of CPs in cats have been identiﬁed.
One dietary study in Beagle dogs investigating effects of an MCCP (Cereclor S52, C14–17, 52%
chlorination, containing epoxidised vegetable oil stabiliser) is described in Section 3.1.2.2.2. The
NOEL was 10 mg/kg bw per day, based on an increase of hepatic smooth endoplasmic reticulum at
higher dose levels.
3.1.4.8. Fur animals
No studies investigating effects of CPs in fur animals have been identiﬁed.
3.1.5. Mode of action
Studies in experimental animals indicate that the target organs for toxic effects are the liver,
kidneys and thyroid. Tumours have been observed in these and other tissues. In addition, effects of
MCCP were observed in rat offspring indicative of internal haemorrhaging. The mode of action
regarding these effects in each target organ, and the relevance to humans are considered in this
chapter. The overall data indicate that CPs do not cause genotoxic effects in vivo (see Section
3.1.2.6) and thus a genotoxic mechanism of carcinogenesis does not appear to be relevant. The
observed tumours for SCCPs and LCCPs (see Section 3.1.2.7) are likely to arise by non-genotoxic
mechanism(s) which differ between tissues and which are likely to arise only at dose levels at and
above those in which the responsible non-genotoxic perturbation occurs.
45 The chlorination degree is as reported by EU-RAR (2005, 2008).
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3.1.5.1. Effects in the liver
Repeated dose toxicity studies with CPs in rats and mice have revealed effects in the liver, including
hepatic enzyme induction, increased liver weight, non-neoplastic hepatic lesions and cancer. Necrosis
occurred in mouse liver following dosage of 500 mg/kg bw (see Sections 3.1.2.2 and 3.1.2.7).
3.1.5.1.1. In vivo
Male Sprague–Dawley rats were administered i.p. with 1,000 mg/kg bw per day of SCCPs (C10–13,
49% chlorination or 59% or 71% chlorination), MCCP (C14–17, 50% chlorination) or LCCP (C18–26, 49%
chlorination), daily for 4 days (Nilsen et al., 1980, 1981; Nilsen and Toftgard, 1981). Treatment with
SCCPs, but not with CPs of longer chain lengths, caused an increase in liver weight associated with an
induction of various CYP450 enzymes. The activity of O-deethylation of 7-ethoxyresoruﬁn was
decreased by the SCCPs with higher chlorine content. In contrast, the metabolism of benzo[a]pyrene
was induced by each of the CPs. SCCP (C10–13, 49% chlorination) caused a proliferation of the smooth
endoplasmic reticulum (twofold as assessed by electron microscopy) whereas LCCP (C18–26, 49%
chlorination) caused a smaller increase. All three SCCPs produced an increase in the occurrence and
size of lipid droplets in the cytoplasm. SCCP (C10–13, 49% chlorination) moderately increased the number
of mitochondria and occasionally caused the formation of enlarged mitochondria. MCCP (C14–17, 50%
chlorination) and LCCP (C18–26, 49% chlorination) also increased the number and size of peroxisomes.
An increase in hepatic cytosolic and microsomal epoxide hydrolase activities (130% and 250%
increase compared to the control for cytosolic and microsomal hydrolases, respectively) was observed
in male C57Bl/6 mice after 5 daily i.p. injection of 400 mg/kg bw SCCP (C12, 70% chlorination) (Meijer
and DePierre, 1987). In addition, the amount of microsomal CYP450 was increased by 50%, and
cytosolic DT-diaphorase activity was increased two- to threefold. This was associated with enlargement
of the liver.
Effects on microsomal enzymes in liver from male Sprague–Dawley rats, after i.p. injection of
1,000 mg/kg bw per day SCCP (C10–13, 70% chlorination), MCCP (C14–17, 58% chlorination), LCCP (C22–26,
42% chlorination) or LCCP (C23, 70% chlorination), once daily for 5 days, was observed (Meijer et al.,
1981). Microsomal epoxide hydrolase and glutathione-S-transferase activities were also increased by all
administered CPs except LCCP (C22–26, 42% chlorination).
As described in Section 3.1.2.2, SCCPs and MCCPs induced hepatic peroxisome proliferation in rats
and mice. Male rats and male mice (5 per group) were administered SCCPs (Chlorowax 500C, C10–13,
56% chlorination or Cereclor 56L, C10–13, 58% chlorination) or MCCP (Chlorparafﬁn 40G, C14–17, 40%
chlorination) at doses of 0, 10, 50, 100, 250, 500 or 1,000 mg/kg bw per day in corn oil per gavage for
14 days (Wyatt et al., 1993). Palmitoyl CoA oxidation as indicator for peroxisome proliferation was
increased in rats from 250 mg/kg bw per day (SCCP, C10–13, 56% chlorination) and from 500 mg/kg bw
per day (MCCP, C14–17, 40% chlorination). The mice proved to be more responsive than the rats showing
increased palmitoyl CoA oxidation from 250 mg/kg bw per day (SCCP, C10–13, 56% chlorination or 58%
chlorination) and from 500 mg/kg bw per day (MCCP, C14–17, 40% chlorination). In general, higher dose
levels were required for induction of peroxisome proliferation compared to those required for an elevation
of liver weight. SCCPs caused a greater increase in palmitoyl CoA oxidation (up to approximately a
10-fold increase) compared to the increase caused by MCCPs (up to approximately a 4-fold increase).
SCCP (C10–13,56.5% Chlorination) given to rats by gavage daily for 28 days (100 mg/kg bw per day) also
caused an upregulation of 11 genes in the liver that are activated by peroxisome proliferator activated
receptor a (PPARa) and are involved in fatty acid metabolism. This was associated with enhanced fatty
acid oxidation (Gong et al., 2019).
As mentioned in Section 3.1.2.2, MCCP (C14–17, 52% chlorination) signiﬁcantly increased UDPGT
activity in two 90-day rat studies (Poon et al., 1995; CXR Biosciences Ltd, 2005b, unpublished study,
see Documentation provided to EFSA). The induction of UDPGT (see Section 3.1.5.3) in the rat liver
is mediated by interaction of SCCPs with the constitutive androstane receptor (CAR) (Gong et al.,
2018). The altered liver metabolism of T4 via elevation of UDPGT is considered to be an important
component of the mode of action for disturbance of thyroid physiology and pathology leading to
thyroid gland follicular-cell adenoma and carcinoma in the rat. Details of these responses and the
relevance to human risk assessment of the role of altered hepatic metabolism of T3/T4 is discussed in
Section 3.1.5.3.
The effects of CPs in the liver have been studied in F344 rats, B6C3F1 mice and male Alpk:Dunkin
Hartley guinea pigs. The responses were compared with those produced by a range of known inducers
of hepatic enzymes (ICI, 1997, unpublished study, see Documentation provided to EFSA). CPs were
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given to animals by gavage in corn oil for 14 days (4–5 animals per group). Dose levels were 1,000 to
2,000 mg/kg bw per day of the following CPs: SCCP (C500C, C10–13, 58% chlorination; C56L, C10–13,
56% chlorination), MCCP (C40G, C14–17, 40% chlorination) and LCCP (C20–30, 43% chlorination).
Relative liver weight was increased (approximately 1.5-fold) by SCCPs and MCCP, but not by LCCP. The
increased liver weight was associated with hepatocellular hypertrophy, peroxisome proliferation
(assessed by electron microscopy and by increase in palmitoyl CoA oxidation) and proliferation of
hepatic cell smooth endoplasmic reticulum in both rats and mice. SCCPs and MCCPs also caused
induction of CYP450 4A1 in rat and mouse liver and CYP450 2B1/2B2 in the rat liver. In guinea pigs
administered 1,000 mg/kg bw per day of SCCP and MCCP liver weight was also increased by 1.5-fold
but no histological or biochemical parameters measured were altered.
In a study by Elcombe et al. (2000) (abstract only), male and female F344 rats were administered
SCCP (Chlorowax 500C (C500C), C10–13, 58% chlorination) or MCCP (Chlorparafﬁn 40G (C40G), C14–17,
40% chlorination) in corn oil by gavage in doses of 0, 312 or 625 mg/kg bw per day for up to
90 days. In addition, male Dunkin Hartley Guinea pigs were administered SCCP (Chlorparafﬁn 40G
(C40G), C10–13, 58% chlorination) in corn oil by gavage in doses of 0, 500 or 1,000 mg/kg bw per day
for 14 consecutive days. Liver weight, liver palmitoyl CoA oxidation, UDPGT activity were increased in
male and female rats by SCCP and MCCP. Therefore, no effect of SCCP on liver weights and no
observable hepatic histopathology in male guinea pigs could be observed.
A recent study by Geng et al. (2019) conﬁrmed in vitro studies (see Section 3.1.5.1.2) in
demonstrating oxidative stress, PPARa activation and inhibition of energy metabolism produced by
SCCPs in the liver of male rats. There was suppression of oxidative phosphorylation, glycolysis and
gluconeogenesis, reducing the levels of amino acids and nucleotides. Some of these effects on energy
metabolism were produced at the lowest dose studied (0.01 mg/kg bw per day for 28 days). The
authors noted the need for further studies to verify the impact on the energy metabolism. While these
ﬁndings demonstrate a mode of action in hepatotoxicity, the CONTAM Panel could not conclude on a
dose level whereby these changes lead to adversity.
3.1.5.1.2. In vitro
Information on a range of parameters altered by an SCCP (C12, 60% chlorination) in human liver
cells (not speciﬁed) has been reported in the ToxCast database (US-EPA, 2019). The results are given
in the section relating to the kidney below (see Section 3.1.5.2). In support of the role of PPARa in
mediating the proliferation of peroxisomes in rodent liver, Gong et al. (2019) found that SCCP
activated luciferase expression in an in vitro dual-luciferase reporter gene linked to the rat PPARa gene
response element. Moreover, an in silico molecular docking analysis using LeDock46 simulated the
interaction of SCCP with PPARa.
A cell viability assay and targeted metabolomic approach were used to evaluate the effects of
SCCPs of different chain lengths and chlorine contents (C10, C11, C12 or C13; e.g. C10 chlorine content
of 40.4%, 57.9% or 64.4%) at environmentally relevant concentrations (0, 1, 10 or 100 lg/L) on
human hepatoma HepG2 cells (Geng et al., 2015). Viable cell number (measured by the MTT assay)
was found to be decreased with increases in exposure concentrations of SCCPs. Exposure for 48 h to
SCCPs resulted in a signiﬁcant reduction in cell number compared with 24 h, even at 1 lg/L, while
exposure with 100 lg/L SCCP resulted a potent decrease down to 60% after 48 h. The CONTAM
Panel noted that the MTT assay does not necessarily indicate cell death since cell number may be
reduced by inhibition of cell proliferation. SCCPs exposure caused oxidative stress, as shown with
increased catalase and superoxide dismutase activities and altered the intracellular redox status as
shown with decreased glutathione contents at 10 ng/L and above. Furthermore, SCCPs exposure
caused signiﬁcant metabolic disruption. SCCPs speciﬁcally stimulated the b-oxidation of unsaturated
fatty acids and long-chain fatty acids. Moreover, SCCPs exposure disturbed glycolysis and amino acid
metabolism, and led to the upregulation of glutamate metabolism and urea cycle. Thus, the toxic
effects of SCCPs appear mainly to involve the perturbation of energy production, protein biosynthesis,
fatty acid metabolism and ammonia recycling.
The effects of SCCP, MCCP and LCCP (1, 10, 100 and 1000 lg/L for 24 h) on viable cell number
and disturbance of metabolism was also compared in HepG2 cells (Ren et al., 2019). Viable cell
number was reduced at the lowest concentration tested (1 lg/L) for all CPs. ATP levels were reduced
and levels of reactive oxygen species and malondialdehyde levels (indicative of lipid peroxidation and
oxidative stress) were elevated by all CPs at 100 lg/L. The potency of all three CPs was similar with
46 http://lephar.com
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respect to overall effect on perturbation of various aspects of metabolism, particularly in relation to
phospholipid and fatty acid metabolism, however LCCP produced a relatively greater suppression of
amino acid transport than seen with SCCP and MCCP. Furthermore, the marked elevation of purines by
SCCP and MCCP was not seen with LCCP which reduced the levels of various purines. The CONTAM
Panel noted an inability to extrapolate the concentrations of CPs applied in all of the above cell culture
studies to cellular concentrations or to tissue concentrations achievable in vivo and hence no attempt
was made to interpret the effects in vitro on a quantitative basis.
3.1.5.1.3. Summary on liver toxicity
Regarding the mode of action for liver toxicity, it is considered that enzyme induction and
proliferation of the smooth endoplasmic reticulum leading to hypertrophy (and associated increases in
liver size) is an adaptive physiological response to CPs. In addition, proliferation of rodent peroxisomes
occurs mediated by PPARa. These responses could lead to rodent hepatocellular carcinogenicity (see
below) and also to toxicity if the energy balance to support this compensatory response becomes
sufﬁciently perturbed so as to compromise the cell viability. This mode of action of toxicity appears to
be achievable in vitro based on the evidence presented above for perturbation by SCCP of energy
production in human hepatoma HepG2 cells (Geng et al., 2015). Furthermore, a metabolomic study in
these cells showed a clear disturbance by an SCCP of the TCA cycle as well as perturbation of
glycerophospholipid and linoleic acid metabolism (Wang et al., 2018a).
3.1.5.1.4. Mode of action in liver carcinogenesis
Regarding the MOA for carcinogenicity of SCCPs in the rodent liver, the Panel considered the following
as potentially involved: (1) CAR activation, (2) PPAR alpha activation, (3) cytotoxicity; in the absence of
evidence for genotoxicity. The relevance of these rodent liver effects to humans was considered.
Regarding CAR activation, the key associative events in rodents comprise increased hepatocyte
replication, induction of cytochrome P450 CYP2B subfamily enzymes and these lead to liver hypertrophy
and hepatocellular adenomas/carcinomas. It is well established that various activators of CAR in the rat
do not stimulate replicative DNA synthesis in cultured human hepatocytes or in chimeric mice with
humanised livers (see Lake (2018) and Felter et al. (2018)). The lack of mitogenic response to activators
of CAR in human hepatocytes is shared by other species (hamster and guinea pig). The conclusion
regarding the human liver being refractory to the hepatocarcinogenicity of CAR activators is supported
by epidemiological studies in which humans chronically exposed to the CAR activator phenobarbital
show no evidence of an increased incidence of liver tumours (La Vecchia and Negri, 2014).
The histological and biochemical evidence for peroxisome proliferation (see Sections 3.1.2.2 and
3.1.5.1.1) is considered a toxic response for the rat and mouse and is likely to be a key factor in the
development of rat and mouse hepatocellular adenoma and carcinoma. However, it is well documented
that, as with guinea pigs, primates, including humans, are insensitive to peroxisome proliferator-
induced hepatic effects (Bentley et al., 1993). The susceptibility of rodents to hepatic tumours
produced by peroxisome proliferators has been linked to the activation of the PPARa and the
associated liver cell proliferation and inhibition of apoptosis. Although PPARa activation can occur in
both rodents and humans, the responses leading to tumourigenesis are unique to mice and rats,
human hepatocytes being refractory to the cell proliferative response as discussed in detail by
Gonzalez et al. (1998), Roberts (1999), Bentley et al. (1993) and Corton et al. (2018).
Of the responses listed above as potentially contributing to rodent liver carcinogenesis by SCCPs,
cytotoxicity could be relevant to human carcinogenesis involving a threshold dose response (Felter
et al., 2018).
Based on the available information, the relevance to humans of the rodent liver tumours can be
excluded provided cytotoxicity does not occur.
3.1.5.2. Effects in the kidney
Information on a range of parameters altered by an SCCP (C12, 60% chlorination) in human kidney
(and liver) cells has been reported in the ToxCast database (US-EPA, 2019). Particularly sensitive
responses in the activation of the nuclear transcription factors pregnane X receptor (PXR), renin/prorenin
receptor (RER), vitamin D3 receptor (VDR) and nuclear receptor family 1 group H member 4 (NR1H4)
were observed at concentrations below those required for loss of mitochondrial membrane potential.
Effects on PPARs were only seen at similar or even higher concentrations of SCCP required for changes in
membrane potential. It is noted that the data points suggesting an apparent very high potency for cell
death in kidney cells, based on DNA staining, are not considered reliable since it is based on a single
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replicate and at a concentration far below that causing effects on mitochondrial membrane potential and
expression of nuclear transcription factors.
Repeated dose toxicity studies in rodents have revealed nephrotoxicity caused by CPs such as
increased kidney weight, pigmentation in tubules, nephritis and nephropathy. This includes tumours in
male (but not female) rats, but not in mice treated with SCCPs (see Sections 3.1.2.2 and 3.1.2.7).
In the study by Elcombe et al. (2000) (only abstract available), SCCPs and MCCPs produced chronic
nephropathy in male rats only, associated with regenerative hyperplasia and increased S-phase in the
proximal tubules. No histopathological changes were seen in kidneys of the SCCP-treated guinea pigs.
In the 90-day and 2-year rat studies (NTP, 1986a), and in the 2-year mouse study (NTP, 1986b)
nephropathy was observed in both males and females.
A study was performed to elucidate the mechanisms for the induction of renal tumours in male rats
by SCCPs (Warnasuriya et al., 2010). SCCP (C12, 60% chlorination) was administered to male F344 rats
at doses of 0 and 625 mg/kg bw per day in corn oil by gavage for 28 consecutive days. SCCP (C12,
60% chlorination) caused downregulation of a2u-microglobulin synthesis in the liver of male rats.
Speciﬁc binding of radiolabelled SCCP to the a2u-microglobulin could be demonstrated followed by a
slow accumulation of a2u-microglobulin in the kidney followed by delayed onset of a2u-nephropathy.
As a result, the authors suggested a complex, yet uncharacterised mechanism for the carcinogenic
effects of SCCP in the kidney of male rats.
Kidney tumours caused by SCCPs in male rats cannot be ascribed to a classic proﬁle of a2u-
microglobulin-induced nephropathy. While SCCPs bind speciﬁcally to a2u-microglobulin and slow
accumulation of the protein in the kidney occurs followed by delayed nephropathy, SCCPs do not
induce, but signiﬁcantly downregulate, a2u-microglobulin synthesis in the liver which complicates the
interpretation of a2u-microglobulin-induced nephropathy (see Section 3.1.2.2). Overall, although
histological evidence for classical hyaline droplet nephropathy is limited, it appears that a2u-
microglobulin-induced nephropathy is the most likely contributing factor in kidney tumourigenesis
involving the reported increase in kidney tubular hyperplasia produced by SCCP in male rats (NTP,
1986a). An area of uncertainty is the evidence also seen in female rats and mice (both sexes) of
nephropathy produced by SCCPs (see Section 3.1.2.2). However, the importance of this effect in
females is questionable since kidney tumours were only found in male rats treated with SCCP.
Since a genotoxic mechanism has been ruled out, the mode of action therefore may relate to
sustained cellular damage (at least in part related to nephropathy induced by a2u-microglobulin in the
male rat), compensatory regenerative hyperplasia and increased S-phase possibly also involving
inhibition of intercellular communication (see below) as non-genotoxic inﬂuences. However, there is
insufﬁcient evidence to conclude that nephropathy responsible for carcinogenesis is solely male rat
speciﬁc event mediated by a2u-microglobulin and, for that reason, the CONTAM Panel concluded that
the relevance of renal carcinogenesis to humans cannot be ruled out.
3.1.5.3. Effects in the thyroid
Repeated dose toxicity studies revealed diverse effects of SCCPs and MCCPs in the thyroid such as
increased thyroid weight, increased incidences of thyroid hypertrophy and hyperplasia, as well as
follicular cell lesions, reduced follicle sizes and cytoplasmic vacuolation. In carcinogenicity studies,
SCCP caused thyroid follicular cell adenomas and carcinomas in female rats and female mice. No
carcinogenicity studies with MCCPs have been conducted so far.
As described in Section 3.1.2.2, in two 90-day rat studies with MCCP (C14–17, 52% chlorination),
liver enzyme UDPGT activity was signiﬁcantly increased (Poon et al., 1995; CXR Biosciences Ltd, 2005b,
see Documentation provided to EFSA). In one of these studies, FT3 in plasma was found to be
decreased (CXR, 2005b, see Documentation provided to EFSA).
In another study, male F344 rats (5 per group) received 0 or 1,000 mg/kg bw per day of two
different SCCPs (Cereclor 56L, C10–13, 56% chlorination or Chlorowax 500C, C10–13, 58% chlorination)
or MCCPs (Chlorparafﬁn 40G, C14–17; 40% chlorination) by oral gavage for 14 days (Wyatt et al., 1993)
(see Section 3.1.2.2). No females were examined in this study. Signiﬁcant reductions in both free
and total plasma T4 levels (by 44 and 53%, respectively) and an almost twofold increase in UDPGT
activity was noted at the treated group. T3 levels remained unaffected, while TSH levels showed an
approximate 1.5-fold increase at 1,000 mg/kg bw per day.
In the study by Elcombe et al. (2000) (abstract only), SCCPs and MCCPs decreased plasma T4 and
increased plasma TSH concentrations and thyroid follicular cell hypertrophy and hyperplasia could be
observed. No effect on any of the plasma thyroid hormones or plasma TSH concentration could be
observed in SCCP-treated guinea pigs.
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Gong et al. (2018) found that an SCCPs (C10–13, 56.52% chlorination; mass ratio of C10:C11:C12:C13
= 1:1:1:1) was able to reduce the plasma FT3 level signiﬁcantly in rats treated by gavage with 10 and
100 mg/kg bw per day for 28 days. SCCPs did not show signiﬁcant effects on the expression of thyroid
hormone synthesis genes. However, various changes in hepatic metabolism were noted that help to
explain the modulation of plasma thyroid hormone levels. The relative hepatic mRNA levels of Dio3
(gene for type III deiodinase ID3), Slc22a7 (gene for organic anion transporter 2 (OAT2)), Slco1a4
(gene for organic anion transporting polypeptide 1a4 (OATP1A4)) and Slc10a1 (gene for sodium
taurocholate cotransport polypeptide (NTCP)) were signiﬁcantly and dose-relatedly increased at 10 and
100 mg/kg bw per day. The relative mRNA levels of Cyp2b1 (gene for CYP450 2B1) and Ugt1a1 (gene
for UDPGT1A1) were signiﬁcantly increased at 100 mg/kg bw per day. UDPGT protein (which
conjugates T4) was also increased at 100 mg/kg bw per day and this is likely to contribute to the
observed reduction of the plasma FT4 level at the same dose level. However, this induction was not
seen at 10 mg/kg bw per day or below suggesting that an additional mechanism contributes to the
perturbation of plasma thyroid hormone levels. In this study, liver OAT2 protein and its mRNA
(Slc22a7) were found to be elevated at 1 mg/kg bw per day. The authors referred to OAT2 as being
involved in T3 transport into the liver, but the CONTAM Panel could not ratify this conclusion since
organic anion transporting polypeptide 2 (OATP2) (which was not measured) is responsible for T3
transport. No evidence in the literature could be found for a role of OAT2 in T3 transport. However, it
is likely that OATP2 is also elevated by SCCP because this protein is induced by CAR which Gong et al.
(2018) showed was activated by SCCP (see Section 3.1.5.1.1) and was responsible for induction of
UDPGT. Therefore, it is likely that the reduction of plasma FT3 is inﬂuenced by OATP2 induction.
Thus, thyroid tumours in rodents, as caused by SCCPs in female rats and female mice, can arise
due to stimulation of the thyroid via a negative feedback mechanism. This includes a potential increase
in uptake of thyroid hormones, increased hepatic UDPGT levels and conjugation of T4, consequent
decrease in plasma T4/T3, compensatory release of pituitary TSH, and a compensatory increase in T4
production in the thyroid. This eventually leads to hypertrophy, hyperplasia and an increased sensitivity
to develop thyroid tumours. The effect was not evident in guinea pigs.
Rodents appear to be particularly susceptible to thyroid changes partly due to having T4-binding
proteins other than the high afﬁnity T4-binding globulin (TBG), which is present in humans. TBG is
expressed in rats, but varies according to age. In adult rats, its levels are low between 2 and 7 months
of age and transthyrethin (TTR) is the dominant T4 plasma carrier in adult rats. TTR has a lower
afﬁnity for T4 and is therefore less efﬁcient in binding T4 than TBG. The primary function of carrier
proteins is extra-thyroidal storage of thyroid hormones to ensure sustained hormone action across
tissues, and this contributes to the control of thyroid hormone homeostasis and protection from
peripheral elimination. Thus, in species in which TBG is not the major T4 carrier, the free fraction of T4
is larger than in humans and TT4 half-life is shorter (around 24 h in rats, versus 5–6 days in humans)
(Lewandowski et al., 2004). However, even though TBG is the major and speciﬁc transport protein of
thyroid hormones in humans, it has recently been shown not to be the physiologically most relevant
(Alshehri et al., 2015). The most physiologically relevant carrier protein in humans is also TTR.
Furthermore, the differences in half-lives of the active hormone T3 between rats and humans are
much smaller than for T4, as T3 half-lives for humans are 22–24 h and around 6 h in rats. Based on
these more recent ﬁndings, the previous assumptions about large qualitative species differences in
thyroid hormones homeostasis between rats and humans may be incorrect, and should not be used to
dismiss the rat as a predictor for all thyroid related effects in humans. This is despite the fact that,
although some studies have shown drug-induced changes in thyroid hormones in humans, elevations of
thyroid stimulating hormone have not been reported in humans for a range of drugs (including
delavirdine, ﬂuvastatin, nicardipine, phenobarbital, simvastatin and spironolactone), all of which cause
hyperplasia or tumours in rats (Wu and Farrelley, 2006). In addition, there are various reasons why
changes affecting the thyroid that are mediated through altered hepatic metabolism may be more
pronounced than in humans as discussed in detail by Bartsch et al. (2018).
Overall, this raises uncertainty about the validity of extrapolating changes related to the thyroid
from rats to humans when these changes are mediated by induction of hepatic transporters and
hepatic metabolism.
Using the current understanding of thyroid physiology and toxicology, the ECHA/EFSA Guidance for
the identiﬁcation of endocrine disruptors (ECHA/EFSA, 2018) “proposed that the following be applied
when interpreting data from experimental animals: 1) Substances inducing histopathological changes
(i.e. follicular cell hypertrophy and/or hyperplasia and/or neoplasia) in the thyroid, with or without
changes in the circulating levels of thyroid hormones, would pose a hazard for human thyroid hormone
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insufﬁciency in adults as well as pre- and post-natal neurological development of offspring. 2) Substances
that alter the circulating levels of T3 and/or T4 without histopathological ﬁndings would still present a
potential concern for neurodevelopment.”
Irrespective of the uncertainties regarding extrapolation of liver-mediated effects on changes in
thyroid hormone levels in rodents to humans as discussed above, the Panel noted that in the three rat
studies on SCCPs and MCCPs in which thyroid hormone levels have been examined, there are
inconsistencies in the hormonal changes seen amongst these studies, as well as between the two
genders. Consequently, because of these inconsistencies, the Panel considered that changes in thyroid
hormone levels could not be used as a basis for deriving a reference point. However, despite
uncertainties regarding extrapolation of liver-mediated effects from rat to human (discussed above),
the thyroid histopathology is used as a basis for deriving a reference point.
There is a potential for modulation of thyroid hormone levels to have an effect in rodents on pre-
and postnatal neurological development of offspring. It has also been shown that developmental
neurotoxicity can arise via thyroid disruption in humans (Fan and Wu, 2016; Ghassabian et al., 2014).
In addition, the human fetus and neonate has a shorter T4 half-life than adults, which may make them
more susceptible to a lowering of serum T4 levels (Li et al., 2019c). The CONTAM Panel could not
identify any studies on potential neurodevelopmental effects of CPs in mammals. Because of the
reported changes in thyroid hormone levels produced by SCCP and MCCP in rodents, the Panel
concludes that an assessment of potential neurodevelopmental toxicity is needed.
3.1.5.3.1. Additional thyroid effects investigated in zebraﬁsh
Thyroid hormones play an important role in the development, growth, differentiation and metabolism
in early life stage in ﬁsh. Zebraﬁsh embryos were exposed to seven different SCCPs, namely from the C10-
group (C10H18Cl4, 1,2,5,6,9,10-C10H16Cl6 and C10H15Cl7), from the C12-group (C12H22Cl4, C12H19Cl7 and
1,1,1,3,10,12,12,12-C12H18Cl8) and the commercial Cereclor 63L (C10–13, 63% chlorination)
47 (Liu et al.,
2016). The TT3 and TT4 were measured after exposure from 2 to 96 h post fertilisation to 0, 0.5 and
100 lg/L SCCPs. A dose-dependent decrease of TT3 was observed after exposure to the three C10-group
compounds. However, the effects varied among different congeners. 1,2,5,6,9,10-C10H16Cl6 and
C10H15Cl7 decreased TT3 signiﬁcantly by 32.4% and 65.3%, respectively, at 0.5 lg/L and by 70.8% and
82.9%, respectively, at 100 lg/L. In comparison, C10H18Cl4 showed no effects on TT3 at 0.5 lg/L, but
decreased TT3 signiﬁcantly by 48.9% at 100 lg/L. The C12-group compounds and Cereclor 63L caused
no effects on TT3. For TT4, signiﬁcant effects were only observed in two of the three C10-SCCP treated
groups at the low dose of 0.5 lg/L. 1,2,5,6,9,10-C10H16Cl6 and C10H15Cl7 showed signiﬁcant decreases of
TT4 by 48.5% and 31.6%, respectively, at 0.5 lg/L. No signiﬁcant change was observed after exposure
to the three C10-SCCP treated groups at 100 lg/L and after exposure to the C12-group compounds and
Cereclor 63L at 0.5 and 100 lg/L. The mRNA levels of the six genes tyr, ttr, dio2, dio3, oatp3a1 and thraa
were measured in exposed zebraﬁsh larvae (0, 0.5 and 100 lg/L of all 7 SCCP compounds) at 96 h post
fertilisation. Signiﬁcant changes in gene expression were only found in the C10H18Cl4- and C12H22Cl4-
treated groups. Compared to the control, the mRNA of tyr, ttr, dio2 and dio3 were signiﬁcantly
downregulated by C10H18Cl4 in a dose-dependent manner while thraa was only signiﬁcantly upregulated
at 0.5 lg/L by 2.1-fold. Signiﬁcant reduction of ttr expression was observed in larvae treated with
C12H22Cl4 at 0.5 and 100 lg/L. For other SCCPs treatment groups, there were no effects on the mRNA
expression. 1,2,5,6,9,10-C10H16Cl6 showed an apparent but non-signiﬁcant dose-related expression
increment of dio2 and dio3 by 25.1 and 15.6-fold at 100 lg/L. SCCPs from the C10-group were found to
be more potent to disrupt thyroid hormone homeostasis than those from the C12-group. C10H18Cl4 might
cause a disturbance of thyroid status in zebraﬁsh by inhibiting T3 production through a mechanism of
dio2 inhibition effect. In zebraﬁsh, T3 is produced in plasma and local tissues from T4 conversion mainly
by type II iodothyronine deiodinase (Dio2). In the same study, SCCPs caused malformations in zebraﬁsh
embryo/larvae at higher concentrations of 1,000 and 10,000 lg/L. Again, SCCPs from the C10-group
were more toxic for this endpoint than C12-group compounds and Cereclor 63L.
3.1.5.4. Other tumour incidences in rodents treated with CPs
In addition to the tumourogenic effects in liver, kidney and thyroid of rodents, SCCPs were found to
induce additional tumour types (Section 3.1.2.7) which are not considered relevant to humans.
Mononuclear cell leukaemia seen in both male and female rats is a uniquely common spontaneous
47 No detailed composition of the commercial Cereclor 63L could be found but it may have similar composition as Cereclor 60L.
The latter was reported to contain 15.5% C10, 32.3% C11, 35.2% C12, and 17.0% C13 (Reth et al., 2006).
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disorder in F344 rats. The occurrence of such tumours in F344 rats following treatment with non-
genotoxic chemicals is considered not relevant to humans (Caldwell, 1999). The incidence of
pancreatic acinar cell tumours in male rats only showed no dose response and was also seen in
controls. In addition, there were Harderian gland tumours at the lowest dose of SCCPs in female mice.
The absence of this gland in humans coupled with the lack of genotoxicity renders this not relevant to
human.
In addition, malignant lymphomas were observed in male mice treated with LCCPs
(Section 3.1.2.6). However, genotoxicity is not implicated in the mode of action of LCCPs and the
lymphomas were only observed at very high-dose levels being statistically signiﬁcant at 5,000 mg/kg
bw per day only.
Adrenal gland medullary pheochromocytomas in high-dosed LCCP female rats were also observed.
However, this a common tumour in rats but rare in humans (Haschek et al., 2001).
3.1.5.5. Potential additional non-genotoxic inﬂuences of CPs in carcinogenesis
In addition to the speciﬁc modes of action described above for the three target organs for
carcinogenesis, the recorded effects of CPs on inhibition of intercellular gap junctional communication
and on oxidative stress may also be involved. Indeed, these effects are features of many chemicals
that cause peroxisome proliferation (Chipman et al., 2003).
In addition to studies on the genotoxicity of CPs as detailed above (Section 3.1.2.5), cell
transformation assays in vitro have also been reported. In baby hamster kidney cells (BHK21/C13), no
increase in cell transformation frequency was detected after treatment with SCCP (Cereclor 50LV, C10–
13, 50% chlorination) in the absence of metabolic activation up to cytotoxic concentrations (up to
2,500 lg/mL) (Birtley et al., 1980). However, in contrast, increases in transformation frequency were
measured when cells were treated with SCCP (C12, 58% chlorination) with and without metabolic
activation, at both cytotoxic and non-cytotoxic concentrations (Richold et al., 1982a, unpublished
study, as cited by WHO/IPCS (1996)).
Cell transformation frequency was not increased after treatment with MCCP (Cereclor S52, C14–17,
52% chlorination) in the absence of metabolic activation at concentrations up to 2,500 lg/mL (Birtley
et al., 1980).
No evidence of increased cell transformation frequency could be found after treatment with LCCP
(Cereclor 42, C20–30, 42% chlorination) in the absence of metabolic activation at concentrations up to
2,500 lg/mL (Birtley et al., 1980). In contrast, transformation frequency was increased when cells
were exposed to LCCP (C20–28, 70% chlorination) or LCCP (C22–28, 70% chlorination) with and without
metabolic activation, at both cytotoxic and non-cytotoxic concentrations (Richold et al., 1982b,
unpublished study, as cited by WHO/IPCS (1996)).
Inhibition of cell communication is suggested to play an important role in the carcinogenic process
since many tumour promoters including 12-O-tetradecanoylphorbol-13-acetate (TPA) have been shown
to inhibit gap junctional communication in vitro (Warngard et al., 1996). The effects of six different CPs
on cell-cell communication were investigated in rat liver epithelial cells IAR 20 in vitro (Kato and Kenne,
1996). Communication was completely inhibited at 20 lg/mL SCCP (C10–13, 50% chlorination), 15 lg/mL
SCCP (C10–13, 60% chlorination), 80 lg/mL MCCP (C14–17, 45% chlorination) and 35 lg/mL MCCP (C14–17,
52% chlorination), but not at concentrations up to 200 lg/mL of LCCP (C22–26, 42% chlorination or 48%
chlorination). All these concentrations were non-cytotoxic. SCCPs and MCCPs were shown to alter the
phosphorylation pattern of connexin 43 which is different from that in reaction to TPA. In conclusion,
both tested SCCPs and MCCPs, but no LCCPs were found to be potent inhibitors of gap junction
intercellular communication. SCCPs and MCCPs may therefore act as tumour promoters in combination
with other potentially relevant non-genotoxic mechanisms discussed above for each tissue type.
3.1.5.6. Conclusions on the relevance of the carcinogenic modes of action to human risk
assessment
The overall weight of evidence indicates that CPs are not genotoxicants. The CONTAM
Panel concluded that the rodent hepatocarcinogenicity of SCCPs (as shown with C12, 60% chlorination)
is not relevant to humans because activation of CAR or PPARa is rodent speciﬁc. Furthermore, the
additional potential role of liver toxicity in rodent hepatocarcinogenicity was considered irrelevant to
human risk based on the dose levels required for rodent liver necrosis (500 mg/kg bw SCCP in the
mouse).
The tumourogenicity of SCCPs in the male rat kidney and the female thyroid involve modes of
actions that cannot be clearly eliminated for their relevance to humans.
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Thus, SCCPs are reasonably anticipated to be human carcinogens via non-genotoxic mechanisms in
the absence of evidence for genotoxicity in vivo. This conclusion is in accordance with the CLP
classiﬁcation as Carc Cat 2 (H351), as well with the NTP Report on Carcinogens (NTP, 2016).
The malignant lymphoma in male mice caused by LCCP were only seen at very high-dose levels and
considered not relevant to humans.
3.1.5.7. Haemorrhaging effect in offspring
Reduced pup survival during lactation, but not at birth, have been observed in offspring of rats
administered an MCCP (C14–17, 52% chlorination) (see Section 3.1.2.3). Effects observed in the dead
pups were indicative of internal haemorrhaging and included an increased occurrence and severity of
subcutaneous haematoma/haemorrhage, bruised areas, discolouration and blood around the oriﬁces,
pale liver, kidneys and lungs, blood in the cranial cavity, brain, stomach and intestines and/or the
abdominal or thoracic cavities. Three studies were performed with the aim of investigating the possible
haemorrhagic mode of action of MCCPs.
Groups of male and female Wistar rats were exposed to 0 or 6,250 mg/kg MCCP (C14–17, 52%
chlorination) in the diet for 4 weeks before mating (ICI, 1985, unpublished study, see Documentation
provided to EFSA). This is equivalent to a dose averaged over the ﬁrst 4 week of treatment of 0 or
560 mg/kg bw per day.34 After conﬁrmation of mating, the pregnant females were allocated to ﬁve
treatment groups: (1) 16 females fed control diet rearing their own pups; (2) 26 females fed MCCP
diet rearing pups fostered from group 3 control females; (3) 26 females fed control diet rearing pups
fostered from group 2 treated females; (4) 16 females fed MCCP diet rearing their own pups; and (5)
16 females fed MCCP diet up to day 10 of pregnancy, rearing their own pups while fed control diets.
During the pre-mating period and pregnancy, no deaths or clinical signs of toxicity were observed in
the parental animals. During days 12–22 post-partum, pup mortality was signiﬁcantly increased in
group 2 (control pups fostered to treated mothers) and group 4 (treated pups reared by their own
treated mothers). Pup mortality was 77% in group 2 and 67% in group 4 compared to 4% in control
group 1. Mortality was not increased in pups of groups 3 and 5. Of the total number of pups found
dead between days 1 and 22, haemorrhages were seen in 17% and 8%, respectively, of group 2 and
group 4 offspring. The observations of dark red bulging eyes, blood clots within the membranes lining
the cranium and pale livers were indicative of haemorrhages. In group 4, animals a statistically
signiﬁcant 21% reduction of pup body weight was observed on day 22 post-partum.
Throughout lactation, a statistically signiﬁcant reduction in the concentration of clotting factor X in
groups 2 and 4 was observed (up to approx. 70% relative to pups in group 1). The concentration of
factor X in groups 3 and 5 was similar to control group 1.
Prothrombin times were prolonged in groups 2 and 4 becoming greater with time up to day 11. At
day 22, they were still increased but more similar to the controls. No changes were seen in the levels
of factor VIII. The high incidence of death speciﬁcally in group 2 and 4 pups compared to controls
indicate mother-to-pup transfer during weaning. Continued availability of MCCP appeared to be
necessary for effects. Based on these ﬁndings, it can be suggested that the pups received less vitamin
K in the breast milk due to treatment-related effects upon their mothers and as a consequence the
vitamin K dependent clotting pathway was impaired, or alternatively that MCCP or a metabolite was
either transferred via breast milk, causing interference of the clotting system in the pups.
To test the ﬁrst hypothesis, i.e. a reduction of vitamin K in the breast milk, 6 female adult Sprague–
Dawley rats fed on either a normal diet or a diet deﬁcient in vitamin K3 were administered by oral
gavage 0, 500 or 1,000 mg/kg bw per day MCCP (C14–17, 52% chlorination) for 21 days (CXR, 2003,
unpublished draft study, see Documentation provided to EFSA). Factor X levels were not affected by
treatment. However, plasma vitamin K1 levels were lower at termination (by 34%) in the high-dose
animals fed vitamin K3-deﬁcient diet. In animals on the normal diet, a statistically signiﬁcant, dose-
related decrease (by 18% and 42% at the low and high dose of MCCP, respectively) in Factor VII
levels was observed. A marked decrease in Factor VII levels was also reported in both control and
MCCP-treated animals fed the vitamin K3-deﬁcient diet (by 25%, 24% and 44% of the normal diet
control group levels at 0, 500 and 1,000 mg/kg per day, respectively). Prothrombin clotting times were
not affected in a biologically relevant magnitude. Thus, the haemorrhaging effects on the offspring are
unlikely to be caused by reduced levels of vitamin K in breast milk under the conditions in this study.
Another study was conducted to test the second hypothesis, whether MCCP is transferred to the
pups through breast milk and causes disruption of the clotting system in the pups (CXR, 2004,
unpublished draft study, see Documentation provided to EFSA). Groups of 16 male and 32 female
Sprague–Dawley rats were administered 0 or 6,250 mg/kg MCCP (C14–17, 52% chlorination) in the diet
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for 4 weeks prior to mating, and during mating, gestation and lactation. This equates to an average
dose (over the ﬁrst 4 week of treatment) of 0 or 560 mg/kg bw per day.34 However, the study was
terminated prematurely at around day 12 as a result of excessive mortality (and evidence of
haemorrhages at necropsy) in pups derived from treated animals. At day 1 of lactation, MCCP was
measured in the milk of three MCCP-treated dams and compared to controls. A mean ( SD) level of
1,057  530 mg/L was detected in milk from treated dams compared to non-detectable levels in milk
from control dams. There was a signiﬁcant decrease in the plasma vitamin K concentration measured
on day 12 of lactation in the treated dams (0.03  0.05 ng/mL) compared to the control dams
(0.41  0.14 ng/mL) (MCCP and vitamin K levels in dam milk not mentioned in the CXR (2004) report;
but as cited by EU-RAR, 2011). This ﬁnding conﬂicts with the results discussed above (CXR, 2003) in
which plasma vitamin K concentrations were not affected by treatment. One possible explanation for
this inconsistency is length of treatment time (7–8 weeks compared to 3 weeks in the CXR (2004)
study). Furthermore, in the CXR (2004) study, in which treated females continued through pregnancy
and lactation, vitamin K was decreased in maternal plasma and in the milk of treated dams. Vitamin K
was not detected in pooled samples from treated dams on days 1 and 4 compared to 0.28 ng/mL
(SD = 0.10) detected in samples from 5 control dams. This ﬁnding was further substantiated by
pooling samples from days 9 and 12 from treated dams in which the vitamin K concentrations were
approximately 50% of the concentration in control dams (0.61  0.29 ng/L)
The plasma concentration of vitamin K of adult females following pregnancy and lactation was
markedly decreased by treatment with MCCP. This was associated with a decrease in the activity of the
plasma clotting factors VII and X in the treated dams compared to controls on day 12 of lactation.
However, prothrombin times in the dams were not affected, suggesting a sufﬁcient reserve.
Although insufﬁcient plasma was available from pups to measure vitamin K, clotting factor activities
were measured as a surrogate. Treatment with MCCPs decreased clotting factor VII and X activities
after day 4 post-partum.
Overall, these studies suggest that MCCPs perturb the clotting system in lactating neonates of
treated mothers. In adult animals, although concentrations of vitamin K and of the clotting factors VII
and X were reduced, their prothrombin times were not biologically signiﬁcantly affected indicating that
the functional reserve in these adult animals is sufﬁcient. The fetus in utero appears to receive
sufﬁcient vitamin K via the placenta, but after birth becomes deﬁcient in vitamin K and related clotting
factors when reliant of these factors via the mother’s milk. A further reduction of vitamin K in neonates
may occur through receiving MCCP via the milk. In conclusion, haemorrhaging appears to result in
neonates as a consequence of vitamin K deﬁciency. The CONTAM Panel concluded that the
haemorrhagic effects are considered as being relevant to humans.
3.1.5.8. Additional endocrine effects
3.1.5.8.1. In vitro
The endocrine effects of three SCCPs (C10, 40.4% chlorination; C10, 66.1% chlorination and C11,
43.2% chlorination) were investigated in two in vitro models: (i) the dual-luciferase reporter gene assay
reporter gene assays for oestrogen receptor a (ERa), glucocorticoid receptor (GR) and thyroid receptor
b (TRb) with Chinese hamster ovary CHO-K1 cells and (ii) the human adrenal corticocarcinoma cell line
H295R (Zhang et al., 2016). In the dual-luciferase reporter gene assay, all three SCCPs signiﬁcantly
induced oestrogenic activities, which were ERa-mediated in the following order: SCCP (C11, 43.2%
chlorination; effective concentration by 20% induction (EC20) = 6.5 9 10
9 mol/L) > SCCP (C10, 66.1%
chlorination; EC20 = 2.7 9 10
8 mol/L) > SCCP (C10, 40.4% chlorination; EC20 = 2.87 9 10
7 mol/L).
In addition, both SCCPs (C10, 40.4% chlorination and C10, 66.1% chlorination) showed anti-oestrogenic
activities. Only SCCP (C11, 43.2% chlorination) induced GR-mediated antagonistic activity, with a 20%
inhibitory concentration (IC20) value of 2.6 9 10
8 mol/L. None of the SCCPs showed any agonistic or
antagonistic activities against TRb. All three SCCPs stimulated the secretion of 17b-oestradiol. Both
SCCPs (C10, 66.1% chlorination and C11, 43.2% chlorination) increased the production of cortisol at a
high level in H295R cell lines. Possible mechanisms underlying the endocrine effects of SCCPs through
the non-receptor mediated pathway were explored by the measurement of mRNA levels of 9
steroidogenic genes in H295R by real-time polymerase chain reaction. All three SCCPs upregulated
StAR, 17bHSD, CYP11A1, CYP11B1, CYP19 and CYP21 in a concentration-dependent manner.
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3.1.5.8.2. In vivo
There are indications for thyroidal effects from the repeated toxicity and carcinogenicity studies
with SCCPs and from the repeated toxicity study with MCCPs that are mediated by alteration of hepatic
metabolism (see Sections 3.1.2.2, 3.1.2.7 and 3.1.4.3), but there was no evidence for interaction
with TRb (see above) and there is no evidence to implicate an endocrine-mediated mode of action for
thyroid effects (Gong et al., 2018).
3.1.6. Consideration of critical effects and dose–response analysis for the human
risk assessment
3.1.6.1. Consideration of critical effects
No studies on observations in humans of relevance for the risk assessment of CPs within the scope
of this opinion were available. Therefore, the human risk assessment is based on data from studies in
experimental animals.
A number of repeated dose toxicity studies have been performed in experimental animals using only
a few CPs of different carbon chain length and different degrees of chlorination. These studies have
shown that the liver, kidney and thyroid are target organs in experimental animals. The effects observed
in the kidneys and the thyroid are considered as being relevant to humans (see Section 3.1.5.2 and
3.1.5.3, respectively). Liver toxicity observed consistently in rats and mice is considered secondary to
an adaptive physiological response and the associated energy costs, but could be relevant to humans at
high-dose levels (see Section 3.1.5.1). In addition, decreased pup survival and incidence of
subcutaneous haematoma/haemorrhage were identiﬁed as critical effects for an MCCP in a dose-range
ﬁnding study for a two-generation study; these effects are also considered as being relevant to humans
(see Section 3.1.5.7). The toxicokinetic studies in rats and mice indicate that the toxicokinetics vary
depending on carbon chain length, as well as on position and degree of chlorination (see
Section 3.1.1.4). Therefore, the toxicokinetic and toxicity studies performed with only a few CPs can
in principle only provide information on the CPs investigated. Read-across to other CPs, both within the
same class as well as in other classes, is therefore problematic and will have high uncertainty.
SCCPs
In two chronic gavage studies in rats and mice with an SCCP (C12, 60% chlorination) (NTP, 1986a),
effects were observed at the lowest tested dose levels of 312 mg/kg bw per day for rats (liver and
kidney) and 125 mg/kg bw per day for mice (kidney and thyroid). This, combined with the fact that
only two dose levels were used, precluded these studies from being used to perform dose–response
analysis. A NOAEL could, however be identiﬁed from subchronic studies with SCCPs (see below).
From two 90-day rat studies with the same SCCP (C10–12, 58% chlorination), one with dietary
administration (IRDC, 1984a, see Documentation provided to EFSA) and the other with gavage (IRDC,
1984b, see Documentation provided to EFSA), a NOAEL of 10 mg/kg bw per day was identiﬁed. In the
dietary study, increased liver and kidney weights and histopathological changes in liver, kidney (males)
and thyroid (males) were observed at ≥ 100 mg/kg bw per day. In the gavage study, increased liver
and kidney weights and histopathological changes in liver (males) and kidneys (males) were observed
at ≥ 100 mg/kg bw per day; effects in the thyroid (increased weight and histopathological changes)
were only observed in males at 625 mg/kg bw per day.
A NOEL for effects in the thyroid was identiﬁed for an SCCP (C10–13, 56.5% chlorination; mass ratio
of C10:C11:C12:C13 = 1:1:1:1) in a 28-day gavage study with male rats (Gong et al., 2018). The NOEL
was 1 mg/kg bw per day, based on decreased free T3 (20% at the next dose level of 10 mg/kg bw
per day) and increased TSH levels (15% at 10 mg/kg bw per day) in the plasma. No histopathological
changes were observed in the thyroid at 100 mg/kg bw per day, the only dose examined. In a 14-day
study with male rats (Wyatt et al., 1993) plasma FT4 and TT4 levels were decreased and the plasma
TSH level was signiﬁcantly increased at 1,000 mg/kg bw per day (the only dose at which these
parameters were examined). No differences in plasma FT3 or TT3 were observed at 1,000 mg/kg bw
per day. The CONTAM Panel noted the inconsistencies in the hormonal changes between the two
studies (FT3 decreased in the 28-day study, FT4 and TT4 decreased in the 14-day study).
Consequently, the Panel decided that changes in thyroid hormone levels could not be used as a basis
for deriving a reference point. Therefore, only the histopathological changes have been considered as
a basis for deriving a reference point.
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An SCCP (carbon chain length not speciﬁed, 58% chlorination) caused post-implantation loss and
decreased number of viable fetuses, as well as teratogenic effects in the form of absence of digits
(adactyly) or shortened digits at 2,000 mg/kg bw per day (gavage) in a developmental toxicity study
in rats, in the presence of maternal toxicity (high mortality and decreased body weight gain from
500 mg/kg bw per day). In a rabbit developmental toxicity study, the NOAEL for developmental
toxicity was 10 mg/kg bw per day, based on increased number of resorptions, in the absence of
maternal toxicity.
Following administration by gavage of an SCCP (C12, 60% chlorination) (NTP, 1986a) increased
incidences of tumours were observed in several organs in rats and mice, i.e. liver (rats, mice), kidneys
(male rats only) and thyroid (female rats and mice). Mononuclear-cell leukaemia was also observed in
rats. The relevance to humans of the rodent liver tumours can be excluded provided liver cell toxicity
does not occur (see Section 3.1.5.1.4). Tumours in the male rat kidney and the female thyroid
involve modes of actions that cannot be clearly eliminated for their relevance to humans (see
Sections 3.1.5.2 and 3.1.5.3, respectively). Mononuclear-cell leukaemia is a uniquely common
spontaneous disorder in the rat strain used by NTP (the F344 rat) and therefore, not relevant to
humans (see Section 3.1.5.4). SCCPs are reasonably anticipated to be carcinogens via non-genotoxic
mechanisms (see Section 3.1.2.6). The CONTAM Panel considered that there is a threshold for the
carcinogenic effects of this SCCP. Therefore, tumours in the kidneys and thyroid would not be relevant
to humans provided that the exposure is insufﬁcient to bring about the relevant non-genotoxic
changes, i.e. nephropathy and thyroid hyperplasia, respectively.
Overall, the CONTAM Panel identiﬁed a NOAEL of 10 mg/kg bw per day, based on increased kidney
weights, histopathological changes in the kidney and thyroid, and developmental effects.
MCCPs
No chronic/carcinogenicity studies have been identiﬁed for MCCPs.
The studies summarised below have all been performed with the same MCCP (C14–17, 52%
chlorination).
In a 90-day dietary rat study (IRDC, 1984c, see Documentation provided to EFSA), a NOAEL of
10 mg/kg bw per day was identiﬁed, based on an increase in liver and kidney weights at 100 mg/kg
bw per day; histopathological changes in the liver and the kidney (males) were noted at the next
higher dose level (625 mg/kg bw per day). Effects in the thyroid (increased absolute weight) were
noted in male rats at 625 mg/kg bw per day; trace to moderate hypertrophy and hyperplasia were
observed in almost all control and treated males with a trend towards increasing severity with
increasing dose (10, 100, 625 mg/kg bw per day).
A NOEL for effects in the thyroid was identiﬁed from another 90-day dietary rat study (CXR, 2005b,
see Documentation provided to EFSA). The NOEL was 9.3/9.7 mg/kg bw per day for males/females,
respectively, based on decreased plasma FT3 in males and increased plasma TSH in females (see
Section 3.1.2.2.2). A small increase in histopathological changes (ultimobranchial cysts) was
observed in the thyroid of male rats at 23 mg/kg bw per day; this was not seen at higher dose levels
and therefore, not considered of toxicological relevance. The Panel noted the inconsistencies in the
hormonal changes between the two genders (FT3 decreased only in males, TSH increased only in
females). Consequently, the Panel decided that the changes in thyroid hormone levels could not be
used as a basis for deriving a reference point. Absolute and relative liver and kidneys weights were
increased at the highest dose level (222/242 mg/kg bw per day for males/females, respectively) and
minimal centrilobular hepatocellular hypertrophy was observed in males.
The NOAEL for postnatal effects is considered to be 9 mg/kg bw per day, based on decreased pup
survival and subcutaneous haematoma/haemorrhage at the two higher dose levels (90 and 560 mg/kg
bw per day) in a dose-range ﬁnding study for a two-generation dietary rat study (IRDC, 1985, see
Documentation provided to EFSA). Decreased pup survival was observed at 90 mg/kg bw per day and
above, achieving statistical signiﬁcance at 560 mg/kg bw per day (100% mortality before PND21). The
NOEL for parental toxicity and fertility was 560 mg/kg bw per day (the highest dose level tested).
No developmental toxicity, including malformations were observed in developmental toxicity studies
in rats and rabbits at the highest dose levels tested, 5,000 mg/kg bw per day for rats (IRDC, 1984f,
see Documentation provided to EFSA) and 100 mg/kg bw per day for rabbits (IRDC, 1983c, see
Documentation provided to EFSA).
Overall, the CONTAM Panel identiﬁed a NOAEL of 10 mg/kg bw per day, based on increased kidney
weights and postnatal effects (decreased pup survival and subcutaneous haematoma/haemorrhage).
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LCCPs
In a chronic gavage study in rats with an LCCP (C23, 43% chlorination) (NTP, 1986b), effects
(increased liver weight and histopathological changes such as diffuse lymphohistiocytic inﬂammation in
liver, pancreatic and mesenteric lymph nodes) were observed at 100 mg/kg bw per day for female rats
(the lowest dose level tested). No effects were observed in a chronic gavage study in mice with the
same LCCP at dose levels up to 5,000 mg/kg bw per day (the highest dose level tested) (NTP, 1986b).
For another LCCP (C22–26, 43% chlorination), the LOAEL was 100 mg/kg bw per day (the lowest
dose level tested), based on increased liver weight and histopathological changes in the liver of female
rats in a 90-day oral gavage study (IRDC, 1984d, see Documentation provided to EFSA). For an LCCP
of the same carbon chain length, but with a higher chlorination degree (C22–26, 70% chlorination), the
NOAEL was 900 mg/kg bw per day, based on liver effects at 3,750 mg/kg bw per day in a 90-day rat
dietary study (IRDC, 1984e, see Documentation provided to EFSA).
No developmental toxicity, including malformations, was observed for two LCCPs (C22-26, 43% or
70% chlorination) in developmental toxicity studies in rats and rabbits at the highest dose levels
tested, 1,000 mg/kg bw per day for rabbits with the 70% chlorinated LCCP (IRDC, 1982b) and
5,000 mg/kg bw per day in the three other studies (IRDC, 1983d, 1981e, 1983e, see Documentation
provided to EFSA).
Oral gavage dosing with an LCCP (C23, 43% chlorination) caused increased incidence of tumours in
different organs and tissues in rats and mice, i.e. malignant lymphomas (male mice), adrenal gland
medullary pheochromocytomas (female rats), and to a marginal extent of hepatocellular neoplasms
(female mice). Therefore, there is some evidence for this LCCP to be carcinogenic in mice and rats at
very high-dose levels (mice: 2,500 and 5,000 mg/kg bw per day; female rats: 900 mg/kg bw per day).
The possible carcinogenic effects at very high-dose levels are reasonably anticipated to be exerted via
non-genotoxic mechanisms in the absence of evidence for genotoxicity in vivo. Therefore, the CONTAM
Panel considered that there is a threshold for the possible carcinogenic effects of this LCCP.
Overall, the LOAEL of 100 mg/kg bw per day for two low chlorinated LCCPs (43%) and the NOAEL
of 900 mg/kg bw per day for a high chlorinated LCCP (70%) are based on liver effects.
3.1.6.2. Dose–response analysis (including BMD modelling)
In view of the critical effects identiﬁed in Section 3.1.6.1, the CONTAM Panel performed
Benchmark dose (BMD) modelling on the effects observed in the kidneys and the thyroid as these
effects are considered as being relevant to humans. BMD modelling was performed for changes in
kidney weights (SCCPs and MCCPs), and histopathological changes in the kidneys (SCCPs) and thyroid
(SCCPs). BMD modelling was also performed for decreased pup survival and incidences of
subcutaneous haematoma/haemorrhage identiﬁed as critical effects for an MCCP in a dose-range
ﬁnding study for a two-generation study.
No dose–response modelling was performed for LCCPs, as only liver effects were observed in the
available studies. The effects in the liver are considered secondary to an adaptative response and the
associated energy costs, and only relevant to humans at high-dose levels.
The EFSA guidance on the use of BMD in risk assessment (EFSA Scientiﬁc Committee, 2017a) was
used. The results of the BMD modelling are summarised in Table 23 and 24 and the details of the
BMD analysis are reported in Appendix C for the different studies. For the selection of the benchmark
response (BMR), the CONTAM Panel deviated from the default BMRs in the following cases: (i) for
kidney weight, the CONTAM Panel considered the biological relevance of increased absolute and
relative kidney weights. It concluded that the selection of the default BMR of 5% for continuous data
is not appropriate for these endpoints considering also that histopathological changes of only minimal
to mild severity were observed only in some studies and generally at higher doses than those at which
increased kidney weights started to be observed. The Panel concluded that a BMR of 10% is sufﬁcient
to protect towards adverse changes in kidney weights. (ii) For pup survival, considering the severity of
the effect, the CONTAM Panel selected a BMR of 5%, lower than the default BMR of 10%
recommended for quantal data. From a statistical point of view, the high study population (> 100 pups
per dose group) supported the selection of a lower BMR. (iii) For subcutaneous haematoma/
haemorrhage, considering the association of this effect with the decreased pup survival observed in
the study, the CONTAM Panel considered applying the same BMR of 5% selected for the dose–
response analysis of pup survival. The Panel noted that in this case the selection of a lower BMR is less
justiﬁed from a statistical point of view considering the low study number of animals evaluated in some
dose groups.
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For one tested SCCP (C10–12, 58% chlorination), a BMDL10 of 2.29 mg/kg bw per day (rounded to
2.3 mg/kg bw per day) was selected as the reference point for the risk characterisation, based on
increased incidence of nephritis in male rats. This BMDL10 is considered to cover other critical effects
of the tested SCCPs (see Section 3.1.6.1).
For the tested MCCP (C14–17, 52% chlorination), a BMDL10 of 36.4 mg/kg bw per day (rounded to
36 mg/kg bw per day) was selected as the reference point for the risk characterisation, based on
increased relative kidney weight in male and female rats. This BMDL10 is considered to cover other
critical effects of the tested MCCP (see Section 3.1.6.1).
Table 23: Benchmark dose modelling for the critical effects of short-chain chlorinated parafﬁns in
experimental animals.
Critical effect Model
BMDL10 BMDU10
Reference
(mg/kg bw per day)
Nephritis (a) – M rats Model averaging 2.29 76.4 IRDC (1984a)
Thyroid hypertrophy – M rats Model averaging 15.5 210 IRDC (1984a)
Increased absolute left kidney weights – M + F rats Hill m3-a
Exp m3-a
38.0 186 IRDC (1984a)
Increased relative left kidney weights – M rats Hill m3-ab
Exp m3-ab
32.5 92.5 IRDC (1984a)
Increased relative left kidney weights – F rats Hill m3-ab
Exp m3-ab
71.0 180 IRDC (1984a)
Nephropathy – M rats Model averaging 87.2 410 IRDC (1984b)
Thyroid hypertrophy – M rats Model averaging 14.7 195 IRDC (1984b)
Thyroid hyperplasia – M rats Model averaging 45.1 266 IRDC (1984b)
Increased absolute kidney weights – M rats Hill m5-ab
Exp m5-ab
31.4 111 IRDC (1984b)
Increased absolute kidney weights – F rats Hill m5-ab
Exp m5-ab
83.7 345 IRDC (1984b)
Increased relative kidney weights – M rats Hill m3-abv
Exp m3-abv
5.55 68.6 IRDC (1984b)
Increased relative kidney weights – F rats Hill m3-abv
Exp m3-abv
40.7 268 IRDC (1984b)
bw: body weight; M: males; F: females.
(a): For details of the effects observed see Section 3.1.2.2.1.
Table 24: Benchmark dose modelling for the critical effects of medium-chain chlorinated parafﬁns
in experimental animals
Critical effect Model
BMDL10 BMDU10
Reference
(mg/kg bw per day)
Increased absolute kidney weight – M + F rats Expon m3-a
Hill m3-a
81.5 364 CXR (2005b)
Increased relative kidney weight – M + F rats Expon m3-a
Hill m3-a
67.9 182 CXR (2005b)
Increased absolute kidney weight (left) – M + F
rats
Expon m3-a
Hill m3-a
101 418 IRDC (1984c)
Increased relative kidney weight (left) – M + F
rats
Expon m3-a
Hill m3-a
36.4 224 IRDC (1984c)
Critical effects Model
BMDL5 BMDU5
Reference(mg/kg bw per day)
Combined incidence of subcutaneous
haematoma/haemorrhage – rats
Model
averaging
48.5 63.8 IRDC (1985)
Pup mortality – rats Model
averaging
53.0 96.5 IRDC (1985)
bw: body weight; BMDL: benchmark dose lower conﬁdence limit; BMDU: benchmark dose upper conﬁdence limit; F: females; M: males.
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3.1.6.3. Derivation of a health-based guidance value/margin of exposure approach
The CONTAM Panel concluded that due to the limitations and uncertainties in the current database
on SCCPs, MCCPs and LCCPs (see Section 3.1.6.1), the derivation of a health-based guidance value
(HBGV) was not appropriate. Instead, the Panel used a margin of exposure (MOE) approach to assess
a possible health concern.
The available toxicity studies in experimental animals have been performed with only a few CPs of
different carbon chain length and different degrees of chlorination. The toxicokinetic studies in rats
and mice indicate that read-across from one speciﬁc CP to other CPs, both within the same class as
well as to other classes is problematic and will have high uncertainty.
For the tested SCCP (C10–12, 58% chlorination; C12, 60% chlorination; C10–13, 56.5% chlorination;
carbon chain length not speciﬁed, 58% chlorination), the BMDL10 of 2.3 mg/kg bw per day was
selected as the reference point for the risk characterisation (see Section 3.1.6.2).
For the only tested MCCP (C14–17, 52% chlorination), the BMDL10 of 36 mg/kg bw per day was
selected as the reference point for the risk characterisation (see Section 3.1.6.2).
For LCCPs, the LOAEL for the lower chlorinated LCCP (C22–26, 43% chlorination) of 100 mg/kg bw
per day and the NOAEL for the higher chlorinated LCCP (C22–26, 70% chlorination) of 900 mg/kg bw
per day are based on liver effects. As effects in the liver observed consistently in rats and mice are
considered secondary to an adaptative response and the associated energy costs and only being
relevant to humans at high-dose levels, and as no other non-neoplastic effects were observed in the
studies with LCCPs, a reference point has not been identiﬁed.
An MOE higher than 1,000 might indicate that there is no health concern, taking into account the
variability between species (a factor of 10), the variability within human individuals (a factor of 10),
and extrapolation from subchronic studies to chronic exposure duration (a factor of 2). It could be
questioned whether possible bioaccumulative properties are covered by the general default factor of
10 for interspecies differences; however, in case of no substance speciﬁc information, as is the case for
the CPs, the default factor of 10 is applied. According to the EFSA Scientiﬁc Committee Guidance on
selected default values (EFSA Scientiﬁc Committee, 2012a) the default factor of 2 for extrapolating
from subchronic toxicity studies to chronic exposure duration should not be applied when toxicokinetic
data show that the substance under consideration can accumulate, e.g. has a long biological half-life.
However, because of the limited substance speciﬁc information on bioaccumulative properties for the
CPs, the Panel decided to apply the default factor of 2. According to the EFSA Scientiﬁc Committee
Guidance on selected default values (EFSA Scientiﬁc Committee, 2012a) an additional factor can be
considered in case of deﬁciencies in the database on a case-by-case basis. A default value has not
been proposed, as it will be directly dependent on the data set available. WHO/IPCS (1994, 1999) has
recommended a factor of 3 or 5 if there are minor deﬁciencies in the database and a factor of 10 if
there are major deﬁciencies in the database. The CONTAM Panel considered a factor of 5 to take into
account the limitations in the database, e.g. toxicity data are only available for a few CPs whereas the
risk assessment is covering a large number of CPs, the impact of the degree of chlorination, chlorine
position and carbon chain length on toxicokinetics and toxicity cannot be evaluated, the limited
information on possible bioaccumulative properties and no two-generation reproductive toxicity study
is available for any CP.
3.1.7. Consideration of critical effects and reference points for farm animals,
horses and companion animals risk assessment
The CONTAM Panel reviewed the available studies in order to derive a possible NOAEL or LOAEL for
farm animals, horses and companion animals. No studies were identiﬁed in ruminants, pigs, horses,
cats or fur animals.
For poultry, a limited number of studies have been conducted and some of these were designed to
assess the performance and capacity for food production. The CONTAM Panel concluded that none of
them was robust enough for the identiﬁcation of a NOAEL/LOAEL as reference point.
For rabbits, no studies have been located other than the developmental toxicity studies in
experimental animals. For an SCCP (carbon chain length not speciﬁed, 58% chlorination), the NOAEL
for developmental toxicity was 10 mg/kg bw per day, based on increased number of resorptions. The
NOEL for maternal toxicity was 100 mg/kg bw per day (the highest dose tested). For an MCCP (C14–17,
52% chlorination), the NOEL for developmental and maternal toxicity was 100 mg/kg bw per day (the
highest dose tested). For an LCCP (C22–26, 43% chlorination), the NOEL for developmental and
maternal toxicity was 5,000 mg/kg bw per day (the highest dose tested). For another LCCP (C22–26,
Chlorinated parafﬁns in feed and food
www.efsa.europa.eu/efsajournal 98 EFSA Journal 2020;18(3):5991
70% chlorination), the NOEL for developmental and maternal toxicity was 1,000 mg/kg bw per day
(the highest dose tested).
For ﬁsh, most studies showed no or minor effects. Based on the available information, the CONTAM
Panel could not identify a NOAEL or a LOAEL.
For dogs, a NOEL of 10 mg/kg bw per day was identiﬁed for an MCCP (Cereclor S52, C14–17, 52%
chlorination) from a dietary study in Beagle dogs, based on an increase of hepatic smooth endoplasmic
reticulum.
3.2. Occurrence data
3.2.1. Occurrence data submitted to EFSA
Occurrence data on food
A total of two data sets were submitted to EFSA consisting of 510 analytical results of 228 samples.
Data set A
Data set A consisted of a total of 88 analytical results for 44 samples taken in 2007 in the United
Kingdom on various foods. The samples were analysed by GC-HRMS for both SCCPs and MCCPs. The
results are summarised on Foodex1 Level 2 in Appendix D.
For SCCPs, the highest UB mean level per category or one single food sample of animal origin was
found in crustaceans (one sample with 39.2 lg/kg fat weight), sausages (one sample with 27.9 lg/kg
fat weight), ﬁsh oil (one sample with 25.0 lg/kg fat weight) and ﬁsh meat (12 samples with a mean of
23.8 lg/kg fat weight). For foods with plant origin, SCCPs were detected in one composite bread and
one composite fruit sample.
For MCCPs the highest UB mean level or that from one single sample of animal origin was found in
livestock meat (four samples with a mean of 91.8 lg/kg fat weight), ﬁsh oil (one sample with 72.0 lg/kg
fat weight), sausages (one sample with 53.6 lg/kg fat weight) and edible offals (four samples with a
mean of 40.3 lg/kg fat weight). For foods with plant origin, MCCPs were detected in one composite
bread sample.
No CP contamination was found in vegetable, liquid milk and egg samples.
The CONTAM Panel noted these data, but due to the fact that they were taken over a decade ago,
included pooled samples and consisted of only a limited number of samples, the Panel considered that
it was not appropriate to use them for a formal current exposure assessment.
Data set B
Data set B consisted of a total of 422 analytical results from 184 samples of ﬁsh meat collected in
Germany between 2014 and 2017, and analysed using GC-Orbitrap-HRMS.
Some of the samples were analysed and reported more than once. In these cases, the mean of the
analytical results related to each sample was calculated and used in the assessment in order to avoid
bias.
Samples of Data set B were analysed for both SCCPs and MCCPs and their results are summarised
on Foodex1 Level 2 and 3 in Tables 25 and 26. All results are expressed in whole weight (ww).
No occurrence data were submitted on LCCPs in food.
Table 25: Mean and P95 levels of ‘Alkanes, C10–13, chloro’ (SCCPs) (lg/kg ww)
FOODEX1 Level 3 N % LC MEAN (LB) MEAN (UB) P95(LB)(a) P95 (UB)(a)
Salmon and trout (Salmo spp.) 153 3 8.8 8.9 18 18
Tuna (Thunnus) 18 78 0.4 0.6 – –
Sea catﬁsh and wolfﬁsh (Anarhichas) 13 77 0.6 0.8 – –
FOODEX1 Level 2 N % LC MEAN (LB) MEAN (UB) P95 (LB) P95 (UB)
Fish meat 184 15 7.5 7.5 18 18
SCCPs: short-chain chlorinated parafﬁns; LB: lower bound; UB: upper bound; N: number of samples; % LC: Percentage of left-
censored data.
(a): The 95th percentile estimates obtained with less than 60 observations may not be statistically robust (EFSA, 2011a). Those
estimates were not included in this table.
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Production method of ﬁsh
Regarding the different production methods of various ﬁsh species (Tables 27 and 28), it was
found that all samples of tuna were wild caught while all sampled sea catﬁsh and wolfﬁsh were coming
from farmed production.
For salmon, organic-, wild caught- and farmed production methods were reported. Considering the
SCCP levels, the highest mean contamination was reported in farmed salmon (9.55 lg/kg ww) while in
case of MCCPs, organic production showed the highest mean (29.07 lg/kg ww). In both cases wild
caught salmon had the lowest levels, though in case of SCCPs the differences between the mean of
reported values of the respective production methods were smaller than in case of MCCPs.
Occurrence data in feed
No occurrence data for feed were submitted to EFSA.
3.2.2. Previously reported occurrence data in the open literature in food and
feed
3.2.2.1. Food
Several studies were identiﬁed in the open literature reporting the levels of CPs in individual food
categories or as part of duplicate or market basket studies. A larger number of studies reporting the
levels of SCCPs in foodstuff were identiﬁed, while less data were available on MCCPs and especially
limited data were available on LCCPs. Two studies reporting levels for feed materials were identiﬁed.
Details about these studies are described below and in Table 29, including the analytical method used
for the determination of the CPs.
Table 26: Mean and P95 levels of ‘Alkanes, C14–17, chloro’ (MCCPs) (lg/kg ww)
FOODEX1 Level 3 N % LC MEAN (LB) MEAN (UB) P95 (LB)(a) P95 (UB)(a)
Salmon and trout (Salmo spp.) 153 5 15 15 49 49
Tuna (Thunnus) 18 67 1.7 2.0 – –
Sea catﬁsh and wolfﬁsh (Anarhichas) 13 54 2.5 2.8 – –
FOODEX1 Level 2 N % LC MEAN (LB) MEAN (UB) P95 (LB) P95 (UB)
Fish meat 184 14 13 13 44 44
MCCPs: medium-chain chlorinated parafﬁns; LB: lower bound; UB: upper bound; N: number of samples; % LC: Percentage of
left-censored data.
(a): The 95th percentile estimates obtained with less than 60 observations may not be statistically robust (EFSA, 2011a). Those
estimates were not included in this table.
Table 27: Production methods of ﬁsh for ‘Alkanes, C10–13, chloro’ (SCCPs) (lg/kg ww)
FOODEX1 Level 3 Production method N MEAN(LB/UB) Min (LB/UB) Max (LB/UB)
Salmon and trout (Salmo spp.) Organic production 15 7.5 7.5 2.7 2.7 14
Salmon and trout (Salmo spp.) Wild 13 4.1 4.2 0 0.3 13
Salmon and trout (Salmo spp.) Farmed 125 9.5 9.6 0 0.6 172
Tuna (Thunnus) Wild 18 0.4 0.6 0 0.2 3.6
Sea catﬁsh andwolfﬁsh (Anarhichas) Farmed 13 0.6 0.8 0 0.2 5.3
LB: lower bound; UB: upper bound; N: number of samples.
Table 28: Production methods of ﬁsh for ‘Alkanes, C14–17, chloro’ (MCCPs) (lg/kg ww)
FOODEX1 Level 3 Production method N MEAN(LB/UB) Min (LB/UB) Max (LB/UB)
Salmon and trout (Salmo spp.) Organic production 15 29 29 6.2 6.2 55
Salmon and trout (Salmo spp.) Wild 13 4.5 4.7 0 0.3 16
Salmon and trout (Salmo spp.) Farmed 125 14 14 0 0.3 70
Tuna (Thunnus) Wild 18 1.7 2.0 0 0.3 14
Sea catﬁsh andwolfﬁsh (Anarhichas) Farmed 13 2.5 2.8 0 0.3 19
LB: lower bound; UB: upper bound; N: number of samples.
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Comparisons between studies should be done carefully due to the differences in and reliability of
methods used for the determination of the CPs and the sampling and geographical origin of the
samples.
3.2.2.1.1. SCCPs
The EU-RARs on SCCPs (EU-RAR, 2000, 2008) (see Section 1.3.5) gave a summary of
concentrations of SCCPs in aquatic biota and in other biota. The earlier report (EU-RAR, 2000) showed
that SCCPs were found in ﬁsh at concentrations up to 1,600 lg/kg fat (unspeciﬁed chain length),
marine mammals (up to ~ 500 lg/kg ww) and mussels (up to 12,000 lg/kg ww, sum of SCCPs and
MCCPs). In other biota, SCCPs were found to be present in various terrestrial mammals, bird livers and
muscle, and various foodstuffs. The 2008 report (EU-RAR, 2008) added to these data for ﬁsh taken
from close to industrial areas where CP production was known to take place, and SCCPs (60–70%
weight chlorination) in white suckers from the St. Lawrence River, were present at up to 3,500 lg/kg
dw. Other data for ﬁsh were also summarised in the report, but were at concentrations closer to those
reported in the earlier assessment in 2000. The updated report mentioned that SCCPs were not found
in cows’ milk, but were found in butter samples from several European countries at concentrations up
to 2.7 lg/kg fat.
UK-COT (2009) reported the levels in 45 samples, including composites, of various food types on
sale in the UK and sampled in 2007. These data have been submitted to EFSA (see Section 2.2).
SCCPs were detected in ﬁsh at concentrations of < 1.0–6.0 lg/kg ww. SCCPs were also detected in
butter (1.23 lg/kg ww), pork sausage (3.9 lg/kg ww), bread (2.1 lg/kg ww), fruit (2.0 lg/kg ww),
beef (< 1.0–1.2 lg/kg ww) and lamb (< 1.0–2.4 lg/kg ww). They were rarely or never detected in
milk products, eggs and poultry samples. They were rarely or never detected in milk products, eggs
and poultry samples. The highest concentrations were in a cod liver oil sample (25 lg/kg ww).
A number of studies reporting the concentrations of SCCPs in ﬁsh and seafood collected in different
geographic areas in Europe and Asia were identiﬁed.
In Europe, Lahaniatis et al. (2000) determined the levels of SCCPs (and MCCPs) in ﬁsh, ﬁsh oil and
cod liver oil samples originating from Europe except one sample from Chile. For ﬁsh the concentrations
ranged from 88 to 237 lg/kg fat. In ﬁsh oil and cod liver oil, similar concentrations were reported
(range 44–284 and 57–385 lg/kg fat, respectively). Parera et al. (2013) reported the levels of SCCPs
in ﬁsh (conger, seabream, ﬂunder, sardine and eels) and shellﬁsh from the Ebro Delta in Spain. The
levels in ﬁsh ranged from 33.2 and 141 lg/kg ww, while in shellﬁsh the values ranged from 3.1 to
34.6 lg/kg ww. Labadie et al. (2019) reported the concentrations of CPs in tissues of common barbel
(Barbus), a ﬁsh species frequently used for water quality monitoring purposes in Europe, that is also
sometimes consumed. SCCPs were found to be widespread within the Rhone river basin (France), with
concentrations ranging from 0.3 to 10.6 lg/kg ww which were lower than concentrations of MCCP at
all sites. The authors reported that variations of SCCP composition proﬁles were generally greater than
for MCCPs, suggesting a greater inﬂuence of local sources. Kr€atschmer et al. (2019) determined the
levels of SCCPs (and MCCPs) in farmed and wild salmon bought at German supermarkets and collected
between 2014 and 2017. These data have been submitted to EFSA (see Section 2.2). Samples
consisted of farmed salmon from Norway, Scotland, Denmark, Chile and other locations, and wild
salmon from different Eastern Paciﬁc locations. The mean (range) SCCP level was 14 (0.97–170) lg/kg
ww. The C11H13Cl11 was the predominant SCCP homologue in all salmon samples.
In Asia, several studies have reported the levels of SCCPs in different ﬁsh and shellﬁsh species
collected from different rivers, lakes or estuaries, especially in China. Wei et al. (2016) reviewed the
occurrence and distribution of SCCPs. The concentrations varied widely considering the inﬂuence of
point sources in some areas. For most biota samples the SCCP congeners were dominated by C10 and
C11 and Cl5 and Cl7. Yuan et al. (2012) determined SCCPs in molluscs collected in nine coastal cities
along the Bohai Sea. The authors reported concentrations in the range 64.95,510 lg/kg dw with an
average chlorine content of 61.1%. The predominant chain length was C10 and C11, which accounted
for about 30% of the total SCCP content. The predominant substitution was Cl6 and Cl7. In a study
designed to calculate bioconcentration factors, Sun et al. (2017) reported concentrations between
1,700 and 95,000 lg/kg fat in several aquatic species including ﬁsh and invertebrates in South China.
Levels of CPs in foodstuff other than ﬁsh have also been reported.
Sprengel et al. (2019) investigated the levels of SCCPs (and MCCPs) in oil-based dietary
supplements available on the German online market. Fourteen were Vitamin E dietary supplements, 12
containing palm oil and two soybean oil, seven were marine oil supplements, and four were other oil
supplements. The mean (min–max) SCCP concentrations were 3,810 (< LOQ–61,100) lg/kg fat. In 13
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out of the 25 samples analysed CPs were not detected (< 100 lg/kg fat). Six of the Vitamin E dietary
supplements containing palm oil showed the highest SCCP levels ranging from < LOD to 61,100 lg/kg
fat, while the levels in the remaining six samples ranged from < LOD to 1,9 lg/kg fat.
Zeng et al. (2016) analysed CPs in home-produced eggs from China. The eggs (17 chicken and 23
goose eggs) were collected in 2013 from two sites, one close to an e-waste recycling area and the
other far from the e-waste site. Chicken eggs collected close to the e-waste site showed mean (range)
SCCP levels of 3,400 (2,300–5,500) lg/kg fat, while those collected far way were 4,000 (2,600–6,800)
lg/kg fat. For the goose eggs, the concentrations were 60,000 (< LOD–150,000) and 4,600 (< LOD–
11,000) lg/kg fat, respectively, for those collected close and far to the e-waste site. The authors
suggested that differences between the two type of eggs could be due to species-speciﬁc differences
in habitat preference, and the fact that levels in chicken eggs were higher in those eggs collected far
from the e-waste site could be due the high migration ability of SCCPs (Zeng et al., 2016). The same
authors reported the levels of SCCPs (and MCCPs) in home-produced eggs collected in 2013 and 2016
in a village form an area that was once a typical e-waste recycling site (Zeng et al., 2018). SCCPs were
detected in all samples, with median concentrations of 926 ng/g fat (year 2013) and 1,490 ng/g fat
(year 2016). The authors reported no signiﬁcant differences in the levels between the two sampling
years, but in the homologue group proﬁles. While in eggs collected in 2013 an almost equal
abundance of C10, C11, C12 and C13 was observed, in the samples from 2016, C10 and C11 homologues
were signiﬁcantly more abundant than C12 and C13.
Huang et al. (2018) assessed the dietary exposure for the general Chinese population through
meat and meat products collected in 2011 from 20 Chinese provinces. SCCPs were determined in pork,
mutton, beef, chicken, duck, rabbit, pork liver and swine blood samples purchased from local markets,
grocery stores and rural households, and prepared according to local cooking methods of steaming,
frying, boiling and pan-frying. The mean (SD) concentration across provinces was 129 (4.1) lg/kg ww.
The authors noted that the geographical distribution of SCCP concentrations was similar to the
distribution of CPs manufacturing plants in China. The most abundant SCCP congeners were C10 and
C11, and the Cl6 and Cl7 congeners dominated the proﬁle.
The levels of SCCPs in cooking oil, fried confectionary products and raw seeds collected in China in
2010 and 2012 were reported by Cao et al. (2015). SCCPs were found in 48 out of the 49 cooking oil
samples analysed with SCCP concentrations ranging from < 9 to 7,500 lg/kg. C13 followed by C11 were
the predominant homologue groups, and Cl6 were the most abundant ones. In fried confectionary
products, the levels ranged from 11 to 1,000 lg/kg, with the C11 and Cl6 homologues as the most
abundant ones. The raw seeds analysed showed lower levels than the cooking oils and confectionery
products, with concentrations of < 2–68 lg/kg. The C11 and Cl5 homologues were the dominant ones.
Wang et al. (2019b) analysed SCCPs (and MCCPs) on cereals and legumes as important foodstuff in
the Chinese diet. A total of 19 pooled cereal samples and 19 pooled legume samples were collected in
2011 from different provinces in China. Mean SCCP levels were 343 and 328 lg/kg ww in cereals and
legumes, respectively. The dominant SCCP congener groups were C10 and Cl5 Cl6 and Cl7 in all
samples.
Several studies have determined the levels in more than one food category and estimated the
corresponding dietary exposure. Few of these were carried out with samples collected in Europe, while
more are available from Asian countries. In this section the levels in the foodstuff are summarised,
while in Section 3.3.2 the exposure estimated in these studies is reported.
In Europe, Yuan et al. (2017) measured the levels of SCCPs (and MCCPs and LCCPs) in Swedish
food market baskets and estimated the exposure to compare it then to the estimated exposure from
hand blender use (see also Section 3.2.3). The market baskets consisted of 13 food categories (up
to 31 items per category) purchased from ﬁve different Swedish food grocery chains in 2015. The
highest SCCP levels were found in ‘ﬁsh’ (4.6 lg/kg ww), while in ‘fruits’ a value of 0.49 lg/kg ww was
reported. The remaining food categories presented levels below the method LOD for each matrix.
Kr€atschmer et al. (2019a, see Documentation provided to EFSA) analysed raw food samples (meat
and offal, eggs, milk and dairy, and fats and oils) collected from supermarkets, full meal samples
(meat- and vegetarian-based) collected from gastronomy and caterers, and total diet samples from a
hospital (light and full diet). All samples were collected in Germany between 2018 and 2019.
Regarding the raw food samples, the highest levels of total CPs were found in oils and fats
(15–800 lg/kg ww), followed by ﬁsh (1.8–360 lg/kg ww). Lower levels were reported in meat and
offal, eggs and milk and dairy (see Table 29). The authors found lower levels in the full meal samples
analysed compared to the raw food samples, with SCCPs ranging from 1.2 to 8.9 lg/kg ww. In the
total diet samples, the SCCP levels ranged from 1.0 to 4.7 lg/kg ww.
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In Asia, Iino et al. (2005) carried out a Market Basket Study in Japan with samples collected in
2003. Eleven food categories were considered with 18% of the products coming from countries other
than Japan. The food category ‘fats’ was the one showing the higher mean levels (140 lg/kg ww),
followed by ‘ﬁsh’ (16 lg/kg ww, or 170 lg/kg fat) and ‘shellﬁsh’ (18 lg/kg ww, or 2,500 lg/kg fat).
‘Milk’ was the group with the lowest levels (0.75 lg/kg ww).
Harada et al. (2011) estimated the exposure to SCCPs (C10–13) of Chinese, Japanese and Korean
adults via duplicate 24 h food composite samples. The food composite samples were collected in China
(Beijing), Japan (Hokkaido, Kyoto and Okinawa) and Korea (Seoul) at two time points: in the 1990s
(archived samples) and between 2007 and 2009. The food samples collected in China showed the
highest levels (range: < LOD to 28.0 lg/kg), and the concentrations in 2009 were higher than those in
the 1990s. In the samples from Japan, SCCP levels ranged from < LOD to 1.10 lg/kg with no
substantial changes between the two time points. The samples collected in Seoul showed the lowest
levels (range: < 0.050–0.056 lg/kg). Regarding the congener proﬁle, the C12 congeners (especially the
Cl7 to Cl9) were the most frequently detected in samples from Japan (both time periods) and in Beijing
in 1993. A different proﬁle was reported for the Beijing samples in 2009, where C10 to C13 congeners
dominated. Although the samples from China showed high total SCCP concentrations (in 2009) than
the Japanese ones, highly chlorinated dodecanes (i.e. C12H18Cl8 and C12H17Cl9) showed comparable
levels to those in Japanese samples.
Gao et al. (2018) estimated the exposure of the general population in Beijing (China) through a
duplicate diet study that consisted of two parts: one part where food was collected from fast food
outlets and the other part where food was collected by 6 participants who provided duplicate portions
of what they consumed for their three meals per day. In addition, three different brands of milk
powder purchased in supermarkets were analysed. The authors reported a mean (min–max)
concentration of SCCPs in the duplicate diet samples of 113 (24.4–546) lg/kg dw, and in the milk
power samples of 18.3 (16.2–20.5) lg/kg dw. The C13 and C11 were the predominant congeners
(contributing 35 and 31%, respectively) followed by C12 and C10 congeners (23 and 12%,
respectively). The Cl7 and Cl8 congeners were the most abundant ones.
Chen et al. (2018) determined SCCPs (and MCCPs) in four types of dust samples and nine
categories of locally produced staple foods collected from an e-waste recycling industrial park and its
surrounding villages in China. When expressed on a fat weight basis, the highest SCCP levels were
found in vegetables (local lettuce, 519,000 lg/kg fat, or 3,540 lg/kg ww) and ﬁsh (mrigal carp,
408,000 lg/kg fat), followed by shrimp, rice, duck, pork, shellﬁsh, chicken and eggs. In foods of
animal origin, the C10, C11, C12 and C13 contributed almost equally, although some differences were
found for some food categories. Congeners with Cl7 and Cl8 were predominant.
Gao et al. (2019) analysed SCCPs in raw foodstuff and cooked food collected from markets in Beijing
(China) between 2014 and 2016. A total of 122 food samples including different meats, offals, ﬁsh,
vegetables, fruit, seafood, oil, ﬂour and rice were analysed. SCCPs ranged from 0.67 to 5,100 lg/kg ww.
The highest mean concentrations were found in meat samples (117 lg/kg ww), followed by seafood
(60.5 lg/kg ww) and ﬁsh (46 lg/kg ww). Lower levels were found in fruit (16.4 lg/kg ww) and
vegetables (11.7 lg/kg ww). The concentrations in oils varied widely from 15.7 to 5,100 lg/kg ww for
corn blend oil and peanut oil, respectively. The main carbon homologues were C10 and C11, and the
chlorination pattern was dominated by Cl7, Cl6 and Cl8. In addition, the authors analysed seven types of
raw foodstuff (chicken eggs, potato, pork, mutton, shrimps, cabbage, rice and oil) after cooking by
frying, stewing, boiling or steaming (see Section 3.2.3 for further details on the effects of cooking).
3.2.2.1.2. MCCPs
The EU-RAR (2011) did not report any occurrence data for food or feed except for cows’ milk
(highest value of 63 lg/kg fat based on published data), but estimates of total exposure (including
dietary) were made on the basis of predicted concentrations, made from models and experiments
conducted to assess bioavailability (see Section 3.3.2).
UK-COT (2009) reported the levels of MCCPs in 45 samples of various food types on sale in the UK
and sampled in 2007. These data have been submitted to EFSA (see Section 2.2). The levels in ﬁsh
ranged from < 1.0 to 31.9 lg/kg ww and were higher than those in butter (2.84 lg/kg ww), pork
sausage (7.5 lg/kg ww), bread (4.0 lg/kg ww), fruit (< 1.0 lg/kg ww), beef (< 1.0–8.3 lg/kg ww)
and lamb (< 1.0–12.6 lg/kg ww). As for SCCPs, they were rarely or never detected in milk products,
eggs and poultry samples. The highest concentrations were in the cod liver oil sample (72 lg/kg ww).
MCCPs were usually found in these samples at a higher concentration than SCCPs.
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Several of the studies reporting the levels of SCCPs (see previous Section 3.2.2.1) also
determined MCCPs in the same samples.
Lahaniatis et al. (2000) reported MCCP (C14–17) levels in ﬁsh samples ranging from 29 to 99 lg/kg
fat. For the ﬁsh oil and cod liver oil samples, the concentration ranges were 63 to 191 lg/kg fat and
105 to 248 lg/kg fat, respectively. For most of the ﬁsh samples, SCCPs showed higher concentrations
than MCCPs, while in the ﬁsh oil and cod liver oil samples the contribution varied depending on the
sample. In the study mentioned above for SCCPs, Labadie et al. (2019) also analysed MCCPs in the
common barbel. MCCPs were widespread with concentrations ranging from 1.3 to 72.7 lg/kg ww,
which are higher than the values found for SCCPs. Kr€atschmer et al. (2019) reported mean (range)
MCCP levels of 19 (1.1–79) lg/kg ww in the 122 farmed and 11 wild salmon samples bought at
German supermarkets. The C15H23Cl9 and C15H21Cl11 were the predominant MCCPs homologues. Based
on mean and median concentration, MCCPs were predominant over SCCPs in the salmon samples. A
slight decrease of the mean CP concentrations in the Norwegian salmon samples analysed from 2014
to 2017 was observed, with some high SCCP levels in samples from 2015. The authors could not
however conclude on a decreasing trend due to the number of samples analysed and comparatively
wide range of concentrations measured. The authors also determined PCBs48 and HBCDDs in the same
salmon samples. The sum of SCCPs and MCCPs was higher than the sum of PCBs and that of HBCDDs
in most of the samples.
Sprengel et al. (2019) reported levels of MCCPs in oil-based dietary supplements. The mean (min,
max) MCCP concentrations were higher than that found for SCCPs, and were 15,200 (< LOQ, 151, 000)
lg/kg fat. In 13 out of the 25 samples analysed, CPs were not detected (< 100 lg/kg fat). Six of the
palm-oil-containing Vitamin E dietary supplements showed again the highest levels, ranging from < LOD
to 15,200 lg/kg fat, while the levels in the remaining six samples ranged from < LOD to 1.9 lg/kg fat.
Yuan et al. (2017), in a Swedish food market basket study, found the highest MCCP levels in the
category ‘fat/oil’ (14.5 lg/kg ww), followed by ‘sugar/sweets’ (6.3 lg/kg ww), ‘ﬁsh’ (5.1 lg/kg ww)
and ‘pastries’ (4.3 lg/kg). ‘The categories ‘fruit’ and ‘potatoes’ showed values of 0.90 and 0.98 lg/kg
ww, respectively, and the remaining food categories contained levels below the method LOD for each
matrix.
Kr€atschmer et al. (2019) reported MCCP levels in full meal samples ranging from 0.6 to 7.8 lg/kg
ww, and in total diet samples ranging from 0.4 to 4.8 lg/kg ww.
Huang et al. (2018) also reported levels of MCCPs in the meat and meat products collected in 20
Chinese provinces. The concentration was lower than for SCCPs, with a mean (SD) level across
provinces of 5.7 (0.59) lg/kg ww. As for SCCPs, the authors noted that the geographical distribution
of MCCP concentrations was similar to the distribution of CPs manufacturing plants in China. The most
abundant MCCP congeners were the C14, and the Cl7 and Cl8 congeners dominated the proﬁle.
Zeng et al. (2018) reported the levels of MCCPs in home produced eggs in 2013 and 2016 collected
from an area that used to be an e-waste site. Median values of 1,030 ng/g fat (year 2013) and
999 ng/g fat (year 2016) were reported. The homologues proﬁle was similar between the two time
periods (unlike those for SCCPs), with C14 and C15 as the most abundant groups.
Wang et al. (2019b) also analysed MCCPs in pooled samples of cereals and legumes and the mean
levels were 213 and 184 lg/kg ww, respectively. The values were lower than those found for SCCPs.
Gao et al. (2018), in their duplicate diet study, reported that the mean (min–max) concentration of
MCCPs in the duplicate diet samples was 55.5 (17.3 to 384) lg/kg dw, and in the milk powder samples
it was 8.87 (17.0 to 384) lg/kg dw. In this case, the C14 congeners dominated the proﬁle, and Cl8 CPs
were the most abundant ones.
Chen et al. (2018) also reported the levels of MCCPs in the nine categories of locally produced
staple foods collected from an e-waste recycling industrial park and its surrounding villages in China.
As for SCCPs, when expressed on a fat weight basis, the highest MCCP levels were found in vegetables
(local lettuce, 635,000 lg/kg fat, or 4,360 lg/kg ww) and ﬁsh (mrigal carp, 443,000 lg/kg fat),
followed by shrimp, rice, duck, pork, shellﬁsh, chicken and eggs. In all food samples, MCCPs were
found at higher levels than SCCPs. The C14 homologues dominated the proﬁle for most food samples,
and Cl810 groups were predominant.
3.2.2.1.3. LCCPs
Yuan et al. (2017), besides SCCPs and MCCPs also measured the levels of LCCPs in their Swedish
food market basket study. The highest LCCP levels were found in the category ‘sugar/sweets’
48 ICES-6: PCB-28, -52, -101, -138, -153, -180.
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(0.54 lg/kg ww), followed by ‘fruit’ (0.14 lg/kg ww) and ‘potatoes’ (0.12 lg/kg ww). The remaining
food categories presented levels below the LOD for each matrix.
3.2.2.2. Feed
3.2.2.2.1. SCCPs
Two reports of CPs in animal feed were identiﬁed. Lahaniatis et al. (2000) determined the levels of
SCCPs (and MCCPs, see below) by GC-ECNI-MS in one ﬁsh feed sample. The concentration of C10–13
congeners was 169 lg/kg fat.
Dong et al. (2019) measured SCCPs (and MCCPs) in 16 samples of animal feed material (pools,
each of them consisting of at least 8 individual samples), collected in China in 2016, by GC9GC-ECNI-
TOF. Thirteen of the samples were of animal origin and three were of plant origin. The feed materials
analysed were sampled at feed factory warehouses in China: four of the six ﬁsh meal samples
analysed were imported (one from Chile, two from Peru, and one from the USA), all other samples
were produced in China, but the geographical origins of the raw materials used in these products was
reported to be uncertain. SCCP concentrations ranged from 120 to 1,700 lg/kg whole product basis
with a mean of 640 lg/kg. Fish meal had the highest SCCP concentrations (up to 1,700 lg/kg whole
product basis (range 400–1,700)), and peanut meal the lowest (120 lg/kg whole product basis). The
predominant congener groups were C10–11Cl6–7.
3.2.2.2.2. MCCPs
The two studies of SCCPs in animal feed materials also determined MCCPs. Lahaniatis et al. (2000)
reported the levels of C14–C17 congeners in one ﬁsh feed samples to be 1,550 lg/kg fat, while Dong
et al. (2019) reported concentrations in the 16 feed materials ranging from 6.4 to 260 lg/kg whole
product basis (mean 78 lg/kg whole product basis). As for SCCPs, ﬁsh meal showed the highest levels
and whey powder the lowest. The C14Cl7 congeners dominated the MCCP proﬁle. The MCCP levels
were lower than those of SCCPs.
3.2.2.2.3. LCCPs
No studies reporting the levels of LCCPs for feed materials were identiﬁed.
3.2.2.3. Conclusions on the occurrence data reported in the literature
Most of the limited data reported in the scientiﬁc literature are for SCCPs and MCCPs, with only one
study identiﬁed reporting concentrations of LCCPs in food. The majority of information originates for
samples taken and analysed in China, which is where much of the global production takes place. The
studies in China reported higher concentrations (tens of micrograms) than in other Asian countries
(few nanograms).
SCCP and MCCP concentrations can vary dramatically from region to region and between different
food types. As is the case for other POPs, highest concentrations may be found in ﬁsh and marine
mammals, followed by liver and fatty tissues of terrestrial animals. Highest levels have been observed
in foods produced in areas of known contamination.
The variation between regions, and the impact of local contamination sources makes it difﬁcult to
assess overall typical levels. Some studies report higher values for SCCPs while others report higher
values for MCCPs. Both are likely to be within the same order of magnitude. Very little data are
available for LCCPs. Occurrence is likely to be shifting away from SCCPs towards the MCCPs and LCCPs
as production and usage moves in this direction.
There are some conﬂicts in reports of the most dominant congeners within each group, which may
reﬂect the contaminant proﬁle within the samples, or may reﬂect the analytical methodology used. For
this reason, it is always recommended to be cautious when comparing data or drawing conclusions
about contamination proﬁles.
The concentrations of SCCPs and MCCPs in the data on ﬁsh submitted to EFSA are in line with
some of the data reported in the scientiﬁc literature, where samples were taken from the same
geographical region i.e. Europe and where no speciﬁc contamination source was identiﬁed. Fish from
Asia, and near known production or contamination sites can contain much higher levels of SCCPs and
MCCPs for the reasons suggested above.
There are very few data reported in the literature about animal feed, and the few data that are
available are not from Europe. It is therefore not possible to make any general conclusion about the
concentrations of CPs in animal feed.
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Great care needs to be taken when comparing data, and factors to consider include proximity to a
known or suspected contamination source, the analytical methods used to measure CPs and the way
the results are expressed (e.g. wet, fat or dry weight).
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Table 29: Occurrence data on short-chain chlorinated parafﬁns (SCCPs), medium-chain chlorinated parafﬁns (MCCPs) and long-chain chlorinated
parafﬁns (LCCPs) in food reported in the open literature
Reference Country Number of samples Year
Analytical
method
Compounds
SCCPs MCCPs LCCPs
Lahaniatis et al.
(2000)
Fish samples
consumed in Europe,
ﬁsh oil and cod liver
oil from Europe and
America
Fish (n = 8): sprat, redﬁsh,
salmon, herring, mackerel,
halibut, sardine and trout
Fish oil (n = 4)
Cod liver oil (n = 4)
n.r. GC-ECNI-
MS
lg/kg fat
Fish: 88–237
Fish oil: 44–284
Cod liver oil: 57–385
lg/kg fat
Fish: 29–99
Fish oil: 63–191
Cod liver oil: 105–248
–
Parera et al.
(2013)
Spain
(Ebro River delta)
Fish (1 kg of muscle meat
for each species): sardine,
eel, ﬂounder, conger,
gilthead sea bream
Shellﬁsh (1 kg of muscle
meat for each species):
mussel, carpet shell, murex
2012 GC-ion trap-
MS
lg/kg ww
Fish: 33.2–141
Conger: 141
Seabream: 60.5
Flounder: 33.2
Sardine: 104
Eel: 80.4
Shellﬁsh: 3.1–34.6
Mussel: 12.0
Carpet shell: 3.1
Murex: 34.6
– –
Kr€atschmer et al.
(2019)
Germany Fish (n = 133): farmed
salmon (n = 122), wild
salmon (n = 11)
2014–2017 GC-
Orbitrap-MS
lg/kg ww
Mean (range):
14 (0.97–170)
lg/kg ww
Mean (range):
19 (1.1–79)
–
Labadie et al.
(2019)
France
(Rhone River basin)
Fish (n = 22): common
barbel
2009, 2011 GC-ECNI-
TOF-MS
lg/kg ww
0.3–10.6
lg/kg fat
63–1,492
lg/kg ww
1.3–72.7
lg/kg fat
99–11,300
–
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Reference Country Number of samples Year
Analytical
method
Compounds
SCCPs MCCPs LCCPs
Yuan et al. (2017) Sweden Food market basket study:
13 food categories, up to 31
items per category
2015 Direct
injection
APCI-qTOF-
MS
lg/kg ww
Cereals: < 1.1
Pastries: < 1.8
Meat: < 1.0
Fish: 4.6
Dairy (ﬂuent): < 2.0
Dairy (solids): < 2.0
Eggs: < 1.3
Fat/oils: < 5.7
Vegetables: < 0.57
Fruit: 0.49
Potatoes: < 0.75
Sugar/sweets: < 0.90
Beverages: < 0.51
lg/kg ww
Cereals: < 1.1
Pastries: 4.3
Meat: < 1.0
Fish: 5.1
Dairy (ﬂuent): < 2.0
Dairy (solids): < 2.1
Eggs: < 1.4
Fats/oils: 14.5
Vegetables: < 0.58
Fruit: 0.90
Potatoes: 0.98
Sugar/sweets: 6.3
Beverages: < 0.52
lg/kg ww
Cereals: < 0.04
Pastries: < 0.07
Meat: < 0.04
Fish: < 0.08
Dairy (ﬂuent): < 0.08
Dairy (solids): < 0.08
Eggs: < 0.05
Fat/oils: < 0.22
Vegetables: < 0.02
Fruit: 0.14
Potatoes: 0.12
Sugar/sweets: 0.54
Beverages: < 0.02
Kr€atschmer et al.
(2019a, see
Documentation
provided to EFSA)
Germany Raw food samples (n = 49):
meat and offal (n = 17),
eggs (n = 5), milk and dairy
(n = 6), ﬁsh (n = 13), fats
and oils (n = 8)
2018–2019 GC-ECNI-
Orbitrap-
HRMS
Total CPs
lg/kg ww
Meat and offal: 1.4–12
Eggs: 14–23
Milk and dairy: 0.5–17
Fish: 1.8–360
Fats and oils: 15–800
Kr€atschmer et al.
(2019a, see
Documentation
provided to EFSA)
Germany Full meals (n = 10): meat-
based (n = 8), vegetarian
(n = 2)
Total diet samples (n = 5):
light diet (n = 3), full diet
(n = 2)
2018–2019 GC-ECNI-
Orbitrap-
HRMS
lg/kg ww
Full means:
Meat-based: 1.8–8.9
Vegetarian: 1.2–1.9
Total diet samples:
Light diet: 1.0–2.1
Full diet: 4.0–4.7
lg/kg ww
Full meals:
Meat-based: 1.0–7.8
Vegetarian: 0.6–2.0
Total diet samples:
Light diet: 0.4–1.1
Full diet: 4.3–4.8
n.a.
Sprengel et al.
(2019)
Germany (available
from the German
online market)
Oil-based supplements
(n = 25): vitamin E
supplements (n = 14),
marine oil supplements
(n = 7), other oil
supplements (n = 4)
n.r. GC-ECNI-
MS
lg/kg fat
mean (min–max)
3,810 (< LOD–61,100)
lg/kg fat
mean (min–max)
15,200 (< LOD–
151,000)
n.a.
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Reference Country Number of samples Year
Analytical
method
Compounds
SCCPs MCCPs LCCPs
Yuan et al. (2012) China (Bohai Sea) Molluscs (91 composite
samples): bivalves (9
species), gastropods (2
species)
2009 GC-ECNI-
MS
lg/kg dw
Molluscs: overall
range: 64.95,510
Median (min, max)
Bivalves: 1,150–2,910
(64.9–5,510)
Gastropods: 506–640
(135–1,660)
n.a. n.a.
Iino et al. (2005) Japan Market basket study (11
food categories: grain crops,
seeds/potatoes, sugar, fats,
vegetables, fruit, ﬁsh,
shellﬁsh, meat, eggs, milk)
2003 GC-ECNI-
HRMS
lg/kg ww
Mean (SD)
Grain crops: 2.5 (3.1)
Seeds/potatoes: 1.4
(2.0)
Sugar/sweets/snacks/
seasoning/beverages:
2.4 (3.0)
Fats: 140 (150)
Legumes/vegetables:
1.7 (2.3)
Fruit: 1.5 (1.9)
Fish: 16 (17) [or
170 lg/kg fat]
Shellﬁsh: 18 (19) [or
2,500 lg/kg fat]
Meat: 7.0 (6.6)
Eggs: 2.0 (2.7)
Milk: 0.75 (1.6)
n.a. n.a.
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Reference Country Number of samples Year
Analytical
method
Compounds
SCCPs MCCPs LCCPs
Harada et al.
(2011)
China
Korea
Japan
24 h food composite
samples (a total of 200 24 h
duplicate samples)
1990s, 2007–
2009
GC-ECNI-
HRMS
lg/kg(a)
Samples China: < LOD
–28.0
Year 1990s: < 0.20–
0.60
Year 2009: 8.5–28.0
Samples Japan: < LOD
–1.10
Year 1990s: < 50–760
Year 2009: < 50–1.100
Samples Seoul:
< 0.050–0.056
Year 2009: 1 sample
with trace levels
Year 1990s: all < LOD
n.a. n.a.
Huang et al.
(2018)
China Meat and meat products
(n = 20): pork, mutton,
beef, chicken, duck, rabbit,
pork liver, swine blood
2011 GC9GC-
ECNI-TOF-
MS
lg/kg ww
Mean (SD): 129 (4.1)
lg/kg ww
Mean (SD): 5.7 (0.59)
–
Wang et al.
(2019b)
China Cereals (n = 19 pooled
samples, consisting of 1,710
individual samples)
Legumes (n = 19 pooled
samples, consisting of 1,710
individual samples)
2011 GC9GC-
TOF-MS
lg/kg ww
Cereals: 343
Legumes: 328
lg/kg ww
Cereals: 213
Legumes: 184
–
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Reference Country Number of samples Year
Analytical
method
Compounds
SCCPs MCCPs LCCPs
Zeng et al. (2016) China
(collection site close
to an e-waste
recycling area or far)
Home-produced eggs
Chicken eggs (n = 17)
Goose eggs (n = 23)
2013 GC-ECNI-
MS
lg/kg fat
mean, range
Chicken eggs:
Close to e-waste site:
3,400 (2,300–5,500)
Far from e-waste site:
4,000 (2,600–6,800)
Goose eggs
Close to e-waste site:
60,000 (< LOD–
150,000)
Far from e-waste site:
4,600 (< LOD–11,000)
– –
Zeng et al. (2018) China (collection
area used to be an
e-waste site)
Home-produced eggs
(n = 68): year 2013
(n = 38), year 2016 (n = 30)
2013, 2016 GC-ECNI-
MS
lg/kg fat
Median:
2013: 926
2016: 1,490
Overall range:
477–111,000
lg/kg fat
Median:
2013: 1,030
2016: 999
Overall range:
125–91,100
–
Cao et al. (2015) China Cooking oil (n = 49)
Fried confectionary products
(n = 20)
Raw seeds (n = 13)
2010, 2012 GC-ECNI-
HRMS
lg/kg(a)
Cooking oil:
(detected in 48
samples):
< 9–7,500
Fried confectionary
products:
(detected in all
samples):
11–1,000
Raw seeds:
(detected in 11
samples):
< 2–68
– –
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Reference Country Number of samples Year
Analytical
method
Compounds
SCCPs MCCPs LCCPs
Sun et al. (2017) China (collection site
e-waste
contaminated area)
Fish and invertebrates
Oriental river prawn
(n = 50), Chinese mitten
crab (n = 16), crucian carp
(n = 16), mud carp
(n = 5–60), catﬁsh (n = 2),
snakehead (n = 5)
2014 GC-ECNI-
MS
lg/kg fat
1,700–95,000
Highest mean:
Chinese mitten crab:
44,000
Lowest mean:
Large mud carp: 2,100
– –
Gao et al. (2018) China Duplicate Diet study
Part I: fast food outlets
(n = 15)
Part II: collected by 6
participants who provided
duplicate portions of what
they consumed for their
three meals per day (n = 18)
Milk powder (n = 6)
2016 GC-TOF-
HRMS
lg/kg dw
Mean (range)
Duplicate diet
samples: 113 (24.4–
546)
Milk power samples:
18.3 (16.2–20.5)
lg/kg dw
Mean (range)
Duplicate diet
samples: 55 (17.3–
384)
Milk power samples:
8.87 (17.0–384)
–
Chen et al. (2018) China (collected from
an e-waste recycling
industrial park and
its surrounding
villages)
Locally produced staple
foods (n = 92): 9 food
categories: ﬁsh, shellﬁsh,
shrimp, meat, poultry, egg,
vegetable, cereal, culinary oil
2016–2017 GC-ECNI-
MS
lg/kg fat
Fish: 94.3–487
Shellﬁsh: 37.1–66.9
Shrimp: 76.5–118
Meat (pork): 37.2–58.6
Poultry: 25.3–88.3
Eggs: 1.62–6.84
Vegetables: 132–605(b)
Cereals: 37.2–88.6
Culinary oil: 0.892–
1.32
lg/kg fat
Fish: 116–563
Shellﬁsh: 35.5–59.9
Shrimp: 76.5–118
Meat (pork): 48.3–
69.3
Poultry: 31.9–111
Eggs: 207–10.6
Vegetables: 245–747(b)
Cereals: 55.4–108
Culinary oil: 1.22–1.76
–
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Reference Country Number of samples Year
Analytical
method
Compounds
SCCPs MCCPs LCCPs
Gao et al. (2019) China Food samples (n = 122):
meat (n = 22), offals
(n = 10), ﬁsh (n = 10),
vegetables (n = 27), fruit
(n = 15), seafood (n = 21),
oil (n = 6), ﬂour (n = 5), rice
(n = 6)
2014–2016 GC-ECNI-
LRMS
lg/kg ww
Overall range:
0.67–5,100
Mean
Meat: 117
Seafood: 60.5
Fish: 46
Offals: 27.8
Fruit: 16.4
Vegetables: 11.7
Oils: 15.7–5,100
– –
n.a.: not analysed; n.r.: not reported; GC: gas chromatography; ECNI: electron capture negative ionisation; MS: mass spectrometry; HRMS: high-resolution MS; TOF-MS: time-of-ﬂight MS.
(a): Not clear whether the results were expressed on a wet, fat or dry basis.
(b): The CONTAM Panel noted that it is uncommon to express levels in vegetables on fat weight basis.
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3.2.3. Food processing
Two studies were identiﬁed on the effects of cooking on the levels of CPs. Gao et al. (2019)
analysed SCCPs in seven types of raw foodstuff (chicken eggs, potato, pork, mutton, shrimps,
cabbage, rice and oil) before and after cooking by frying, stewing, boiling or steaming. Lower
concentrations were found in the cooked food compared to the raw food in the case of eggs, potato,
shrimps, mutton and pork (overall from 3.26–52.1 lg/kg ww in the raw food to 0.67–10.8 lg/kg ww
in the cooked food). The highest loss was reported for cooked mutton (raw vs fried), shrimp (raw vs
boiled) and eggs (raw vs boiled). For those foods the authors reported elimination of 82, 85 and 93%
SCCPs, respectively. In rice and cabbage, SCCP concentrations were lower in the raw food (3.60 and
3.26 lg/kg ww, respectively) than when cooked (6.38 and 5.14 lg/kg ww, respectively). The authors
concluded that at low concentrations, water and cookware may introduce SCCPs during the cooking
process.
Perkons et al. (2019) analysed SCCPs and MCCPs in unprocessed pastry dough (e.g. pies, buns,
strudels, croissants, cinnamon rolls) and in oven-baked pastry products (e.g. puff pastry, shortcrust
pastry, pizza dough and yeast dough). The mean level in the unprocessed dough (12.9 ng/g dw) was
twofold higher than those determined in the pastry products (6.3 ng/g dw). An additional experiment
with unprocessed dough spiked with SCCPs, subsequently baked for 15 min at 180°C showed a 24%
lower concentration in the baked product compared to the dough. The authors also reported a higher
proportion of CPs with lower chlorination degree in baked products compared to the unprocessed
dough samples. The authors indicated that it is most likely that such transformations are caused by
thermally induced dehydrochlorination of CPs and carbon chain cleavage of MCCPs and LCCPs. In this
respect, thermal decomposition of a CP technical product was studied by Xin et al. (2019), reporting
signiﬁcant amount of MCCPs, SCCPs and aromatic and chlorinated polycyclic aromatic hydrocarbons
(chlorinated PAHs) being formed during the thermal decomposition of CP-52 (10.9% SCCPs and 85.5%
MCCPs in weight, 52% chlorination degree). After an initial dehydrochlorination and carbon chain
cleavage, the chlorinated and unsaturated hydrocarbons formed undergo cyclisation and aromatisation
at temperatures of 200–400°C, producing mostly aromatic hydrocarbons. At higher temperature,
radical-induced reactions were reported to be the predominant pathways, leading to the formation of
chlorinated-PAHs.
Because CPs can be used in the manufacturing of kitchen utensils, there exists the potential for
migration from these products into food. This can either be direct, or via practices such as cleaning
using dish cloths. CPs are not authorised for use in plastic food contact materials in Europe.
Yuan et al. (2017) investigated levels of CPs from hand blender use and compared this with
background CP exposure from diet. The study quantiﬁed 6 SCCPs, 9 MCCPs and 6 LCCPs with details
of the individual compounds given in the paper (Yuan et al., 2017). CPs were analysed in food market
baskets, in cooking oil/water samples (1 g oil/100 mL water) mixed using 16 different hand blenders,
and in dismantled components of the hand blenders. Background dietary intake of CPs was estimated
from a food market basket survey and was calculated to be 4.6 lg per day per person for Swedish
adults (see Section 3.3.2). Total CP amounts in oil/water leakage samples from the hand blenders
ranged from < 0.09 to 120 lg (determined by direct injection into an APCI-qTOF-MS after sample
preparation). Migration of CPs did not decrease even after 20 times of hand blender usage. The CP
proﬁles in the leakage samples matched those of self-lubricating bearings and/or polymer components
disassembled from the hand blenders. The authors concluded that most hand blenders tested had
signiﬁcant levels of CPs, that were estimated to increase the exposure when used to prepare food. The
additional dietary intake from the hand blenders was calculated assuming that only one person eats
the prepared food and that everything was consumed, resulting in a possible overestimation of
exposure due to the fact that some foods may be shared between several people. Also, some
preparation methods may require multiple application of the blender, which could result in additional
CP migration into foodstuffs. The median intake of SCCPs from one-time use based on results from all
hand blenders (0.10 lg/day) was reported to contribute an additional 4% and 7% to the dietary
exposure for breastfed infants and adults in Sweden, respectively. For other countries (China, Japan
and the UK), the authors reported that hand blender use would contribute less due to higher dietary
intakes from food. The median intake of ∑MCCPs from one-time hand blender use per day was
calculated to contribute an additional 19%–160% to total dietary exposure for Swedish infants and
adults. For China and the UK, the authors reported that the increase in exposure of infants to ∑MCCPs
would be 253 and 69 times higher, respectively, than the median dietary intake.
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The German National reference Laboratory for Materials for Food Contact carried out a study to
investigate the release of CPs from hand blenders (BfR, 2019, see Documentation provided to EFSA).
The release test was carried out at room temperature using 19 hand blenders with isooctane as food
simulant. The release test was repeated three times. The CP determination was carried out by GC-NCI-
MS. In six out of the 19 hand blenders tested, CPs were found in the isooctane, while for the remaining
blenders, concentrations in the isooctane used were below the LOQ. In most the cases, the
concentrations in the ﬁrst release were the highest, with values up to 690 lg/kg isooctane. For one of
the hand blenders, the release of total CPs increased with subsequent uses, with a value of 3,000 lg/kg
total CPs in isooctane released on the third repeat use.
Gallistl et al. (2017) investigated CPs and other contaminants in dish cloths after their regular use
in a conventional household setting in Germany, over a 14-day period. The individual dish cloths
(n = 19) showed a highly variable pattern of contribution from the various classes of polyhalogenated
compounds. When they were detected, MCCPs were by far the most prominent compound class with
up to 55,400 ng per dish cloth (determined by GC-ECNI-MS). In addition to the potential for dermal
exposure, there is a potential for transfer from the dish cloth directly or indirectly into foods in the
kitchen environment (see Section 3.3.3).
Gallistl et al. (2018) also reported SCCPs and MCCPs (and polybrominated diphenyl ethers (PBDEs))
in household oven components, where it is suggested they are used because of their ﬂame retarding
properties. Fat obtained by wipe tests on the inner surface ovens was analysed for several
halogenated ﬂame retardants including PBDEs, decabromodiphenyl ethane (DBDPE), dechlorane plus
(DP), polychlorinated biphenyls (PCBs) in addition to SCCPs and MCCPs (determined by GC-ECNI-MS).
In about 50% of the samples, CPs were present in the mg/g fat range, i.e. three to four orders of
magnitude higher concentrated than the sum of all other compounds measured. The other half of the
samples were <LOD, while the other ﬂame retardants were comparable in CP-positive and CP-negative
samples. The high concentrations of CPs in half of the samples produced strong evidence that these
compounds were released from the oven that was used. This hypothesis was further supported by the
presence of MCCPs at even higher concentrations in the inner components of one dismantled oven.
The authors concluded that the release of substantial amounts of CPs from the oven casing during use
may make a signiﬁcant contribution to human exposure to these compounds. In a previous study,
Bendig et al. (2013) analysed CPs and other halogenated contaminants in fat residues in kitchen hoods
(n = 15). CPs showed the highest concentrations among all compounds analysed, with a mean of
3,500 lg/kg, and for most samples represented around 70% of the total halogenated contaminants
determined in the samples. The authors reported that SCCPs were detected in all samples, while
MCCPs were detected in 3 out of 15 samples.
CPs have also been analysed in domestic polymeric products, and the migration from plastic food
packaging into food simulants have also been reported in one study.
Wang et al. (2018b) analysed SCCPs and MCCPs in domestic polymeric products, such as plastics,
rubber and food packaging (chips, dried fruit and pie packaging). Mean SCCP concentrations in
polyethylene terephthalate (PET), polypropylene (PP), polyethylene (PE) and food packaging were 234,
3,968, 150 and 188 lg/kg, respectively. The concentrations of MCCPs were in general lower, with
mean values of 37.4, 2,537, 208 and 644 lg/kg, respectively. The C11 and C13 congeners dominated
the SCCP proﬁle, while the C14 congeners dominated the MCCP proﬁle. The Cl6, Cl7 and Cl8 congener
groups were predominant in all samples. The same authors studied the migration of CPs from six
plastic food packaging materials into four food simulants to simulate the migration of CPs into
aqueous, acidic, alcoholic and fatty food (Wang et al., 2019c). The overall migration concentrations of
SCCPs were < LOD–350, < LOD–702, < LOD–276 and 164–4,412 ng/L in aqueous (water), acidic (3%
acetic acid), alcoholic (15% ethanol) and fatty food (hexane) simulants. The total migration
concentrations of CPs in hexane food simulant were signiﬁcantly higher than in other food simulants
(one-way ANOVA, p < 0.05). The authors also reported that the average migration efﬁciencies of
SCCPs (12.15%) were signiﬁcantly higher than those of MCCPs (1.51%) except in hexane food
simulants (ANOVA, p < 0.05), and that the shorter chain length and lower chlorinated congener
groups the higher migration efﬁciency.
In conclusion, limited information is available on the effects of food processing on the
concentrations of CPs. The one study identiﬁed on the effects of different cooking practices indicates a
reduction of the SCCP contents in the case of meat (mutton and pork) after frying and stewing,
respectively.
CPs have been found in some common kitchen equipment, e.g. dish cloths, hand blenders and
household oven components. This suggests that food could become more contaminated at the
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preparation stage as a result of transfer during contact (direct or secondary), and this is an important
consideration when making exposure estimates.
CPs have also been found in domestic plastic and food packaging, and the possibility that those
migrate into the food has been studied. Based on the studies available, migration from plastic and
kitchen equipment’s can contribute to the total CP exposure. However, because of the limited available
information exposure levels cannot be estimated.
3.2.4. Levels in humans
Several studies have been found in the literature reporting the levels of SCCPs, MCCPs and LCCPs
in human milk, blood and other human tissues. These studies are described below and in Tables 30,
31 and 32 for human milk, blood and other tissues, respectively, in which details about the analytical
methods used for the CP determination and detection frequency are provided.
3.2.4.1. Human milk
The EU-RAR (2011) reported about an industry sponsored study that determined the levels of
MCCPs in breast milk samples from the UK (Thomas and Jones, 2002, as cited in EU-RAR, 2011). A
total of 22 breast milk samples were analysed from Lancaster and London. MCCPs were found in one
sample at 61 lg/kg fat while the remaining 21 samples were below the LOD. The method LOD ranged
from 16 to 740 ng/g fat.
Thomas et al. (2006) also reported the levels of SCCPs and MCCPs in 25 human milk samples from
UK women from the London area and from the more rural Lancaster area collected between 2001 and
2002. The median SCCP (C10–13) level was 180 lg/kg fat (range of detected values: 49–820 lg/kg fat)
while the median MCCP (C14–17) level was 21 lg/kg fat (range: 6.2 to 320 lg/kg fat). The authors
reported no signiﬁcant differences in the levels between the samples from London and Lancaster
areas. The C11 and C12 homologues groups contributed most to the total SCCP proﬁle, dominated by
the Cl6, Cl7 and Cl8 congeners. The C14 homologues were the highest contributor for the MCCPs,
dominated by the Cl5 and Cl6 congeners.
Samples from human milk collected in Sweden between 1996 and 2010 were analysed for SCCPs and
MCCPs (Darnerud et al., 2012). A total of 12 pooled milk samples from primiparae women were analysed.
The mean (range) level of SCCPs was 107 (45–157) lg/kg fat and of MCCPs was 14 (< 1.1–30) lg/kg fat.
The authors reported that although notable differences were observed in the levels between years, no
trend was obvious.
Tomy (1997) analysed CPs (reported as ‘polychlorinated alkanes’) in three milk samples from Inuit
women from Northern Quebec. The mean (range) concentrations were 12.8 (10.6–16.5) lg/kg fat.
In Germany, Reth et al. (2005) determined the levels of total CPs in six human milk samples from
South Germany. The concentrations ranged from 55 to 275 lg/kg fat. As part of the Bavarian
Monitoring Breast Milk Study, Hilger et al. (2011) reported levels of SCCPs and MCCPs in 60 human milk
samples. For SCCPs only three samples showed levels above the LOQ, with a median concentration of
15.9 lg/kg fat for the samples with detectable levels, and a maximum of 59.9 lg/kg fat. MCCPs were
quantiﬁable in 2/3 of the samples, with a mean (range) value of 115.4 (9.6–903) lg/kg fat.
As part of the WHO/UNEP Coordinated Survey of Human Milk for Persistent Organic Pollutants, the
EU-RL for Halogenated POPs in Feed and Food has determined the levels of SCCPs and MCCPs in
pooled human milk samples from 11 European countries collected between 2014 and 2016. The levels
of SCCPs across countries ranged from 13 to 97 lg/kg fat. The levels of MCCPs across countries
ranged from < LOQ (5.5 lg/kg fat) to 112 lg/kg fat (Kr€atschmer et al., 2019b; see Documentation
provided to EFSA).
Several studies have reported the levels of CPs in human milk samples from China and other Asian
countries.
Cao et al. (2017) analysed SCCPs in pooled human milk samples from Chinese, Korean and Japanese
primiparae or multiparous women. Samples were collected between 2007 and 2010. In the samples
from China, the SCCPs ranged from < LOD (< 20 lg/kg fat) to 54 lg/kg fat. In these samples, the C13
homologues were the ones most frequently detected, and mainly the Cl7 and Cl8 substituted ones. The
Korean and Japanese samples showed levels < LOD, and the authors reported that in the samples that
showed trace levels, the C11 and C12 homologues were the most frequently detected, respectively.
Xia et al. (2017a) analysed pooled human milk samples from urban areas from 28 Chinese
provinces in 2007 and in 2011. Median concentrations of SCCPs were 681 and 733 lg/kg fat in 2007
and 2011, respectively, while the median levels of MCCPs were 60.4 and 64.3 lg/kg fat, respectively.
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The authors reported variations of more than 2 orders of magnitude in the SCCP and MCCP levels
between the different provinces, although the congener group proﬁles were similar among all samples.
The most abundant SCCP congener groups were C10 (47%) and C11 (31%), while for MCCPs it was C14
that accounted for around 70% of the total. The Cl6 and Cl7 congeners dominated the SCCP proﬁle,
while the Cl7 and Cl8 dominated the MCCP proﬁle.
The same authors reported the concentrations of SCCPs and MCCPs in pooled human milk samples
this time from rural areas from 24 Chinese provinces, for the same time frame 2007 and 2011 (Xia
et al., 2017b). The levels were lower than those reported in the urban areas, with median SCCP and
MCCP concentrations in 2007 of 303 and 35.7 lg/kg fat, respectively, and in 2011 of 360 and 45.4 lg/
kg fat. The most abundant congener groups in the rural areas were similar to those reported for the
urban areas, with the C10 and C11 congener groups being the most abundant ones for SCCPs (around
50% and 28% of the total, respectively) and the Cl6 and Cl7 congeners dominating the proﬁle. For the
MCCPs, the C14 congener group was the most abundant (around 80%), as well as the Cl7 and Cl8
congeners. In both studies the levels reported in 2011 were higher than those in 2007.
Yang et al. (2018) analysed 86 human milk samples from 55 healthy Chinese mothers during
different nursing periods in 2014 and 2015. The samples were collected in the Hebei province, a CP-
manufacturing area. The median (range) SCCP level was 1,460 (210–16,200) lg/kg fat. The authors
reported a decrease in the levels according to the nursing period, with the highest levels at childbirth
(median: 770 lg/kg fat) followed by those collected at later periods (370, 140 and 170 lg/kg fat at 1,
3 and 6 months, respectively). The most abundant SCCP congener group was C12 (34.9%) followed by
C10 (29.1%) and C11 (28.8%). This pattern was constant throughout nursing periods. However,
differences were observed between nursing periods on the chlorination degree: the proportion of lower
chlorinated congener groups (Cl6 and Cl7) decreased from childbirth to 3 months, while those with Cl8
increased. The relevance of age, body weight, place of residence, occupation and lipid content of the
human milk samples, as potential factors affecting the concentrations of SCCPs in human milk, was
also analysed. The authors reported that women working indoors had higher levels than those who
worked outdoors, and that no differences in SCCP concentrations were observed between the urban
and rural residents (most residences were near the central city area). It was also reported that no
signiﬁcant linear relationships existed between the concentration of SCCPs and age, body weight
before pregnancy, or lipid content. However, signiﬁcant linear relationships were reported between
SCCP levels and body weight or body mass index at the end of pregnancy. A positive linear relationship
was reported between the concentrations of most individual SCCP congeners and body mass index at
the end of pregnancy. The authors concluded that increased body weight during pregnancy is a key
factor in the accumulation of SCCPs in human milk, and that the internal exposure to SCCPs is higher
in obese people than in the general population. In addition, a signiﬁcant positive linear correlation was
reported between the number of carbon atoms and the body mass index–concentration slope. The
authors also suggested based on the data that the bioaccumulation in human milk of SCCP congeners
with Cl7 or Cl8 is most likely to be affected by BMI.
3.2.4.2. Blood
Four studies reporting the levels of CPs in blood were identiﬁed, with samples collected in China
and Australia. Details are given in Table 31.
Li et al. (2017) determined SCCPs, MCCPs and LCCPs in 50 human blood samples collected in 2012
from an urban area in China. The mean (range) levels were 3,500 (370–35,000), 740 (130–3,200) and
150 (22–530) lg/kg fat for SCCPs, MCCPs and LCCPs, respectively. The SCCP proﬁle in the blood
samples was dominated by the C13 congeners (59%) with a major contribution of the Cl7 to Cl9
congeners. For MCCPs, C14 (42%) and C15 (23%) congeners were dominant with major contributions
from Cl8 to Cl10 congeners. The LCCP proﬁle was dominated by C18 (28%) and C19 (15%) congeners
with major contributions of the Cl8 and Cl9 congeners.
Xu et al. (2019) analysed SCCPs in 50 plasma samples from the general adult population in China.
SCCPs were detected in all but one plasma samples, and the mean (range) SCCP concentrations were
32.0 (< LOD–203) lg/kg ww. The C10 and C11 homologues dominated the congener proﬁle, with major
contribution from the Cl6 and Cl7 congeners.
Qiao et al. (2018) reported the levels of SCCPs and MCCPs in 21 paired samples of maternal and
umbilical cord blood serum collected in China (Beijing) in 2013. The SCCP concentrations in maternal
serum ranged from 2,570 to 57,700 lg/kg fat, while MCCPs ranged from 478 to 6,400 lg/kg fat. For
SCCPs, the C10 homologues were the most abundant ones (77.3–85.6%), with the Cl6 and Cl7
congeners dominating the proﬁle. For MCCPs, C14 was the major carbon chain length (54.1–62.4%),
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dominated by the Cl7 and Cl8 congeners. In cord blood, the levels ranged from 3,750 to 40,500 lg/kg
fat for SCCPs, and from 522 to 4,600 lg/kg fat for MCCPs. As in maternal serum, the C10 homologues
were the predominant ones.
Van Mourik (2018) analysed SCCPs, MCCPs and LCCPs in serum samples of Australian adult males
covering the period 2004–2015. Five time points were used to investigate the time trend of CP levels
(2004–2005, 2008–2009, 2010–2011, 2012–2013 and 2014–2015), and for the time point 2012–2013
pools were collected for different age groups from 0–4 to 46 years old. Two pools consisting of 100
individual samples each were analysed per time point (except for the time point 2014–2015 where one
pool was analysed). LCCPs were below the LOD in all samples, while SCCPs and MCCPs were detected
in 4 and 8 pooled samples, respectively. The mean (range) levels of SCCPs and MCCPs were 300
(< LOD–360) lg/kg fat and 610 (< LOD–930) lg/kg fat, respectively, across time points. The authors
reported no age trend for SCCPs due to the low number of samples >LOD, while for MCCPs an
increased age trend in males above 16 years old was observed, although not signiﬁcant. Regarding
the time trend, SCCPs were < LOD in the pool samples until 2011. Between 2012 and 2015, the SCCP
levels were above the LOD. The author indicated this might have been due to a shift to indoor
applications of SCCPs causing a higher exposure. For MCCPs, a positive time trend correlation was
observed since 2005, explained by the authors as in line with the increasing global production of
MCCPs. In all these Australian samples MCCPs showed higher concentrations than SCCPs. A
comparison of the congener proﬁle in the serum samples across time points was performed, showing
that the abundance pattern in samples collected before 2009 was different from that in samples
collected in the later years. The author also compared the congener proﬁle with air samples from
Australia, showing also in this case a different abundance pattern in both matrices.
3.2.4.3. Other human tissues
In 1985, Schmid and Muller (1985) determined the levels of CPs in one sample of human adipose
tissue. The sample was obtained from a 65-year-old male from Switzerland and the concentration was
200 lg/kg adipose tissue.
Campbell and McConnell (1980) determined the levels of total CPs as C10–20 in human post-mortem
organs and tissues from 20 adults, one adolescent, one child and two infants. In fat, kidney, liver and
brain the levels ranged from < 0.05–0.54, < 0.05–0.4, < 0.05–1.5 and < 0.05–0.08 ppm (i.e. mg/kg)
ww, respectively. CPs as C20–30 showed concentrations below the LOD in most of the samples.
In 2016, Wang et al. (2018c) analysed 54 human placentas collected from a hospital in China
(Henan province). SCCPs were detected in all 54 samples, while MCCPs were found at detectable
levels in 38 of the placentas. Mean (range) SCCP concentrations were 593 (98.5–3,771) lg/kg fat, and
MCCPs were 316 (80.8–954) lg/kg fat. For SCCPs, C10 and C11 were the major carbon chain lengths
(59 and 36%, respectively), dominated by the Cl6 (39%) and Cl7 (52%) congeners. For MCCPs, C15
was the major carbon chain length, dominated by Cl7. The authors reported that C15H25Cl7 accounted
for approximately 80% of the total MCCP content, followed by C14Cl7–8.
3.2.4.4. Conclusions on the levels in human samples
Comparisons between studies should be done carefully due to the differences in and reliability of
methods used for the determination of the CPs. From the few available studies in European countries,
the median SCCPs levels in human milk samples ranged from 15.9 to 180 lg/kg fat, with maximum
values reported at 820 lg/kg fat. MCCPs levels in those studies were lower, with median values
ranging from 14 to 115.4 lg/kg fat, with maximum values of 903 lg/kg fat.
These levels were lower than those reported in human milk samples from Asia (mainly China), in
which the median levels ranged from 303 to 1,460 lg/kg fat with maximum reported values of
16,200 lg/kg fat. MCCPs showed again lower levels, with median concentrations ranging from 35.7 to
64.3 lg/kg fat, with maximum values of 1,501 ng/g fat. As for the food samples, there are some
differences in reports of the most dominant congeners within each group, which may reﬂect the
contaminant proﬁle within the samples, or may reﬂect the analytical methodology used.
Levels in blood samples were only identiﬁed for three Chinese and one Australian studies. In China,
SCCP levels ranged from 370 to 57,700 lg/kg fat (median values of 3,500 lg/kg fat in one study). In
the Australian samples the levels were lower, with a median of 300 lg/kg fat. For MCCPs, the levels in
the Chinese samples ranged from 13 to 6,400 lg/kg fat while in the Australian samples, levels up to
930 lg/kg fat were found (median of 610 lg/kg fat). In the Chinese samples the levels of SCCPs were
higher than those of MCCPs, while in the Australian samples MCCPs showed higher levels than those of
SCCPs.
Chlorinated parafﬁns in feed and food
www.efsa.europa.eu/efsajournal 118 EFSA Journal 2020;18(3):5991
Table 30: Concentrations of chlorinated parafﬁns in human milk samples. The detection frequency is indicated when provided in the study
Reference Country
Number of
samples
Sampling
year
Analytical
method
Concentration (lg/kg fat)
SCCPs MCCPs LCCPs
EUROPEAN COUNTRIES
Thomas and Jones
(2002), as cited in
EU-RAR (2011)
UK 22
Lancaster n = 8,
London n = 14
n.r n.r. n.a. 61
(detected in 1 sample)
–
Thomas et al. (2006) UK 25 (18 individuals
at different times)
London area n = 20
Lancaster area
n = 5
2001–2002 GC-ECNI-
HRMS
Median (range)
180 (49–820)
(detected in 21 samples,
range corresponds to the
samples > LOD)
Median (range)
21 (6.2–320)
(detected in all samples)
–
Darnerud et al. (2012) Sweden 12 pooled samples
(438 individual
samples)
1996–2010 GC-ECNI-
HRMS
Median (range)
107 (45–157)
(detected in all samples)
Median (range)
14 (< 1.1–30)
(detected in 10 samples, the range
corresponds to all samples analysed)
–
Reth et al. (2005) Germany 6 2004–2005 GC-EI-MS/MS Total CPs:
Range: 52–275
Hilger et al. (2011) Germany 60 n.r. GC-ECNI-
LRMS
Median (range)
15.9 (< LOD–59.9)
(detected in 43% of the
samples, the median refers
to the detectable samples)
Median (range)
115.4 (9.6–903)
(detected in 58% of the samples, the
values correspond to the detectable
samples)
–
Kr€atschmer et al.
(2019b, see
Documentation
provided to EFSA)
11 European
countries (a)
11 pooled samples
(each from about
50 ﬁrst-time
mothers)
2014–2016 GC-ECNI-
Orbitrap-
HRMS, GC-EI-
MS/MS
Range across countries:
13–97
Range across countries: < LOQ (5.5)–112 –
OTHER COUNTRIES
Tomy (1997) Canada 3 (samples from
Inuit women in
Northern Quebec)
n.r. GC-MS Total CPs:
Mean (SD) (range)
12.8 (3.2) (10.6–16.5)
Cao et al. (2017) China
(Beijing)
Korea (Busan,
Seoul)
Japan (Kyoto,
Sendai)
Pooled samples
China (n = 17)
Korea (n = 16)
Japan (n = 44)
2007–2010 GC-ECNI-
HRMS
China: < 20–54
(detected in 8 samples)
Korea: < 20
(undetected in all samples)
Japan: < 20
(undetected in all samples)
– –
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Reference Country
Number of
samples
Sampling
year
Analytical
method
Concentration (lg/kg fat)
SCCPs MCCPs LCCPs
Xia et al. (2017a) China
(urban areas)
28 pooled samples
(1,370 individual
samples)
2007,
2011
GC9GC-ECNI-
TOF-MS
Median (min–max)
Year 2007:
681 (170–6,150)
Year 2011:
733 (131–16,100)
(detected in all samples)
Median (min–max)
Year 2007:
60.4 (18.7–350)
Year 2011:
64.3 (22.3–1,501)
(detected in all samples)
–
Xia et al. (2017b) China
(rural areas)
24 pooled samples
(1,412 individual
samples)
2007,
2011
GC9GC-ECNI-
TOF-MS
Median
Year 2007:
303 (68.0–1,580)
Year 2011:
360 (65.6–2,310)
(detected in all samples)
Median
Year 2007:
35.7 (9.05–139)
Year 2011:
45.4 (9.51–146)
(detected in all samples)
–
Yang et al. (2018) China
(Hebei
Province)
86 samples from 55
women at different
nursing periods
(from childbirth to
6 months)
2014–2015 GC-ECNI-MS Median (range)
1460
(210–16,200)
(detected in all samples)
– –
SCCPs: short-chain chlorinated parafﬁns; MCCPs: medium-chain chlorinated parafﬁns; LCCPs: long-chain chlorinated parafﬁns; n.r.: not reported; GC: gas chromatography; MS: mass spectrometry;
HRMS: high-resolution MS; ECNI: electron negative chemical ionisation; TOF-MS: time-of-ﬂight MS; bw: body weight.
(a): Bulgaria, Croatia, the Czech Republic, Georgia, Romania, the Netherlands, Moldova, Lithuania, Belgium, Austria, Switzerland.
Table 31: Concentrations of chlorinated parafﬁns in human blood samples. The detection frequency is indicated when provided in the study
Reference Country
Number of
samples
Sampling
year
Analytical
method
Concentration (lg/kg fat)
SCCPs MCCPs LCCPs
OTHER COUNTRIES
Li et al.
(2017)
China
(urban
area)
50 2012 UPLC-qTOF-
MS
Median (range)
3,500 (370–35,000) (for
samples with > 50% detection
frequency)
Median (range)
740 (130–3,200)
(for samples with > 50%
detection frequency)
Median (range)
150 (22–530)
(for samples with > 50%
detection frequency)
Xu et al.
(2019)
China 50 2015 GC-ECNI-
LRMS
Mean (range) (ww)
32.0 (< LOD–203) (detected in
49 samples)
– –
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Reference Country
Number of
samples
Sampling
year
Analytical
method
Concentration (lg/kg fat)
SCCPs MCCPs LCCPs
Qiao et al.
(2018)
China
(Beijing)
21 paired samples of
maternal and umbilical
cord serum
2013 GC9GC-ECNI-
TOF
Range
Maternal serum
2,570–57,700
Umbilical cord blood
3,750–40,500
(detected in all samples)
Range
Maternal serum
478–6,400
Umbilical cord blood
522–4,600
(detected in all samples)
–
Van Mourik
(2018)
Australia 9 pooled samples (100
individual samples each,
males < 65 years old)
2004–2015 APCI-TOF-
HRMS
Mean (range)
300 (< LOD–360) (detected in 4
samples)
Mean (range)
610 (< LOD–930)
(detected in 8 samples)
Mean (range)
LCCPs: < LOD
(undetected in all samples)
SCCPs: short-chain chlorinated parafﬁns; MCCPs: medium-chain chlorinated parafﬁns; LCCPs: long-chain chlorinated parafﬁns; n.r.: not reported; GC: gas chromatography; MS: mass spectrometry;
HRMS: high-resolution MS; ECNI: electron negative chemical ionisation; TOF-MS: time-of-ﬂight MS; bw: body weight.
Table 32: Concentrations of chlorinated parafﬁns in human samples other than human milk and blood. The detection frequency is indicated when
provided in the study
Reference Country
Number of
samples
Sampling
year
Analytical
method
Concentration (lg/kg fat)
SCCPs MCCPs LCCPs
Schmid and
Muller (1985)
Switzerland Adipose tissue
(n = 1)
n.r. GC-ECNI-MS Total CPs (equivalents to Witaclor-352):
200
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Reference Country
Number of
samples
Sampling
year
Analytical
method
Concentration (lg/kg fat)
SCCPs MCCPs LCCPs
Campbell and
McConnell
(1980)
UK Adipose tissue,
kidney, liver,
brain
Adults
(n = 20, 21–
92 years old)
Adolescent
(n = 1, 17 years
old)
Child
(n = 1, 5 years
old)
Infants
(n = 2, 20 h,
5 months)
n.r. TLC with
argentation
Total CPs (as C10–20, 45–52% chlorination) - reported as mg/kg ww
Fat:
Adults: < 50–540 (analysed and detected in all samples)
Adolescent: < 50
Child: 100
Infants: n.a.
Kidney:
Adults: ND–400 (analysed in 17 samples and detected in 13 samples)
Adolescent: < 50
Child: 60
Infants: 160 (analysed and detected in 1 sample)
Liver:
Adults: n.d.–1,500 (analysed in all samples, detected in 16 samples)
Adolescent: < 50
Child: < 50
Infants: 50 (analysed and detected in all samples)
Brain:
Adults: < 50–80 (analysed in 19 samples, detected in 9 samples)
Adolescent: < 50
Child: n.a.
Infants: n.a.
Total CPs (as C20–30) - reported as mg/kg ww
All samples below the LOD except for the following subjects identiﬁed with a number as in the
study:
Subjects (1), (2) and (3): Fat: 0.1, Kidney: not measured (insufﬁcient tissue available).
Subject (3): Liver 0.08
Subject (20): Fat: 3.5, Liver: 0.2
Subject (15): liver: n.d., Other tissues: not measured (insufﬁcient tissue available).
Subjects (22), (23) and (24): Brain: not measured (insufﬁcient tissue available)
Subject (24): Fat: not measured (insufﬁcient tissue available)
Wang et al.
(2018c)
China Placenta
(n = 54)
2016 GC-qTOF-
HRMS
Mean (range)
593 (98.5–3,771)
(detected in all samples)
Mean (range)
316 (80.8–954)
(detected in 38 samples)
-
SCCPs: short-chain chlorinated parafﬁns; MCCPs: medium-chain chlorinated parafﬁns; LCCPs: long-chain chlorinated parafﬁns; n.d.: not detected; n.r.: not reported; TLC: thin-layer
chromatography; GC: gas chromatography; MS: mass spectrometry; HRMS: high-resolution MS; qTOF: quadrupole time-of-ﬂight; bw: body weight.
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3.3. Dietary exposure assessment
3.3.1. Current dietary exposure assessment for humans
3.3.1.1. Mean and high dietary exposure
Chronic dietary exposure resulting from ‘Fish meat’ consumption was estimated for the consumers
only population across Europe following the methodology described in Section 2.5. A total of 38
dietary surveys, carried out in 22 different Member States, were selected for this assessment. These
dietary surveys and the number of subjects available per age class are described in Annex A (Tables
2, 3, 4).
Two exposure assessments were carried out for SCCPs and for MCCPs. The mean and 95th
percentile of chronic exposure estimates at the LB and UB, obtained for different age groups, are
shown in Tables 33 and 34, respectively. Detailed mean and 95th percentile dietary exposure
estimates calculated for each dietary survey are presented in Annex A (Tables 2, 3).
For SCCPs, the mean UB exposure ranged from 1.9 to 35 ng/kg bw per day across dietary surveys
and age groups. At the 95th percentile exposure, the UB estimates ranged from 5.0 to 87 ng/kg bw
per day. For MCCPs, the mean UB exposure ranged from 3.2 to 59 ng/kg bw per day. At the 95th
percentile exposure, the UB estimates ranged from 8.5 to 148 ng/kg bw per day. The lowest
exposures were found in the Adult groups while the highest were for Toddlers.
Table 33: Mean and 95th percentile estimates of chronic exposure resulting from ﬁsh consumption
(for ﬁsh consumers only) at the LB and UB for SCCPs
Age class(a) Number of surveys
Mean dietary exposure (ng/kg bw per day)
Minimum Median Maximum
LB UB LB UB LB UB
Infants 11 4.7 4.7 13 13 33 34
Toddlers 14 3.2 3.2 13 13 34 35
Other children 19 4.0 4.1 12 12 19 19
Adolescents 18 2.0 2.0 6.6 6.6 12 12
Adults 19 1.9 1.9 6.1 6.1 8.2 8.3
Elderly 18 2.2 2.2 6.5 6.5 8.1 8.1
Very elderly 14 3.3 3.3 6.3 6.4 14 15
Age class(a) Number of surveys
95th percentile dietary exposure (ng/kg bw per day)(b)
Minimum Median Maximum
LB UB LB UB LB UB
Infants 5 10 10 25 25 77 77
Toddlers 8 9.8 9.8 32 32 86 87
Other children 17 11 12 28 28 52 52
Adolescents 15 5.8 5.9 16 16 33 33
Adults 18 4.9 5.0 15 16 20 21
Elderly 14 5.6 5.6 16 16 20 20
Very elderly 7 10 10 16 16 17 17
SCCPs: short-chain chlorinated parafﬁns; bw: body weight; LB: lower bound; SCCPs: short-chain chlorinated parafﬁns; UB: upper
bound.
(a): Section 2.3 describes the age range within each age class.
(b): The 95th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be
statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Chlorinated parafﬁns in feed and food
www.efsa.europa.eu/efsajournal 123 EFSA Journal 2020;18(3):5991
3.3.1.2. Exposure of infants through breastfeeding
For the exposure assessment of breastfed infants under 6 months of age, a median age of three
months was selected, equivalent to a body weight of about 6.1 kg, with an estimated average daily
milk consumption of about 800 mL and a high consumption of 1,200 mL, each with a mean fat
content of 3.5%.
The occurrence levels were taken from the information provided to EFSA on the levels in human
milk pools collected from 11 European countries between 2014 and 2016 and analysed within the
WHO/UNEP Coordinated Survey of Human Milk for POPs (see Section 3.2.4).
The exposure to SCCPs for breastfed infants with average and high human milk consumption was
estimated to range from 60 to 445 ng/kg bw per day, and from 90 to 668 ng/kg bw per day,
respectively. The exposure to MCCPs for breastfed infants with average and high human milk
consumption was estimated to range from < 25 to 514 ng/kg bw per day, and from < 38 to 771 ng/kg
bw per day, respectively.49
The Panel noted that since these were pooled samples, it was not possible to estimate speciﬁc
values for highly exposed individuals.
3.3.2. Previously reported dietary exposure assessments
Some international bodies have estimated the dietary exposure to CPs while performing their risk
assessments related to the presence of CPs in food and the environment (see Section 1.3.5). Other
studies have described occurrence data in different foodstuff (see Section 3.2.2.1) or in breast milk
samples (see Section 3.2.4) and have then estimated the exposure for the adult population or
breastfed infants, respectively.
A summary of these studies is presented below and in Tables 35 (dietary exposure) and 36
(breastfeeding) for SCCPs, MCCPs and LCCPs, respectively. Interpretation and comparison between
Table 34: Mean and 95th percentile estimates of chronic exposure resulting from ﬁsh consumption
(for ﬁsh consumers only) at the LB and UB for MCCPs
Age class(a) Number of surveys
Mean dietary exposure (ng/kg bw per day)
Minimum Median Maximum
LB UB LB UB LB UB
Infants 11 8.0 8.0 22 22 57 57
Toddlers 14 5.5 5.5 22 22 59 59
Other children 19 6.9 6.9 21 21 33 33
Adolescents 18 3.4 3.4 11 11 20 20
Adults 19 3.2 3.2 10 10 14 14
Elderly 18 3.8 3.8 11 11 14 14
Very elderly 14 5.6 5.6 11 11 25 25
Age class(a) Number of surveys
95th percentile dietary exposure (ng/kg bw per day)(b)
Minimum Median Maximum
LB UB LB UB LB UB
Infants 5 18 18 42 43 132 132
Toddlers 8 17 17 54 55 147 148
Other children 17 19 20 47 48 89 89
Adolescents 15 10 10 27 28 57 57
Adults 18 8.5 8.5 26 27 35 35
Elderly 14 9.5 9.6 27 27 34 34
Very elderly 7 17 17 27 27 29 29
MCCPs: medium-chain chlorinated parafﬁns; bw: body weight; LB: lower bound; MCCPs: medium-chain chlorinated parafﬁns; UB:
upper bound.
(a): Section 2.3 describes the age range within each age class.
(b): The 95th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be
statistically robust (EFSA, 2011a). Those estimates were not included in this table.
49 Using the LOQ value of 5.5 ng/g fat as the numerical value for the estimation.
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these exposure assessments should be done with care due to different sampling methodologies, the
different consumption habits between countries, and due to the differences in and reliability of the
methods used for the determination of the CPs. Levels reported in the studies have been expressed as
ng/kg bw per day for comparison.
No studies were identiﬁed in the literature that estimated the exposure to CPs for farm animals,
horses and companion animals.
3.3.2.1. SCCPs
The EU-RAR (2000) estimated the daily human intake of SCCPs from various sources using the
predictive EUSES (EU System for the Evaluation of Substances) model to estimate concentrations in
various food, air and drinking water. However, uncertainty was reported in the concentrations of SCCPs
estimated by this model in the different matrices. Based on data reported in published studies, e.g.
from Campbell and McConnell (1980), a maximum human intake from food of 20,000 ng/kg bw per
day (assuming a 70-kg bw person and 100% absorption via the oral route) was estimated. The major
contributor was ﬁsh and shellﬁsh. In its updated risk assessment report of 2008 in relation to human
health (EU-RAR, 2008), exposure of infants via breast milk and cow’s milk was considered. Intake
estimates were not provided in the updated report on SCCPs, but it is mentioned that the exposure via
breast milk and cow’s milk for SCCPs was estimated as it was done for MCCPs (EU-RAR, 2011).
Regarding breast milk, it is mentioned that the 95th percentile level of 680 lg/kg fat from a very well
conducted survey was used for the risk characterisation. Regarding cow’s milk, a concentration of
16 lg/kg fat is mentioned as the worst-case estimate to be used for the risk characterisation.
Health Canada (2008) estimated the exposure of the Canadian population divided in six age
groups, from 0 to 60 + years old, considering uptake via ambient air, indoor air, drinking water, food
and soil based on measured concentrations from published studies. For all age groups, food was the
major source contributing virtually to 100% of the total intake. For breastfed infants, an intake of
1,700 ng/kg bw per day was estimated, based on the levels in human milk reported by Tomy (1997)
and assuming a consumption of 0.75 kg of human milk per day. For formula fed infants, the intake
was estimated at 10 ng/kg bw per day, assuming a consumption on 0.8 L per day of reconstituted
formula. The intake estimated for the remaining age groups ranged from 5,140 ng/kg bw per day for
adults > 60 years of age, to 25,970 ng/kg bw per day for infants who were not formula fed (i.e. those
being introduced solid foods) (Health Canada, 2008).
UK-COT (2009) analysed the levels of SCCPs in various food samples in 2007 on sale in the UK
market. Due to the limited number of samples analysed, the authors estimated an extreme worst case
as if all solid food consumed by an adult contained SCCPs at the level of 6.0 lg/kg, the highest level
determined in a sample of freshwater eel. The exposure was estimated at 120 ng/kg bw per day for
the 97.5th percentile adult consumer. For the age group 4–6 years old, the exposure was estimated at
290 ng/kg bw per day for the 97.5th percentile child.
Yuan et al. (2017) measured the levels of SCCPs (and MCCPs and LCCPs) in Swedish food market
baskets. The mean dietary intake of SCCPs from all food groups considered for Swedish consumers
was 18 ng/kg bw per day (based on a mean body weight of 76.6 kg).
Kr€atschmer et al. (2019) estimated the exposure of SCCPs (and MCCPs) via the consumption of
salmon only available at German supermarkets (see Section 3.2.2.1 for details of the study). Based
on a ﬁsh and seafood consumption of 2.5–5 g per day in Germany, the SCCP exposure ranged from
1.22–19.1 and from 1.98–20.3 ng/kg bw per week for adult females and males, respectively (that
would correspond on a daily basis to 0.17–2.7 and 0.28–2.9 ng/kg bw per day, respectively).
Sprengel et al. (2019) also estimated the exposure to CPs from the ingestion of oil-based dietary
supplements available from the German online market assuming a consumption according to label (1–4
capsules of different size per day) and based on the concentration of the palm-oil based supplements
that contained the highest CP levels (see Section 3.2.2). The authors estimated an SCCP intake of
5.5 lg/day, corresponding to 77.7 ng/kg bw per day considering a 70.8 kg bw. The CONTAM
Panel noted that exposure from these dietary supplements could be in the same order of magnitude as
from the consumption of ﬁsh meat (see Section 3.3.1).
Several studies have estimated the dietary intake of SCCPs in Japan, China and Korea and are
summarised below. Details on the occurrence of SCCPs in these studies are provided in
Section 3.2.2.1 (for food) or Section 3.2.4 (for human milk).
In a Market Basket Study in Japan (Iino et al., 2005), the median intakes were higher for infants
(1-year-old males, 340–370 ng/kg bw per day), than for children/adolescents (5–15 years old, 120–
200 ng/kg bw per day) and adults (20–60 years old, 110–120 ng/kg bw per day). In adults > 60 years
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old the exposure was estimated to be the lowest, at 89–97 ng/kg bw per day. Congeners C10 and C11
were the most abundant ones, as well as the Cl6 to Cl8 congeners. The categories ‘fats’, ‘ﬁsh’ and
‘shellﬁsh’ were the highest contributors to the dietary intake.
Harada et al. (2011) estimated the exposure to SCCPs (C10–C13) via duplicate 24 h food composite
samples from Chinese, Japanese and Korean adults collected in the 1990s (archived samples) and
between 2007 and 2009. The estimated daily intake (in ng/kg bw per day) in Beijing was much higher
in 2009 (range: 390–1,000) than in 1993 (range: ND–36). In Japan, the estimated intakes were lower
than those in Beijing, and were similar between the two time periods studied (ND–76 vs. ND–93, in
the 1990s and in 2009, respectively). In Korea, SCCPs were not detected in the 1994 samples, and in
2009 the exposure was reported to range from ND to 50 ng/kg bw per day (based on detection in one
sample).
Gao et al. (2018) estimated the SCCP exposure of the general population in Beijing (China) through
a duplicate diet study. The mean (range) exposure for adults was 611 (316–1,101) ng/kg bw per day.
The same authors estimated the dietary intake of SCCPs by the Chinese population based on the
analysis of 122 food samples from markets in Beijing (China) collected between 2014 and 2016 (Gao
et al., 2019). The mean dietary exposure, excluding the oil samples, were 221 to 227 ng/kg bw per
day for adult male and females, respectively. The 95th percentile intakes were 747 and 725 ng/kg bw
per day, respectively. When the oil samples were included, the mean intake raised to 1,106 and
1,136 ng/kg bw per day and the 95th percentile intake from 3,544 and 3,594 ng/kg bw per day, for
males and females, respectively. In a second analysis, the authors estimated the dietary intake based
on the occurrence data from seven foodstuff that had been previously cooked (see Section 3.2.3 for
further details). The dietary exposure was estimated to be 145 ng/kg bw per day, lower than that
estimated using the raw food concentrations.
Huang et al. (2018) assessed the dietary exposure to SCCPs for the general Chinese population
through meat and meat products that were prepared according to local cooking methods, steaming,
frying, boiling and pan-frying before analysis and collected in 2011 from 20 Chinese provinces. The
exposure was estimated considering the data on meat consumption of a standard Chinese adult male
(average body weight of 63 kg). The intake estimates ranged from 20 to 560 ng/kg bw per day across
provinces.
Dietary exposure to SCCPs from Chinese cooking oil and fried confectionery products was estimated
by Cao et al. (2015). The estimated SCCP dietary intakes from the cooking oil ranged from < 780 to
38,000 ng per day. The estimated mean dietary intake of SCCPs was 14,800 ng per day for residents
of Beijing. The estimated dietary intakes in fried confectionery ranged from 590 to 49,700 ng per day.
The authors concluded that cooking oil might be one of the main sources of SCCPs in the Chinese diet
(Cao et al., 2015).
The estimated intakes of SCCPs (and MCCPs) by adults and children via the consumption of home-
produced chicken eggs in two time periods from an area that was once an e-wasted site was reported
by Zeng et al. (2018). Mean intakes of SCCPs for adults were 65.4 (year 2013) and 274 (years 2016)
ng/kg bw per day. For children, higher estimates were reported, of 281 (years 2013) and 1,180 (year
2016) ng/kg bw per day.
Wang et al. (2019b) estimated the SCCP dietary intake from cereals and legumes to be 5,185 and
529 ng/kg bw per day, respectively, for an adult Chinese male.
Chen et al. (2018) estimated the dietary intake of SCCPs based on the analysis of several locally
produced foods collected from an e-waste recycling industrial park and its surrounding villages in
China. For adult local residents, the median dietary intake was estimated at 15,400 ng/kg bw per day,
while in children it was 34,100 ng/kg bw per day. The main contributors to the dietary intake were
vegetables, ﬁsh and rice, followed by poultry and pork meat.
Three studies estimated the lactational exposure to SCCPs in infants from China, Korea and Japan.
Xia et al. (2017b) estimated the intake based on the levels in human milk samples from China
collected in 2007 and in 2011. The authors assumed an average breast milk intake of 750 mL per day
and a body weight of 6 kg. The median (range) estimated daily intake (in ng/kg bw per day) was
1,310 (357–6,320) in 2007 and 1,520 (344–8,650) in 2011.
Lower mean intakes were reported by Cao et al. (2017), that estimated the intake based on human
milk samples from China, Korea and Japan collected the same years. The authors assumed a human
milk consumption of 600 g per day and a body weight of 7.3 kg for a 1-year-old infant. In Japan and
Korea, the mean exposure via breast milk was similar (247 and 242 ng/kg bw per day, respectively),
while in China it was higher (337 ng/kg bw per day).
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Higher estimates were reported by Yang et al. (2018), that estimated the breastfed infant SCCP
intake based on the analysis of 86 human milk samples collected at different nursing periods in the
period 2014 and 2015 from a CP-manufacturing area in China. The mean intakes were 13,000, 7,100
and 2,500 ng/kg bw per day for infants at 1, 3 and 6 months of age, respectively (considering a body
weight of 4.9, 7.37 and 8.41 kg, and intakes of 673, 702 and 756 mL human milk per day,
respectively).
3.3.2.2. MCCPs
The EU-RAR (2011) estimated the exposure to MCCPs. The total daily human exposure from
regional sources (most relevant for population exposure estimates) was estimated to be 130 ng/kg bw
per day, and the highest local daily human exposure was estimated to be 16,000 ng/kg bw per day.
For breastfed infants, a daily intake for the ﬁrst three months of life was estimated at 305 ng/kg bw
per day. Based on levels in cow’s milk reported in the literature, an exposure of 145 ng/kg bw per day
was estimated for infants fed cow’s milk.
As for SCCPs, Health Canada (2008) also estimated the exposure to MCCPs from different sources.
In this case, exposure from ambient or indoor air was not considered since concentration in those
matrices in Canada or elsewhere were not identiﬁed at the time of the report. As for SCCPs, food was
virtually the major source of the total intake. No estimate was reported for breastfed infants, while for
formula fed infants an intake of 50 ng/kg bw per day was estimated. The largest total exposure was
found for non-formula fed infants (25,480 ng/kg bw per day), while the lowest was for adults above
60 years (3,470 ng/kg bw per day).
UK-COT (2009) analysed the levels of MCCPs in various food samples in 2007 on sale in the UK
market. Due to the limited number of samples analysed, the authors estimated an extreme worst case
as if all solid food consumed by an adult contained MCCPs at the level of 31.9 lg/kg, the highest level
determined in freshwater eel samples. The exposure was estimated at 630 ng/kg bw per day for the
97.5th percentile adult consumer. For the age group 4–6 years old, the exposure was estimated at
1,600 ng/kg bw per day for the 97.5th percentile child.
Yuan et al. (2017) measured the levels of MCCPs in Swedish food market baskets and estimated
the exposure to compare it then to the estimated exposure from hand blender use (see also
Section 3.2.3). The mean dietary intakes of MCCPs from all food groups considered for Swedish
consumers was 39 ng/kg bw per day (based on a mean body weight of 76.6 kg).
Kr€atschmer et al. (2019) estimated the exposure of MCCPs via the consumption of salmon available
at German supermarkets to range from 1.72–15.9 and from 2.79–16.8 ng/kg bw per week for adult
females and males, respectively.
Sprengel et al. (2019) also estimated the exposure to CPs from the ingestion of oil-based dietary
supplements assuming a consumption according to label (1–4 capsules of different size per day) and
based on the concentration of the palm-oil based supplements that contained the highest CP levels
(see Section 3.2.2). The authors estimated an MCCP intake of 38 lg/day, corresponding to around
537 ng/kg bw per day considering a 70.8 kg bw. The intake of MCCPs was higher than that of SCCPs,
and the authors noted that these intakes were on average around 4 times higher or 13 times higher
(for SCCPs and MCCPs, respectively) compared to that estimated from market basket studies.
Gao et al. (2018) estimated the MCCP exposure of the general population in Beijing (China)
through a duplicate diet study (see Section 3.2.2.2 for the description of the study and details on
the occurrence). The exposure levels to MCCPs for adults ranged from 153 to 1,307 ng/kg bw per day,
and for toddlers ranged from 164 to 1,465 ng/kg bw per day.
As for SCCPs, Huang et al. (2018) estimated the dietary intake to MCCPs through meat and meat
products in China. The intake estimates ranged from 3 to 31 ng/kg bw per day across provinces, with
50th and 95th percentile estimated daily intakes of 4.7 and 31 ng/kg bw per day.
The estimated intakes of MCCPs by adults and children via the consumption of home-produced
chicken eggs in two time periods from an area that was once an e-wasted site was reported by Zeng
et al. (2018). Mean intakes of MCCPs for adults were 151 (year 2013) and 193 (years 2016) ng/kg bw
per day. For children, higher estimates were reported, of 651 (year 2013) and 829 (year 2016) ng/kg
bw per day.
Chen et al. (2018) also estimated the dietary intake of MCCPs based on the analysis of several
locally produced food collected from an e-waste recycling industrial park and its surrounding villages.
For adult local residents, the median dietary intake was estimated at 19,500 ng/kg bw per day, while
in children it was 43,300 ng/kg bw per day. The MCCP intakes were higher than those for SCCPs.
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Wang et al. (2019b) estimated the MCCP dietary intake of cereals and legumes to be 3,093 and
295 ng/kg bw per day, respectively, for an adult Chinese male.
Regarding lactation exposure, Xia et al. (2017b) also estimated the exposure to MCCPs based on
milk samples collected in 2007 and in 2011. The median (range) estimated intake was 152 (43.0–554)
ng/kg bw per day in 2007 and 212 (43.1–450) ng/kg bw per day in 2011. Those values were lower
than those estimated for SCCPs.
3.3.2.3. LCCPs
Yuan et al. (2017) measured the levels of LCCPs (and SCCPs and MCCPs, see above) in Swedish
food market baskets and estimated the exposure to compare it then to the estimated exposure from
hand blender use (see also Section 3.2.3). The mean dietary intakes of LCCPs from all food groups
considered for Swedish consumers was 2.0 ng/kg bw per day.
In 2012, Health Canada performed an update of its previous exposure assessment of the Canadian
population to LCCPs (C18H37Cl1, C18H22Cl16 and C18H30Cl8) from different sources (Health Canada,
2008, 2012). Exposure was estimated using a Farﬁeld Human Exposure model (FHX 2008). This model
brings together information on chemical partitioning, degradation, environmental fate and transport,
and food web bioaccumulation for assessing human age-class-speciﬁc exposure from chemicals
released to the environment, to calculate steady-state concentrations in, e.g. air, water and soil and
various food groups, including fruits, vegetables, milk, dairy, ﬁsh and meat based on the unit emission
rate. Food was again the major source of the total intake. For C18H37Cl1, no estimate was reported for
breastfed infants, while for formula fed infants an intake of 0.000226 ng/kg bw per day was
estimated. The largest total exposure was found for infants 0.5–4 years old (24 ng/kg bw per day)
while the lowest was for adults above 60 years (7 ng/kg bw per day). The intake estimates for C18H22Cl16
and C18H30Cl8 were reported at an order of magnitude lower than C18H37Cl1. The authors predicted UB
intakes for the C>20 type to range from 13 ng/kg bw per day (> 60 years old) to 40 ng/kg bw per day
(0.5–4 years old).
3.3.2.4. Total CPs
An estimate of the dietary intake for adults in Germany based on the occurrence data in raw food
samples (meat and offal, eggs, milk and dairy, and fats and oils) collected from supermarkets in
Germany has been reported by Kr€atschmer et al. (2019). The exposure to total CPs (sum of SCCPs
and MCCPs) based on raw food for adults was 240 or 860 ng/kg bw per day, considering mean and
maximum total CP concentrations of each food or sample group, respectively. The highest contributor
to the exposure was from processed vegetable oils. For the exposure assessment, the results for mean
and maximum total CP contamination level of each food or samples group, and summary statistics
from the EFSA Comprehensive Food Consumption Database were used, resulting in conservative
estimates. The mean exposure for the general adult population considering the full meals ranged from
4.3 to 22 ng/kg bw per day (meat based) and from 2.4 to 3.5 ng/kg bw per day (vegetarian),
although a possible underestimation by using the consumption data referring only to ‘composite food’
for the exposure estimation was reported. The mean exposure from the total diet samples analysed
ranged from 47 to 190 ng/kg bw per day.
3.3.2.5. Impact of bioaccessibility on exposure estimates
Cui et al. (2109) suggested that studies that used the total concentrations of SCCPs for exposure
estimates without considering their bioaccessibility may overestimate dietary intakes. Factors such as
lipid and protein content of the food may have an inﬂuence but bioaccessibility was in the range of
33% to 84%, meaning that only about half of the SCCPs in foods are bioavailable.
3.3.2.6. Conclusions on the dietary exposure assessments reported in the literature
The studies available have estimated the intake of CPs via food based on the analysis of speciﬁc
food categories or via food market basket or duplicate diet studies. The majority of the studies were
carried out in Asia and only few were carried out in European countries. Interpretation and comparison
between these exposure assessments should be done with care due to different sampling
methodologies, different consumption habits between countries, and due to the differences in and
reliability of the methods used for the determination of the CPs.
In Europe, from a food market basket study carried out in Sweden, the dietary intake of SCCPs,
MCCPs and LCCPs in adults was estimated to be 18, 39 and 2.0 ng/kg bw per day, respectively. From
another more recent study in Germany, the total SCCP and MCCPs exposure was estimated to be
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240–860 ng/kg bw per day. From a study on dietary supplements available from the German online
market, the CONTAM Panel noted that exposure from these products could be in the same order of
magnitude as from the consumption of ﬁsh meat as estimated by EFSA.
In market basket and duplicate diet studies carried out in China, higher median intakes were
reported, ranging from 110 to 1,101 ng/kg bw per day for SCCPs, and from 153 to 1,307 ng/kg bw
per day for MCCPs (no data on LCCPs). Thus, the few available studies suggest that MCCPs might
contribute more than SCCPs to the dietary intake.
Regarding breastfeeding, studies on SCCPs were only available for China, Japan and Korea. In
those studies, mean intakes of 242 ng/kg bw per day were reported from Korean breast milk samples
and up to 2,500 ng/kg bw per day from Chinese breast milk samples. For MCCPs, the one study
identiﬁed in China reported medians of 212 ng/kg bw per day, and the EU-RAR (2011) estimated a
daily intake for the ﬁrst three months of life at 305 ng/kg bw per day of MCCPs from breast milk.
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Table 35: Dietary exposure assessments to chlorinated parafﬁns reported in the literature
Reference Country
Sample type
Number of samples
Year
Analytical
method
Estimate of exposure (ng/kg bw per day) Main contributors
to the exposure(a)SCCPs MCCPs LCCPs
EUROPEAN COUNTRIES
EU-RAR (2000) As reported
by Campbell
and
McConnell
(1980) and
other reports
Butter, margarine,
cheese, beef meat,
sheep offals, oils of
plant and animal
origin, coffee, tea,
beer, wine, fruits(a)
1977–1978 Thin-layer
chromatography
with argentation
Adults: 20,000 – – Fish, shellﬁsh
EU-RAR (2011) Europe Cows’ milk (from
Thomas and Jones,
2002)
n.r. n.r. – Regional sources:
130
Highest local:
16,000
Infants fed cow
milk:
145
– –
UK-COT (2009)(c) UK Food (n = 45): ﬁsh,
butter, pork sausage,
bread, fruit, beef,
lamb, milk products,
eggs, poultry, cod liver
oil
2007 GC-HRMS 97.5th percentile
consumers:
4–6 years old: 290
Adults: 120
97.5th percentile
consumer
4–6 years old:
1,600
Adults: 630
– –
Yuan et al.
(2017)
Sweden Food market basket
study
2015 APCI-qTOF-MS Adults:
18
Adults:
39
Adults:
2.0
Sugar/sweets, dairy
products, fats/oil,
ﬁsh(b)
Kr€atschmer
(2019a, see
Documentation
provided to EFSA)
Germany Meat and offals, eggs,
milk and dairy, ﬁsh,
fats and oils
Full meals (meat
based and vegetarian)
Total diet samples
2018–2019 GC-ECNI-
Orbitrap-HRMS
Total CPs
Adults: 240–860
Full meals:
Meat based: 4.3–22
Vegetarian: 2.4–3.5
Total diet samples: 47–190
Processed
vegetable oils
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Reference Country
Sample type
Number of samples
Year
Analytical
method
Estimate of exposure (ng/kg bw per day) Main contributors
to the exposure(a)SCCPs MCCPs LCCPs
Kr€atschmer et al.
(2019)
Germany Fish (salmon) 2018 GC-Orbitrap-MS Adult females:
1.22–19.1 ng/kg
bw/week
Adult males:
1.98–20.3 ng/kg
bw/week
Adult females:
1.72–15.9 ng/kg
bw/week
Adults males:
2.79–16.8 ng/kg
bw/week
– –
Sprengel et al.
(2019)
Germany
(available
from the
German
online
market)
Oil-based
supplements: vitamin
E supplements, marine
oil supplements, other
oil supplements
n.r. GC-ECNI-MS Adults:
77.7
Adults:
537
– –
OTHER COUNTRIES
Health Canada
(2008)
As reported
by Campbell
and
McConnell
(1980) and
other studies
Based on
concentrations in food
reported in the
literature for dairy,
fats, fruits, vegetables,
cereal products, meat
and poultry, ﬁsh, eggs,
sugar, soft drinks,
alcohol, coffee, tea
1977–1978 Liquid–solid
adsorption
chromatography
Infants
Formula fed: 10
Non-formula fed:
25,970
0.5–4 years old:
24,260
5–11 years old:
16,440
12–19 years old:
9,020
20–59 years old:
7,180
> 60 years old:
5,140
Infants
Formula fed: 50
Non-formula fed:
25,480
0.5–4 years old:
18,480
5–11 years old:
11,640
12–19 years old:
6,300
20–59 years old:
4,690
> 60 years old:
3,470
– –
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Reference Country
Sample type
Number of samples
Year
Analytical
method
Estimate of exposure (ng/kg bw per day) Main contributors
to the exposure(a)SCCPs MCCPs LCCPs
Health Canada
(2012)
– Farﬁeld Human
Exposure (FHX) model
to calculate steady-
state concentrations in
the multi-media
compartments
including various food
groups, including
fruits, vegetables,
milk, dairy, ﬁsh and
meats
based on the unit
emission rate
– – – – C18H37Cl1 (UB
estimates):
>60 years old: 7
0.5–4 years old: 24
C18H22Cl16 and
C18H30Cl8 :
an order of
magnitude lower
than C18H37Cl1
C>20:
>60 years old:
13
0.5–4 years old:
40
–
Iino et al. (2005) Japan Market basket study
(11 food categories:
grain crops, seeds/
potatoes, sugar, fats,
vegetables, fruit, ﬁsh,
shellﬁsh, meat, eggs,
milk)
2003 GC-ECNI-HRMS Range of median
intakes
1 year old:
340–370
5–15 years old:
120–200
20–60 years old:
110–120
>60 years old:
89–97
– – Fats, ﬁsh, shellﬁsh
Harada et al.
(2011)
China
Korea
Japan
24 h food composite
samples
China: 10 adults
Korea: 10 adults
Japan: 40 adults
1990s,
2007–2009
GC-ECNI-HRMS Range of intakes
China
1993: n.d.–36
2009: 390–1,000
Japan
1990s: n.d.–76
2009: n.d–93
Korea
1994: ND
2007: ND–50
– – –
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Reference Country
Sample type
Number of samples
Year
Analytical
method
Estimate of exposure (ng/kg bw per day) Main contributors
to the exposure(a)SCCPs MCCPs LCCPs
Huang et al.
(2018)
China Meat and meat
products from 20
Chinese provinces
2011 GC9GC-ECNI-
TOF
Median (range)
130 (20–560)
Median (range)
4.7 (3–31)
– –
Cao et al. (2015) China Cooking oil (n = 49)
Fried confectionery
products (n = 20)
2010–2012 GC-ECNI-HRMS Mean (range)
Cooking oil:
< 780 to
38,000 ng/day
Fried confectionery
products:
590 to 49,700 ng/
day
– – –
Chen et al.
(2018)
China
(e-waste
recycling
industrial
park and its
surrounding
villages)
Locally produced
staple food samples
(n = 92)
2016–2017 GC/ECNI-LRMS Median:
Adults: 15,400
Children: 34,100
Median:
Adults: 19,500
Children: 43,300
– Vegetables, Cereals,
Fish
Gao et al. (2018) China Duplicate Diet study 2016 GC-TOF-HRMS Mean (range)
Adults:
611 (316–1,101)
mean (range)
Toddlers:
705 (164–1,465)
Adults:
n.r. (153–1,307)
– –
Chlorinated parafﬁns in feed and food
www.efsa.europa.eu/efsajournal 133 EFSA Journal 2020;18(3):5991
Reference Country
Sample type
Number of samples
Year
Analytical
method
Estimate of exposure (ng/kg bw per day) Main contributors
to the exposure(a)SCCPs MCCPs LCCPs
Gao et al. (2019) China 122 food samples
7 food samples cooked
(duplicate food
approach)
2014–2016 GC-ECNI-LRMS Estimate without
cooking oil
Mean
Males: 221
Females 227
P95
Males: 747
Females: 725
Estimate with
cooking oil:
Mean
Males: 1,106
Females: 1,136
P95
Males: 3,544
Females: 3,594
Duplicate food
approach (cooked
food): 145
– –
Zeng et al.
(2018)
China
(collection
area used to
be an e-
waste site)
Home-produced eggs
(n = 68):
year 2013 (n = 38),
year 2016 (n = 30)
2013, 2016 GC-ECNI-MS Mean:
Adults:
Year 2013: 65.4
Year 2016: 274
Children:
Year 2013: 281
Year 2016: 1,180
Mean:
Adults:
Year 2013: 151
Year 2016: 193
Children:
Year 2013: 651
Year 2016: 829
– –
Wang et al.
(2019b)
China Cereals and legumes
(n = 19 pool samples
each)
2011 GC9GC-TOF Male adult:
Cereals: 5,185
Legumes: 529
Adult male:
Cereals: 3,093
Legumes: 295
– –
SCCPs: short-chain chlorinated parafﬁns; MCCPs: medium-chain chlorinated parafﬁns; LCCPs: long-chain chlorinated parafﬁns; n.r.: not reported; GC: gas chromatography; MS: mass spectrometry;
HRMS: high-resolution MS; ECNI: electron negative chemical ionisation; TOF-MS: time-of-ﬂight MS; LCCPs: long-chain chlorinated parafﬁns; MCCPs: medium-chain chlorinated parafﬁns; SCCPs:
short-chain chlorinated parafﬁns; bw: body weight.
(a): For studies with several food categories analysed and when the information was available from the study.
(b): The authors noted that the contribution from the dairy group is entirely based on values below LOQ (Yuan et al., 2017).
(c): The authors noted that since the concentrations were measured and reported in a small number of samples, they may not be representative of these foods and it is not possible to calculate a
reliable estimate of UK dietary exposure. The authors estimated an extreme worst-case basis by considering that all solid food consumed by an adult (1.5 kg per day for the 97.5th percentile
consumer) contained SCCPs or MCCPs at the levels determined in freshwater eel (UK-COT, 2009).
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Table 36: Exposure to chlorinated parafﬁns for breastfed infants reported in the literature
Reference Country
Number of
samples
Year Analytical method
Estimate of exposure (ng/kg bw per day)
SCCPs MCCPs LCCPs
EUROPEAN COUNTRIES
EU-RAR (2011) Europe Breast milk (from
Thomas et al., 2003)
n.r. n.r. – 350 –
OTHER COUNTRIES
Health Canada
(2008)
As reported by
Tomy (1997)
Breast milk 1977–1978 Liquid–solid adsorption
chromatography
1,700 – –
Xia et al. (2017b) China Breast milk
24 pooled samples
(1,412 individual
samples)
2007, 2011 GC9GC-ECNI-TOF-MS Median (range)
Year 2007:
1,310 (357–6,320)
Year 2011:
1,520 (344–8,650)
Median (range)
Year 2007:
152 (43.0–554)
Year 2011:
212 (43.1–450)
–
Cao et al. (2017) China
Korea
Japan
Breast milk, pooled
samples
China (n = 17)
Korea (n = 16)
Japan (n = 44)
2007–2010 GC-ECNI-HRMS Mean (max)
China: 337 (468)
Korea: 242 (246)
Japan: 247 (290)
– –
Yang et al.
(2018)
China Breast milk
(n = 86)
2014–2015 GC–ECNI-MS 1-month infant: 13,000
3-month infant: 7,100
6-month infant: 2,500
– –
SCCPs: short-chain chlorinated parafﬁns; MCCPs: medium-chain chlorinated parafﬁns; LCCPs: long-chain chlorinated parafﬁns; n.r.: not reported; GC: gas chromatography; MS: mass spectrometry;
HRMS: high-resolution MS; ECNI: electron negative chemical ionisation; TOF-MS: time-of-ﬂight MS; LCCPs: long-chain chlorinated parafﬁns; MCCPs: medium-chain chlorinated parafﬁns; SCCPs:
short-chain chlorinated parafﬁns; bw: body weight.
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3.3.3. Non-dietary sources of exposure
Humans can be exposed to CPs via the environment (from e.g. dust or air), via consumer products
treated with CPs, and from the working environment (i.e. occupational exposure).
In occupational exposure, skin contact and inhalation are the major routes of occupational
exposure in the production, formulation and use of SCCPs. Bardin et al. (2005) reported health effects
in workers in the automobile industry in the United States that had been exposed to metalworking
ﬂuids and CPs (see Section 3.1.3). Mean exposure to CPs was estimated to be 0.6–2.2 mg/m3.
Non-occupational exposure can arise from the use of products treated with CPs such as leather,
textiles and others, such as metal working ﬂuids available to consumers (EU-RAR, 2000, see
Section 1.3.2 on uses). In addition, the presence of CPs in kitchen dish cloths has been reported by
Gallistl et al. (2017) (see Section 3.2.3). The authors conducted a dermal uptake assessment to
study the relevance of CP skin uptake by dish cloths and daily dermal uptake values were calculated
using the concentrations determined in the dish cloth samples studied. The authors assumed even
distribution of the contaminants on the dish cloths and a constant level of the contaminants during the
whole usage time. The estimated skin uptake of SCCPs and MCCPs due to contact with dish cloths and
considering skin absorption factors was 0.07 and 64 ng per day, respectively. For MCCPs, this value
corresponded to ~26% of the total daily uptake of all polyhalogenated compounds determined in the
study (240 ng per day). The authors concluded that dermal absorption of these compounds by
contaminated dish cloths represents a potential uptake route and contributes to the total human
exposure, noting that dish cloths are used daily without hand-protecting gloves.
Cherri and Semple (2010) concluded that dermal and inhalation exposure may be of comparable
magnitude for those who are regularly exposed to metal working ﬂuids. The estimated dermal
exposure from oil-based products was 520 mg/day and in a worst-case scenario 35,000 mg/day. The
estimated exposure from using water-based products was lower (30 and 520 mg/day, respectively).
In addition, environmental (background) exposure due to diffuse emission sources affects the
entire general population which may be exposed by several routes, including inhalation of air including
particulates in the air as well as intake of house dust. For children, crawling and hand-to-mouth habits
should be considered as habits possibly increasing the ingestion of dust.
Several studies have estimated the relative contribution of different source of exposure to the total
CP intake.
Cao et al. (2019) reported occurrence data and made a human exposure assessment of SCCPs and
MCCPs in dusts from plastic sports courts and synthetic turf in Beijing, China. The mean concentration
of SCCPs and MCCPs in dusts from plastic tracks were 5,429 and 15,157 lg/g and in basketball courts
the mean values were 5,139 and 11,878 lg/g. These concentrations were signiﬁcantly higher than
those found in plastic tennis and badminton courts, and in synthetic turf, and were 13 orders of
magnitude higher than in dusts from other indoor environments. It was proposed that the friction
between the soles of footwear and the plastic track materials may lead to the wear and decomposition
of the surface which may be an important source of CPs. The authors concluded that the mean
estimated daily intakes of CPs from plastic tracks and basketball courts are generally higher than those
estimated from dietary, breast milk, or other indoor dust sources.
Concentrations and speciﬁc congener proﬁles of SCCPs in various environmental matrices, including
air, soil and dust, from locations within and nearby a plant producing CPs were analysed to explore
SCCP pollution and transportation behaviours (Wang et al., 2018d). SCCP concentrations in air (129–
1,442 ng/m3) and soil (28–554 lg/g) found in samples taken inside the facility were higher than those
in air (91–333 ng/m3) and soil (102–441 ng/g) samples taken from nearby locations outside the plant.
Based on the congener proﬁles, lighter homologues (C10–11 and Cl5–6) had greater long-range transport
potential, whereas heavier fractions (C12–13 and Cl7–10) were more likely to deposit from the
atmosphere. The authors found that large amounts of SCCPs were released from the CP production
plant, which resulted in contamination of the environment. The daily occupational exposure of
employees in the production facility to SCCPs was estimated as 21.8 lg/kg bw per day).
Concentrations, particle size distributions and inhalation exposure characteristics of CPs were
investigated in indoor air particulate matter by Zhou et al. (2019b) (see Section 1.3.3.4). The
estimated daily CP intakes from 2.5 lm particles by inhalation were 8.1–24.6 and 25.1–76.0 ng/kg bw
per day for all age subgroups based on both mean and 95th percentile concentrations of CPs. It was
noted that estimated daily uptakes decreased to 4.4–16.4 and 13.5–50.6 ng/kg bw per day,
respectively, when the deposition fractions of these particles in the human lung were considered.
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Gao et al. (2018) estimated exposure sources for SCCPs and MCCPs for the population in Beijing
(China) from four exposure pathways: (i) food (described in Sections 3.2.2.1 and 3.3.2.1), (ii)
indoor air, (iii) indoor dust and (iv) drinking water. The overall daily intakes of SCCPs and MCCPs for
adults were estimated to be 1.01 and 0.83 lg/kg bw per day, respectively and for toddlers 2.31 and
1.32 lg/kg bw per day, respectively. For adults, the predominant exposure source was dietary intake
which accounted for 88% for SCCPs and 93% for MCCPs. Indoor dust was the next highest contributor
at 9.3% and 6.9% for MCCPs. However, for toddlers, dust ingestion was the predominant exposure
route, accounting for 59% for SCCPs and 51% for MCCPs. Dietary intake was the second most
relevant source, accounting for 38% for SCCPs and 49% for MCCPs. Exposure via indoor air and
drinking water contributed to a minor extent to the overall exposure.
The contribution of dust ingestion and dermal permeation of dust contact to the toddlers could be
as high as 70% according to a study in malls in China (Shi et al., 2017).
Chen et al. (2018) determined SCCPs and MCCPs in four types of dust samples and nine categories
of locally produced staple foods collected from an e-waste recycling industrial park and its surrounding
villages (see Sections 3.2.2 and 3.3.2 for further details on the food samples). Dust mean
concentrations of SCCPs and MCCPs from the surrounding residential homes near the park were 580
and 1,760 lg/g, respectively, which were about 10 times lower than those found in the e-waste
workshops, but higher than those in the control homes (59.0 and 185 lg/g, respectively). For SCCPs
dietary and dust intakes in adult local residents were 15.4 and 0.21 lg/kg bw per day, while in
children they were 34.1 and 1.79 lg/kg bw per day, respectively. For MCCPs, dietary and dust intakes
in adults were 19.5 and 0.54 lg/kg bw per day while in children they were 43.3 and 4.64 lg/kg bw
per day. For both adults and children local residents dietary intake was the predominant exposure
route over dust ingestion (and dermal absorption).
CPs were measured in Canadian house dust by Shang et al. (2019). A comparison was made
between CP concentrations in paired dust samples collected using two different methods from the
same homes: fresh or ‘active’ dust (FD) collected by technicians and a sample taken from the
household vacuum cleaner (HD). There was a signiﬁcant positive correlation (p < 0.01) between FD
and HD samples for both MCCPs and SCCPs. CPs were detected in every house dust sample (n = 48
HD samples), with median (range) concentrations of 6.2 (4.0–57) lg/g and 19 (5.9–901) lg/g for
SCCPs and MCCPs, respectively. The authors reported a wide variability in Canadian household
exposures to CPs from dust.
Friden et al. (2011) estimated the exposure of the sum of CPs via the indoor environment,
considering (i) indoor air inhalation and (ii) dust ingestion, based on samples collected in domestic
apartments in Stockholm (Sweden). The exposure was estimated considering mean inhalation rates,
and mean and high dust ingestion rates. For a 25-year-old male adult, mean and high dust intakes of
4 and 55 mg/day were considered, while for toddlers (12–24 months) these were 100 and 200 mg/
day, respectively. Based on this, for adults, median exposure considering mean and high dust ingestion
was 1 and 1.3 lg/day, respectively. For toddlers, median exposure was higher, estimated at 1.1 and
16 lg/day, respectively for mean and high dust ingestion. The authors concluded that for adults, the
exposure via indoor environment is dominated by the inhalation pathway that accounts for 98% or
76% depending on the dust intake rate. Dust ingestion could be important for adult individuals
exposed to highlight contaminated dust and with high dust ingestion rate. For toddlers, inhalation and
dust ingestion contribute more equally, pointing to dust as a more important source for toddlers than
for adults. The authors compared those estimates with exposure estimates via the diet available at the
time of the study, and concluded that diet might be the dominant pathway for adults, while in toddlers
indoor environment might be the dominant one.
The CONTAM Panel made a scenario to estimate the ingestion from dust in toddlers and adults.
The US-EPA assumed that while an adult ingests an average of 20 mg/day, a child of 1–2 years old
ingests an average of 50 mg/day (US-EPA, 2017). The highest median values found in dust from four
European countries were 6,300 lg/kg for SCCPs, 35,000 lg/kg for MCCPs and 2,700 lg/kg for LCCPs
(see Section 1.3.3). Considering a body weight of 12 kg for a 1- to 3-year-old child and 70 kg for
adults (EFSA Scientiﬁc Committee, 2012a), the resulting daily exposures via dust ingestion would be
26, 150 and 11 ng/kg bw per day for toddlers and 1.8, 10 and 0.77 ng/kg bw per day for adults, for
SCCPs, MCCPs and LCCPs, respectively. The CONTAM Panel noted that this is only a very crude
estimate of the exposure via dust and has a large associated uncertainty, but it shows that for toddlers
exposure from dust could be in the same order of magnitude as the dietary exposure estimated from
ﬁsh. For adults the exposure from dust is lower both in absolute terms and in comparison with the
exposure estimated from ﬁsh consumption.
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3.3.4. Dietary exposure assessment for farm animals, horses and companion
animals
No exposure assessment was possible for any of the farm animal species as no occurrence data in
feed were submitted to EFSA. The data for feed reported in the literature were too limited to attempt
an exposure scenario.
3.4. Risk characterisation
3.4.1. Human health risk characterisation
Due to the lack of occurrence data for CPs in food, the CONTAM Panel was not able to carry out a
robust dietary exposure estimate for the general population. This means that a complete risk
characterisation could not be performed.
In order to provide a rough indication of whether there could be a possible health concern with
respect to dietary exposure to CPs, the CONTAM Panel made a preliminary exposure assessment to
SCCPs and MCCPs resulting from ‘Fish meat’ consumption (for ﬁsh consumers only) across Europe,
noting that exposure will be higher due to the contribution of other foods. MOEs for this limited
scenario were calculated for the mean and 95th percentile exposures across surveys and age groups
(see Section 3.1.1). For LCCPs, in the absence of occurrence data and as no reference point has
been identiﬁed, a risk characterisation could not be performed.
For SCCPs, the mean UB exposure resulting from ‘Fish meat’ consumption ranged from 1.9 to
35 ng/kg bw per day, and the 95th percentile UB exposure ranged from 4.9 to 87 ng/kg bw per day.
Comparison of these dietary exposures with the BMDL10 of 2.3 mg/kg bw per day, which was
identiﬁed as a reference point for the risk characterisation (see Section 3.1.6), resulted in MOEs of
about 7 9 104 and 3 9 104 or higher for the mean and 95th percentile exposure, respectively.
For MCCPs, the mean UB exposure resulting from ‘Fish meat’ consumption ranged from 3.2 to
59 ng/kg bw per day, and the 95th percentile UB exposure ranged from 8.5 to 148 ng/kg bw per day.
Comparison of these dietary exposures with the BMDL10 of 36.4 mg/kg bw per day, rounded to
36 mg/kg bw per day (see Section 3.1.6), which was identiﬁed as a reference point for the risk
characterisation (see Section 3.1.6), resulted in MOEs of about 6 9 105 and 3 9 105 or higher for
the mean and 95th percentile exposure, respectively.
The CONTAM Panel concluded that these MOEs for this limited scenario do not suggest a health
concern, while noting uncertainties because the dietary exposure will be higher due to the contribution
of CPs from other foods, the lack of toxicokinetic data for humans and that only a few CPs have been
tested in the available toxicity studies.
For breastfed infants, comparison of the exposure estimates for SCCPs from 11 European countries
based on pooled samples collected between 2014 and 2016 (See Section 3.3.1) with the BMDL10 of
2.3 mg/kg bw per day, resulted in MOEs of about 5 9 103 and 3 9 103 or higher for average and high
human milk consumption, respectively. For MCCPs, comparison of the exposure estimates with the
BMDL10 of 36 mg/kg bw per day resulted in MOEs of about 7 9 10
4 and 5 9 104 or higher for
average and high human milk consumption, respectively. The CONTAM Panel concluded that these
MOEs do not suggest a health concern. The Panel noted that since these were pooled samples, it was
not possible to estimate speciﬁc values for highly exposed individuals.
3.4.2. Farm animals, horses and companion animal health risk characterisation
Due to the lack of occurrence data in feed, an exposure assessment for farm and companion
animals could not be carried out, and thus a risk characterisation could not be performed. In addition,
for ruminants, pigs, horses and fur animals no studies on the adverse effects of CPs were identiﬁed.
Limited data on the adverse effects in poultry, rabbits, ﬁsh and dogs were identiﬁed (see
Section 3.1.7).
3.5. Uncertainty analysis
The evaluation of the inherent uncertainties in the assessment of exposure to CPs has been
performed following the guidance of the Opinion of the Scientiﬁc Committee related to Uncertainties in
Dietary Exposure Assessment (EFSA, 2007). In addition, the report on ‘Characterizing and
Communicating Uncertainty in Exposure Assessment’ has been considered (WHO/IPCS, 2008). The
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CONTAM Panel took note of the new guidance on uncertainties of the Scientiﬁc Committee (EFSA
Scientiﬁc Committee, 2018), but it was not implemented in this opinion.
3.5.1. Assessment objectives
The objectives of the assessment are clariﬁed in Section 1.2 Interpretation of the Terms of
Reference.
3.5.2. Exposure scenario/exposure model
Occurrence data
In response to EFSA’s request to submit occurrence data on CPs only limited data on the
occurrence of SCCPs and MCCPs in food were received. No data were submitted on the presence of
LCCPs in food. The majority of the results on SCCPs and MCCPs were obtained from the analysis of
samples in the food category ‘Fish meat’ submitted by one European country. Thus, there is
uncertainty whether the occurrence data used in the present assessment are representative for all
European countries.
There is no information on speciﬁc SCCP or MCCP congeners detected in the ﬁsh samples.
Much of the data available in the literature originate from Asia, in particular China and regions
where CPs are manufactured or thought to have a potential for environmental pollution. The levels
documented in these studies may therefore not be representative to the situation found in Europe.
Changes in the CP composition of the technical products due to market requirements and
restrictions, as well as the use of recycled materials result in different CP congener proﬁles being found
in the environment and food. The congener proﬁle, or ‘ﬁngerprint’ of CP mixtures changes between
production of technical mixtures for industrial use, to the proﬁles that are found in the environment
and in food that are the result of the effects of weathering, breakdown, metabolism and time. Further
changes can occur as CPs pass as contaminants through the food chain. The impact of these changes
is difﬁcult to estimate as there is little information on the exposure pathways, as well as on the CP
congener proﬁle to which humans are exposed.
Consumption data
Uncertainties and limitations related to the use of the EFSA Comprehensive Food Consumption
Database were described by EFSA (2011a) and are not further detailed in this Scientiﬁc Opinion. These
relate to the use of different dietary survey methodologies, standard portion sizes, representativeness
of samples included in surveys, or to the inclusion of consumption surveys covering only few days to
estimate high percentiles of chronic exposure.
Dietary exposure
Due to the limited number of samples analysed on food commodities other than ﬁsh, a robust
exposure assessment for the general population could not be performed. In order to obtain an
estimate of the potential magnitude of exposure, the data submitted to EFSA on SCCPs and MCCPs in
few ﬁsh species (salmon, tuna and catﬁsh) were used for a tentative estimation of exposure resulting
from ‘Fish meat’ consumption (for ﬁsh consumers only). No exposure could be estimated for LCCPs
due to the lack of occurrence data.
Since it is expected that other food categories contribute to the exposure (as shown in
Section 3.3.2), the exposure levels to SCCPs and MCCPs calculated in this opinion are
underestimated. A Swedish market basket study including a wider range of food types was carried out
in 2015 (Yuan et al., 2017, see Section 3.3.2). The mean total CP exposure for adults was estimated
to be up to 59 ng/kg bw per day with ﬁsh contributing only about 10%, thus the overall exposure of
the European population will be higher than the one estimated in the present document due to the
contribution of foods other than ﬁsh. In addition, exposure estimates presented in this opinion did not
consider the exposure to LCCPs. Mean exposure for the German general adult population to the sum
of SCCPs and MCCPs for total diet using mean occurrence was estimated to be 170 ng/kg bw per day
by Kr€atschmer et al. (2019, see Documentation provided to EFSA) which also indicates that the
exposure only based on ﬁsh samples is underestimated.
The exposure of breastfed infants was estimated based on pooled samples from 11 European
countries, showing a wide range of concentrations. Since these were pooled samples, it was not
possible to estimate speciﬁc values for highly exposed individuals.
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Limited information is available on the effects of food processing on the concentrations of CPs. The
presence of CPs in some common kitchen equipment (dish cloths, hand blenders, household oven
components) suggests that food could become more contaminated at the preparation stage, due to
either direct or secondary contact, and thus add to the dietary exposure. CPs have also been found in
domestic plastic and food packaging and shown to migrate into the food. Based on the studies
available, migration from plastic and kitchen equipments can contribute to the total CP exposure.
It was established that dust could be an important source of exposure, but only a crude estimate
was made for intake of CPs from dust. Concentrations of CPs in dust cover several orders of
magnitude which gives rise to uncertainty in the values used to estimate exposure from this source.
No estimates were made for intake of CPs from other non-dietary sources meaning that total non-
dietary exposure will be underestimated.
No data were available on the occurrence of CPs for feed materials and thus an exposure
assessment for farm animals, horses and companion animals could not be performed.
3.5.3. Model input (parameters)
There are no analytical criteria or standard methods for the analysis of CPs in food and feed. The
choice of analytical instrument and quantiﬁcation method strongly inﬂuences the results. Depending on
the analytical method used the results can vary as there are differences in the performance of the
different analytical and deconvolution methods used for homologue pattern and quantitative
determination. There is a lack of analytical standards and reference materials. All these points
introduce a high degree of uncertainty into the occurrence data and exposure assessment.
3.5.4. Other uncertainties
Studies in experimental animals
Toxicity data were retrieved only for a limited number of mixtures (SCCPs: C10–12, 58% chlorination;
C10–13, 56% chlorination; C10–13, 58% chlorination; C12, 60% chlorination; C10–13, 56.5% chlorination;
carbon chain length not speciﬁed, 58% chlorination; MCCPs: C14–17, 52% chlorination; C14–17, 40%
chlorination; LCCPs: C22–26, 43% chlorination; C23, 43% chlorination; C22–26, 70% chlorination) and
there is uncertainty on the representativeness of the tested mixtures towards the pattern of CPs present
in food. The approach followed in the present opinion was to consider read-across within and between
the SCCP, MCCP and LCCP classes and to use the information available from the tested CPs to conclude
on the risks for the general population exposed to an unknown mixture of CPs in food. The available
toxicokinetic data indicate that differences among CP congeners, in particular in relation to the degree of
chlorination, suggest that read-across to other CPs, both within the same class as well as to other
classes is problematic and will have high uncertainty. In addition, the physicochemical properties of the
CPs indicate a potential for accumulation in organs and tissues and the available toxicokinetic studies in
experimental animals conﬁrm accumulation in adipose tissue/fat rich organs and tissues. The available
information suggests that elimination from these tissues is slower than from other organs and tissues,
but the information is insufﬁcient to derive elimination half-lives from these tissues.
The possible presence in food of CPs with higher toxicity than those for which toxicity data are
available and possible accumulation of CPs in humans were considered in the MOE approach followed
in the opinion (see Section 3.1.6.3) to minimise the possibility of underestimating risks. However, the
lack of data on the CP mixtures of relevance for human dietary exposure adds to the overall
uncertainty of the assessment.
For SCCPs, the reference point was derived based on histopathological changes in the thyroid.
Changes in thyroid hormone levels (decreased FT3, increased TSH) were observed in one study in
rats at a lower dose than the selected reference point. The Panel noted inconsistencies in the
hormonal changes between the two available studies, which prevented these effects being used as a
basis for deriving a reference point albeit with uncertainty. Although there is uncertainty about the
validity of extrapolating changes related to the thyroid from rats to humans when these changes are
mediated by induction of hepatic transporters and hepatic metabolism, histopathological changes in
the rat thyroid were still taken as a reference point. There is a potential for modulation of thyroid
hormone levels to have an effect in rodents on pre- and postnatal neurological development of
offspring. However, the Panel could not identify any studies on potential neurodevelopmental effects of
CPs in mammals.
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Farm animals, horses and companion animals
No studies investigating effects of CPs in ruminants, pigs, horses, cats and fur animals have been
identiﬁed. Only limited data are available for other animal species. For poultry, none of the studies
were sufﬁciently robust for hazard characterisation. For rabbits, only developmental toxicity studies are
available; these studies are of a very short exposure duration and therefore, not adequate for a
chronic risk characterisation.
3.5.5. Summary of uncertainties
In Table 37, a summary of the uncertainty evaluation is presented, highlighting the main sources
of uncertainty and indicating an estimate of whether the respective source of uncertainty might have
led to an over- or underestimation of the exposure or the resulting risk.
The CONTAM Panel considered that the impact of the uncertainties on the risk assessment of
exposure to CPs in food is substantial, and due to the limited data on occurrence of CPs in food the
dietary exposure is considered to be underestimated.
Due to the lack of occurrence and toxicity data, a risk assessment of CPs for farm animals, horses
and companion animals was not possible.
4. Conclusions
CPs are complex technical mixtures of polychlorinated alkanes, with varying chain length and
degree of chlorination. The commercially available CPs are generally divided into three groups: short-
chain CPs (SCCPs) comprising 10 to 13 carbon atoms, medium-chain CPs (MCCPs) comprising 14 to 17
carbon atoms and long-chain CPs (LCCPs) with 18 or more carbon atoms. Some technical mixtures
may contain CPs from more than one of these three groups, and some newer CPs do not conﬁne
themselves to these groups. Technically, the terms ‘SCCP’, ‘MCCP’ and ‘LCCP’ refer to the commercial
mixtures of CPs. In this opinion the nomenclature of SCCP(s), MCCP(s) and LCCP(s) will be used to
refer to any CP mixture(s) that falls within the range of carbon chain lengths indicated above.
Table 37: Summary of qualitative evaluation of the impact of uncertainties on the risk assessment
of exposure to chlorinated parafﬁns from food and feed
Sources of uncertainty Direction(a)
Difference in analytical results arising from the application of different methods and due to the
lack of available analytical standards
+/
Exposure
Exposure is estimated by considering only occurrence levels in ﬁsh due to unavailability of
occurrence data on other foodstuffs

Extrapolation of the occurrence data in ﬁsh reported by one country to the whole of Europe +/
Extrapolation of occurrence data on salmon, tuna and catﬁsh to all other kinds of ﬁsh meat +/
Consumption data: different methodologies/representativeness/underreporting/misreporting/no
portion size standard
+/
Methodology used to assess long-term exposure based on food consumption surveys covering
only a few days to estimate high percentiles
+
No estimates for exposure to CPs from other non-dietary sources than dust 
Hazard identiﬁcation and characterisation
Uncertainty in the read-across approach followed for SCCPs and MCCPs, in the absence of
toxicological data on the CP mixtures relevant for human dietary exposure
+/
Uncertainty in the accumulation potential of CPs 
Uncertainty about the validity of extrapolating changes related to the thyroid from rats to
humans when these changes are mediated by induction of hepatic transporters and hepatic
metabolism
+/
Toxicity database for farm animals, horses and companion animals very limited +/
CPs: chlorinated parafﬁns; SCCPs: short-chain chlorinated parafﬁns; MCCPs: medium-chain chlorinated parafﬁns; UDPGT: uridine
5’-diphospho-glucuronosyltransferase.
(a): + = uncertainty with potential to cause over-estimation of exposure/risk;  = uncertainty with potential to cause under-
estimation of exposure/risk.
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4.1. Analytical methods
• Analysis of CPs is highly demanding and current methods have been shown to lack precision
and accuracy. Congener speciﬁc analysis is not currently possible. Several different approaches
to analysis exist, and lead to differences in results obtained. Only a limited number of
analytical standards are available, and these represent only a tiny fraction of the total number
of individual CP congeners that may be found. Care is therefore needed when using
occurrence data to perform exposure estimates.
4.2. Hazard identiﬁcation and characterisation
4.2.1. Toxicokinetics
• No data are available on toxicokinetics in humans, horses and companion animals and only
limited data are available for experimental animals and some farm animals.
• Absorption to some extent is indicated in various animal species by excretion of a small
amount of radiolabelled CPs and or metabolites in the urine, distribution of radiolabelled CPs
and or metabolites to different organs and tissues, and systemic effects observed in toxicity
studies.
• Detection of CPs in human blood and milk samples indicates that CPs are absorbed to some
extent in humans and detection of CPs in umbilical cord blood indicates that CPs can be
transferred to the fetus.
• Accumulation in adipose tissue and fat rich organs and tissues is indicated and elimination
from these tissues seems to be slower than from other organs and tissues. The available
information is insufﬁcient to derive elimination half-lives from these tissues.
• Studies in mice suggested that highly chlorinated SCCPs and MCCPs are metabolised and
excreted via faeces whereas lower chlorinated SCCPs and MCCPs can be partly metabolised
and exhaled as carbon dioxide.
• Following oral administration of CPs to rats and mice, the major route of excretion was the
faeces with only a small proportion excreted in urine and expired air.
• There are very limited data on the transfer of CPs from feed to the food of animal origin.
4.2.2. Toxicity in experimental animals
• CPs are of low acute toxicity with oral LD50 values all exceeding 4 g/kg bw.
• The liver, kidney and thyroid were identiﬁed as the target organs for the two SCCPs and the
single MCCP tested in the subchronic and chronic toxicity studies in experimental animals. For
the LCCPs tested in the subchronic and chronic toxicity studies in rats and mice, only the liver
was identiﬁed as a target organ.
• For the SCCPs tested, a NOAEL of 10 mg/kg bw per day was identiﬁed, based on increased
kidney weights, and histopathological changes in the kidney and thyroid.
• For the MCCP tested, a NOAEL of 10 mg/kg bw per day was identiﬁed, based on increased
kidney weights.
• For the LCCPs tested, a LOAEL of 100 mg/kg bw per day was considered for the two LCCPs
with a 43% chlorination degree, and a NOAEL of 900 mg/kg bw per day for the LCCP with a
70% chlorination degree, based on liver effects, including increased weight and
histopathological changes.
• An SCCP caused teratogenic effects such as absence of digits or shortened digits in rats at
2,000 mg/kg bw per day (gavage) in the presence of maternal toxicity (high mortality and
decreased body weight gain); the NOAEL for developmental toxicity was 500 mg/kg bw per
day, and for maternal toxicity 100 mg/kg bw per day. In the developmental toxicity study in
rabbits with the same SCCP; the NOAEL for developmental toxicity was 10 mg/kg bw per day,
based on increased number of resorptions, in the absence of maternal toxicity.
• For the MCCP tested, no developmental toxicity was observed in rats and rabbits at the highest
dose levels tested, 5,000 mg/kg bw per day for rats and 100 mg/kg bw per day for rabbits. No
parental toxicity or effects on fertility were observed for the same MCCP in a dose-range
ﬁnding study for a two-generation dietary rat study. In this study, postnatal effects in the form
of decreased pup survival and subcutaneous haematoma/haemorrhage were observed; a
NOAEL of 9 mg/kg bw per day was identiﬁed for these effects.
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• For the two LCCPs tested, no developmental toxicity was observed in rats and rabbits at the highest
dose levels tested, 1,000 mg/kg bw per day for rabbits with the 70% chlorinated LCCP and
5,000 mg/kg bw per day in the three other studies with the 43% or the 70% chlorinated LCCP.
• The overall weight of evidence indicates that CPs are not genotoxic.
• The SCCP tested caused increased incidences of tumours in rats and mice, i.e. in the liver
(rats, mice), kidneys (male rats only) and thyroid (female rats and mice). The LCCP tested also
caused increased incidences of tumours in mice, i.e. malignant lymphomas (male mice), and to
a marginal extent of hepatocellular neoplasms (female mice). No carcinogenicity study on
MCCPs was identiﬁed.
4.2.3. Observations in humans
• No studies on observations in humans of relevance for the risk assessment of CPs within the
scope of this opinion were identiﬁed.
4.2.4. Adverse effects in farm animals, horses and companion animals
• No data on adverse effects of CPs in ruminants, pigs, horses, cats and fur animals were identiﬁed.
• In poultry, none of the available studies were robust enough for the identiﬁcation of a reference
point.
• For rabbits, no other studies than the developmental toxicity studies described for
experimental animals have been identiﬁed.
• For ﬁsh, most studies showed no or minor effects. Based on the available information, the
CONTAM Panel could not identify a NOAEL or a LOAEL.
• For dogs, no other studies than the toxicity study described for experimental animals have
been identiﬁed.
4.2.5. Mode of action
• Rodent hepatic enzyme induction and proliferation of the smooth endoplasmic reticulum
leading to hypertrophy (and associated increases in liver size) is considered as an adaptive
physiological response to CPs which can contribute to hepatocarcinogenicity in rodents.
Interference with the TCA cycle and energy balance leads to liver cell toxicity.
• The rodent liver tumours induced by an SCCP, and associated with CAR or PPARa transactivation,
appear not relevant to humans. Human hepatocarcinogenicity is not anticipated provided hepatic
cell toxicity does not occur.
• SCCP-induced kidney tumours in male rats appear to relate to sustained nephropathy (induced
partly, but not necessarily entirely, by a2u-microglobulin accumulation), compensatory
regenerative hyperplasia and increased S-phase.
• Thyroid effects caused by CPs in rodents can arise due to stimulation of the thyroid via a negative
feedback mechanism. This includes a potential increase in hepatic uptake of thyroid hormones,
increased hepatic UDPGT levels and conjugation of T4, consequent decrease in plasma T4/T3,
compensatory release of pituitary TSH and a compensatory increase in T4 production in the
thyroid. This eventually leads to hypertrophy, hyperplasia and thyroid tumours. Additional
mechanisms that may contribute to carcinogenesis by CPs include oxidative stress and inhibition
of intercellular communication.
• The CONTAM Panel decided not to use changes in thyroid hormone levels as a basis for a
reference point since there were inconsistencies in the hormonal changes between the two
available studies on SCCPs, as well as gender differences in the available study with the MCCP.
Overall, there is uncertainty about the validity of extrapolating changes related to the thyroid
from rats to humans when these changes are mediated by induction of hepatic transporters
and hepatic metabolism. However, despite these uncertainties, the thyroid histopathology is
used as a basis for the reference point. Potential neurodevelopmental effects from thyroid
hormone changes could not be assessed because of a lack of developmental neurotoxicity
studies.
• In rats, the tested MCCP perturbed the clotting system in lactating neonates of treated
mothers. The haemorrhaging effect in lactating neonates appears to result as a consequence
of vitamin K deﬁciency.
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4.2.6. Margin of exposure (MOE) approach
• Due to the limitations and uncertainties in the current database on SCCPs, MCCPs and LCCPs
the derivation of HBGVs was not considered appropriate. Instead, an MOE approach was
applied to assess a possible health concern.
• For one tested SCCP, a BMDL10 of 2.3 mg/kg bw per day was derived from BMD modelling,
and selected as the reference point for the risk characterisation, based on increased incidence
of nephritis in male rats.
• For the tested MCCP, a BMDL10 of 36 mg/kg bw per day was derived from BMD modelling, and
selected as the reference point for the risk characterisation, based on increased relative kidney
weight in male and female rats.
• For the tested LCCPs, only the liver was identiﬁed as a target organ. As effects in the liver
observed consistently in rats and mice are considered as an adaptive physiological response
and the associated energy costs, a reference point has not been identiﬁed.
• An MOE higher than 1,000 might indicate that there is no health concern, taking into account the
variability between species (a factor of 10), the variability within human individuals (a factor of
10), and extrapolation from subchronic studies to chronic exposure duration (a factor of 2). An
additional factor of 5 was considered to take into account the limitations in the database.
4.3. Occurrence and exposure
4.3.1. Food
• Only limited data on the occurrence of SCCPs and MCCPs, and only for some ﬁsh species, were
submitted to EFSA, while no data were submitted on the presence of LCCPs.
• Due to the lack of sufﬁcient occurrence data on foodstuffs other than ﬁsh, it was not possible
to carry out a robust exposure assessment. A preliminary exposure assessment of the chronic
exposure to SCCPs and MCCPs was made based on the consumption of ‘Fish meat’ and for ﬁsh
consumers only.
• A data set consisting of 422 analytical results from 184 samples of ‘Fish meat’ collected in
Germany between 2014 and 2017 was used for this purpose. CPs were quantiﬁed in the
majority of the samples, with 15% and 14% of left-censored data for SCCPs and MCCPs,
respectively. The mean and P95 occurrence levels were 7.5 and 18 lg/kg ww (LB = UB) for
SCCPs, respectively, and 13 and 44 lg/kg ww (LB = UB) for MCCPs, respectively.
• For SCCPs, the mean LB and UB exposure estimates ranged from 1.9 to 35 ng/kg bw per day. At
the 95th percentile exposure, the LB and UB estimates ranged from 4.9 to 87 ng/kg bw per day.
• For MCCPs, the mean LB and UB exposure estimates ranged from 3.2 to 59 ng/kg bw per day.
At the 95th percentile exposure, the LB and UB estimates ranged from 8.5 to 148 ng/kg bw
per day.
• The lowest exposures were found in the Adult groups while the highest were for Toddlers.
• For breastfed infants, exposure levels were estimated considering data on pooled human milk
samples from 11 European countries based on samples collected between 2014 and 2016.
Exposure to SCCPs ranged from 60 to 445 ng/kg bw per day for average consumption of
human milk and from 90 to 668 ng/kg bw per day for high consumption of human milk,
respectively. For MCCPs, the exposure ranged from < 25 to 514 ng/kg bw per day and
from < 38 to 771 ng/kg bw per day, respectively, for average and high consumption of human
milk.
• The highest median values found in dust from four European countries were 6,300 lg/kg for
SCCPs, 35,000 lg/kg for MCCPs and 2,700 lg/kg for LCCPs. For toddlers, exposure from
ingestion of dust could be in the same order of magnitude as the dietary exposure estimated
from ﬁsh. For adults, the estimated exposure from dust was lower than for toddlers both in
absolute terms and when compared with the exposure estimated from ﬁsh consumption, but
could nevertheless still be an important source of exposure to CPs. No estimates were made
for intake of CPs from other non-dietary sources.
4.3.2. Feed
• No data for feed were submitted to EFSA. The data for feed reported in the literature were too
limited to attempt an exposure scenario.
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4.4. Risk characterisation
4.4.1. Human health risk characterisation
• A complete risk characterisation could not be performed due to lack of occurrence data for CPs
in food.
• A preliminary risk assessment could only be performed for SCCPs and MCCPs based on a limited
exposure assessment related to the consumption of ‘Fish meat’ (for ﬁsh consumers only).
• For LCCPs, no risk characterisation could be performed in the absence of occurrence data and
identiﬁcation of a reference point.
• For SCCPs, MOEs of about 7 9 104 and 3 9 104 or higher for the mean and 95th percentile
exposure, respectively. For MCCPs, MOEs of about 6 9 105 and 3 9 105 or higher for the mean
and 95th percentile exposure, respectively. The Panel concluded that these MOEs for this limited
scenario do not suggest a health concern, while noting uncertainties because the dietary
exposure will be higher due to the contribution of CPs from other foods, the lack of toxicokinetic
data for humans and that only a few CPs have been tested in the available toxicity studies.
• For breastfed infants, MOEs for SCCPs of about 5 9 103 and 3 9 103 or higher for average
and high human milk consumption, respectively, were obtained. For MCCPs, MOEs were about
7 9 104 and 5 9 104 or higher for average and high human milk consumption, respectively.
The CONTAM Panel concluded that these MOEs do not suggest a health concern. The
Panel noted that since these were pooled samples, it was not possible to estimate speciﬁc
values for highly exposed individuals.
4.4.2. Farm animals, horses and companion animal health risk characterisation
• No risk characterisation could be performed due to the lack of occurrence data of CPs for feed
and due to the lack of, or limited, data on the adverse effects of CPs in farm animals, horses
and companion animals.
5. Recommendations
• There is a need for validated analytical methods for the determination of CPs, as well as
suitable standards and reference materials.
• Research is needed to identify which speciﬁc CP congeners are more relevant in terms of
occurrence in food and of relevance for human health.
• There is a need for occurrence data in food for SCCPs, MCCPs and LCCPs to enable a robust
human exposure assessment, as well as data on the possible transfer of CPs from, e.g. kitchen
equipment, during food preparation.
• More data on variation of occurrence of CPs in human milk are needed to enable a more
robust exposure assessment for breastfed infants.
• More information is needed on the toxicokinetics in humans and experimental animals, with
respect to the impact of the degree of chlorination, chlorine position and carbon chain length.
The development of TK models would facilitate a body burden approach.
• There is a need for chronic toxicity studies for relevant CP mixtures.
• A better understanding of the relevance of SCCP and MCCP thyroid hormone changes in
rodents and of SCCP-induced rodent thyroid tumours to humans is needed.
• There is a need for developmental neurotoxicity studies with SCCP and MCCP because of the
reported changes in rodent thyroid hormone levels.
• There is a need for occurrence data in feed.
• Data on the transfer of CPs from feed to the food of animal origin are needed.
• There is a need for data on adverse effects of CPs in ruminants, pigs, poultry and ﬁsh. Data in
horses, companion animals and fur animals would also be needed to perform a risk
assessment on these species.
Documentation provided to EFSA
1) Kr€atschmer K, Sch€achtele A, Malisch R and Vetter W, 2019a. Data provided to EFSA by Kerstin
Kr€atschmer, Alexander Sch€achtele, Rainer Malisch and Walter Vetter on a study of CPs exposure
through food in Southern Germany. Results submitted as an extended abstract to the
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DIOXIN2019 conference for publication in Organohalogen Compounds. Used in Section 3.2.2
and 3.3.2.
2) Kr€atschmer K, Sch€achtele A, Malish R and Vetter W, 2019b. Data provided to EFSA by the EU-
Reference Laboratory (EU-RL) for Halogenated POPs in Feed and Food on the occurrence of CPs
in human milk samples from European countries analysed as part the WHO/UNEP Coordinated
Survey of Human Milk for Persistent Organic Pollutants. Used in Section 3.2.4 and 3.3.1.
3) BfR (Bundesinstit}ut f}ur Risikobewertung), 2019. Data provided to EFSA on the release of CPs
from hand blenders, performed by the National Reference laboratory for Food Contact
Materials, BfR, Germany. Used in Section 3.2.3.
4) EuroCHLOR, 2018. Data provided to EFSA on unpublished study reports on CPs, and used in
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BauA German Federal Institute for Occupational Safety and Health
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FT4 free thyroxine
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GC9GC comprehensive two-dimensional gas chromatography
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HRMS high-resolution mass spectrometry
i.p. intraperitoneal
i.v. intravenous
IARC International Agency for Research on Cancer
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IRDC International Research and Development Center
Jak-STAT Janus kinase-signal transducer and activator of transcription
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LC50 lethal concentration, median
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LD50 lethal dose, median
LLE liquid–liquid extraction
LOAEL lowest-observed adverse effect level
LOEL lowest-observed effects level
LOD limit of detection
LOQ limit of quantiﬁcation
LRMS Low-resolution mass spectrometry
LRTAP Long-range transboundary air pollution
LT50 time required for 50% of the animals to die following exposure to a known
concentration of the test agent
MCCPs medium-chain chlorinated parafﬁns
MOE margin of exposure
MS mass spectrometry
MTT assay 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide for assay
MWF metal working ﬂuids
m/z mass-to-charge ratio
NF-jB nuclear factor kappa-light-chain-enhancer of activated B cells
NICNAS National Industrial Chemicals Notiﬁcation and Assessment Scheme
NIVA Norwegian Institute for Water Research
NOAEL no-observed adverse effect level
NOEL no-observed effect level
NR1H4 nuclear receptor family 1 group H member 4
NTCP sodium taurocholate cotransport polypeptide
NTP National Toxicology Programme
OAT2 organic anion transporter 2
OATP2 organic anion transporting polypeptide 2
OECD Organisation for Economic Co-operation and Development
Palmitoyl CoA palmitoyl coenzyme A
PBK physiologically based kinetic
PBT persistent, bioaccumulative and toxic
PCAs polychlorinated alkanes
PCBs polychlorinated biphenyls
PLE pressurised liquid extraction
PM particulate matter
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POPs persistent organic pollutants
PPARa peroxisome proliferator activated receptor a
PXR pregnane X receptor
RAR risk assessment report
RER renin/prorenin receptor
REACH registration, evaluation, authorisation and restriction of chemicals
RfD reference dose
RSD relative standard deviation
SCCPs short-chain chlorinated parafﬁns
SD standard deviation
SIDS Screening Information Dataset
SOP standard operational procedures
SPE solid-phase extraction
SSD standard sample description
StAR steroidogenic acute regulatory protein
T3 triiodothyronine
T4 Thyroxine
TBG T4-binding globulin
TD05 tumourigenic Dose05
TDI tolerable daily intake
Th17 T helper 17 cells
TIC total ion count
TMF trophic magniﬁcation factors
TOF-MS time-of-ﬂight mass spectrometry
TPA 12-O-tetradecanoylphorbol-13-acetate
TRb thyroid receptor b
TSH thyroid-stimulating hormone
TTR transthyrethin
UB upper bound
UDPGT uridine 5’-diphospho-glucuronosyltransferase
UDS unscheduled DNA synthesis
UK-COT UK-Committee on Toxicity
UNECE United Nations Economic Commission for Europe
UNEP United Nations Environment Programme
US-EPA US-Environmental Protection Agency
VDR vitamin D3 receptor
vPvB very toxic very bioaccumulative
vSCCP very short-chain CP
WBA whole body autoradiography
WHO World Health Organization
ww wet weight
WWTP municipal waste water treatment plant
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Appendix A – Detailed description of the toxicokinetic studies in laboratory
animals
The studies on the toxicokinetics of CPs in laboratory animals (rats and mice) included in
Section 3.1.1.1 are described in more detail in this Appendix.
A.1. Studies in rats
A.1.1. SCCPs
The absorption, distribution and excretion of SCCPs have been investigated in a study in rats (Geng
et al., 2016). Male Sprague–Dawley rats (8 weeks old, 339–407 g, four animals/group) were
administered either a single oral dose of a mixture of C10-, C11-, C12- and C13-CPs (1:1:1:1, chlorine
content of the mixture as determined to be 56.5%, 1,000 mg/kg bw in corn oil) or corn oil (the vehicle
control group). The animals were placed in metabolic cages just before the dosing and kept there for
28 days. A blood sample was taken from the eye socket vein at 1, 2, 3, 6, 7 and 15 days after dosing,
and on day 28 blood was collected by the abdominal aortic method. Urine and faeces samples were
collected at 1, 3, 6, 7, 10, 14, 17, 20, 24 and 28 days after dosing. A total of 20 urine samples and 20
faeces samples were obtained by mixing the excreta from four rats at each sampling time. Blood, urine
and faeces samples were analysed using a solvent extraction followed by a multilayer silica gel clean
up to separate the SCCPs from metabolites and interfering sample matrix. The ﬁnal measurements
were performed with GC-ECNI-MS. The absorption was rapid with a half-life of 1 day. The peak blood
concentration of total SCCPs was attained at 2.8 day with a Cmax value of 2.3 mg/L. The half-lives of
total SCCPs in blood for distribution and elimination phases were calculated to 1.7 and 6.6 days,
respectively. AUC0-t and AUC0-∞ were 25.0 and 26.4 mg/L per day, respectively. The CONTAM
Panel noted that the SCCP mixture in this study consists of a mixture of many congeners each with
different individual half-lives, resulting in a change in the congener group proﬁle with time.
Consequently, the persistence of each congener is not reﬂected in the overall half-life reported. The
‘mean residence time’ (usually deﬁned as the average time a molecule stays in the body) of total
SCCPs in rat was calculated to be 9.6 days. The total SCCPs in urine and faeces decreased rapidly at
the beginning, and then reached a steady state after the sixth day. About 28% and about 3.5% of the
administered SCCPs were excreted without metabolism in the faeces and urine, respectively. Congener
group abundance proﬁles of SCCPs in blood, urine and faeces samples indicated that Cl6-SCCPs were
the most abundant chlorine homologues in the blood and excreta sampled in the earlier stage,
whereas Cl5-SCCPs were the predominant chlorine homologues in all samples collected in the later
stage. The relative abundances of Cl7–10-SCCPs were increased in all faeces samples, but were
decreased in urine samples collected in the later stage. The carbon chain congener group C10-CPs
showed a decrease in blood, urine and faeces in the earlier stage, and then a slight increase in the
later stage. The increasing tendency was also seen for C11-CPs in blood and urine in the later stage.
C12-CPs and C13-CPs tended to decrease in blood in the later stage, whereas C13-CPs in faeces were
increased. The authors concluded that the distribution discrepancies in blood and excreta between
SCCPs congener groups were more dependent on chlorine contents than on carbon chain lengths.
As part of a dietary repeated dose toxicity study in rats with an SCCP, there was an assessment of
toxicokinetics (IRDC, 1984a, unpublished study, see Documentation provided to EFSA) (see also
Section 3.1.2.2.1). F344 rats (25 animals/sex per group) were administered 10 or 625 mg/kg bw
per day of an SCCP (C10–12, 58% chlorination) daily in the diet for 13 weeks. After 13 weeks, groups
of animals received a single oral dose of the 14C-labelled SCCP by gavage, the same dose level as
received daily in the previous weeks. Other groups of animals (18 animals/sex per group), which were
not treated previously with the SCCP, received a single oral dose of the 14C-labelled SCCP by gavage at
10 or 625 mg/kg bw. Following administration of the radiolabelled test substance, three animals per
sex from each dose level were placed in metabolism cages and urine, faeces and exhaled air were
collected for 12 h or 7 days. Additional groups of three animals per sex from each dose level were
kept for 24 h or 48 h, 28 or 90 days following administration of the radiolabelled test substance and at
the end of 12 h, or 7, 28 or 90 days samples of tissues (adipose, brain, gonads, heart, kidney and
liver) were collected from designated surviving animals. In addition, samples of whole blood were
collected from the orbital sinus prior to sacriﬁce of animals at 12, 24 and 48 h and 7 days. Overall,
only small differences in excretion were observed between sexes, dose levels or dosing regimen (single
or repeated). Approximately 54–66% of the administered radioactivity was recovered in the faeces in
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7 days, approximately 14% in the urine, and less than 1% in exhaled air as carbon dioxide. Blood
levels were generally proportional to the dose level and the decline over 7 days was found to be
similar between sexes and dosing regimen. Tissue levels of radioactivity were also generally
proportional to the administered dose and were similar, irrespective of dosing regimen. The highest
initial concentrations of radioactivity were found in the liver, adipose tissue, kidneys and ovaries. In
general, the elimination of radioactivity from the adipose tissue was slower, particularly through day
28, than for the other three tissues.
As part of a gavage repeated dose toxicity study in rats with an SCCP, there was an assessment of
toxicokinetics (IRDC, 1984b, unpublished study, see Documentation provided to EFSA) (see also
Section 3.1.2.2.1). The test substance, animal species, dosing regimens and sample collection were
identical to those described above for the dietary study. Also, the results were similar to those described
above for the dietary study, except for a slight difference in the percentage of the administered
radioactivity recovered in faeces (approximately 48–65%) and urine (approximately 13%).
A.1.2. MCCPs
As part of a dietary repeated dose toxicity study in rats with an MCCP, there was an assessment of
toxicokinetics (IRDC, 1984c, unpublished study, see Documentation provided to EFSA) (see also
Section 3.1.2.2.2). F344 rats (25 animals/sex per group) were administered 10 or 625 mg/kg bw
per day of Cereclor S52 (C14–17, 52% chlorination) daily in the diet for 13 weeks. After 13 weeks,
groups of animals received a single oral dose of a 14C-labelled MCCP (about equal amounts of an
8-14C-labelled chlorinated n-pentadecane (C15) and Cereclor S52) by gavage, the same dose level as
received daily in the previous weeks. Other groups of animals (18 animals/sex per group), which were
not treated previously with the MCCP, also received a single oral dose of the 14C-labelled MCCP by
gavage at 10 or 625 mg/kg bw. Following administration of the radiolabelled test substance, three
animals per sex from each dose level were placed in metabolism cages and urine, faeces and exhaled
air were collected for 12 h or 7 days. Additional groups of three animals per sex from each dose level
were kept for 24 or 48 hours, 28 or 90 days following administration of the radiolabelled test
substance and at the end of 12 hours, 7, 28 or 90 days samples of tissues (adipose, brain, gonads,
heart, kidney and liver) were collected from designated surviving animals. In addition, samples of
whole blood were collected from the orbital sinus prior to sacriﬁce of animals at 12, 24 and 48 h and
7 days. Faecal excretion was the main route of elimination with 40–48% and 53–61% of the dose in
low- and high-dose males, respectively, and 28–31% and 62–74% of the dose in low- and high-dose
females, respectively; most of the radioactivity (11–75%) was excreted during the ﬁrst 2 days. Only a
small proportion of the dose was excreted in urine (0.8–3%) and exhaled air (0.1–0.3%) within
7 days. Due to large interanimal variability in blood levels, a relationship between blood levels and
dosing was difﬁcult to quantify, but there was some evidence of a proportional relationship and decline
over 7 days irrespective of sex and dosing regimen. There was also an indication that tissue levels
were proportional to the administered dose. The highest initial concentrations of radioactivity were
found in the liver, ovaries and kidneys. In adipose tissue, the concentration of radioactivity was highest
at 7 days and then declined by a rate slower than that in liver and kidney.
In a dietary study brieﬂy summarised by Birtley et al. (1980), distribution of an MCCP was examined.
Male Wistar rats were administered 0.4 or 40 mg/kg of a 36Cl-labelled Cereclor S52 (C14–17, 52%
chlorination) in the diet for 10 or 8 weeks, respectively. At both dose levels, equilibrium levels of
radioactivity were reached within 1 week for the liver and within 7 weeks for adipose tissue. No
radioactivity was found in the brain or the adrenals. When the diet was changed from the 0.4 mg/kg
radioactive MCCP containing diet to untreated diet, the half-life for elimination of radioactivity from the
abdominal fat was approximately 8 weeks; no radioactivity was detected in the liver 1 week post-dosing.
As part of a dietary repeated dose toxicity study in rats with an MCCP, distribution to the liver and
abdominal fat was examined (Poon et al., 1995, see also Section 3.1.2.2.2). Samples of liver and
adipose tissue were taken at termination of the study from groups of Sprague–Dawley rats that had
received a diet containing 0, 5, 50, 500 or 5,000 mg/kg (corresponding to 0, 0.4, 3.6, 36.2 or
362.9 mg/kg bw per day for males, and 0, 0.4, 4.2, 42.2 or 418.9 mg/kg bw per day for females) of an
MCCP (C14–17, 52% chlorination) in the diet for 13 weeks. There was a dose-dependent increase in the
concentration of the MCCP in both liver and abdominal fat. The concentration in the abdominal fat was
similar to that in the diet and was approximately 20–60 times higher than the concentration in the liver.
A study has been conducted to determine the elimination half-life of MCCPs in the rat following a
single oral administration (CXR, 2005, unpublished study, as cited in EU-RAR, 2011). Male F344 rats
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received a single oral dose of an 8-14C-labelled CP (C15, 52% chlorination) at 525 mg/kg bw in corn oil
by gavage. The highest concentrations of radioactivity were detected in the liver, kidney, fat and skin/
fur at 24 h post-dosing. The elimination half-life was approximately 2–5 days for most tissues, and
about 2 weeks for white adipose tissue. At termination of the study (day 89) approximately 2% of the
administered radioactivity remained in the tissues, primarily in the skin/fur. Faecal excretion was the
main route of elimination with approximately 50% of the administered radioactivity eliminated within
the ﬁrst 24 h after dosing, and approximately 70% at day 5 after dosing. Approximately 5% of the
administered radioactivity was eliminated in the urine at day 5 after dosing.
A dietary study has been performed to investigate the bioaccumulation of MCCPs in rats (CXR,
2005a, interim report, see Documentation provided to EFSA). One group of F344 rats (48 animals of
each sex, 6–9 weeks old at study start) was administered Cereclor S52 (C14–17 MCCP, 52%
chlorination) in the diet ad libitum at 3,000 mg/kg ‘of supplied chemical, without any correction for
purity’ corresponding to approximately 201 mg/kg bw per day for males and 234 mg/kg bw per day
for females for 13 weeks. The animals were fed the diet until a steady-state tissue (white adipose)
level of the test compound was achieved which occurred after 14 weeks. The steady-state tissue level
was evaluated by sacriﬁcing eight animals (four of each sex) at approximately 3-week intervals and
analysing the white adipose tissue level. After the steady-state tissue level was attained, the remaining
animals were fed a control diet. After the steady-state tissue level was attained, the remaining animals
were fed a control diet and groups of eight animals (four of each sex) were sacriﬁced at week 14, 15,
16, 18, 22 and 30 in order to determine the toxicokinetic elimination of the test compound by
analysing blood, liver, kidney and white adipose tissue. In this interim report, only the content of the
test compound in the white adipose tissue was reported. The average ingested doses of the test
compound from the start of the study to the end of week 14 were approximately 201 mg/kg bw per
day for males and 234 mg/kg bw per day for females. The content of the test compound in the white
adipose tissue increased with time until the steady-state concentration was achieved at week 13;
females had an almost twofold higher content than males (males: 961  395 lg MCCP/g adipose
tissue; females: 1726  236 lg MCCP/g adipose tissue). After the switch to the control diet, there was
an initial (weeks 15–18) rapid elimination of the test compound from the white adipose tissue; initial
half-life of approximately 4 weeks. Then the elimination rate decreased markedly between weeks 18
and 22, and appeared to be almost stable between weeks 22 and 30.
The formation of sulfur-containing metabolites of an MCCP has been studied in rats (Ahlman et al.,
1986). Bile duct-cannulated Sprague–Dawley rats (four females) were injected with 1-chloro-polychloro
[U-14C]hexadecane (14C-PCHD; 65% chlorine by weight) into the portal vein (5–6 mg/kg bw). Bile was
collected for 2 (3 animals) or 3 days (one animal), and the rat was then sacriﬁced and tissues (liver,
kidney, fat, muscle, adrenal, ovary) were removed for measurement of radioactivity; radioactivity was also
determined in bile, urine and faeces. Besides radioactivity determinations also thin-layer chromatography
was carried out to detect potential metabolites. The radioactivity was rapidly excreted in the bile (9–12%
of the administered dose in 24 hours); the excretion rate was constant during 24–48 hours after
administration of the dose, and only declined slightly on day 3 (one rat). The excretion of radioactivity in
urine and faeces (three rats) was low (urine: 0.3–0.5%, faeces: 0.1–0.3% of the administered dose in
48 hours). In the tissues, the liver contained most of the radioactivity, but high concentrations were also
found in the ovary and adrenals. Less than 3% of the total radioactivity excreted in the bile was due to the
parent compound and it was indicated that the MCCP was conjugated to glutathione and N-acetylcysteine
(mercapturic acid). According to the authors, the study indicates that the mercapturic acid pathway is
important in the metabolism of this MCCP, but the ﬁnal identiﬁcation of the metabolites requires further
studies.
A.1.3. LCCPs
As part of an oral repeated dose toxicity study in rats with an LCCP, there was an assessment of
toxicokinetics (IRDC, 1984d, see also Section 3.1.2.2.3). F344 rats (25 animals/sex per group) were
administered 100 or 3,750 mg/kg bw per day of an LCCP (C22–26, 43% chlorination) daily by gavage
for 13 weeks. After 13 weeks, groups of animals received a single oral dose of a 14C-labelled LCCP (a
43.2% chlorinated pentacosane C25) by gavage, same dose level as received daily in the previous
weeks. Other groups of animals (18 animals/sex per group), which were not treated previously with
the LCCP, also received a single oral dose of the 14C-labelled LCCP by gavage at 100 or 3,750 mg/kg
bw. Following administration of the radiolabelled test substance, three animals per sex from each dose
level were placed in metabolism cages and urine, faeces and exhaled air were collected for 12 h or
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7 days. Additional groups of three animals per sex from each dose level were kept for 24 or 48 hours,
28 or 90 days following administration of the radiolabelled test substance and at the end of 12 hours,
7, 28 or 90 days samples of tissues (adipose, brain, gonads, heart, kidney and liver) were collected
from designated surviving animals. In addition, samples of whole blood were collected from the orbital
sinus prior to sacriﬁce of animals at 12, 24 and 48 h and 7 days. Faecal excretion was the main route
of elimination and mainly during the ﬁrst two days with only insigniﬁcant amounts thereafter. Only
insigniﬁcant amounts of radioactivity were detected in urine and exhaled air. The concentrations of
radioactivity in blood were similar between the two dose levels regardless of sex and dosing regimen.
The highest initial concentration of radioactivity was found in the liver. In adipose tissue, the
concentration increased between 7 and 28 days and then declined only slightly by 90 days. The
concentration in ovaries was higher than in the adipose tissue after 12 h and 7 days, but was
comparable with that in the adipose tissue at 28 days.
As part of a dietary repeated dose toxicity study in rats with a higher chlorinated LCCP, there was
also an assessment of toxicokinetics (IRDC, 1984e, see also Section 3.1.2.2.3). F344 rats were
administered 100 or 3,750 mg/kg bw per day of Electroﬁne S70 (C22–26, 70% chlorination) daily in the
diet for 13 weeks. The animal species, dosing regimens and sample collection in the TK part of
the study were identical to those described above for the 43.2% chlorinated LCCP, except for that the
radiolabelled test material was a 70% chlorinated pentacosane. Almost all the radioactivity was
excreted in the faeces irrespective of the sex, dose and dosing regimen. Only insigniﬁcant amounts of
radioactivity were detected in urine and exhaled air. The concentrations of radioactivity in blood were
greater in high-dose animals. A similar difference was also noted for tissue concentrations of
radioactivity. The highest initial concentration of radioactivity was found in the liver. In adipose tissue,
the concentration increased slowly after dosing with only a little decline by 90 days. The concentration
in ovaries was generally similar or lower than in other tissues.
An oral absorption study was carried out with an LCCP (Yang et al., 1987). Three female Sprague–
Dawley rats (3–6 months old) were given a single oral dose of a 14C-labelled C18-chlorinated parafﬁn
(50–53% chlorination) at 500 mg/kg bw. Urine and faeces were collected at 24, 48, 72 and 96 h after
dosing and the animals were then sacriﬁced four days after dosing and tissues (liver, kidneys,
stomach, small intestine, large intestine, urinary bladder, brain, heart, lung, spleen, muscle, bone
(femur), gonads, retroperitoneal fat and residual carcass) were removed for measurement of
radioactivity. Additionally, faeces were extracted and subjected to thin-layer chromatography to
separate the parent compound from the metabolites; the metabolites were not characterised. A total
of 24.7% of the applied dose was recovered in the excreta at 24 h after dosing followed by more
gradual increases to reach an average of 86.2% at 96 h after dosing. Signiﬁcantly higher radioactivity
was excreted in the faeces (76.4% of the dose) than in exhaled air (4.5%) and urine (1.9%) at 96 h
after dosing; approximately 20% of the radioactivity in the faeces (approximately 16% of the dose)
was identiﬁed as the parent LCCP. Approximately 3.3% of the dose was recovered in the tissues at
96 hours after dosing, primarily in the liver, intestines and fat.
A.2. Studies in mice
A.2.1. SCCPs
The disposition of three SCCP was studied in mice (Darnerud et al., 1982). Female C57B1 mice
were administered a single oral dose or a single dose by i.v. injection of two different terminally 14C-
labelled 1-chloro-polychloro-1-14C-dodecanes (SCCP-I, chlorinated at the 14C-atom but otherwise
randomly, (C11H18.1Cl4.9)-
14CH2Cl, 55.9% chlorination by weight, number of chlorine atoms/mol = 5.9;
and SCCP-II, chlorinated at the 14C-atom but otherwise randomly, (C11H14.2Cl8.8)-
14CH2Cl, 68.5%
chlorination by weight, number of chlorine atoms/mol = 9.8) or a monochlorododecane (SCCP-III,
chlorinated only at the 14C-atom, H3C-(CH2)10-
14CH2Cl, 17.4% chlorination by weight, number of
chlorine atoms/mol = 1). Distribution of the three SCCPs following oral administration was investigated
using WBA in one mouse (SCCP-I, SCCP-III) or two mice (SCCP-II), and following i.v. injection in three
to ﬁve mice and in either one or two pregnant mice. Determination of radioactivity in liver and fat, as
well as in exhaled air, urine and faeces was performed in four animals per SCCP. In the
autoradiography part of the study, uptake of radioactivity at 24 h after administration (oral and i.v.
injection) was seen in tissues with high cell turnover/high metabolic activity, e.g. intestinal mucosa,
bone marrow, salivary glands and thymus (most pronounced for SCCP-III, less for SCCP-I and weak
for SCCP-II). The liver and intestinal contents contained most radioactivity in animals administered
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SCCP-II. Radioactivity was also observed in white fat, as well as in bile and urine. At 4–12 days after
i.v. injection, the radioactivity was most prominent in the liver and white fat; radioactivity was still
present in bile and urine. At 30–60 days after i.v. injection, the authors reported that a considerable
retention of radioactivity was seen in the central nervous system for SCCP-III and SCCP-I, but not for
SCCP-II. Radioactivity was still present in the liver and white fat, in the fat marked for SCCP-II and
weak for SCCP-III. Autoradiograms from pregnant mice of late gestation (day 16 or 17) showed that
the distribution of radioactivity within the fetuses was similar with the distribution in adult mice. The
radioactivity in the fetuses was most pronounced for SCCP-III and only weak for SCCP-II. The tissue
retention part of the study showed a marked labelling in the liver and fat at 24 h after oral
administration of SCCP-I and SCCP-II; at 30 days, the radioactivity was minimal in the liver but still
high in the fat. For SCCP-I, 67% of the administered radioactivity was recovered 12 h after oral
administration with 33% as 14CO2 in exhaled air, 29% in the urine and 5% in the faeces, whereas for
SCCP-II, only 33% was recovered 12 h after oral administration with 8% as 14CO2 in exhaled air, 4%
in the urine and 21% in the faeces. According to the authors, the uptake of radioactivity in
metabolically active tissues and the formation of 14CO2 are inverse to the degree of chlorination of the
chloroalkanes. And the retention of radioactivity in liver and fat was most marked for the highest
chlorinated CP, i.e. SCCP-II. This means that the metabolic fate of CPs should be discussed on the
basis of chlorine contents (and probably also chain length) and that results from one CP preparation
cannot be considered valid for CPs in general.
The degradation of SCCPs (1-14C-chlorododecanes) to carbon dioxide was studied in mice
(Darnerud, 1984). Before the administration of 1-14C-chlorododecanes), female C57B1 mice were
administered the following substances by i.p. injection for three consecutive days with the last dose
24 h before the start of the study: phenobarbital (60 mg/kg bw, in 0.9% sodium chloride), 3-
methylcholanthrene (80 mg/kg bw, in corn oil), Cereclor S52 (C14–17, 52% chlorination by weight,
1,000 mg/kg bw, in corn oil), Witaclor 149 (C10–13, 49% chlorination by weight, 1,000 mg/kg bw, in
corn oil) and Witaclor 171P (C10–13, 70–72% chlorination by weight, 1,000 mg/kg bw, in corn oil).
Aroclor 1254 (PCB mixture, 54% chlorination by weight, 500 mg/kg bw, in corn oil) was administered
as a single dose 4 days before the administration of 1-14C-chlorododecanes. Piperonyl butoxide
(400 mg/kg bw, in corn oil) and metyrapone (100 mg/kg bw, in 0.9% sodium chloride) were
administered as single doses 30 minutes before the administration of 1-14C-chlorododecanes. The
vehicles as above were given to control mice. Groups of mice, pretreated as described above, were
then given by i.v. injection the following radiolabelled substances: two different 1-chloro-polychloro-
1-14C-dodecanes (PCDD-I, chlorinated at the 14C-atom but otherwise randomly, (C11H18.1Cl4.9)-
14CH2Cl,
55.9% chlorination by weight, number of chlorine atoms/mol = 5.9; and PCDD-II, chlorinated at the
14C-atom but otherwise randomly, (C11H14.2Cl8.8)-
14CH2Cl, 68.5 chlorination by weight, number of
chlorine atoms/mol = 9.8)), a 1-monochloro-1-14C-dodecane (MCDD, chlorinated only at the 14C-atom,
H3C-(CH2)10-
14CH2Cl, 17.4% chlorination by weight, number of chlorine atoms/mol = 1), or an
unchlorinated 1-14C-dodecane (DD, H3C-(CH2)10-
14CH3). Pretreatment with inducers of CYP450
(phenobarbital, 3-methylcholanthrene, Aroclor 1254) or technical grade CPs (Cereclor S52, Witaclor
149, Witaclor 171 P) generally had limited effects on the degree of 14CO2-exhalation (results are only
tabulated for PCDD-II in the article, the number of animals per group was in general four).
Pretreatment with CYP450 inhibitors (piperonyl butoxide, metyrapone) decreased the exhalation of
14CO2 considerably when measured as peak
14CO2-exhalation rate (results are only tabulated for PCDD-
II in the article). Presentation of data with piperonyl butoxide (the most effective of the two inhibitors)
showed that the inhibitory effect increased with increasing degree of chlorination of the parafﬁns.
According to the authors, the results indicate a CYP450-dependent degradation of C12-chloroalkanes to
14CO2 in vivo and that the degradation seems to be more important for higher chlorinated parafﬁns.
A.2.2. MCCPs
The distribution and metabolism of a 14C-labelled MCCP was studied in mice (Darnerud and Brandt,
1982). C57B1 mice were administered a terminally 14C-labelled polychlorinated hexadecane (PCHD,
1-14C-C16H30.7Cl3.3, chlorinated at random, 34.1% chlorination by weight. The distribution was
investigated by WBA. Eight females, two males and ﬁve pregnant females were given a single dose by
i.v. injection and three females received a single dose orally. Sacriﬁce of the animals varied in the
groups, from 5 minutes to 30 days. Tissue retention of radioactivity was determined in ﬁve groups
given a single dose by i.v. injection (four females per group) and in ﬁve groups given a single dose orally
(four females per group). One group from each administration route was sacriﬁced at 1 h, 4 h, 24 h,
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4 days and 12 days after administration, respectively; blood and tissue samples from the liver, kidney,
white (abdominal) fat, brown fat and the brain were collected and the radioactivity was measured. Ether
extracts of tissues taken at one hour were separated by thin-layer chromatography (TLC) and localised
autoradiographically. The exhalation of 14C-carbon dioxide was determined in four females given PCHD
by i.v. injection and four females administered PCHD orally. Carbon dioxide was sampled from
15 minutes and until 12 h after administration of the test compounds; urine and faeces were collected
at the end of the experiment (12 h after administration of the test compounds) and the radioactivity
was measured. The autoradiography part of the study showed an initial high uptake of PCHD in tissues
with a high cell turnover rate and/or high metabolic capacity such as the brown fat, intestinal mucosa,
bone marrow and exocrine glands and only a low distribution to the white fat depots independent of the
administration route (no autoradiogram presented in the article). Twenty-four hours after i.v. injection,
the highest radioactivity was seen in brown fat, liver, kidneys, spleen, adrenals, bone marrow, Harderian
gland, salivary glands, pancreas and intestinal mucosa. At 12 days after i.v. injection, a high
concentration of radioactivity was seen in the adrenal cortex, abdominal fat and the bile. At 30 days
after i.v. injection, a high concentration of radioactivity was seen in the brain at a similar level to that in
the liver (no autoradiogram presented in the article). Radioactivity was seen in fetuses on GD10 and at
GD17 the distribution pattern was partly similar to that observed in adult mice. The tissue retention part
of the study showed measurable radioactivity in all tissues examined (blood, liver, kidney, white and
brown fat, and brain). The radioactivity in the tissues was generally higher following i.v. injection. For
liver and kidneys, peak levels were observed at four hours. The highest levels were measured in brown
fat and to a lesser extent in white fat and these tissue levels declined much more slowly than in the liver
and kidney. No data were presented for the brain. TLC of samples taken from the liver, kidney and
brown fat revealed a radiolabelled substance with the same retention value as the reference parent
compound (PCHD), indicating that the PCHD was distributed to these tissues without further
metabolism. The exhalation part of the study showed that 33% of the administered radioactive dose
was eliminated as 14C-carbon dioxide within 12 hours after oral administration; about 6.5% was
eliminated in the urine and about 14% in the faeces. According to the authors, the PCHD is, at least
partly, metabolised and eliminated in mice. But it is also emphasised that the results in this speciﬁc
study are valid only for this PCHD and should not be taken as general for all CP preparations.
The disposition of a highly chlorinated MCCP was investigated in mice (Biessmann et al., 1983). Female
C57B1 mice (22 g) were given a single dose of a uniformly 14C-labelled 1-chloro-polychlorohexadecane
(PCHD, C16H20.6Cl13.4, 69% chlorination by weight) orally (4 animals) or by i.v. injection (3 animals).
Exhalation of 14CO2 was during 8 h after administration of PCHD, and urine and faeces were collected
every 8th hour for 4 days, and assayed for radioactivity. For autoradiography one animal was sacriﬁced at
4 hours, and 1, 4, 12 and 30 days after the administration of PCHD. The autoradiography part of the study
showed high radioactivities in bile, liver, kidney and intestinal contents up to 24 h after oral administration.
In addition, the corpora lutea showed a high uptake of radioactivity up to 30 days after dosing. A long
retention in fat was also seen. The elimination of radioactivity in urine was about 1% during 8 h and about
3% during 96 h after both oral and i.v. administration. The elimination in faeces during 8 h was about
22% and 2% after oral and i.v. administration, respectively, and about 66% and 43% during 96 h. The
elimination in exhaled air was about 1%.
The distribution of radioactivity in the brain of a highly chlorinated MCCP has been studied in pre-
weaning mice (Eriksson and Darnerud, 1985, as cited in EU-RAR, 2008). NMRI mice (aged 3, 10 or
20 days old; six and two animals per group for tissue retention and autoradiography, respectively)
were administered a single oral dose of a 14C-labelled PCHD (C16, 69% chlorination) by gavage.
Animals were sacriﬁced one and seven days after administration of PCHD. The only quantitative
determinations of levels of radioactivity made were for the brain and liver. The autoradiography part of
the study showed high levels of radioactivity in adipose tissue, adrenals and in myelinated areas of the
brain in 10-day-old mice (no data were presented for 3- or 20-day-old mice). The tissue retention part
of the study showed a level of radioactivity in the brain of approximately 3% of the dose administered
in 3-day-old mice and approximately 0.5% in 20-day-old mice, at 24 hours after administration of
PCHD. For mice of each age, the level of radioactivity was lower at seven days compared to 24 h in
both brain and liver samples.
A.2.3. LCCPs
No studies on the toxicokinetics of LCCPs in mice have been identiﬁed.
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Appendix B – Detailed description of the toxicokinetic studies in farm
animals
The studies on the toxicokinetics of CPs in farm animals (poultry and ﬁsh) included in
Section 3.1.1.3 are described in more detail in this Appendix.
B.1. Studies in poultry
Chickens/hens
SCCPs
The tissue distribution of an SCCP was investigated in broiler chickens (Uebersch€ar and Matthes,
2004). Male ‘Lohmann meat’ broiler chickens (1 day old) were given diets supplemented with an SCCP
(C10–13, 60% chlorination) in concentrations of 0 (48 animals), 2 (eight animals), 20 (eight animals),
45 (eight animals), 70 (eight animals) and 100 mg/kg bw (48 animals) for 31 days. The SCCP
concentrations in abdominal fat (0.36, 1.32, 10.0, 19.4, 27.3, 38.5 mg/kg ww), breast meat (0.02,
0.07, 0.06, 0.16, 0.15, 0.20 mg/kg ww), liver (0.03, 0.10, 0.22, 0.35, 0.54, 0.60 mg/kg ww) and
kidneys (0.05, 0.11, 0.28, 0.42, 0.67. 0.79 mg/kg ww) were related linearly to the SCCP concentration
of the feed. The highest contents were recovered in abdominal fat with lower contents in liver and
kidneys and the lowest contents in blood, meat and bile.
The tissue distribution, accumulation and elimination kinetics of an SCCP were investigated in laying
hens (Uebersch€ar et al., 2007). Laying hens of the ‘Lohmann selected Leghorn’ strain (24 weeks old)
were given diets supplemented with an SCCP (C10–13, 60% chlorination) in concentrations of 0 (21
animals), 2 (nine animals), 20 (nine animals), 45 (nine animals), 70 (nine animals) and 100 mg/kg bw
(36 animals) for 8 weeks. To follow-up the decrease of the SCCP concentrations in the tissues, and to
describe the elimination kinetics, a withdrawal study was started with additional 15 birds from the
high-dose group at the end of experiment (8th week of the experiment), in total 24 hens. Three
animals were slaughtered on days 1, 2, 4, 8, 14, 21, 28 and 42 after the study started; in the control
group three animals were slaughtered on days 14, 28 and 42. At the end of the experiment (32 weeks
of age), tissue samples were pooled from nine animals of each group, a mixed sample of eggs (yolk
and albumen) from nine animals of each group was prepared, and excreta from ﬁve birds of each
group were collected. To follow the increase in SCCP concentrations in eggs, samples of yolk and
albumen pooled from ten eggs from different birds of the control group and the high-dose group were
analysed on nine speciﬁc dates from the beginning until the end of the experiment. The SCCP
concentrations in the tissues were linearly related to the SCCP concentration of the feed. The highest
SCCP concentrations were found in abdominal fat (0.13, 0.74, 2.02, 4.25, 7.92, 11.1 mg/kg ww), egg
yolk (0.03, 0.14, 1.00, 1.98, 4,43, 6,37 mg/kg ww) and liver (0.02, 0.07, 0.17, 0.37, 0.73, 0.97 mg/kg
ww), whereas breast muscle (0.03, 0.04, 0.07, 0.06, 0.10, 0.45 mg/kg ww), egg albumen and bile
contained minimal or no residues. The kinetic part of the study revealed a biphasic elimination with
half-lives of 4–40 minutes in the liver, kidneys, legs, fat and blood for the initial rapid phase, and 15–
30 days in blood, fat, liver, yolk, kidneys and legs for the terminal slow phase.
MCCPs
No studies on the toxicokinetics of MCCPs in broiler chicken/hens have been identiﬁed.
LCCPs
No studies on the toxicokinetics of LCCPs in broiler chicken/hens have been identiﬁed.
Quail
SCCPs and MCCPs
The distribution and metabolism of an SCCP and an MCCP were studied in Japanese quail
(Biessmann et al., 1982). Female laying Japanese quail (165 g) were given a single oral dose by
gavage of either a 14C-labelled SCCP (C12H20.1Cl5.9, 55.9% chlorination by weight, chlorinated at
random but all 14C positions chlorinated) or a 14C-labelled MCCP (C16H30.7Cl3.3, 34.1% chlorination by
weight, chlorinated at random). For whole-body autoradiography, individual animals were sacriﬁced at
1 and 4 hours, and 1, 4 and 12 days after dosing. Four animals at each survival time were taken for
radioactivity measurements of 14C in selected organs (not further speciﬁed). Additionally, the ﬁrst 10
eggs laid by the quail from the 12-day group were collected, separated into shell, albumen and yolk,
Chlorinated parafﬁns in feed and food
www.efsa.europa.eu/efsajournal 168 EFSA Journal 2020;18(3):5991
and assayed for radioactivity. Solvent partitioning was carried out with pooled tissue samples (fat, yolk,
uropygial gland, kidney, oviduct) of each quail of each survival time. Exhaled air was collected from
four quail after 15 minutes, 30 minutes and then every hour up to 8 h and measured for 14CO2; urine
and faeces were collected after 8 h. WBA showed high radioactivity levels in tissues with high
metabolic activity and high cell turnover rate (liver, intestinal mucosa, spleen, bone marrow and
oviduct) up to 1 day after exposure; high levels were also seen in the gall bladder and the kidney, as
well as in lipid-rich tissues such as the outer layers of the yolk of the growing follicles and in the
uropygial gland epithelium. There was also a high uptake of radioactivity in the eggshells and, to a
lesser extent, in the albumen. In the fat, radioactivity increased with time. At 4 and 8 days after
exposure, the highest radioactivity was observed in fat, the yolk of the follicles and in the uropygial
gland. The distribution patterns of the SCCPs and the MCCPs were almost identical after all exposure
times. The quantitative radioactivity measurements in selected organs revealed a higher amount of
radioactivity in the gall bladder and kidney with the SCCP compared with the MCCP, whereas the
opposite was seen in the yolk of the follicles. The radioactivity in the tissues declined steadily during
12 days after dosing, whereas the decline in the lipid-rich tissues (e.g. fat, uropygial gland, follicle
yolk) was comparably slower. In the egg yolk and albumen, the concentration of the SCCP was about
half of the MCCP. The partition quotients in heptane/water of fat, yolk and uropygial gland showed a
similar increase during the exposure time for both CPs, whereas the quotients in dimethyl formamide/
heptane were considerably higher with SCCP compared with MCCP, particularly in the body fat.
Following dosing with the MCCP, the exhalation of 14CO2 was about twice (38.8%) that of the SCCP
(21.6%). The excretion of radioactivity in urine and faeces (combined) was also higher following
dosing with MCCP (13.5%) compared with SCCP (9.8%). In eggs, the radioactivity in yolk, albumen
and eggshells following dosing with MCCP was about twice that of the SCCP. The results of this study
showed a higher distribution of the CPs to lipid-rich tissues. Quantitative differences were observed in
the rate of metabolism of the CPs depending on the chain length and/or the degree of chlorination
and high chlorination seemed to favour the retention in fatty tissues as the parent compound.
The disposition of a highly chlorinated MCCP was investigated in Japanese quail (Biessmann et al.,
1983). Female Japanese quail were given a single dose of a uniformly 14C-labelled 1-chloro-
polychlorohexadecane (PCHD, C16H20.6Cl13.4, 69% chlorination by weight) orally or by i.v. injection. For
assessment of elimination in excreta, urine and faeces were collected every 8th hour during 4 days,
and assayed for radioactivity. For whole-body autoradiography, one animal was sacriﬁced at 4 hours,
and 1, 4, 12 and 30 days after the administration. The elimination of radioactivity in urine and faeces
combined was about 2% and 17% during 8 h after oral and i.v. injection, respectively, and about 58%
during 96 hours after oral administration (elimination after i.v. administration was not determined).
The elimination in exhaled air was about 1%. The autoradiographic distributions showed high
radioactivities in bile, liver, kidney and intestinal contents up to 24 h after dosing. In addition, high
radioactivity was observed in the hypophysis, retina, blood and egg yolk. After 12 days, radioactivity
was only observed in the lipid-rich tissues (fat, uropygial gland, egg yolk) and in the liver.
LCCPs
No studies on the toxicokinetics of LCCPs in quail have been identiﬁed.
B.2. Studies in ﬁsh
SCCPs
Bioaccumulation of an SCCP from food was studied in rainbow trout (Salmo Gairdneri Richardson)
(Lombardo et al., 1975). Fingerling rainbow trout were fed a diet containing Chlorowax 500C50 at
10 mg/kg for up to 82 days. Samples of 20 experimental and 10 control ﬁsh were collected at 22, 30,
58, 72 and 82 days for residue analysis. The analysis was carried out on the whole ﬁsh, but without
head, tail and viscera. SCCP residues ranging from 0.5 to 1.1 mg/kg were observed when expressed
on a tissue basis, 11 to 18 mg/kg when expressed on a fat basis.
MCCPs
Distribution of an MCCP was studied in carp and bleak (Darnerud et al., 1983). Carp (Cyprinus
carpio) (body weight 370–415 g) and bleak (Alburnus alburnus) (body weight 4.5–5.5 g) were injected
50 Chlorowax 500C was an SCCP product with a predominant carbon chain length range of C10-12 and an average of 50%
chlorine by weight (information provided by EuroChlor to EFSA).
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(intra-arterial) with a polychloro-1-14C-hexadecane (PCHD, 34% chlorination by weight). Excreted
14CO2 was collected from three carp at 4, 24, 72 and 96 hours after injection. Whole-body
autoradiography was performed in one carp sacriﬁced 1, 5 and 13 days after dosing. Ten bleaks were
exposed during 14 days to PCHD added to the tank water and two ﬁsh were removed after 24 hours
and 14 days of exposure; the remaining ﬁsh were transferred to clean water and two of these ﬁsh
were removed after 24 hours, and 7 and 35 days. In carp, the cumulated excretion of 14CO2 during
96 hours amounted to 6.4% of the injected radioactivity. Autoradiography of the carp showed a high
concentration of labelled substance in the bile and intestinal contents. One day after dosing, the
highest radioactivity appeared in the kidney, liver, nasal mucosa and fat and was still dominating
5 days after dosing and a marked uptake was also observed in gills, testis and brain; tissue levels were
generally lower 13 days after dosing. In the bleak, a marked uptake of radioactivity was noted in gills,
nasal cavity, skin, liver and fat after one day of exposure; a high level was also present in the brain,
bile and intestinal contents. A similar distribution pattern was seen after 14 days of exposure, as well
as in ﬁsh allowed to recover for 1, 7 and 35 days.
LCCPs
Uptake of two different LCCPs from food was studied in the Atlantic salmon (Zitko, 1974). Juvenile
Atlantic salmon (Salmo salar) (20 ﬁsh per tank) were fed with dry ﬁsh food containing Cereclor 4251
and Chlorez 70052 at concentrations of 10 and 100 lg/g for up to 181 days followed by a control diet
for 74 days. At times one ﬁsh from each tank was sacriﬁced and analysed. The analysis was carried
out on the whole ﬁsh. The two CPs did not accumulate in the ﬁsh.
Bioaccumulation of an LCCP was studied in rainbow trout and mussels (Madeley and Birtley, 1980).
Rainbow trout (Salmo gairdneri) and mussels (Mytilus edulis) were administered diets uniformly mixed
with Cereclor 42 (C20–30, 42% chlorination). A
14C centrally labelled pentacosane (C25, 42%
chlorination) allowed concentrations of CP to be followed in food and animal tissues. Fish (40
individuals) were fed diets containing average concentrations for 47 and 385 mg/kg for 35 days; a
control group was fed the same but uncontaminated diet. Subsequently, all ﬁsh were fed the control
diet for a further 49 days. Mussels received dry baker’s yeast dosed with a mean concentration of
524 mg/kg before suspension in freshwater for addition to the test tanks for 47 days; a control group
received untreated yeast. Subsequently, all mussels received untreated yeast for a further 56 days.
Test and control animals were sampled regularly during the feeding with dosed food, as well as after
substitution with uncontaminated diet (six mussels and three ﬁsh at each sampling time) and dissected
into appropriate tissue and organs for determination of radioactivity. The LCCP was found in the
tissues of both ﬁsh and mussels. Comparison of the LCCP concentration in tissues suggested that
mussels eliminated the LCCP as the parent compound whereas the ﬁsh appeared to metabolise the
test compound.
Studies with SCCPs, MCCPs and LCCPs
Structure related uptake of three SCCPs, one MCCP and one LCCP when added to tank water was
studied in bleak (Bengtsson et al., 1979). Bleak (Alburnus alburnus L) were caught in the Baltic Sea
and acclimated to laboratory conditions during three to ﬁve months. The ﬁsh (15 ﬁsh/group, average
weight of 4.5 g) were exposed during 14 days to the CP test solutions (125 lg/L) added to the tank
water (natural Baltic Sea water) and renewed every second or third day. The CP test solutions included
Witaclor 149 (C10–13, 49% chlorination), Witaclor 159 (C10–13, 9% chlorination), Witaclor 171P (C10–13,
71% chlorination), Witaclor 350 (C14–17, 50% chlorination) and Witaclor 549 (C18–26, 49%
chlorination). The ﬁsh were not fed during the experiments. Five ﬁsh were sampled from each of the
six groups and placed in uncontaminated Baltic Sea water, which was renewed with the same
frequency as the test solutions. Additional samples of ﬁsh were taken after one and seven days in the
uncontaminated water. A clear relation between the structure of the CPs and their uptake in the ﬁsh
was seen with a short-chain length and a low level of chlorination being the most effective form for
uptake among the tested CPs.
Uptake and elimination of two SCCPs and one LCCP from food was studied in bleak (Bengtsson and
Ofstad, 1982). Bleak (Alburnus alburnus) were caught in the Baltic Sea and kept in brackish water
51 Cereclor 42 is an LCCP product with a predominantly C20-30 range and an average chlorination level of 42% by weight
(information provided by EuroChlor to EFSA).
52 Chlorez 700 is an LCCP product with a predominant range of C20-28 and an average of 70% chlorine by weight (information
provided by EuroChlor to EFSA).
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from the bay. The ﬁsh (30 ﬁsh/group, average weight of 4 g) were exposed to CP-treated food every
day for 91 days (accumulation period) and then the same food, without the CPs, was given for
316 days (elimination period). The CPs included Witaclor 149 (C10–13, 49% chlorination, three different
concentrations: 590, 2,500, 5,800 lg/g food), Witaclor 171P (C10–13, 71% chlorination, 3,180 lg/g
food) and Witaclor 549 (C18–26, 49% chlorination, 3,400 lg/g food). The content of CPs in the ﬁsh was
determined in three ﬁsh (pooled sample, whole-body measurements) from each of the test groups and
three ﬁsh from the control group. Samples were taken on days 14, 28, 56 and 91 of the accumulation
period and on days 7, 35 and 133 of the elimination period. For Witaclor 149, there was a direct
correlation between the amount of CP in the food and the level of organic chlorine found in the ﬁsh
tissues during the ﬁrst 56 days. During the next 5 weeks, a steep increase in tissue levels of organic
chlorine was observed in the low-dose and mid-dose, while levels in the high-dose ﬁsh were
unchanged. When the data were transformed to indicate efﬁciency in uptake and retention about 45%
of the CP given to the low-dose ﬁsh was found in the ﬁsh tissues after 91 days, whereas for the mid-
dose and high-dose ﬁsh retention was about 10% and 5%, respectively, indicating a less effective
uptake and/or a more effective metabolism of the CP with increasing concentrations in food. The levels
of Witaclor 149 decreased rapidly during the elimination period. For Witaclor 171P, the bioaccumulation
pattern was similar to the mid-dose Witaclor 149 group. The uptake was fairly constant during the
whole accumulation period. At the end of the accumulation period the uptake from food was around
6%. A high retention was observed and this CP remained in the ﬁsh tissues on a steady level until the
end of the elimination period. For Witaclor 549, the uptake was inefﬁcient with only about 2% by the
end of the accumulation period. During the elimination period, about 50% was excreted within 4–
5 weeks, whereas the remaining 50% did not seem to be excreted during the subsequent 40 weeks.
Accumulation of one SCCP and two MCCPs when added to tank water was studied in rainbow trout
(Darnerud et al., 1989). Rainbow trout (Salmo gairdneri) (15–25 g, four ﬁsh per group) were exposed
during 7 days to PCHD-L (1-chloro-polychloro-[U-14C]hexadecane, 23.1% chlorination by weight,
3.64 lmol), PCHD-M (1-chloro-polychloro-[U-14C]hexadecane), 51.4% chlorination by weight,
3.64 lmol) and PCDD-H (1-chloro-polychloro-[1-14C]dodecane, 68.5% chlorination by weight,
1.74 lmol) added to the newly changed water. Fish were removed for whole-body autoradiography
after 24 hours and 7 days of exposure. The remaining ﬁsh were transferred to clean water and
removed after 7 or 21 days. After 24 hours exposure to PCHD-L, the highest radioactivities were found
in the contents of the gall bladder, pyloric caeca and intestines; a pronounced uptake of radioactivity
was also observed in the olfactory organs and gills whereas the labelling of the liver, kidney and skin
was low. At 7 days, the uptake in the olfactory organs and gills was less marked; the concentration of
radioactivity in fat tissue had increased. After 7 and 21 days in clean water, the distribution pattern
were similar to that found after 7 days in contaminated water; the olfactory organs and the gills still
retained radioactivity. After 24 hours exposure to PCHD-M, the distribution pattern was almost similar
to that observed for PCHD-L, including the selective uptake in the olfactory organs and gills; however,
the liver was comparably more labelled after PCHD-M exposure. After 7 days in PCHD-M-containing
water the uptake in the ﬁsh was also generally the same as for PCHD-L. However, the uptake in fat
seemed more accentuated for PCHD-M and the accumulation of radioactivity in fatty tissues was even
more prominent at later time points, although the highest radioactivity was still observed in the bile
and intestinal contents, while the olfactory organs and gills only contained low concentrations of
radioactivity. For PCDD-H, high uptake was initially observed in the liver, olfactory organs, gills, skin
and kidneys. At longer exposure times the radioactivity decreased in the olfactory organs, gills and
skin, while the radioactivity in fat steadily increased. At the end of the experiment radioactivity was
mainly present in fat, intestinal contents, liver and bile.
Bioaccumulation, metabolism and tissue distribution following dietary administration of two SCCPs
and two MCCPs was studied in the rainbow trout (Fisk et al., 1996). Juvenile rainbow trout
(Oncorhynchus mykiss) (initial weights of 2–7 g) were fed diets with two different SCCPs (C12H20Cl6,
56% chlorination by weight; C12H16Cl10, 69% chlorination by weight) and two different MCCPs
(C16H31Cl3, 35% chlorination by weight; C16H21Cl13, 69% chlorination by weight) for 40 days. The daily
rate of feeding was equal to 1.5% of the mean weight of the rainbow trout, corrected after each
sampling period. The dietary concentrations were 20 and 200 ng/g for each CP, and also 2,000 ng/g
for C16H21Cl13. The feeding period was followed by 160 days (C12H20Cl6, C12H16Cl10, C16H31Cl3) or
173 days (C16H21Cl13) of depuration. Fifty ﬁsh were used in the control tank and the three C16H21Cl13
treatments, and 36 ﬁsh were used in the other treatments. From each treatment group three ﬁsh were
taken for determination 14C radioactivity on days 5, 10, 20, 30 and 40 of the uptake period and on
days 5, 10, 20, 40, 80 and 160 (or 173 for C16H21Cl13 treatments) of the depuration period. In
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addition, six ﬁsh from the C16H21Cl13 high-concentration treatment group were given the MCCP-spiked
food for 80 days to follow the uptake for a longer exposure period. The ﬁsh were separated into liver,
gastrointestinal (GI) tract and carcass (i.e. whole ﬁsh minus liver and GI tract) and each part was
weighed and analysed for 14C radioactivity. All four CPs accumulated in the ﬁsh by day 5 of the uptake
phase without reaching steady state; the depuration rate in ﬁsh exposed to C16H31Cl3 was signiﬁcantly
more rapid than the depuration rates in ﬁsh exposed to the other three CPs. Whole-body half-lives
varied from 37  2 days in the high-concentration C16H31Cl3 group to 87  11 days in the low-
concentration C12H16Cl10 group. Assimilation efﬁciencies based on whole-body concentrations ranged
from 9.4  1.1% in the mid-concentration C16H21Cl13 group to 37.6  1.1% in the low-concentration
C12H16Cl10 group. Whole-body biomagniﬁcation factors varied from 0.44 in the mid-concentration
C16H21Cl13 group to 2.15 in the low concentration C12H16Cl10 group. It should be noted that the
biomagniﬁcation factors are maximum values as they include 14C-labelled formed metabolites. The
highest percentages of radioactivity were found in the carcass for all four CPs (ranging from 50% to
higher than 70%. Relative amounts in the liver were low (about 1.5% of the total ﬁsh weight). HPLC
chromatograms of extracts indicate that the CPs are metabolised, most pronounced for C12H20Cl6. The
more highly chlorinated SCCP and MCCP showed lower degree of metabolism. According to the
authors, the results of this study indicate that the highly chlorinated SCCP and the lower chlorinated
MCCP have the greatest potential for bioaccumulation by aquatic organisms; however, uptake from the
GI of the highly chlorinated MCCP may have been hindered because of its large molecular size.
Bioaccumulation following dietary administration of CPs was studied in the rainbow trout (Fisk
et al., 1998). Juvenile rainbow trout (Oncorhynchus mykiss) (initial weights of 2–7 g) were fed diets
containing one of 19 different CPs with varying carbon chain length (C10, C11 and C14) and chlorine
content (4–8 chlorine atoms) for 40 days followed by 80 days of depuration. The CONTAM Panel noted
that the CPs used in this study are with known carbon chain length, chlorine content and chlorine
position, but also that the authors clearly stated that although the CPs included in the study have the
same carbon chain lengths and chlorine content as some CPs, all were 1,2-chlorine substituted and
would not likely be prevalent in commercial CPs. Three ﬁsh were sampled from each treatment for 14C
determination on days 5, 10, 20, 30 and 40 of the uptake period and on days 5, 10, 20, 40 and 80 of
the depuration period. Sampled ﬁsh were separated into liver, GI tract and carcass (i.e. whole ﬁsh
minus liver and GI tract). Each tissue (including the carcass) was weighed and analysed for 14C
radioactivity. All of the CPs were detected in the ﬁsh after 5 days of exposure. With the exception of
the C14-CPs, most compounds reached steady state between food and ﬁsh within 30 or 40 days.
Differences in bioaccumulation parameters between CPs with the same molecular formula (C10H15Cl7)
but different chlorine positions were observed for some of the CPs (e.g. C10H15Cl7(a) and
C10H15Cl7(b)), but not for others (C10H17Cl5(a) and C10H17Cl5(b)). The half-lives of the CPs ranged from
7 days for C10H17Cl5 to 53 days for C14H25Cl5, The inﬂuence of adjacent and terminal chlorine
substitution (1,2,9,10-C10, 1,2,10,11-C11 and 1,2,13,14-C14, common to all CPs used in this study) on
the half-lives were, according to the authors, difﬁcult to interpret. There was a large range in the
assimilation efﬁciencies, from 13% for C10H17Cl5(a) to 130% for C10H16Cl6(a) and C14H24Cl6(a).
According to the authors, these results showed that all of the CPs were rapidly accumulated and had
high assimilation efﬁciencies from food, that the half-lives increased with increasing carbon chain
length and chlorine content, indirectly, that the CPs were metabolised in the rainbow trout with the
susceptibility to metabolism decreasing with greater carbon chain length and chlorine content, and
that higher chlorinated C10- and C11-CPs, and all C14-CPs, would biomagnify from food to ﬁsh in
aquatic food chains.
Bioaccumulation and biotransformation following dietary administration of an SCCP, an MCCP and
an LCCP was studied in the rainbow trout (Fisk et al., 2000). Juvenile rainbow trout (Oncorhynchus
mykiss) (initial weights of 1–5 g) were fed diets containing one of three 14C-CPs (C10H15.3Cl6.7,
C14H23.3Cl6.7 and C18H31.4Cl6.6). The daily rate of feeding was equal to 1.5% of the mean weight of the
rainbow trout, corrected after each sampling period. Thirty-six ﬁsh were used in each group. Three
ﬁsh were sampled from each treatment for 14C determination on days 5, 10, 20, 30 and 40 of the
uptake period and on days 5, 10, 20, 40, 80 and 160 of the depuration period. Sampled ﬁsh were
separated into liver, GI tract and carcass (i.e. whole ﬁsh minus liver and GI tract). Each tissue was
weighed, but only the carcass was analysed for 14C radioactivity. Biotransformation of CPs was
examined by comparing toluene extractable and non–toluene extractable 14C radioactivity in the
carcass on day 40 of uptake and on day 40 of depuration. All three CPs accumulated readily from the
food, but without reaching steady state. The uptake curves were similar for all three CPs, and for the
two concentrations. The assimilation efﬁciencies varied from 10 to 22%, except for the high-
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concentration C10H15.3Cl6.7 group (approximately 72%) and were, according to the authors, much
lower than reported assimilation efﬁciencies for other CPs in rainbow trout. Depuration of the CPs
appeared to be a ﬁrst-order process. The half-lives of C18H31.4Cl6.6 (79 and 91 days) were signiﬁcantly
greater than those of the two shorter chain CPs (26–58 days) although a clear pattern was not seen
between the shorter chain CPs or for the concentrations. The biomagniﬁcation factors (BMFs) were
between 0.1 and 1 when calculated from the feeding and depuration rates indicating that these CPs
may not biomagnify in the aquatic food chains, but that food-chain transfer remains an important
route of accumulation in aquatic organisms. The BMFs calculated assuming assimilation efﬁciencies of
50 and 90% resulted in BMFs that were greater than 1 (0.9–2.8) and both exhibited increasing trends
with increasing carbon chain length; these BMFs indicate that the CPs have the potential to biomagnify
in aquatic food chains. The biotransformation evaluation of the CPs showed that on day 40 of uptake,
the percentage of extractable 14C in rainbow trout exposed to the C10H15.3Cl6.7 was less than that in
rainbow trout exposed to longer-chain CPs, indicating greater biotransformation of C10H15.3Cl6.7; the
differences were not as obvious on day 40 of depuration. According to the authors, these results
showed that all three CPs have the potential to biomagnify in aquatic food chains with increasing
trends with increasing carbon chain length and greater biotransformation of the short-chain compared
to the longer chain CPs.
Chlorinated parafﬁns in feed and food
www.efsa.europa.eu/efsajournal 173 EFSA Journal 2020;18(3):5991
Appendix C – BMD modelling of rodent studies
C.1. Introduction
This Appendix contains the details of the BMD modelling performed on experimental animal data.
In this introduction a general description of the approach followed in the modelling is given.
Selection of the BMR
The benchmark dose (BMD) is deﬁned as the estimated dose that corresponds with a predeﬁned
change in response compared with the background response. The benchmark response (BMR) is the
response corresponding with the estimated BMD of interest.
The CONTAM Panel considered the default BMRs of 5% and 10% for continuous and quantal data,
respectively, as indicated in the EFSA guidance on BMD in risk assessment (EFSA Scientiﬁc Committee,
2017a). Deviations from the default BMR were selected on a case-by-case basis and are justiﬁed in the
speciﬁc modelling reports in this Appendix.
A 90% conﬁdence interval around the BMD was estimated, the lower bound is reported by BMDL
and the upper bound by BMDU.
Software used
Results were obtained using the EFSA web-tool for BMD analysis, which used the R-package
PROAST, version 66.38, for the underlying calculations.
Averaging results from multiple ﬁtted benchmark dose models (used only for modelling of quantal
data) is based on the methodology in Wheeler and Bailer (2008).
Speciﬁcation of deviations from default assumptions
No deviations from general assumptions were introduced.
The CONTAM Panel selected the following default models:
Default set of ﬁtted models:
Model Number of parameters Formula
Null 1 y = a
Full no. of groups y ¼ groupmean
Logistic 2 y ¼ 11þexp abxð Þ
Probit 2 y ¼ pnorm x  að Þ  bð Þ
Log-logistic 3 y ¼ aþ 1a
1þexp clog bxð Þð Þ
Log-probit 3 y ¼ aþ 1 að Þ  pnorm c  log xb
  
Weibull 3 y ¼ aþ 1 að Þ 1 exp  xb
 c  
Gamma 3 y ¼ pgamma bx; cð Þ
Two-stage 3 y ¼ aþ 1 að Þ 1 exp  xb c xb
 2  
Exp model 3 3 y ¼ a  exp bxd 
Exp model 5 4 y ¼ a  c  c  1ð Þexp bxd  
Hill model 3 3 y ¼ a  1 xdbdþxd
 
Hill model 5 4 y ¼ a  1þ c  1ð Þ xdbdþxd
 
In the case of quantal data, for the Exp and Hill family, models were ﬁt with 3 and 4 parameters as
listed in the table. The 3-parameter model is selected if the difference in AIC is smaller than 5,
otherwise the 4-parameter model is selected.
Procedure for selection of BMDL
BMDL was selected applying the following ﬂow chart given in the EFSA Scientiﬁc Committee
(2017a,b,c) guidance:
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Flow chart for selection of BMDL
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C.2. Incidence of nephritis in male rats exposed to SCCP (C10–12, 58%
chlorination) (IRDC, 1984a)
Data description
The endpoint to be analysed is: increased incidence of nephritis.
Data used for analysis:
Concentration (mg/kg bw per day) Incidence of nephritis N
0 3 15
10 2 15
100 9 15
625 14 15
Selection of the BMR
A default BMR of 10% was selected (EFSA Scientiﬁc Committee, 2017a).
Results
Response variable: increased incidence of nephritis
Fitted Models:
Model No.par loglik AIC accepted BMDL BMDU BMD conv
Null 1 41.46 84.92 NA NA NA NA
full 4 27.17 62.34 NA NA NA NA
two.stage 3 27.99 61.98 yes 12.800 39.2 21.50 yes
log.logist 3 27.44 60.88 yes 4.110 62.3 22.60 yes
Weibull 3 27.84 61.68 yes 1.550 58.3 13.10 yes
log.prob 3 27.42 60.84 yes 4.470 63.4 22.10 yes
gamma 3 27.90 61.80 yes 0.842 64.5 14.00 yes
logistic 2 29.37 62.74 yes 32.000 85.2 52.90 yes
probit 2 29.51 63.02 no NA NA 57.90 yes
LVM: Expon. m3- 3 28.12 62.24 yes 0.592 58.9 8.53 yes
LVM: Hill m3- 3 27.97 61.94 yes 0.976 56.9 10.50 yes
Estimated Model Parameters:
two.stage
estimate for a- : 0.1702
estimate for BMD- : 21.46
estimate for c : 1e-06
log.logist
estimate for a- : 0.1593
estimate for BMD- : 22.58
estimate for c : 1.464
Weibull
estimate for a- : 0.1552
estimate for BMD- : 13.1
estimate for c : 0.8471
log.prob
estimate for a- : 0.1618
estimate for BMD- : 22.14
estimate for c : 0.8319
gamma
estimate for a- : 0.1585
estimate for BMD- : 14
estimate for cc : 0.8121
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logistic
estimate for a- : -1.12
estimate for BMD- : 52.94
probit
estimate for a- : -0.6793
estimate for BMD- : 57.94
EXP
estimate for a- : 1.291
estimate for CED- : 8.53
estimate for d- : 0.4994
estimate for th(ﬁxed) : 0
estimate for sigma(ﬁxed) : 0.25
HILL
estimate for a- : 1.292
estimate for CED- : 10.5
estimate for d- : 0.6013
estimate for th(ﬁxed) : 0
estimate for sigma(ﬁxed) : 0.25
Weights for Model Averaging
two.stage log.logist Weibull log.prob gamma logistic probit EXP HILL
0.1 0.17 0.12 0.18 0.11 0.07 0.06 0.09 0.1
Final BMD Values (mg/kg bw per day):
subgroup BMDL BMDU
2.29 76.4
Conﬁdence intervals for the BMD are based on 500 bootstrap data sets.
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Visualisation:
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C.3. Incidence of thyroid hypertrophy in male rats exposed to SCCP
(C10–12, 58% chlorination) (IRDC, 1984a)
Data description
The endpoint to be analysed is: incidence of thyroid hypertrophy.
Data used for analysis:
Concentration
(mg/kg bw per day)
Incidence of thyroid hypertrophy N
0 3 15
10 4 15
100 5 15
625 14 15
Selection of the BMR
A default BMR of 10% was selected (EFSA Scientiﬁc Committee, 2017a).
Results
Response variable: incidence of thyroid hypertrophy.
Fitted Models:
model No.par loglik AIC accepted BMDL BMDU BMD conv
null 1 41.05 84.10 NA NA NA NA
full 4 29.43 66.86 NA NA NA NA
two.stage 3 29.50 65.00 yes 19.70 181.0 73.0 yes
log.logist 3 29.52 65.04 no NA NA 87.4 yes
Weibull 3 29.51 65.02 no NA NA 79.9 yes
log.prob 3 29.52 65.04 no NA NA 89.0 yes
gamma 3 29.52 65.04 no NA NA 83.5 yes
logistic 2 29.50 63.00 yes 41.50 102.0 65.6 yes
probit 2 29.50 63.00 yes 45.70 98.7 66.7 no
LVM: Expon. m3- 3 29.50 65.00 yes 4.09 395.0 70.1 yes
LVM: Hill m3- 3 29.50 65.00 yes 5.77 370.0 74.4 yes
Estimated Model Parameters:
two.stage
estimate for a- : 0.2266
estimate for BMD- : 72.98
estimate for c : 3.585
log.logist
estimate for a- : 0.2328
estimate for BMD- : 87.36
estimate for c : 2.311
Weibull
estimate for a- : 0.2304
estimate for BMD- : 79.92
estimate for c : 1.528
log.prob
estimate for a- : 0.2333
estimate for BMD- : 89.04
estimate for c : 1.355
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gamma
estimate for a- : 0.2319
estimate for BMD- : 83.51
estimate for cc : 2.034
logistic
estimate for a- : -1.253
estimate for BMD- : 65.55
probit
estimate for a- : -0.763
estimate for BMD- : 66.74
EXP
estimate for a- : 1.208
estimate for CED- : 70.07
estimate for d- : 1.027
estimate for th(ﬁxed) : 0
estimate for sigma(ﬁxed) : 0.25
HILL
estimate for a- : 1.205
estimate for CED- : 74.39
estimate for d- : 1.182
estimate for th(ﬁxed) : 0
estimate for sigma(ﬁxed) : 0.25
Weights for Model Averaging:
two.stage log.logist Weibull log.prob gamma logistic probit EXP HILL
0.08 0.08 0.08 0.08 0.08 0.22 0.22 0.08 0.08
Final BMD Values (mg/kg bw per day):
subgroup BMDL BMDU
15.5 210
Conﬁdence intervals for the BMD are based on 500 bootstrap data sets.
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Visualisation:
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C.4. Increased absolute kidney weight in male and female rats
exposed to SCCP (C10–12, 58% chlorination) (IRDC, 1984a)
Data description
The endpoint to be analysed is: increased absolute kidney weight
Data used for analysis:
Dose(mg/kg bw per day) Absolute kidney weight (g) SD1 N1 Sex(a)
0 1.04 0.080 15 1
10 1.04 0.104 15 1
100 1.14 0.127 15 1
625 1.33 0.104 15 1
0 0.60 0.066 15 2
10 0.63 0.048 15 2
100 0.67 0.055 15 2
625 0.75 0.062 15 2
(a): 1: males. 2: females.
Selection of the BMR
The CONTAM Panel considered the biological relevance of increased absolute and relative kidney
weights. It concluded that the selection of the default BMR of 5% for continuous data is not
appropriate for these endpoints considering also that histopathological changes of only minimal to mild
severity were observed only in some studies and generally at higher doses than those at which
increased kidney weights started to be observed. The Panel concluded that a BMR of 10% is sufﬁcient
to protect towards adverse changes in kidney weights.
Results
Response variable: increased absolute kidney weight.
Fitted models:
model converged loglik npar AIC
full model yes 122.06 9 226.12
full-v yes 122.12 10 224.24
null model yes 24.98 2 53.96
null model-a yes 76.82 3 147.64
Expon. m3- yes 19.01 4 46.02
Expon. m3-a yes 120.48 5 230.96
Expon. m3-ab yes 121.00 6 230.00
Expon. m5-a yes 120.58 6 229.16
Expon. m5-ab yes 121.01 7 228.02
Hill m3-a yes 120.48 5 230.96
Hill m3-ab yes 121.00 6 230.00
Hill m5-a yes 120.58 6 229.16
Hill m5-ab yes 121.01 7 228.02
Estimated Model Parameters:
EXP
estimate for var- : 0.00786
estimate for a-1 : 1.027
estimate for a-2 : 0.5994
estimate for CED- : 92.29
estimate for d- : 0.4817
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HILL
estimate for var- : 0.00786
estimate for a-1 : 1.027
estimate for a-2 : 0.5994
estimate for CED- : 92.27
estimate for d- : 0.4825
Final BMD Values (mg/kg bw per day):
model BMDL BMDU BMD
Expon. m3-a 38.0 186 92.29
Hill m3-a 38.1 186 92.27
Lowest BMDL and highest BMDU Values (mg/kg bw per day):
subgroup bmdl.lowest bmdu.highest
all 38.0 186
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Visualisation:
C.5. Increased relative kidney weight in male and female rats exposed
to SCCP (C10–12, 58% chlorination) (IRDC, 1984a)
Data description
The endpoint to be analysed is: increased relative kidney weight.
Data used for analysis:
Dose(mg/kg bw per day) Relative kidney weight (%) SD2 N2 Sex(a)
0 0.36 0.020 14 1
10 0.36 0.023 15 1
100 0.40 0.018 15 1
625 0.50 0.028 15 1
0 0.38 0.033 15 2
10 0.39 0.024 15 2
100 0.43 0.020 15 2
625 0.48 0.030 15 2
(a): 1: males. 2: females.
Selection of the BMR
The CONTAM Panel considered the biological relevance of increased absolute and relative kidney
weights. It concluded that the selection of the default BMR of 5% for continuous data is not
appropriate for these endpoints considering also that histopathological changes of only minimal to mild
severity were observed only in some studies and generally at higher doses than those at which
increased kidney weights started to be observed. The Panel concluded that a BMR of 10% is sufﬁcient
to protect towards adverse changes in kidney weights.
Results
Response variable: increased relative kidney weight.
Fitted models:
model converged loglik npar AIC
full model yes 168.24 9 318.48
full-v yes 169.12 10 318.24
null model yes 73.11 2 142.22
Chlorinated parafﬁns in feed and food
www.efsa.europa.eu/efsajournal 184 EFSA Journal 2020;18(3):5991
model converged loglik npar AIC
null model-a yes 74.44 3 142.88
Expon. m3- yes 151.91 4 295.82
Expon. m3-a yes 157.60 5 305.20
Expon. m3-b yes 151.92 5 293.84
Expon. m3-ab yes 164.51 6 317.02
Expon. m5- yes 153.08 5 296.16
Expon. m5-a yes 158.86 6 305.72
Expon. m5-b yes 157.93 6 303.86
Expon. m5-ab yes 164.51 7 315.02
Hill m3- yes 151.92 4 295.84
Hill m3-a yes 157.61 5 305.22
Hill m3-b yes 151.93 5 293.86
Hill m3-ab yes 164.51 6 317.02
Hill m5- yes 153.08 5 296.16
Hill m5-a yes 158.86 6 305.72
Hill m5-b yes 157.32 6 302.64
Hill m5-ab yes 164.51 7 315.02
Estimated Model Parameters:
EXP
estimate for var- : 0.003688
estimate for a-1 : 0.3524
estimate for a-2 : 0.3825
estimate for CED-1 : 56.72
estimate for CED-2 : 116.4
estimate for d- : 0.5373
HILL
estimate for var- : 0.003688
estimate for a-1 : 0.3524
estimate for a-2 : 0.3825
estimate for CED-1 : 56.71
estimate for CED-2 : 116.5
estimate for d- : 0.5385
Final BMD Values (mg/kg bw per day):
model subgroup BMDL BMDU BMD
Expon. m3-ab 1 32.6 92.5 56.72
Expon. m3-ab 2 71.0 180.0 116.40
Hill m3-ab 1 32.5 92.4 56.71
Hill m3-ab 2 71.0 180.0 116.50
Lowest BMDL and highest BMDU Values (mg/kg bw per day):
subgroup bmdl.lowest bmdu.highest
CED-1 32.5 92.5
CED-2 71.0 180
Chlorinated parafﬁns in feed and food
www.efsa.europa.eu/efsajournal 185 EFSA Journal 2020;18(3):5991
Visualisation:
C.6. Incidence of kidney nephropathy in male rats exposed to SCCP
(C10–12, 58% chlorination) (IRDC, 1984b)
Data description
The endpoint to be analysed is: kidney nephropathy incidence.
Data used for analysis:
Concentration (mg/kg bw per day) Incidence of kidney nephropathy N
0 0 15
10 0 11
100 1 15
13 15
Selection of the BMR
A default BMR of 10% was selected (EFSA Scientiﬁc Committee, 2017a).
Results
Response variable: kidney nephropathy incidence
Fitted models:
model No.par loglik AIC accepted BMDL BMDU BMD conv
null 1 31.49 64.98 NA NA NA NA
full 4 9.56 27.12 NA NA NA NA
two.stage 3 9.59 25.18 yes 47.5 184 132 yes
log.logist 3 9.57 25.14 yes 57.3 537 120 yes
Weibull 3 9.57 25.14 yes 50.1 611 127 yes
log.prob 3 9.56 25.12 yes 59.5 509 117 yes
gamma 3 9.57 25.14 yes 50.8 452 122 yes
logistic 2 10.10 24.20 yes 133.0 341 222 yes
probit 2 9.98 23.96 yes 123.0 293 195 yes
LVM: Expon. m3- 3 9.57 25.14 yes 51.3 445 121 yes
LVM: Hill m3- 3 9.56 25.12 yes 54.1 430 119 yes
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Estimated Model Parameters:
two.stage
estimate for a- : 1e-06
estimate for BMD- : 132.5
estimate for c : 268.3
log.logist
estimate for a- : 1e-06
estimate for BMD- : 119.9
estimate for c : 2.466
Weibull
estimate for a- : 1e-06
estimate for BMD- : 127.3
estimate for c : 1.855
log.prob
estimate for a- : 1e-06
estimate for BMD- : 116.7
estimate for c : 1.425
gamma
estimate for a- : 1e-06
estimate for BMD- : 122.5
estimate for cc : 2.574
logistic
estimate for a- : -4.254
estimate for BMD- : 221.9
probit
estimate for a- : -2.307
estimate for BMD- : 195.1
EXP
estimate for a- : 4.482
estimate for CED- : 121.3
estimate for d- : 0.2503
estimate for th(ﬁxed) : 0
estimate for sigma(ﬁxed) : 0.25
HILL
estimate for a- : 4.482
estimate for CED- : 118.7
estimate for d- : 0.4698
estimate for th(ﬁxed) : 0
estimate for sigma(ﬁxed) : 0.25
Weights for Model Averaging:
two.stage log.logist Weibull log.prob gamma logistic probit EXP HILL
0.09 0.1 0.1 0.1 0.1 0.15 0.17 0.1 0.1
Final BMD Values (mg/kg bw per day):
subgroup BMDL BMDU
87.2 410
Conﬁdence intervals for the BMD are based on 500 bootstrap data sets.
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Visualisation:
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C.7. Incidence of thyroid hypertrophy in male rats exposed to SCCP
(C10–12, 58% chlorination) (IRDC, 1984b)
Data description
The endpoint to be analysed is: incidence of thyroid hypertrophy.
Data used for analysis:
Concentration(mg/kg bw per day) Incidence of thyroid hypertrophy N
0 7 15
10 8 11
100 8 15
625 15 15
Selection of the BMR
A default BMR of 10% was selected (EFSA Scientiﬁc Committee, 2017a).
Results
Response variable: incidence of thyroid hypertrophy.
Fitted Models:
model No.par loglik AIC accepted BMDL BMDU BMD conv
null 1 35.16 72.32 NA NA NA NA
full 4 27.17 62.34 NA NA NA NA
two.stage 3 28.31 62.62 yes 41.40 165.0 89.7 yes
log.logist 3 28.11 62.22 yes 41.50 529.0 172.0 yes
Weibull 3 28.11 62.22 yes 18.30 608.0 320.0 yes
log.prob 3 28.11 62.22 yes 42.00 550.0 230.0 yes
gamma 3 28.11 62.22 yes 17.10 504.0 242.0 yes
logistic 2 28.97 61.94 yes 15.80 66.8 31.1 yes
probit 2 28.78 61.56 yes 17.00 68.3 33.6 yes
LVM: Expon. m3- 3 28.12 62.24 yes 9.47 345.0 253.0 yes
LVM: Hill m3- 3 28.12 62.24 yes 13.70 334.0 225.0 yes
Estimated Model Parameters:
two.stage
estimate for a- : 0.543
estimate for BMD- : 89.69
estimate for c : 1e+12
log.logist
estimate for a- : 0.561
estimate for BMD- : 172.2
estimate for c : 31.68
Weibull
estimate for a- : 0.561
estimate for BMD- : 320.5
estimate for c : 7.311
log.prob
estimate for a- : 0.561
estimate for BMD- : 229.7
estimate for c : 7.444
gamma
estimate for a- : 0.561
estimate for BMD- : 241.6
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estimate for cc : 40.43
logistic
estimate for a- : 0.02905
estimate for BMD- : 31.15
probit
estimate for a- : 0.02583
estimate for BMD- : 33.58
EXP
estimate for a- : 0.9626
estimate for CED- : 252.8
estimate for d- : 4
estimate for th(ﬁxed) : 0
estimate for sigma(ﬁxed) : 0.25
HILL
estimate for a- : 0.9627
estimate for CED- : 225.1
estimate for d- : 4
estimate for th(ﬁxed) : 0
estimate for sigma(ﬁxed) : 0.25
Weights for Model Averaging:
two.stage log.logist Weibull log.prob gamma logistic probit EXP HILL
0.09 0.11 0.11 0.11 0.11 0.12 0.15 0.11 0.11
Final BMD Values (mg/kg bw per day):
subgroup BMDL BMDU
14.7 195
Conﬁdence intervals for the BMD are based on 1000 bootstrap data sets.
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Visualisation:
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C.8. Incidence of thyroid hyperplasia in male rats exposed to SCCP
(C10–12, 58% chlorination) (IRDC, 1984b)
Data description
The endpoint to be analysed is: incidence of thyroid hyperplasia.
Data used for analysis:
Concentration (mg/kg bw per day) Incidence of thyroid hyperplasia N
0 3 15
10 1 11
100 2 15
625 14 15
Selection of the BMR
A default BMR of 10% was selected (EFSA Scientiﬁc Committee, 2017a).
Results
Response variable: incidence of thyroid hyperplasia
Fitted Models:
model No.par loglik AIC accepted BMDL BMDU BMD conv
null 1 36.50 75.00 NA NA NA NA
full 4 20.42 48.84 NA NA NA NA
two.stage 3 20.93 47.86 yes 95.7 177 129.0 no
log.logist 3 20.74 47.48 yes 64.2 603 399.0 yes
Weibull 3 20.74 47.48 yes 53.8 606 441.0 yes
log.prob 3 20.74 47.48 yes 66.6 611 304.0 yes
gamma 3 20.74 47.48 yes 56.1 515 337.0 yes
logistic 2 21.24 46.48 yes 60.1 145 94.4 yes
probit 2 21.29 46.58 yes 60.4 130 89.5 yes
LVM: Expon. m3- 3 20.74 47.48 yes 46.5 411 372.0 yes
LVM: Hill m3- 3 20.74 47.48 yes 49.7 388 345.0 yes
Estimated Model Parameters:
two.stage
estimate for a- : 0.1326
estimate for BMD- : 129.1
estimate for c : 1e+12
log.logist
estimate for a- : 0.1463
estimate for BMD- : 399.1
estimate for c : 10.4
Weibull
estimate for a- : 0.1463
estimate for BMD- : 441.4
estimate for c : 9.161
log.prob
estimate for a- : 0.1463
estimate for BMD- : 304.1
estimate for c : 3.747
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gamma
estimate for a- : 0.1463
estimate for BMD- : 336.9
estimate for cc : 19.26
logistic
estimate for a- : -2.05
estimate for BMD- : 94.38
probit
estimate for a- : -1.204
estimate for BMD- : 89.47
EXP
estimate for a- : 1.301
estimate for CED- : 371.6
estimate for d- : 4
estimate for th(ﬁxed) : 0
estimate for sigma(ﬁxed) : 0.25
HILL
estimate for a- : 1.301
estimate for CED- : 345.1
estimate for d- : 4
estimate for th(ﬁxed) : 0
estimate for sigma(ﬁxed) : 0.25
Weights for Model Averaging:
two.stage log.logist Weibull log.prob gamma logistic probit EXP HILL
0.08 0.1 0.1 0.1 0.1 0.16 0.16 0.1 0.1
Final BMD Values (mg/kg bw per day):
subgroup BMDL BMDU
45.1 266
Conﬁdence intervals for the BMD are based on 1000 bootstrap data sets.
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Visualisation:
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C.9. Increased absolute kidney weights in male and female rats
exposed to SCCP (C10–12, 58% chlorination) (IRDC, 1984b)
Data description
The endpoint to be analysed is: increased absolute kidney weight
Data used for analysis:
Concentration(mg/kg bw per day) Absolute kidney weight(g) Sex(a)
0 1.82 1
0 1.91 1
0 2.00 1
0 1.74 1
0 1.93 1
0 1.51 1
0 1.79 1
0 1.97 1
0 2.07 1
0 2.06 1
0 1.91 1
0 1.81 1
0 1.93 1
0 1.77 1
0 1.85 1
10 1.78 1
10 1.96 1
10 1.74 1
10 1.88 1
10 1.86 1
10 1.90 1
10 1.78 1
10 1.93 1
10 1.90 1
10 1.97 1
10 1.97 1
10 1.94 1
10 1.83 1
10 2.07 1
10 1.92 1
100 2.00 1
100 2.18 1
100 1.89 1
100 1.98 1
100 2.12 1
100 2.19 1
100 2.36 1
100 2.13 1
100 2.22 1
100 2.22 1
100 2.05 1
100 1.94 1
100 2.15 1
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Concentration(mg/kg bw per day) Absolute kidney weight(g) Sex(a)
100 2.17 1
100 2.36 1
625 2.22 1
625 2.60 1
625 2.63 1
625 2.43 1
625 2.34 1
625 2.21 1
625 2.43 1
625 2.14 1
625 2.04 1
625 2.60 1
625 2.76 1
625 2.22 1
625 2.23 1
625 2.02 1
625 2.74 1
0 1.10 2
0 1.16 2
0 1.25 2
0 1.02 2
0 1.15 2
0 1.21 2
0 1.22 2
0 1.28 2
0 1.39 2
0 1.29 2
0 1.24 2
0 1.11 2
0 1.25 2
0 1.23 2
0 1.14 2
10 1.08 2
10 1.28 2
10 1.17 2
10 1.17 2
10 1.15 2
10 1.29 2
10 1.35 2
10 1.38 2
10 1.30 2
10 1.25 2
10 1.14 2
10 1.13 2
10 1.34 2
10 1.43 2
10 1.12 2
100 1.34 2
100 1.29 2
100 1.33 2
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Concentration(mg/kg bw per day) Absolute kidney weight(g) Sex(a)
100 1.38 2
100 1.15 2
100 1.34 2
100 1.11 2
100 1.22 2
100 1.33 2
100 1.22 2
100 1.35 2
100 1.43 2
100 1.16 2
100 1.29 2
100 1.31 2
625 1.38 2
625 1.41 2
625 1.65 2
625 1.38 2
625 1.54 2
625 1.43 2
625 1.50 2
625 1.60 2
625 1.48 2
625 1.55 2
625 1.17 2
625 1.56 2
625 1.42 2
625 1.58 2
625 1.59 2
(a): 1: males. 2: females.
Selection of the BMR
The CONTAM Panel considered the biological relevance of increased absolute and relative kidney
weights. It concluded that the selection of the default BMR of 5% for continuous data is not
appropriate for these endpoints considering also that histopathological changes of only minimal to mild
severity were observed only in some studies and generally at higher doses than those at which
increased kidney weights started to be observed. The Panel concluded that a BMR of 10% is sufﬁcient
to protect towards adverse changes in kidney weights.
Results
Response variable: absolute kidney weight
Fitted Models:
model converged loglik npar AIC
full model yes 138.87 9 259.74
full-v yes 138.98 10 257.96
null model yes 7.95 2 19.90
null model-a yes 87.70 3 169.40
Expon. m3- yes 0.78 4 9.56
Expon. m3-a yes 136.29 5 262.58
Expon. m3-ab Yes 136.81 6 261.62
Expon. m5-a Yes 136.53 6 261.06
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model converged loglik npar AIC
Expon. m5-ab Yes 138.53 7 263.06
Hill m3-a Yes 136.29 5 262.58
Hill m3-ab Yes 136.81 6 261.62
Hill m5-a Yes 136.53 6 261.06
Hill m5-ab Yes 138.43 7 262.86
Estimated Model Parameters:
EXP
estimate for var- : 0.005819
estimate for a-1 : 1.863
estimate for a-2 : 1.212
estimate for CED-1 : 63.5
estimate for CED-2 : 183.2
estimate for c- : 1.271
estimate for d- : 1.006
HILL
estimate for var- : 0.005828
estimate for a-1 : 1.867
estimate for a-2 : 1.214
estimate for CED-1 : 65.35
estimate for CED-2 : 175.3
estimate for c- : 1.295
estimate for d- : 1.296
Final BMD Values (mg/kg bw per day):
model BMDL BMDU BMD Subgroup(a)
Expon. m5-ab 31.9 109 63.50 1
Expon. m5-ab 85.7 345 183.20 2
Hill m5-ab 31.4 111 65.35 1
Hill m5-ab 83.7 317 175.30 2
(a): 1: males. 2: females.
Lowest BMDL and highest BMDU Values (mg/kg bw per day):
Subgroup(a) bmdl.lowest bmdu.highest
CED-1 31.4 111
CED-2 83.7 345
(a): 1: males. 2: females.
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Visualisation:
C.10. Increased relative kidney weights in male and female rats
exposed to SCCP (C10–12, 58% chlorination) (IRDC, 1984b)
Data description
The endpoint to be analysed is: increased relative kidney weight.
Data used for analysis:
Concentration (mg/kg bw per day) Relative kidney weight (%) Sex(a)
0 0.68 1
0 0.66 1
0 0.73 1
0 0.65 1
0 0.70 1
0 0.63 1
0 0.63 1
0 0.66 1
0 0.72 1
0 0.73 1
0 0.67 1
0 0.68 1
0 0.73 1
0 0.64 1
0 0.67 1
10 0.95 1
10 0.71 1
10 0.74 1
10 0.65 1
10 0.66 1
10 0.67 1
10 0.66 1
10 0.68 1
10 0.68 1
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Concentration (mg/kg bw per day) Relative kidney weight (%) Sex(a)
10 0.71 1
10 0.69 1
10 0.87 1
10 0.69 1
10 0.66 1
10 0.69 1
100 0.75 1
100 0.78 1
100 0.75 1
100 0.70 1
100 0.76 1
100 0.75 1
100 0.82 1
100 0.77 1
100 0.81 1
100 0.75 1
100 0.76 1
100 1.28 1
100 0.80 1
100 0.81 1
625 0.94 1
625 0.95 1
625 0.94 1
625 0.88 1
625 1.26 1
625 0.87 1
625 0.93 1
625 0.80 1
625 0.86 1
625 0.89 1
625 1.02 1
625 0.92 1
625 1.40 1
625 0.83 1
625 1.00 1
0 0.64 2
0 0.73 2
0 0.74 2
0 0.70 2
0 0.76 2
0 0.76 2
0 0.77 2
0 0.73 2
0 0.83 2
0 0.80 2
0 0.78 2
0 0.62 2
0 0.78 2
0 0.76 2
0 0.76 2
Chlorinated parafﬁns in feed and food
www.efsa.europa.eu/efsajournal 200 EFSA Journal 2020;18(3):5991
Concentration (mg/kg bw per day) Relative kidney weight (%) Sex(a)
10 0.71 2
10 0.77 2
10 0.74 2
10 0.71 2
10 0.72 2
10 0.84 2
10 0.86 2
10 0.80 2
10 0.82 2
10 0.76 2
10 0.74 2
10 0.76 2
10 0.81 2
10 0.86 2
10 0.74 2
100 0.94 2
100 1.01 2
100 0.84 2
100 0.82 2
100 0.75 2
100 0.80 2
100 0.72 2
100 0.81 2
100 0.86 2
100 0.74 2
100 0.88 2
100 0.82 2
100 0.78 2
100 0.81 2
625 0.84 2
625 0.84 2
625 0.99 2
625 0.86 2
625 0.88 2
625 0.84 2
625 0.83 2
625 0.95 2
625 0.91 2
625 1.00 2
625 0.76 2
625 1.02 2
625 0.87 2
625 0.97 2
625 0.93 2
NA NA NA
(a): 1: males. 2: females.
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The following outliers were identiﬁed for Expon. m3-abv:
Concentration total.K.rel Se(a)
42 100 1.28 1
57 625 1.40 1
The following outliers were identiﬁed for Hill m3-abv:
Concentration total.K.rel Sex(a)
42 100 1.28 1
57 625 1.40 1
The following outliers were identiﬁed for Inv.Expon. m3-abv:
Concentration total.K.rel Sex(a)
42 100 1.28 1
57 625 1.40 1
The following outliers were identiﬁed for LN m3-abv:
Concentration total.K.rel Sex(a)
42 100 1.28 1
57 625 1.40 1
(a): 1: males. 2: females.
Selection of the BMR
The CONTAM Panel considered the biological relevance of increased absolute and relative kidney
weights. It concluded that the selection of the default BMR of 5% for continuous data is not
appropriate for these endpoints considering also that histopathological changes of only minimal to mild
severity were observed only in some studies and generally at higher doses than those at which
increased kidney weights started to be observed. The Panel concluded that a BMR of 10% is sufﬁcient
to protect towards adverse changes in kidney weights.
Results
Response variable: increased relative kidney weight
Fitted Models:
model converged loglik npar AIC
full model yes 106.72 9 195.44
full-v yes 111.17 10 202.34
null model-v yes 66.78 3 127.56
null model-a-v yes 67.71 4 127.42
Expon. m3-v yes 103.58 5 197.16
Expon. m3-av yes 105.38 6 198.76
Expon. m3-bv yes 103.83 6 195.66
Expon. m3-abv yes 110.89 7 207.78
Expon. m5-v yes 103.65 6 195.30
Expon. m5-av yes 105.45 7 196.90
Expon. m5-bv no 103.82 7 193.64
Expon. m5-abv no 110.85 8 205.70
Hill m3-v yes 103.58 5 197.16
Hill m3-av yes 105.38 6 198.76
Hill m3-bv yes 103.83 6 195.66
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model converged loglik npar AIC
Hill m3-abv yes 110.89 7 207.78
Hill m5-v yes 103.65 6 195.30
Hill m5-av yes 105.45 7 196.90
Hill m5-bv yes 103.82 7 193.64
Hill m5-abv no 110.85 8 205.70
Estimated Model Parameters:
EXP
estimate for var-1 : 0.01325
estimate for var-2 : 0.006029
estimate for a-1 : 0.6713
estimate for a-2 : 0.7455
estimate for CED-1 : 22.67
estimate for CED-2 : 110.7
estimate for d- : 0.394
HILL
estimate for var-1 : 0.01325
estimate for var-2 : 0.006029
estimate for a-1 : 0.6713
estimate for a-2 : 0.7455
estimate for CED-1 : 22.66
estimate for CED-2 : 110.8
estimate for d- : 0.3948
The following outliers were identiﬁed:
model Concentration total.K.rel Sex(a)
42 Expon. m3-abv 100 1.28 1
57 Expon. m3-abv 625 1.40 1
421 Hill m3-abv 100 1.28 1
571 Hill m3-abv 625 1.40 1
(a): 1: males. 2: females.
Final BMD Values (mg/kg bw per day):
Model subgroup BMDL BMDU BMD
Expon. m3-abv 1 5.55 68.6 22.67
Expon. m3-abv 2 40.70 250.0 110.70
Hill m3-abv 1 5.55 68.3 22.66
Hill m3-abv 2 40.80 250.0 110.80
Lowest BMDL and highest BMDU Values (mg/kg bw per day):
subgroup bmdl.lowest bmdu.highest
CED-1 5.55 68.6
CED-2 40.7 250
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Visualisation:
C.11. Increased absolute kidney weight in male and female rats
exposed to Cereclor S52 (C14–17, 52% chlorination) (CXR
Biosciences Ltd, 2005b)
Data description
The endpoint to be analysed is: increased absolute kidney weight
Data used for analysis:
Dose(mg/kg bw per day) Absolute kidney weight(g) SD3 N Sex(a)
0.0 1.913 0.207 20 1
2.4 1.881 0.162 10 1
9.3 1.890 0.162 10 1
23.0 1.970 0.145 10 1
222.0 2.076 0.201 10 1
0.0 1.217 0.108 20 2
2.5 1.197 0.116 10 2
9.7 1.260 0.097 10 2
24.6 1.271 0.111 10 2
242.0 1.380 0.078 10 2
(a): 1: males. 2: females.
Selection of the BMR
The CONTAM Panel considered the biological relevance of increased absolute and relative kidney
weights. It concluded that the selection of the default BMR of 5% for continuous data is not
appropriate for these endpoints considering also that histopathological changes of only minimal to mild
severity were observed only in some studies and generally at higher doses than those at which
increased kidney weights started to be observed. The Panel concluded that a BMR of 10% is sufﬁcient
to protect towards adverse changes in kidney weights.
Results
Response variable: increased absolute kidney weight
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Fitted Models:
model converged loglik npar AIC
full model yes 125.36 11 228.72
full-v yes 125.78 12 227.56
null model yes 2.64 2 1.28
null model-a yes 112.54 3 219.08
Expon. m3- yes 4.04 4 0.08
Expon. m3-a yes 123.78 5 237.56
Expon. m3-ab yes 124.11 6 236.22
Expon. m5-a yes 124.14 6 236.28
Expon. m5-ab yes 124.36 7 234.72
Hill m3-a yes 123.78 5 237.56
Hill m3-ab yes 124.11 6 236.22
Hill m5-a yes 124.17 6 236.34
Hill m5-ab yes 124.41 7 234.82
Estimated Model Parameters:
EXP
estimate for var- : 0.00744
estimate for a-1 : 1.878
estimate for a-2 : 1.215
estimate for CED- : 172.8
estimate for d- : 0.5665
HILL
estimate for var- : 0.00744
estimate for a-1 : 1.878
estimate for a-2 : 1.215
estimate for CED- : 172.8
estimate for d- : 0.5668
Final BMD Values (mg/kg bw per day):
model BMDL BMDU BMD
Expon. m3-a 81.5 364 172.8
Hill m3-a 81.5 364 172.8
Lowest BMDL and highest BMDU Values (mg/kg bw per day):
subgroup bmdl.lowest bmdu.highest
all 81.5 364
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Visualisation:
C.12. Increased relative kidney weight in male and female rats
exposed to Cereclor S52 (C14–17, 52% chlorination) (CXR
Biosciences Ltd, 2005b)
Data description
The endpoint to be analysed is: increased relative kidney weight
Data used for analysis:
Dose(mg/kg bw per day) Relative kidney weight(%) SD4 N Sex(a)
0.0 0.559 0.035 20 1
2.4 0.567 0.027 10 1
9.3 0.565 0.029 10 1
23.0 0.576 0.026 10 1
222.0 0.627 0.028 10 1
0.0 0.584 0.025 20 2
2.5 0.612 0.045 10 2
9.7 0.607 0.036 10 2
24.6 0.622 0.037 10 2
242.0 0.679 0.026 10 2
(a): 1: males. 2: females.
Selection of the BMR
The CONTAM Panel considered the biological relevance of increased absolute and relative kidney
weights. It concluded that the selection of the default BMR of 5% for continuous data is not
appropriate for these endpoints considering also that histopathological changes of only minimal to mild
severity were observed only in some studies and generally at higher doses than those at which
increased kidney weights started to be observed. The Panel concluded that a BMR of 10% is sufﬁcient
to protect towards adverse changes in kidney weights.
Results
Response variable: increased relative kidney weight
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Fitted Models
model converged loglik npar AIC
full model yes 186.37 11 350.74
full-v yes 186.38 12 348.76
null model yes 138.84 2 273.68
null model-a yes 151.05 3 296.10
Expon. m3- yes 165.25 4 322.50
Expon. m3-a yes 184.54 5 359.08
Expon. m3-ab yes 184.94 6 357.88
Expon. m5-a yes 184.53 6 357.06
Expon. m5-ab yes 184.94 7 355.88
Hill m3-a yes 184.54 5 359.08
Hill m3-ab yes 184.94 6 357.88
Hill m5-a yes 184.53 6 357.06
Hill m5-ab yes 184.94 7 355.88
Estimated Model Parameters:
EXP
estimate for var- : 0.002703
estimate for a-1 : 0.5536
estimate for a-2 : 0.5902
estimate for CED- : 116.3
estimate for d- : 0.4601
HILL
estimate for var- : 0.002703
estimate for a-1 : 0.5536
estimate for a-2 : 0.5902
estimate for CED- : 116.2
estimate for d- : 0.4605
Final BMD Values (mg/kg bw per day):
model BMDL BMDU BMD
Expon. m3-a 68.0 182 116.3
Hill m3-a 67.9 182 116.2
Lowest BMDL and highest BMDU Values (mg/kg bw per day):
subgroup bmdl.lowest bmdu.highest
all 67.9 182
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Visualisation:
C.13. Increased absolute kidney weight (left) in male and female rats
exposed to Cereclor S52 (C14–17, 52% chlorination) (IRDC, 1984c)
Data description
The endpoint to be analysed is: increased absolute kidney weight
Data used for analysis:
Dose(mg/kg bw per day) Absolute kidney weight(g) SD1 N Sex(a)
0 0.95 0.066 15 1
10 0.93 0.153 15 1
100 1.01 0.065 15 1
625 1.08 0.098 15 1
0 0.61 0.057 14 2
10 0.62 0.042 15 2
100 0.65 0.047 14 2
625 0.72 0.055 15 2
(a): 1: males. 2: females.
Selection of the BMR
The CONTAM Panel considered the biological relevance of increased absolute and relative kidney
weights. It concluded that the selection of the default BMR of 5% for continuous data is not
appropriate for these endpoints considering also that histopathological changes of only minimal to mild
severity were observed only in some studies and generally at higher doses than those at which
increased kidney weights started to be observed. The Panel concluded that a BMR of 10% is sufﬁcient
to protect towards adverse changes in kidney weights.
Results
Response variable: increased absolute kidney weight
Fitted Models:
model converged loglik npar AIC
full model yes 117.67 9 217.34
full-v yes 120.26 10 220.52
null model-v yes 17.74 3 29.48
null model-a-v yes 94.59 4 181.18
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model converged loglik npar AIC
Expon. m3-v yes 33.81 5 57.62
Expon. m3-av yes 118.83 6 225.66
Expon. m3-abv yes 118.95 7 223.90
Expon. m5-av yes 119.34 7 224.68
Expon. m5-abv yes 119.59 8 223.18
Hill m3-av yes 118.83 6 225.66
Hill m3-abv yes 118.95 7 223.90
Hill m5-av yes 119.34 7 224.68
Hill m5-abv yes 119.59 8 223.18
Estimated Model Parameters:
EXP
estimate for var-1 : 0.01072
estimate for var-2 : 0.005635
estimate for a-1 : 0.928
estimate for a-2 : 0.609
estimate for CED- : 231.5
estimate for d- : 0.525
HILL
estimate for var-1 : 0.01071
estimate for var-2 : 0.005635
estimate for a-1 : 0.928
estimate for a-2 : 0.609
estimate for CED- : 231.4
estimate for d- : 0.5255
Final BMD Values (mg/kg bw per day):
Model BMDL BMDU BMD
Expon. m3-av 101.0 418 231.5
Hill m3-av 101.0 417 231.4
Lowest BMDL and highest BMDU Values (mg/kg bw per day):
subgroup bmdl.lowest bmdu.highest
all 101 418
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Visualisation:
C.14. Increased relative kidney weight (left) in male and female rats
exposed to Cereclor S52 (C14–17, 52% chlorination) (IRDC, 1984c)
Data description
The endpoint to be analysed is: increased relative kidney weight.
Data used for analysis:
Dose(mg/kg bw per day) Relative kidney weight(%) sd2 n Cov(a)
0 0.35 0.021 15 1
10 0.35 0.054 15 1
100 0.38 0.031 15 1
625 0.42 0.022 15 1
0 0.36 0.054 14 2
10 0.38 0.026 15 2
100 0.40 0.025 14 2
625 0.45 0.027 15 2
(a): 1: males. 2: females.
Selection of the BMR
The CONTAM Panel considered the biological relevance of increased absolute and relative kidney
weights. It concluded that the selection of the default BMR of 5% for continuous data is not
appropriate for these endpoints considering also that histopathological changes of only minimal to mild
severity were observed only in some studies and generally at higher doses than those at which
increased kidney weights started to be observed. The Panel concluded that a BMR of 10% is sufﬁcient
to protect towards adverse changes in kidney weights.
Results
Response variable: increased relative kidney weight
Fitted Models:
model converged loglik npar AIC
full model yes 116.04 9 214.08
full-v yes 116.09 10 212.18
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model converged loglik npar AIC
null model yes 77.55 2 151.10
null model-a yes 80.96 3 155.92
Expon. m3- yes 109.00 4 210.00
Expon. m3-a yes 114.67 5 219.34
Expon. m3-b yes 113.01 5 216.02
Expon. m3-ab yes 114.81 6 217.62
Expon. m5- yes 109.09 5 208.18
Expon. m5-a yes 114.80 6 217.60
Expon. m5-b yes 113.63 6 215.26
Expon. m5-ab yes 114.95 7 215.90
Hill m3- yes 109.00 4 210.00
Hill m3-a yes 114.67 5 219.34
Hill m3-b yes 113.01 5 216.02
Hill m3-ab yes 114.81 6 217.62
Hill m5- yes 109.09 5 208.18
Hill m5-a yes 114.80 6 217.60
Hill m5-b yes 113.67 6 215.34
Hill m5-ab yes 114.95 7 215.90
Estimated Model Parameters:
EXP
estimate for var- : 0.008384
estimate for a-1 : 0.342
estimate for a-2 : 0.3625
estimate for CED- : 102.5
estimate for d- : 0.4394
HILL
estimate for var- : 0.008384
estimate for a-1 : 0.342
estimate for a-2 : 0.3625
estimate for CED- : 102.5
estimate for d- : 0.4401
Final BMD Values (mg/kg bw per day):
model BMDL BMDU BMD
Expon. m3-a 36.4 224 102.50
Hill m3-a 36.4 223 102.50
Lowest BMDL and highest BMDU Values (mg/kg bw per day):
subgroup bmdl.lowest bmdu.highest
all 36.4 224
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Visualisation:
C.15. Pup mortality in rats, from dams exposed to Cereclor S52 (C14–17,
52% chlorination) (IRDC, 1985)
Data description
The endpoint to be analysed is: pup mortality at post-natal day (PND) 21.
The following data on pup survival at PND 21 were considered:
Dose(mg/kg bw per day) Number of born pups at PND 0 Number of pups surviving at PND 21
0 127 99
9 131 125
90 136 116
560 141 0
Data used for analysis:
Dose(mg/kg bw per day) Pup mortality n
0 11 110(a)
9 6 131
90 20 136
560 124 124(a)
(a): 17 pups/group were euthanised on PND10 and were therefore excluded from the analysis.
Selection of the BMR
Considering the severity of the effect, the CONTAM Panel selected a BMR of 5%, lower than the
default BMR of 10% recommended for quantal data. From a statistical point of view the high study
population (> 100 pups per dose group) supported the selection of a lower BMR.
Results
Response variable: pup mortality
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Fitted Models:
model No.par loglik AIC accepted BMDL BMDU BMD conv
null 1 314.57 631.14 NA NA NA NA
full 4 116.91 241.82 NA NA NA NA
two.stage 3 119.61 245.22 no NA NA 55.8 yes
log.logist 3 118.25 242.50 yes 69.1 101.0 86.2 yes
Weibull 3 118.25 242.50 yes 53.4 112.0 83.8 yes
log.prob 3 118.25 242.50 yes 69.4 100.0 84.6 yes
gamma 3 118.25 242.50 yes 61.9 104.0 82.4 yes
logistic 2 120.04 244.08 yes 37.9 57.9 46.8 yes
probit 2 120.04 244.08 yes 35.5 53.3 43.6 yes
LVM: Expon. m3- 3 118.25 242.50 yes 44.4 123.0 81.3 yes
LVM: Hill m3- 3 118.25 242.50 yes 49.2 117.0 81.0 yes
Estimated Model Parameters:
two.stage
estimate for a- : 0.06357
estimate for BMD- : 55.77
estimate for c : 1e+12
log.logist
estimate for a- : 0.07054
estimate for BMD- : 86.25
estimate for c : 12.53
Weibull
estimate for a- : 0.07054
estimate for BMD- : 83.82
estimate for c : 7.245
log.prob
estimate for a- : 0.07054
estimate for BMD- : 84.62
estimate for c : 4.142
gamma
estimate for a- : 0.07054
estimate for BMD- : 82.38
estimate for cc : 11.63
logistic
estimate for a- : -2.865
estimate for BMD- : 46.82
probit
estimate for a- : -1.609
estimate for BMD- : 43.58
EXP
estimate for a- : 1.445
estimate for CED- : 81.32
estimate for d- : 4
estimate for th(ﬁxed) : 0
estimate for sigma(ﬁxed) : 0.25
HILL
estimate for a- : 1.445
estimate for CED- : 80.96
estimate for d- : 4
estimate for th(ﬁxed) : 0
estimate for sigma(ﬁxed) : 0.25
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Weights for Model Averaging:
two.stage log.logist Weibull log.prob gamma logistic probit EXP HILL
0.04 0.14 0.14 0.14 0.14 0.06 0.06 0.14 0.14
Final BMD Values (mg/kg bw per day):
subgroup BMDL BMDU
53 96.5
Conﬁdence intervals for the BMD are based on 500 bootstrap data sets.
Chlorinated parafﬁns in feed and food
www.efsa.europa.eu/efsajournal 214 EFSA Journal 2020;18(3):5991
Visualisation:
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C. 16. Combined incidence of haematoma/haemorrhage in rats, from
dams exposed to Cereclor S52 (C14–17, 52% chlorination)
(IRDC, 1985)
Data description
The endpoint to be analysed is: Combined incidence of haematoma/haemorrhage on pups found
dead by post-natal day (PND) 21.
Data used for analysis:
Dose(mg/kg bw per day) Combined incidence of haematoma/haemorrhage N(a)
0 0 15
9 0 4
90 9 17
560 64 64
(a): Necropsy performed on dead pups at PND10. Additional pups from the control and high-dose groups were euthanised on
PND 10 and included in the necropsy analysis.
Selection of the BMR
Considering the association of this effect with the decreased pup survival observed in the study, the
CONTAM Panel considered applying the same BMR of 5% selected for the dose–response analysis of
pup mortality (see Section C.11). The Panel noted that in this case the selection of a lower BMR is less
justiﬁed from a statistical point of view considering the low study number of animals evaluated in some
dose groups.
Results
Response variable: Combined incidence of haematoma/haemorrhage
Fitted Models:
model No.par loglik AIC accepted BMDL BMDU BMD conv
null 1 58.33 118.66 NA NA NA NA
full 4 11.75 31.50 NA NA NA NA
two.stage 3 11.78 29.56 no NA NA 23.5 yes
log.logist 3 11.75 29.50 yes 16.10 84.5 63.8 yes
Weibull 3 11.75 29.50 yes 3.05 82.2 62.9 yes
log.prob 3 11.75 29.50 yes 12.60 87.5 53.4 yes
gamma 3 11.75 29.50 yes 2.34 79.3 51.7 yes
logistic 2 11.75 27.50 yes 18.40 79.1 76.0 yes
probit 2 11.75 27.50 yes 16.00 77.6 55.5 no
LVM: Expon. m3- 3 11.75 29.50 yes 2.30 84.6 64.5 yes
LVM: Hill m3- 3 11.75 29.50 yes 4.33 80.8 50.8 yes
Estimated Model Parameters:
two.stage
estimate for a- : 1e-06
estimate for BMD- : 23.52
estimate for c : 1e+12
log.logist
estimate for a- : 1e-06
estimate for BMD- : 63.81
estimate for c : 8.904
Weibull
estimate for a- : 1e-06
estimate for BMD- : 62.91
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estimate for c : 7.505
log.prob
estimate for a- : 1e-06
estimate for BMD- : 53.42
estimate for c : 3.295
gamma
estimate for a- : 1e-06
estimate for BMD- : 51.7
estimate for cc : 11.57
logistic
estimate for a- : -19.53
estimate for BMD- : 75.98
probit
estimate for a- : -4.399
estimate for BMD- : 55.46
EXP
estimate for a- : 4.482
estimate for CED- : 64.53
estimate for d- : 1
estimate for th(ﬁxed) : 0
estimate for sigma(ﬁxed) : 0.25
HILL
estimate for a- : 4.48
estimate for CED- : 50.81
estimate for d- : 1.037
estimate for th(ﬁxed) : 0
estimate for sigma(ﬁxed) : 0.25
Weights for Model Averaging:
two.stage log.logist Weibull log.prob gamma logistic probit EXP HILL
0.08 0.08 0.08 0.08 0.08 0.22 0.22 0.08 0.08
Final BMD Values (mg/kg bw per day):
subgroup BMDL BMDU
48.5 63.8
Conﬁdence intervals for the BMD are based on 500 bootstrap data sets.
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Visualisation:
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Appendix D – Summary statistics of the occurrence submitted to EFSA
Data set A53
Table D.1: Mean levels of ‘Alkanes, C10–13, chloro’ (SCCP) (lg/kg fat weight)
FOODEX1 Level 2 N % LC MEAN (LB) MEAN (UB)
Bread and rolls 1 0 88 88
Vegetables and vegetable products 1 100 0.0 500
Fruit and fruit products 1 0 1,000 1,000
Livestock meat 4 50 13 21
Poultry 3 67 3.3 11
Edible offal, farmed animals 4 75 5.9 22
Sausages 1 0 28 28
Fish meat 12 42 6.9 24
Crustaceans 1 0 39 39
Liquid milk 3 100 0.0 24
Cheese 5 100 0.0 4.0
Eggs, fresh 6 100 0.0 9.1
Animal fat 1 0 1.4 1.4
Fish oil 1 0 25 25
SCCPs: short-chain chlorinated parafﬁns; LB: lower bound; UB: upper bound; N: number of samples; % LC: percentage of left-
censored data.
Table D.2: Mean levels of ‘Alkanes, C14–17, chloro’ (MCCP) (lg/kg fat weight)
FOODEX1 Level 2 N % LC MEAN (LB) MEAN (UB)
Bread and rolls 1 0 167 167
Vegetables and vegetable products 1 100 0.0 500
Fruit and fruit products 1 100 0.0 500
Livestock meat 4 50 83 92
Poultry 3 67 5.3 13
Edible offal, farmed animals 4 50 31 40
Sausages 1 0 54 54
Fish meat 12 33 23 38
Crustaceans 1 0 19 19
Liquid milk 3 100 0.0 24
Cheese 5 60 3.2 5.3
Eggs, fresh 6 100 0.0 9.1
Animal fat 1 0 3.4 3.4
Fish oil 1 0 72 72
MCCPs: medium-chain chlorinated parafﬁns; LB: lower bound; UB: upper bound; N: number of samples; % LC: percentage of
left-censored data.
53 Further details about Data set A can be found in Section 2.2 and Section 3.2.1 where also Data set B is described.
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Annex A – Occurrence data in food submitted to EFSA and dietary
exposure assessment for humans
Annex A can be found as a separate document and also available on the EFSA Knowledge Junction
community on Zenodo at: http://doi.org/10.5281/zenodo.3689718
Description: This Annex is an excel ﬁle which presents tables on chlorinated parafﬁns on
occurrence data in food and dietary exposure assessment for humans.
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